Sentence,class,file
"edu Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Brannon and Hadjifrangiskou Running head recto: Antivirulence therapeutics: current perspectives DOI: http://dx.doi.org/10.2147/DDDT.S98939",Non-OADS,/arxiv_data1/oa_pdf/84/cc/dddt-10-1795.PMC4890686.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/84/cc/dddt-10-1795.PMC4890686.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/84/cc/dddt-10-1795.PMC4890686.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/92/79/bctt-8-117.PMC4890687.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/92/79/bctt-8-117.PMC4890687.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Breast Cancer - Targets and Therapy 2016:8 117–124Breast Cancer - Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 117 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BCTT .S106097The absence of aldehyde dehydrogenase   1 A1-positive cells in benign mammary stroma is  associated with risk factors for breast cancer Björn Logi Isfoss1–3  Bo Holmqvist1,4  Helena Jernström1  Per Alm1  Håkan Olsson1,5 1Department of Oncology and  Pathology, Department of Clinical  Sciences Lund, Lund University,   2Department of Pathology, Skane  University Hospital, Lund, Sweden;   3Department of Pathology, T elemark  Hospital, Skien, Norway; 4ImaGene-iT  AB, Medicon Village, 5Division of  Cancer Epidemiology, Department of Clinical Sciences, Lund University,  Lund, SwedenAbstract: In this study, aldehyde dehydrogenase 1 (ALDH1)-expressing cells in stroma  of histologically normal breast tissue from premenopausal women were investigated in situ  regarding cellular morphology, cell distribution, and relation to the additional stem cell mark- ers, CD44 (+ ) and CD24 (–).",Non-OADS,/arxiv_data1/oa_pdf/92/79/bctt-8-117.PMC4890687.pdf
"ALDH1+ cells in breast carcinoma tissue have also been  found to be associated with adverse prognosis.3,4 However, to date, very few studies Correspondence: Björn Logi Isfoss   Department of Pathology, Telemark  Hospital, 3710 Skien, Norway   Tel +47 47 65 4101   Email isfoss@mac.comJournal name: Breast Cancer - Targets and Therapy Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Isfoss et alRunning head recto: ALDH1 + stromal cells and risk for mammary cancer DOI: http://dx.doi.org/10.2147/BCTT.S106097",Non-OADS,/arxiv_data1/oa_pdf/92/79/bctt-8-117.PMC4890687.pdf
"Breast Cancer - Targets and Therapy 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Breast Cancer - Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/breast-cancer---targets-and-therapy-journal Breast Cancer - Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven-tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/92/79/bctt-8-117.PMC4890687.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 124 Isfoss et al,Non-OADS,/arxiv_data1/oa_pdf/92/79/bctt-8-117.PMC4890687.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8e/21/nss-8-163.PMC4890688.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/8e/21/nss-8-163.PMC4890688.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Nature and Science of Sleep 2016:8 163–180Nature and Science of Sleep Dovepress submit your manuscript | www.dovepress.com Dovepress  163 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NSS.S78946Circadian regulation of metabolic homeostasis:  causes and consequences Graham R McGinnis Martin E Y oung Division of Cardiovascular Disease,   Department of Medicine, University of Alabama at Birmingham, Birmingham,  AL, USAAbstract: Robust circadian rhythms in metabolic processes have been described in both  humans and animal models, at the whole body, individual organ, and even cellular level.",Non-OADS,/arxiv_data1/oa_pdf/8e/21/nss-8-163.PMC4890688.pdf
"Correspondence: Martin E Young Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, 703 19th Street South, ZRB 308, Birmingham, AL 35294, USATel +1 205 934 2328Fax +1 205 975 5104Email meyoung@uabmc.eduJournal name: Nature and Science of Sleep Article Designation: REVIEWY ear: 2016V olume: 8Running head verso: McGinnis and Y oungRunning head recto: Circadian regulation of metabolismDOI: http://dx.doi.org/10.2147/NSS.S78946",Non-OADS,/arxiv_data1/oa_pdf/8e/21/nss-8-163.PMC4890688.pdf
"Nature and Science of Sleep 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Nature and Science of Sleep Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/nature-and-science-of-sleep-journalNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine, including the neurophysiology and functions of sleep, the genetics of sleep, sleep and society, biological rhythms, dreaming, sleep disorders and therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/8e/21/nss-8-163.PMC4890688.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/84/d0/copd-11-1129.PMC4890689.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1129–1137International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1129OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10328 1relationship between plasma matrix  metalloproteinase levels, pulmonary function,  bronchodilator response, and emphysema severity hyeon-Kyoung Koo1 Y oonki hong2 Myoung nam lim2 Jae-Joon Yim3 Woo Jin Kim2 1Department of Internal Medicine,   Division of Pulmonary and Critical  Medicine, Ilsan Paik hospital, Inje  University College of Medicine,   goyang, 2Department of Internal  Medicine and environmental health  Center, Kangwon national University,   Chuncheon-si, 3Department of  Internal Medicine and lung Institute,   Division of Pulmonary and Critical  Care Medicine, seoul national  University College of Medicine,   seoul,  republic of KoreaObjective:  Chronic obstructive pulmonary disease (COPD) is characterized by chronic  inflammation in the airway and lung.",Non-OADS,/arxiv_data1/oa_pdf/84/d0/copd-11-1129.PMC4890689.pdf
"Both animal and human studies have  shown that several MMPs are elevated in sputum, bronchoalveolar lavage (BAL), and  lung tissue specimens from animals and patients with COPD.3–9 However, it should  be noted that there were some inconsistencies between animal and human data.10–12  It is known that MMPs are activated by various different stimuli, including cigarette  smoking and oxidative stress.13–15 The aim of the current study was to determine  whether plasma MMP levels, especially MMP-1, MMP-8, MMP-9, and MMP-12,  are correlated with COPD disease activity, as measured with pulmonary function,  emphysema severity, pulmonary artery (PA) pressure, and quality of life using data Correspondence: Woo Jin Kim Department of Internal Medicine and  environmental health Center, Kangwon  national University College of Medicine,  Baengnyeong-ro 156, Chuncheon-si,  gangwon-do, 24289, republic of Korea Tel +82 33 258 9364 Fax +82 33 258 9299 email wjkim47@gmail.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Koo et al Running head recto: The role of MMPs in COPD DOI: http://dx.doi.org/10.2147/COPD.S103281",Non-OADS,/arxiv_data1/oa_pdf/84/d0/copd-11-1129.PMC4890689.pdf
"Available  from: http://www.goldcopd.or g. Accessed December, 2014.",Non-OADS,/arxiv_data1/oa_pdf/84/d0/copd-11-1129.PMC4890689.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/84/d0/copd-11-1129.PMC4890689.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/84/d0/copd-11-1129.PMC4890689.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d7/ad/amep-7-309.PMC4890690.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d7/ad/amep-7-309.PMC4890690.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 309–310Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 309 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S107189 Improving patient safety in cardiothoracic  surgery:  an audit of surgical handover in a tertiary  center Natasha Johan Bauer Department of Cardiothoracic  Surgery, Royal Brompton Hospital,  London, UKBackground: Novel research has revealed that the relative risk of death increased by 10% and  15% for admissions on a Saturday and Sunday, respectively.",Non-OADS,/arxiv_data1/oa_pdf/d7/ad/amep-7-309.PMC4890690.pdf
"1 With the imminent threat of increasing working hours and  shift-work patterns, a thorough and efficient handover has a pivotal role in ensuring patient safety is paramount.Journal name: Advances in Medical Education and Practice Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: BauerRunning head recto: Improving patient safety in cardiothoracic surgery DOI: http://dx.doi.org/10.2147/AMEP .S107189 Correspondence: Natasha Johan Bauer   Department of Cardiothoracic Surgery,   Royal Brompton Hospital, Sydney Street,  London SW3 6NP, UKTel +44 7703 804 650Email natashabauer@doctors.org.uk",Non-OADS,/arxiv_data1/oa_pdf/d7/ad/amep-7-309.PMC4890690.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/d7/ad/amep-7-309.PMC4890690.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 310 Bauer Materials and methods Ethical approval was not required for this research at the Royal  Brompton Hospital.,Non-OADS,/arxiv_data1/oa_pdf/d7/ad/amep-7-309.PMC4890690.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/67/7a/rmhp-9-075.PMC4890691.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/67/7a/rmhp-9-075.PMC4890691.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Risk Management and Healthcare Policy 2016:9 75–85Risk Management and Healthcare Policy Dovepress submit your manuscript | www.dovepress.com Dovepress 75 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RMHP .S99908Information security risk management for  computerized health information systems in  hospitals: a case study of Iran Javad Zarei1  Farahnaz Sadoughi2 1Health Information Management,   Health Management and Economics  Research Center, School of Health Management and Information Science,  Iran University of Medical Sciences,  T ehran, Islamic Republic of Iran,   2Health Information Management  Department, School of Health Management and Information Science,  Iran University of Medical Sciences,  T ehran, Islamic Republic of IranBackground: In recent years, hospitals in Iran – similar to those in other countries – have  experienced growing use of computerized health information systems (CHISs), which play a  significant role in the operations of hospitals.",Non-OADS,/arxiv_data1/oa_pdf/67/7a/rmhp-9-075.PMC4890691.pdf
"10Correspondence: Farahnaz Sadoughi   Department of Health Information  Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, No 6, Rashidi Yasemi Street, Vali-e Asr   Avenue, Tehran 1995614111, Islamic Republic of Iran Tel +98 21 8879 4302   Fax +98 21 8888 3334   Email Sadoughi.f@iums.ac.irJournal name: Risk Management and Healthcare Policy Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Zarei and SadoughiRunning head recto: Information security risk managementDOI: http://dx.doi.org/10.2147/RMHP .S99908",Non-OADS,/arxiv_data1/oa_pdf/67/7a/rmhp-9-075.PMC4890691.pdf
"Available from: https://www.enisa.europa.eu/topics/threat-risk-management/risk-management.Accessed March 11, 2014.",Non-OADS,/arxiv_data1/oa_pdf/67/7a/rmhp-9-075.PMC4890691.pdf
Available from: http://www.bbc.com/news/technology-12465688.,Non-OADS,/arxiv_data1/oa_pdf/67/7a/rmhp-9-075.PMC4890691.pdf
"The Security Officers Management and Analysis Project (SOMAP .org); 2007:1–35, Available from: http://download.matus.in/security/Open%20Information%20Security%20Risk%20Assessment%20Guide_v1.0.0.pdf.",OADS,/arxiv_data1/oa_pdf/67/7a/rmhp-9-075.PMC4890691.pdf
"France: ANSSI; 2014 [cited October 1, 2014].Available from: http://www.ssi.gouv.fr/uploads/2011/10/EBIOS-1-GuideMethodologique-2010-01-25.pdf.",Non-OADS,/arxiv_data1/oa_pdf/67/7a/rmhp-9-075.PMC4890691.pdf
"Risk Management and Healthcare Policy 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/risk-management-and-healthcare-policy-journalRisk Management and Healthcare Policy is an international, peer-reviewed,  open access journal focusing on all aspects of public health, policy, and preventative measures to promote good health and improve morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/67/7a/rmhp-9-075.PMC4890691.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 85 Information security risk management  59.,Non-OADS,/arxiv_data1/oa_pdf/67/7a/rmhp-9-075.PMC4890691.pdf
Available from: http://www.27000.org/index.htm.,Non-OADS,/arxiv_data1/oa_pdf/67/7a/rmhp-9-075.PMC4890691.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9f/79/ppa-10-957.PMC4890692.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 957–965Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  957OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9218 3Obesity, knee osteoarthritis, and polypathology:  factors favoring weight loss in older people Pilar isla Pera1 Ma carmen Olivé Ferrér1 Montserrat nuñez Juarez2 esther nuñez Juarez3 loreto Maciá soler4 carmen lópez Matheu1 Assumpta rigol cuadra1 María honrubia Pérez1 Diana Marre5 1school of nursing, University  of Barcelona, 2Department of  rheumatology, Musculoskeletal clínic  institute hospital clínic, 3institut  català de la salut, Barcelona, 4nursing  Department, University of Alicante,   Alicante, 5Universitat Autònoma de  Barcelona, Barcelona, spainAim:  We aimed to explore the meaning of obesity in elderly persons with knee osteoarthritis  (KO) and to determine the factors that encourage or discourage weight loss.",Non-OADS,/arxiv_data1/oa_pdf/9f/79/ppa-10-957.PMC4890692.pdf
"correspondence: Pilar isla Pera school of nursing, University of  Barcelona, Feixa llarga s/n l’hospitalet  de llobregat, Barcelona 08907, spain Tel +34 934 024 241 email pisla@ub.ed uJournal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Isla Pera et al Running head recto: Obesity, knee osteoarthritis, polypathology, and weight loss factors DOI: http://dx.doi.org/10.2147/PPA.S92183",Non-OADS,/arxiv_data1/oa_pdf/9f/79/ppa-10-957.PMC4890692.pdf
Available in: http://scielo.isciii.es/scielo.,Non-OADS,/arxiv_data1/oa_pdf/9f/79/ppa-10-957.PMC4890692.pdf
php?script=sci_arttext&pid=S1137-66272011000200011&lng=es;  http://dx.doi.org/10.4321/S1137-66272011000200011.,OADS,/arxiv_data1/oa_pdf/9f/79/ppa-10-957.PMC4890692.pdf
Available from: https://www.sizediversityandhealth.org/ index.asp.,Non-OADS,/arxiv_data1/oa_pdf/9f/79/ppa-10-957.PMC4890692.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/9f/79/ppa-10-957.PMC4890692.pdf
"Available from: http://www.ugr.es/ ~pwlac/ G25_27Luis_Alvarez-Amaia_Alvarez.htm l. Accessed March 8,  2015.",Non-OADS,/arxiv_data1/oa_pdf/9f/79/ppa-10-957.PMC4890692.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/20/f1/idr-9-101.PMC4890693.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/20/f1/idr-9-101.PMC4890693.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Conceptual framework for outcomes research  studies of hepatitis C: an analytical review Urbano Sbarigia1 T om R Denee1 Norris G T urner2 George J Wan3 Alan Morrison4 Anna S Kaufman4 Gary Rice5 Geoffrey M Dusheiko6,7 1Janssen Pharmaceutica, Beerse,   Belgium; 2Johnson & Johnson Health  Care Systems, Inc., Titusville, NJ,   3Mallinckrodt Pharmaceuticals, St.   Louis, MO, USA; 4ScribCo, Effort, PA,   USA, 5Diplomat Specialty Pharmacy,   Flint, MI, USA, 6The University College  London Medical Institute for Liver  and Digestive Health, London, UK;   7Kings College Hospital, London, UK Correspondence: Urbano Sbarigia   Janssen Pharmaceutica, T urnhoutseweg 30,  B-2340 Beerse, Belgium   T el +32 474 943 357   Email usbarigi@its.jnj.co mAbstract:  Hepatitis C virus infection is one of the main causes of chronic liver disease  worldwide.",Non-OADS,/arxiv_data1/oa_pdf/20/f1/idr-9-101.PMC4890693.pdf
"Sovaldi (sofosbuvir) [prescribing  information]; 2013. http://www.accessdata.fda.gov/drugsatfda_docs/ label/2013/204671s000lbl.pd f. Accessed June 5, 2015.",Non-OADS,/arxiv_data1/oa_pdf/20/f1/idr-9-101.PMC4890693.pdf
"Olysio (simeprevir) [Prescribing  information]; 2013. http://www.accessdata.fda.gov/drugsatfda_docs/ label/2013/205123s001lbl.pd f. Accessed June 5, 2015.",Non-OADS,/arxiv_data1/oa_pdf/20/f1/idr-9-101.PMC4890693.pdf
"2015. http://packageinserts.bms.com/pi/pi_daklinza.pd f.  Accesssed April 13, 2016.",Non-OADS,/arxiv_data1/oa_pdf/20/f1/idr-9-101.PMC4890693.pdf
"Harvoni (ledipasvir and sofosbuvir)  [Prescribing information]; 2014. http://www.accessdata.fda.gov/drug - satfda_docs/label/2011/021511s023lbl.pd f. Accessed June 5, 2015.",Non-OADS,/arxiv_data1/oa_pdf/20/f1/idr-9-101.PMC4890693.pdf
"Viekira Pak (ombitasvir, paritaprevir,  and ritonavir tablets; dasabuvir tablets) [Prescribing information]; 2014.  http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206619lbl.",Non-OADS,/arxiv_data1/oa_pdf/20/f1/idr-9-101.PMC4890693.pdf
"Available from: http://www.gastro.org/practice/digestive- health-outcomes-registry/clinical-content/hepatitis-c-measure s.  Accessed March 18, 2016.",Non-OADS,/arxiv_data1/oa_pdf/20/f1/idr-9-101.PMC4890693.pdf
"Available from: http://www.cdc.gov/ socialdeterminants/FAQ.htm l. Accessed February 3, 2015.",OADS,/arxiv_data1/oa_pdf/20/f1/idr-9-101.PMC4890693.pdf
Available from: https://www.nice.org.uk/guidance/indevelopment/gid- cgwave0666.,Non-OADS,/arxiv_data1/oa_pdf/20/f1/idr-9-101.PMC4890693.pdf
Available from: http://www.gastro.org/practice/digestive- health-outcomes-registry/clinical-content/hepatitis-c-measures.,Non-OADS,/arxiv_data1/oa_pdf/20/f1/idr-9-101.PMC4890693.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/20/f1/idr-9-101.PMC4890693.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/f1/idr-9-101.PMC4890693.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b6/01/copd-11-1119.PMC4890694.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1119–1128International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1119OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10019 8resolvin D1 prevents smoking-induced emphysema  and promotes lung tissue regeneration Kang-hyun Kim1 Tai sun Park2,3 Y ou-sun Kim1,3 Jae seung lee2,3 Yeon-Mok Oh2,3 sang-Do lee2,3 sei Won lee2,3 1asan Institute for life sciences,   2Department of Pulmonology and  Critical Care Medicine, Clinical  research Center for Chronic  Obstructive airway Diseases, asan  Medical Center, 3Department of  Pulmonology and Critical Care  Medicine, University of Ulsan College  of Medicine, seoul, republic of KoreaPurpose:  Emphysema is an irreversible disease that is characterized by destruction of lung  tissue as a result of inflammation caused by smoking.",Non-OADS,/arxiv_data1/oa_pdf/b6/01/copd-11-1119.PMC4890694.pdf
"Considering the paucity of treatments  for emphysema, novel approaches are urgently needed.Correspondence: sei Won lee Department of Pulmonary and Critical  Care Medicine, Clinical research  Center for Chronic Obstructive  airway Diseases, asan Medical Center,  University of Ulsan College of Medicine,  88 Olympic-ro 43-gil, songpa-gu,  seoul 05505, republic of Korea Tel +82 2 3010 3990 Fax +82 2 3010 6968 email iseiwon@gmail.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Kim et al Running head recto: Resolvin in emphysema treatment DOI: http://dx.doi.org/10.2147/COPD.S100198",Non-OADS,/arxiv_data1/oa_pdf/b6/01/copd-11-1119.PMC4890694.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/b6/01/copd-11-1119.PMC4890694.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b6/01/copd-11-1119.PMC4890694.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f4/72/ijwh-8-181.PMC4890695.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 181–190International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  181OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S10504 6 Using task analysis to generate evidence for  strengthening midwifery education, practice,  and regulation in ethiopia T egbar Yigzaw1 catherine carr2 Jelle stekelenburg3,4 Jos van roosmalen5 Hannah gibson1 Mintwab gelagay1 azeb admassu6 1Jhpiego, addis ababa, ethiopia;   2Jhpiego, Washington Dc , Usa;   3Department of Obstetrics and  gynecology, leeuwarden Medical  centre, leeuwarden, 4Department  of Health sciences, global Health,   University Medical centre groningen,   University of groningen, groningen,   5Faculty of earth and life sciences,   Vrije Universiteit, amsterdam,   the netherlands; 6Federal Ministry  of Health, addis ababa, ethiopiaPurpose:  Realizing aspirations for meeting the global reproductive, maternal, newborn, and  child health goals depends not only on increasing the numbers but also on improving the  capability of midwifery workforce.",Non-OADS,/arxiv_data1/oa_pdf/f4/72/ijwh-8-181.PMC4890695.pdf
"Health system challenges in the 21st century require correspondence: Tegbar Yigzaw Jhpiego, Kirkos subcity, PO Box 2881,  code 1250, addis ababa, ethiopia Tel +251 1 911 408 682 Fax +251 1 115 508 814 email tegbar.yigzaw@jhpiego.or g Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2016 Volume: 8 Running head verso: Yigzaw et al Running head recto: Midwifery task analysis study in Ethiopia DOI: http://dx.doi.org/10.2147/IJWH.S105046",Non-OADS,/arxiv_data1/oa_pdf/f4/72/ijwh-8-181.PMC4890695.pdf
Available from: http://www.who.int/cancer/ country-profiles/eth_en.pdf?ua =1.,Non-OADS,/arxiv_data1/oa_pdf/f4/72/ijwh-8-181.PMC4890695.pdf
Available from: http://www.moh.gov.et/ documents/26765/0/Health +Sector+Transformation +Plan/5542a23a- 9bc7-46a2-8c1f-8b32c2603208?version =1.0.,OADS,/arxiv_data1/oa_pdf/f4/72/ijwh-8-181.PMC4890695.pdf
Available from: http://www.internationalmidwives.org/ Positio n Statement.,Non-OADS,/arxiv_data1/oa_pdf/f4/72/ijwh-8-181.PMC4890695.pdf
Available from: http://www.human-resources-health.com/ content/12/1/6 1.,Non-OADS,/arxiv_data1/oa_pdf/f4/72/ijwh-8-181.PMC4890695.pdf
"Available from:  http://www.internationalmidwives.org/assets/uploads/documents/ Dissemination/140508%20Dissemination%20ICM%20V06.pd f.  Accessed on May 12, 2016.",OADS,/arxiv_data1/oa_pdf/f4/72/ijwh-8-181.PMC4890695.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/f4/72/ijwh-8-181.PMC4890695.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/72/ijwh-8-181.PMC4890695.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/78/37/amep-7-317.PMC4890696.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/78/37/amep-7-317.PMC4890696.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 317–320Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 317 SHORT REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S107807 Redesigning journal club in residency Morhaf Al Achkar Department of Family Medicine,   Indiana University, Indianapolis, IN,  USAAbstract:  The gap between production and implementation of knowledge is the main reason  for the suboptimal quality of health care.",Non-OADS,/arxiv_data1/oa_pdf/78/37/amep-7-317.PMC4890696.pdf
"7,8 In spite of the wide incorporation of JC in graduate medical education, it is, the  literature shows, rarely successful in maintaining the residents’ interest and achieving Journal name: Advances in Medical Education and Practice Article Designation: SHORT REPORTY ear: 2016V olume: 7Running head verso: Al AchkarRunning head recto: Redesigning journal club in residencyDOI: http://dx.doi.org/10.2147/AMEP .S107807 Correspondence: Morhaf Al Achkar   Department of Family Medicine, Indiana  University, 1520 North Senate Avenue, Indianapolis, IN 46205, USA   Tel +1 317 962 8893   Fax +1 317 962 1048   Email alachkar@iupui.edu",Non-OADS,/arxiv_data1/oa_pdf/78/37/amep-7-317.PMC4890696.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/78/37/amep-7-317.PMC4890696.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 320 Al Achkar  7.,Non-OADS,/arxiv_data1/oa_pdf/78/37/amep-7-317.PMC4890696.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/be/84/oajsm-7-065.PMC4890697.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/be/84/oajsm-7-065.PMC4890697.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Journal of Sports Medicine 2016:7 65–73Open Access Journal of Sports Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 65 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S100242Reliability and concurrent validity between   two-dimensional and three-dimensional  evaluations of knee valgus during drop jumps Alexis Ortiz1  Martin Rosario-Canales2,3  Alejandro Rodríguez3  Alexie Seda3  Carla Figueroa3  Heidi L Venegas-Ríos4 1School of Physical Therapy, T exas  Woman’s University, Houston,   TX, 2Department of Anatomy &  Neurobiology, 3Department of  Physical Therapy, University of Puerto Rico, Medical Sciences Campus, San Juan, PR,  4School of Nutrition & Food  Sciences, T exas Woman’s University,  Houston, TX, USAPurpose: The aim of this study was to establish the concurrent validity and reliability of four  different two-dimensional (2D) video-based techniques for quantifying frontal plane knee  kinematics during a 40 cm double-legged drop jump.",Non-OADS,/arxiv_data1/oa_pdf/be/84/oajsm-7-065.PMC4890697.pdf
"6,7 DKV encompasses a movement pattern characterized by Correspondence: Alexis Ortiz  School of Physical Therapy, Texas Woman’s University, 6700 Fannin Street, Houston, TX 77058, USA   Tel +1 713 794 2077   Fax +1 713 794 2071   Email aortiz10@twu.eduJournal name: Open Access Journal of Sports Medicine Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: Ortiz et alRunning head recto: Validity between 2D and 3D knee valgus assessmentDOI: http://dx.doi.org/10.2147/OAJSM.S100242",Non-OADS,/arxiv_data1/oa_pdf/be/84/oajsm-7-065.PMC4890697.pdf
"Open Access Journal of Sports Medicine 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/open-access-journal-of-sports-medicine-journalThe Open Access Journal of Sports Medicine is an international,   peer-reviewed, open access journal publishing original research,   reports, reviews and commentaries on all areas of sports   medicine.",Non-OADS,/arxiv_data1/oa_pdf/be/84/oajsm-7-065.PMC4890697.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/be/84/oajsm-7-065.PMC4890697.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/27/59/ppa-10-967.PMC4890698.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 967–973Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  967OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10653 0 Quality of life in patients with recurrent aphthous  stomatitis treated with a mucoadhesive patch  containing citrus essential oil esma Kürklü-gürleyen1 Merve Ög ˘üt-Erişen1 Onur Çakır1 Ömer Uysal2 gülsüm Ak1 1Department of Oral surgery, Faculty  of Dentistry, istanbul University,   2Department of Biostatistics and  Medical informatics, Faculty of  Medicine, BezmiÂlem Vakif University,   istanbul, T urkeyPurpose:  To assess 1) patient satisfaction of a mucoadhesive biopatch with citrus essential  oil and 2) the change in pain severity and the oral health-related quality of life in patients with  recurrent aphthous stomatitis.",Non-OADS,/arxiv_data1/oa_pdf/27/59/ppa-10-967.PMC4890698.pdf
"Keywords:  recurrent aphthous stomatitis, pain, quality of life, essential oil, biopatch, local  therapy Introduction Recurrent aphthous stomatitis (RAS) or canker sore is a painful and ulcerative disorder  of the oral mucosa.1,2 It occurs worldwide and is reported in every populated continent  with a prevalence rate of 25%, ranging between 5% and 60%.2,3 It is well recognized  that the symptoms caused by recurrent or chronic oral mucosal lesions such as pain  during speaking, eating, and swallowing; discomfort; impairment in food and liquid  intake; and problems in interpersonal relationships and self-esteem can deeply affect  the oral health-related quality of life (OHRQoL) of patients.4,5 RAS, the most frequent  oral mucosal disease, was shown to cause all of these symptoms with a significant  negative impact in patients’ OHRQoL indicating significantly high scores.5 The common characteristic features of RAS present as recurrent, solitary or mul - tiple, shallow, round or ovoid, and self-limited ulcers with an erythematous, raised  margin, and a yellow grayish floor.6 Minor aphthous ulcers, by far the most common  type, appear as small ulcers (5–10 mm) and heal spontaneously in 7–14 days.2 Etiology of RAS is still unclear and thought to be multifactorial with pre - cipitating factors such as hematologic deficiency,2,7 food hypersensitivity,8 familial correspondence: esma Kürklü-gürleyen Department of Oral surgery, Faculty of  Dentistry, istanbul University, 34093,  capa, Fatih, istanbul, Turkey Tel +90 532 574 7976 Fax +90 212 531 2230 email ekurklu@istanbul.edu.t r Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Kürklü-Gürleyen et al Running head recto: Essential oil containing patch for RAS therapy DOI: http://dx.doi.org/10.2147/PPA.S106530",Non-OADS,/arxiv_data1/oa_pdf/27/59/ppa-10-967.PMC4890698.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/27/59/ppa-10-967.PMC4890698.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/25/96/opth-10-989.PMC4890728.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 989–992Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  989Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10447 5Cataract surgery in the setting of severe  pathologic myopia with high axial length: use  of pars plana lensectomy and vitrectomy Daniel Gologorsky Harry W Flynn Jr Department of Ophthalmology,   Bascom Palmer eye institute,   University of Miami Miller school  of Medicine, Miami, FL, UsaAbstract:  Cataract surgery in patients with pathologic myopia and high axial length can be  challenging for a variety of reasons, including imprecise intraocular lens calculations in eyes  with posterior staphylomas and intraoperative complications such as suprachoroidal hemorrhage,  posterior capsular rupture, and retinal tears.",Non-OADS,/arxiv_data1/oa_pdf/25/96/opth-10-989.PMC4890728.pdf
"At her 1-year postoperative Correspondence: Harry W Flynn Jr Department of Ophthalmology, Bascom  Palmer eye institute, University of Miami  Miller school of Medicine, 900 NW 17th  street, Miami, FL 33126, Usa Tel +1 305 326 6118 Fax +1 305 326 6417 email hflynn@med.miami.ed u Journal name: Clinical Ophthalmology Article Designation: Case Series Y ear: 2016 Volume: 10 Running head verso: Gologorsky and Flynn Running head recto: Cataract surgery in pathologic myopia DOI: http://dx.doi.org/10.2147/OPTH.S104475",Non-OADS,/arxiv_data1/oa_pdf/25/96/opth-10-989.PMC4890728.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/25/96/opth-10-989.PMC4890728.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/25/96/opth-10-989.PMC4890728.pdf
"The numbers represent total progenitor numbers in each individual sample based on frequency  of progenitors, and total cell numbers are aver - ages of three or four samples, http://links.lww.",OADS,/arxiv_data1/oa_pdf/6c/e7/prs-136-414e.PMC4890821.pdf
"The distribu- tions of the six common genotypes of APOE were under Hardy –Weinberg equilibrium in all patients and control participants (Supplementary Table, Supplemental digitalcontent 1, http://links.lww.com/PG/A152 ).",Non-OADS,/arxiv_data1/oa_pdf/7b/2d/ypg-26-124.PMC4890824.pdf
"For comparisons with other SAS [Gujarati INS from Houston, Texas (GIH); Punjabi from Lahore, Pakistan (PJL); Bengali from Bangladesh (BEB); SL Tamils from the UK (STU); Indian Telugufrom the UK (ITU)] and European [Utah residents with Northern and Western European ancestry (CEU)] populations, we used data from 1000 Genomes phase 3 release ( http://www.1000genomes.org ).",OADS,/arxiv_data1/oa_pdf/5a/9b/fpc-26-28.PMC4890825.pdf
"We merged these datasets with the SL dataset and used overlapping SNPs for cross-population comparisons (see Figure, Supplemental digital content 1, http://links.lww.com/FPC/A915 ).",OADS,/arxiv_data1/oa_pdf/5a/9b/fpc-26-28.PMC4890825.pdf
"The data were then filtered for SNPs with call rate less than 90% and for those that deviated from Hardy –Weinberg equilibrium (P<0.001) in at least one ethnic group (see Figure, Supplemental digital content 2, http://links.lww.com/FPC/ A916 ).",OADS,/arxiv_data1/oa_pdf/5a/9b/fpc-26-28.PMC4890825.pdf
"SNPs with clearly different MAFs were excluded (see Figures, Supplemental digital content 1, http://links.lww.com/FPC/A915 and Supplemental digital content 3, http://links.lww.com/FPC/ A917 ).",Non-OADS,/arxiv_data1/oa_pdf/5a/9b/fpc-26-28.PMC4890825.pdf
"The concordance between MAFs of SL Tamils and STU was also checked, and SNPs (see Figure, Supplemental digital content 4, http://links.lww.com/FPC/ A918 )w i t h F STgreater than 0.05 between the SL and STU populations were confirmed using Sanger sequencing or TaqMan genotyping (Life Technologies).",OADS,/arxiv_data1/oa_pdf/5a/9b/fpc-26-28.PMC4890825.pdf
"SNPs with dis- cordant genotypes were excluded from the dataset [for principal component analysis (PCA) and STRUCTURE], but the MAFs for SNPs from TaqMan genotyping were included in the FSTanalysis (see Figure, Supplemental digital content 1, http://links.lww.com/FPC/A915 and Table, Supplemental digital content 5, http://links.lww.com/FPC/ A919 ).CYP2C19 *2(rs4244285), not present on the Illumina array, was genotyped by TaqMan assay accordingPharmacogenomic diversity in Sri Lankans Chan et al.2 9",OADS,/arxiv_data1/oa_pdf/5a/9b/fpc-26-28.PMC4890825.pdf
"After applying quality control filters, we analyzed data from 49 Sinhalese, 72 SL Tamils, and 76 Moors (see Figure, Supplemental digital content 2, http://links.lww.com/FPC/ A916 ).",OADS,/arxiv_data1/oa_pdf/5a/9b/fpc-26-28.PMC4890825.pdf
"2b and Figure, Supplemental digital content 6, http://links.lww.com/FPC/A920 ).",Non-OADS,/arxiv_data1/oa_pdf/5a/9b/fpc-26-28.PMC4890825.pdf
"2b and d and Figure, Supplemental digital content 6, http://links.lww.com/FPC/A920 ).",Non-OADS,/arxiv_data1/oa_pdf/5a/9b/fpc-26-28.PMC4890825.pdf
"Next, we examined the SNPs with the highest level of differentiation within the SL populations, and between the SL population and other populations (see Tables,Supplemental digital contents 7 –10,http://links.lww.com/ FPC/A921 ,http://links.lww.com/FPC/A922 ,http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/5a/9b/fpc-26-28.PMC4890825.pdf
"com/FPC/A923 ,http://links.lww.com/FPC/A924 ).",Non-OADS,/arxiv_data1/oa_pdf/5a/9b/fpc-26-28.PMC4890825.pdf
"Within the SL populations, SLC10A2 rs2301159, associated with increased risk for docetaxel toxicity, and ERCC1 rs3212986, associated with protection from cisplatin-induced nephrotoxicity, were the most differentiated (see Table, Supplemental digital content 7, http://links.lww.com/FPC/A921 ).30 Pharmacogenetics and Genomics 2016, Vol 26 No 1",Non-OADS,/arxiv_data1/oa_pdf/5a/9b/fpc-26-28.PMC4890825.pdf
"There is slight separation of GIH and PJL from the other SAS and SL populations at PC1 [(b) and Figure, Supplemental digital content 6, http://links.lww.com/FPC/A920 ], and they are located slightly closer to CEU than the other SAS and SL populations (d).",Non-OADS,/arxiv_data1/oa_pdf/5a/9b/fpc-26-28.PMC4890825.pdf
"In most cases, the differentiation was driven by differences with the CHS, MAS, and CEU populations (see Tables, Supplemental digital content 9, http://links.lww.com/FPC/ A923 and Supplemental digital content 10, http://links.",Non-OADS,/arxiv_data1/oa_pdf/5a/9b/fpc-26-28.PMC4890825.pdf
"Differentiation at these loci was driven primarily by differences with PJL and GIH populations (see Table, Supplemental digital content 8, http://links.lww.com/FPC/Fig.",OADS,/arxiv_data1/oa_pdf/5a/9b/fpc-26-28.PMC4890825.pdf
"2 and Figure, Supplemental digital content 6, http://links.lww.com/FPC/ A920 ).",Non-OADS,/arxiv_data1/oa_pdf/5a/9b/fpc-26-28.PMC4890825.pdf
"The reported prevalence ofdocetaxel-induced FN in Indian populations (3 –39%) is similar to that reported in Chinese populations (2 –42%) and is higher than that reported in European populations (5–23%), showing rough correspondence to the fre- quency of the rs2301159 risk allele in these three popu-lation groups (0.25, 0.295, and 0.182 in INS, CHS, andCEU, respectively; see Table, Supplemental digitalcontent 11, http://links.lww.com/FPC/A925 ).",Non-OADS,/arxiv_data1/oa_pdf/5a/9b/fpc-26-28.PMC4890825.pdf
Available at: http://data.worldbank.org/ indicator/SP.POP.TOTL .,OADS,/arxiv_data1/oa_pdf/5a/9b/fpc-26-28.PMC4890825.pdf
Available at: http://sis.statistics.gov.lk/statHtml/statHtml.do?orgId = 144&tblId =DT_POP_SER_267&conn_path =I2.,OADS,/arxiv_data1/oa_pdf/5a/9b/fpc-26-28.PMC4890825.pdf
"Genotyping The SNPs rs2229935, rs2247383, rs2070296, andrs2804495 were selected from the major haploblocks of theNRP1 gene for genotyping (see Table, Supplemental digital content 1, http://links.lww.com/FPC/A912 which details the chromosomal location of the SNPs).",Non-OADS,/arxiv_data1/oa_pdf/13/31/fpc-26-20.PMC4890827.pdf
"Primers and probes were developedby LGC (see Table, Supplemental digital content 1, http://links.lww.com/FPC/A912 , which describes the probes used).",OADS,/arxiv_data1/oa_pdf/13/31/fpc-26-20.PMC4890827.pdf
"Older age at first injection ( P=0.01), having a better baseline VA (P<10 –3), and having diabetes mellitus ( P=0.02) were associated with worse response after 3 months of treatment (see Table, Supplemental digital content 2, http://links.lww.com/FPC/A913 , which describes the results of the association tests).",Non-OADS,/arxiv_data1/oa_pdf/13/31/fpc-26-20.PMC4890827.pdf
"These baseline variables were not associated with the SNPs of interest ( P>0.05, lowest P=0.22) (see Table, Supplemental digital content 3, http://links.lww.com/FPC/A914 , which describes the results of the association tests).",OADS,/arxiv_data1/oa_pdf/13/31/fpc-26-20.PMC4890827.pdf
"Volume kinetics This describes an approach that is identical to the way that the half-life of drugs is calculated in pharmacoki- netics (see Supplementary material, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/a2/f5/ejanet-33-475.PMC4890831.pdf
http://creativecommons.org/licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/f9/b2/spa-76-717.PMC4890833.pdf
"Circulation is available at http://circ.ahajournals.org DOI: 10.1161/CIRCULATIONAHA.115.017465Received February 24, 2015; accepted April 8, 2016.From Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark (N.Ø., L.J.D., H.A.B., J.W., M.M.",OADS,/arxiv_data1/oa_pdf/2b/b0/cir-133-2243.PMC4890838.pdf
"September 30, 2005. http://www.eurocat-net- work.eu/ Accessed June 2014.",Non-OADS,/arxiv_data1/oa_pdf/2b/b0/cir-133-2243.PMC4890838.pdf
"May 5,  2015. http://www.whocc.no/ Accessed June 1, 2015.",Non-OADS,/arxiv_data1/oa_pdf/2b/b0/cir-133-2243.PMC4890838.pdf
"The quantitative signiﬁcance of intravascular volume therapy is justiﬁed merely by the fact that the vast majority of the 20 million patients approximately, treated in German hospitals every year (https://www.destatis.de/ DE/ZahlenFakten/Gesellsc haftStaat/Gesundheit/Kran kenhaeuser/Krankenhaeuser.html) require intravascular volume therapy at least on a temporary basis.",Non-OADS,/arxiv_data1/oa_pdf/82/f4/ejanet-33-488.PMC4890839.pdf
(http://www.ema.europa.eu/ema/ index.jsp?curl=pages/medicines/human/referrals/Hydrox yethyl_starch-contain ing_solutions/human_referral_prac_ 000012.jsp&mid= WC0b01ac05805c516f) The recommen- dations of the present AWMF S3 Guideline are based on an analysis of the evidence and are to be viewed separately from the EMA recommendations.,Non-OADS,/arxiv_data1/oa_pdf/82/f4/ejanet-33-488.PMC4890839.pdf
"Table 1 Guideline development S-Classes as deﬁned by the Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften S-Class 1: Expert group An expert group formed of representative members of the specialist association(s) works in loose consensus on a recommendation that is adopted by the Board(s) of the specialist association(s) S-Class 2: Formal evidence-based research or formal consensus buildingGuideline development is based on the formal assessment of statements from the research literature (S2e) or guideline consultation and adoption is based on one of the following proven methods of achieving formal consensus: nominal group process, Delphi technique or consensus conference S-Class 3: Guideline with all elements of systematic developmentGuideline development comprises systematic literature research and assessment, the classiﬁcation of case studies and recommendations according to the criteria of evidence-based medicine, and formal consensus building Source: http://www.awmf.org/leitlinien/awmf-regelwerk/ll-register.html Eur J Anaesthesiol 2016; 33:488–521",Non-OADS,/arxiv_data1/oa_pdf/82/f4/ejanet-33-488.PMC4890839.pdf
"(http://www.cebm.net/ oxford-centre-evidence-based-medicine-levels-evidence- march-2009/) To simplify future updates and to improve comparability, the grading in accordance with version 2011 (http://www.cebm.net/index.aspx?o=5653) was used in parallel.",Non-OADS,/arxiv_data1/oa_pdf/82/f4/ejanet-33-488.PMC4890839.pdf
"These evidence tables, written in Ger- man, can be downloaded at http://www.awmf.org/leitli nien/detail/ll/001-020.html.",OADS,/arxiv_data1/oa_pdf/82/f4/ejanet-33-488.PMC4890839.pdf
"(http://leitlinienprogramm-onkologie.de/uploads/tx_ sbdownloader/LL_OvCA_OL_Langversion.pdf, (http:// www.krebsgesellschaft.de/download/s3-leitlinie-prostata karzinom_2012.pdf).",OADS,/arxiv_data1/oa_pdf/82/f4/ejanet-33-488.PMC4890839.pdf
Table 4 Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften wording schema to formulate recommendations based on the strength of the recommendation Grade of recommendation Strength of recommendation Wording A Strong recommendation ‘must’ B Recommendation ‘should’ 0 Open recommendation ‘may’ Source: http://www.awmf.org/leitlinien/awmf-regelwerk/ll-entwicklung/awmf-regel werk-03-leitlinienentwicklung/ll-entwicklung-graduierung-der-empfehlungen.html.,Non-OADS,/arxiv_data1/oa_pdf/82/f4/ejanet-33-488.PMC4890839.pdf
Table 3 Classiﬁcation of degree of consensus >95% agreement among participants Strong consensus >75 to 95% agreement among participants Consensus >50 to 75% agreement among participants Majority consensus <50% agreement among participants No consensus Source: http://www.awmf.org/leitlinien/awmf-regelwerk/ll-entwicklung/awmf-regel werk-03-leitlinienentwicklung/ll-entwicklung-graduierung-der-empfehlungen.html.,Non-OADS,/arxiv_data1/oa_pdf/82/f4/ejanet-33-488.PMC4890839.pdf
(http://www.awmf.org/leitlinien/detail/ll/ 019-013.html).,Non-OADS,/arxiv_data1/oa_pdf/82/f4/ejanet-33-488.PMC4890839.pdf
(http://www.awmf.org/leitlinien/ detail/ll/001-016.html).,Non-OADS,/arxiv_data1/oa_pdf/82/f4/ejanet-33-488.PMC4890839.pdf
(http://www.awmf.org/ leitlinien/detail/ll/019-013.,Non-OADS,/arxiv_data1/oa_pdf/82/f4/ejanet-33-488.PMC4890839.pdf
"Conﬂicts of interest: Conﬂicts of interests are declared in Appendix X, pages 63 to 67 of the Guideline Report (‘Leitlinienreport’) (http://www.awmf.org/leitlinien/detail/ll/001-020.htmlpublished).",Non-OADS,/arxiv_data1/oa_pdf/82/f4/ejanet-33-488.PMC4890839.pdf
"UIRL:http://www.awmf.org/leitlinien/detail/ll/001-016.html 89 Campo dell’ Orto M, Hamm C, Rolf A, et al.",Non-OADS,/arxiv_data1/oa_pdf/82/f4/ejanet-33-488.PMC4890839.pdf
a detailed descrip- tion of the tMle implementation is provided in eappendix 1  (http://links.lww.com/eDe/B45).,OADS,/arxiv_data1/oa_pdf/d1/8e/ede-27-570.PMC4890840.pdf
"Ses, confidence intervals, and null-hypothesis testing in tMle framework are shown in   eappendix 2 (http://links.lww.com/eDe/B45).",OADS,/arxiv_data1/oa_pdf/d1/8e/ede-27-570.PMC4890840.pdf
"Epidemiology • Volume 27, Number 4, July 2016 572 | www.epidem.com © 2016 Wolters Kluwer Health, Inc. All rights reserved.SOFTWARE FOR IMPLEMENTING TMLE r packages for implementing tMle in both single- point exposure and longitudinal study are available and  easily implemented.23,25 We programmed a SaS macro for  a general implementation of tMle in binary point expo- sure and outcome study (see eappendix 3; http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/d1/8e/ede-27-570.PMC4890840.pdf
"the results are provided in  etable 1 in eappendix 4 (http://links.lww.com/eDe/B45),  showing slightly changed point estimates and improved preci-sion in both inverse probability weighting and tMle espe- cially in the case of high-dimensional covariates adjustment in the propensity score models.",Non-OADS,/arxiv_data1/oa_pdf/d1/8e/ede-27-570.PMC4890840.pdf
2011. available at http://biostats.bepress.com/ ucbbiostat/paper275/.,Non-OADS,/arxiv_data1/oa_pdf/d1/8e/ede-27-570.PMC4890840.pdf
2014. a vailable  at http://cran.r-project.org/web/packages/ltmle/index.html.,Non-OADS,/arxiv_data1/oa_pdf/d1/8e/ede-27-570.PMC4890840.pdf
a vailable at http://www.drugepi.org/dope-downloads/.,Non-OADS,/arxiv_data1/oa_pdf/d1/8e/ede-27-570.PMC4890840.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c2/01/nihms785710.PMC4891215.pdf
"To help users conduct the analyses using these methods, they offer a SAS (Statistical Analysis System) macro at http://actstat.org/associated-links.html.",OADS,/arxiv_data1/oa_pdf/53/6d/SIM-35-2467.PMC4891219.pdf
"Further, the Deeks and Higgins 2010 publication on the statistical algorithms in RevMan 5, http://www.researchgate.net/pro ﬁle/Jonathan_ Deeks2/publication/241313811_Standard_statistical_algorithms_in_Cochrane_reviews_Ve_r_s_i_o_n_ 5/links/54d159b70cf28370d0e07f9f.pdf, does not issue a warning.",Non-OADS,/arxiv_data1/oa_pdf/53/6d/SIM-35-2467.PMC4891219.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on Gene Therapy website (http://www.nature.com/gt)UTMD for hepatic FIX expression CD Anderson et al 519 © 2016 Macmillan Publishers Limited Gene Therapy (2016) 510 –519",Non-OADS,/arxiv_data1/oa_pdf/fc/12/gt201623a.PMC4891223.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/f6/kjfm-37-135.PMC4891314.pdf
"False Replies on Smoking Rate   Surveys and an In-Hospital   Smoking Cessation Clinic Jungun Lee Department of Family Medicine, Wonkwang University Sanbon Hospital, Wonkwang University School of Medicine, Gunpo, Koreahttp://dx.doi.org/10.4082/kjfm.2016.37.3.135  • Korean J Fam Med 2016;37:135-136 Editorial eISSN: 2092-6715 Cigarette smoking is a leading risk factor for cancer and car - diovascular and pulmonary disorders.",Non-OADS,/arxiv_data1/oa_pdf/f8/f6/kjfm-37-135.PMC4891314.pdf
Jungun Lee • False Replies on Smoking Rate Surveys and an In-Hospital Smoking Cessation Clinic 136  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.135 3.,Non-OADS,/arxiv_data1/oa_pdf/f8/f6/kjfm-37-135.PMC4891314.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/kjfm-37-137.PMC4891315.pdf
"Keywords:  Bipolar Depression; Drug Therapy; Mood Stabilizers; Anticonvulsants; Atypical Antipsychotics Received: January 26, 2016, Revised: February 17, 2016, Accepted: February 25, 2016 *Corresponding Author:  Ather Muneer  Tel: +92-51-548-1828, Fax: +92-51-512-5170, E-mail: muneerather2@gmail.comhttp://dx.doi.org/10.4082/kjfm.2016.37.3.137  • Korean J Fam Med 2016;37:137-148 Review Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/kjfm-37-137.PMC4891315.pdf
"Ather Muneer • Pharmacotherapy of Bipolar Depression 138  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.137 INTRODUCTION Bipolar disorder (BD) is a collection of heterogeneous conditions; it is  conceptualized as a spectrum disorder in the current classifications of  Diagnostic and Statistical Manual of Mental Disorders, fifth edition  and International Classification of Diseases-10.1) In the former, at least  four disorders are recognized: BD type I, in which there is the occur - rence of at least one manic or mixed episode in addition to major de - pressive episodes (MDE); BD type II (hypomanic episodes in addition  to MDE); cyclothymic disorder (hypomanic episodes as well as de - pressive episodes which fall short of MDE); and BD not otherwise  specified.",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/kjfm-37-137.PMC4891315.pdf
"Ather Muneer • Pharmacotherapy of Bipolar Depression http://dx.doi.org/10.4082/kjfm.2016.37.3.137www.kjfm.or.kr   139 pressive symptoms are often recalcitrant and show poor response to  currently available psychopharmacological agents.5) Antidepressant  monotherapy is of little efficacy in bipolar depression, and is perhaps  contraindicated because of the liability of causing mood destabiliza - tion with a switch into mania or hypomania, and induction of mixed  episodes, as well as rapid cycling.6) Therefore, the treatment of all  phases of BD is primarily with mood stabilizers, which includes first  line agents such as lithium, sodium valproate, and carbamazepine.",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/kjfm-37-137.PMC4891315.pdf
Ather Muneer • Pharmacotherapy of Bipolar Depression 140  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.137 treatment of BD.,Non-OADS,/arxiv_data1/oa_pdf/0c/f7/kjfm-37-137.PMC4891315.pdf
"Ather Muneer • Pharmacotherapy of Bipolar Depression http://dx.doi.org/10.4082/kjfm.2016.37.3.137www.kjfm.or.kr   141 trial, patients were treated with either quetiapine 300 or 600 mg/d,  lithium 600 to 1,800 mg/d according to serum levels, or placebo.",Non-OADS,/arxiv_data1/oa_pdf/0c/f7/kjfm-37-137.PMC4891315.pdf
Ather Muneer • Pharmacotherapy of Bipolar Depression 142  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.137 has shed light on its role in BD.,Non-OADS,/arxiv_data1/oa_pdf/0c/f7/kjfm-37-137.PMC4891315.pdf
Ather Muneer • Pharmacotherapy of Bipolar Depression http://dx.doi.org/10.4082/kjfm.2016.37.3.137www.kjfm.or.kr   143 All studies consistently showed a statistically notable reduction in  body mass index.,Non-OADS,/arxiv_data1/oa_pdf/0c/f7/kjfm-37-137.PMC4891315.pdf
Ather Muneer • Pharmacotherapy of Bipolar Depression 144  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.137 gene transcription via β-catenin.,Non-OADS,/arxiv_data1/oa_pdf/0c/f7/kjfm-37-137.PMC4891315.pdf
Ather Muneer • Pharmacotherapy of Bipolar Depression http://dx.doi.org/10.4082/kjfm.2016.37.3.137www.kjfm.or.kr   145 of 16 weeks.,Non-OADS,/arxiv_data1/oa_pdf/0c/f7/kjfm-37-137.PMC4891315.pdf
Ather Muneer • Pharmacotherapy of Bipolar Depression 146  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.137 7.,Non-OADS,/arxiv_data1/oa_pdf/0c/f7/kjfm-37-137.PMC4891315.pdf
Ather Muneer • Pharmacotherapy of Bipolar Depression http://dx.doi.org/10.4082/kjfm.2016.37.3.137www.kjfm.or.kr   147 12.,Non-OADS,/arxiv_data1/oa_pdf/0c/f7/kjfm-37-137.PMC4891315.pdf
Ather Muneer • Pharmacotherapy of Bipolar Depression 148  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.137 41.,Non-OADS,/arxiv_data1/oa_pdf/0c/f7/kjfm-37-137.PMC4891315.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/fd/kjfm-37-149.PMC4891316.pdf
"Keywords:  Smoking; Hospitalization; Varenicline; Smoking Cessation Received: August 24, 2015, Revised: August 26, 2015, Accepted: September 27, 2015 *Corresponding Author:  Yoo Seock Cheong  Tel: +82-41-550-6385, Fax: +82-41-556-0524, E-mail: drloved@hanmail.nethttp://dx.doi.org/10.4082/kjfm.2016.37.3.149  • Korean J Fam Med 2016;37:149-155 Original Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/c9/fd/kjfm-37-149.PMC4891316.pdf
"• Smoking Cessation Program for Hospitalized Patients 150  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.149 INTRODUCTION Smoking has been widely known as one of the main causes of respira - tory and circulatory diseases and also various cancers.1) However, it is  not easy for smokers to quit smoking completely.",Non-OADS,/arxiv_data1/oa_pdf/c9/fd/kjfm-37-149.PMC4891316.pdf
"• Smoking Cessation Program for Hospitalized Patients http://dx.doi.org/10.4082/kjfm.2016.37.3.149www.kjfm.or.kr   151 from the hospital before the smoking cessation consultation began, (2)  some of these patients had severe disease so that they could not pro - ceed with the consultation, and (3) some of these patients had refused  to participate in the smoking cessation consultation.",Non-OADS,/arxiv_data1/oa_pdf/c9/fd/kjfm-37-149.PMC4891316.pdf
• Smoking Cessation Program for Hospitalized Patients 152  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.149 cline.,Non-OADS,/arxiv_data1/oa_pdf/c9/fd/kjfm-37-149.PMC4891316.pdf
• Smoking Cessation Program for Hospitalized Patients http://dx.doi.org/10.4082/kjfm.2016.37.3.149www.kjfm.or.kr   153 vascular disease with 9.6% (5 patients: 2 patients with angina and 3  patients with myocardial ischemia) and the patients with a fracture  with 5.8% (3 patients).,Non-OADS,/arxiv_data1/oa_pdf/c9/fd/kjfm-37-149.PMC4891316.pdf
• Smoking Cessation Program for Hospitalized Patients 154  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.149 would actually have a consultation and prescription.,Non-OADS,/arxiv_data1/oa_pdf/c9/fd/kjfm-37-149.PMC4891316.pdf
"• Smoking Cessation Program for Hospitalized Patients http://dx.doi.org/10.4082/kjfm.2016.37.3.149www.kjfm.or.kr   155 patients, those patients who decided to quit smoking at the recom - mendation of their respective doctor had a substantially higher suc - cess rate of smoking cessation than those who decided to quit smoking  based on their own will.",Non-OADS,/arxiv_data1/oa_pdf/c9/fd/kjfm-37-149.PMC4891316.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/e2/kjfm-37-156.PMC4891317.pdf
"Keywords:  Colonoscopy; Pain; Colonoscopic; Decompression Received: August 17, 2015, Revised: October 28, 2015, Accepted: October 30, 2015 *Corresponding Author:  Jung-Hyun Kim  Tel: +82-43-230-6555, Fax: +82-43-230-6231, E-mail: astrobass@hanmail.nethttp://dx.doi.org/10.4082/kjfm.2016.37.3.156  • Korean J Fam Med 2016;37:156-163 Original Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/95/e2/kjfm-37-156.PMC4891317.pdf
"• An Effective Way to Reduce the Pain after Colonoscopy http://dx.doi.org/10.4082/kjfm.2016.37.3.156www.kjfm.or.kr   157 INTRODUCTION In Korea, annual colon cancer incidence has averaged 5.2% since 1999  and has increased steadily, although incidence rates vary between  men and women.1,2) Accordingly, the importance of early detection of  colorectal cancer by colonoscopy, especially in high-risk patients, is  well known.3-6) However, pain after colonoscopy is a major patient  complaint, and this is believed to cause reduced compliance with fol - low-up.7,8)  There have been several efforts to identify the cause of abdominal  pain after a colonoscopy, including a study by Lee et al.9) in which the  sex of the patient and the duration of the examination were found to  be the main causes of pain.",Non-OADS,/arxiv_data1/oa_pdf/95/e2/kjfm-37-156.PMC4891317.pdf
"• An Effective Way to Reduce the Pain after Colonoscopy 158  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.156 of variance (ANOVA) for continuous variables, and by chi-square test  for categorical variables when comparing general characteristics be - tween the 5 groups divided on the basis of reinsertion locations.",Non-OADS,/arxiv_data1/oa_pdf/95/e2/kjfm-37-156.PMC4891317.pdf
• An Effective Way to Reduce the Pain after Colonoscopy http://dx.doi.org/10.4082/kjfm.2016.37.3.156www.kjfm.or.kr   159 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/95/e2/kjfm-37-156.PMC4891317.pdf
"• An Effective Way to Reduce the Pain after Colonoscopy 160  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.156 hard in 35 (8.9%), 174 (43.0%), and 195 (48.1%) cases, respectively.",Non-OADS,/arxiv_data1/oa_pdf/95/e2/kjfm-37-156.PMC4891317.pdf
• An Effective Way to Reduce the Pain after Colonoscopy http://dx.doi.org/10.4082/kjfm.2016.37.3.156www.kjfm.or.kr   161 2.,Non-OADS,/arxiv_data1/oa_pdf/95/e2/kjfm-37-156.PMC4891317.pdf
"• An Effective Way to Reduce the Pain after Colonoscopy 162  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.156 rior mesenteric ganglia; this supports the hypothesis that air distention  of the proximal colon plays a critical role in abdominal pain after colo - noscopy.22-25)  As the pain scores between groups 3 and 4 were not significantly dif - ferent and the odds ratio difference between groups 3 and 2 was large,  scope reinsertion up to the transverse colon where the hepatic flexure  can be observed seems to be sufficiently beneficial, and reinsertion to  the cecum through the ascending colon may not have additional ben - efit.",Non-OADS,/arxiv_data1/oa_pdf/95/e2/kjfm-37-156.PMC4891317.pdf
• An Effective Way to Reduce the Pain after Colonoscopy http://dx.doi.org/10.4082/kjfm.2016.37.3.156www.kjfm.or.kr   163 16.,Non-OADS,/arxiv_data1/oa_pdf/95/e2/kjfm-37-156.PMC4891317.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e2/b5/kjfm-37-164.PMC4891318.pdf
"Keywords:  Frail; Cognition; Hand Strengths; Walking; Depression Received: February 27, 2015, Revised: September 16, 2015, Accepted: September 27, 2015 *Corresponding Author:  Cheol-Hwan Kim  Tel: +82-2-2001-2277, Fax: +82-2-2001-1260, E-mail: kchosh@nate.comhttp://dx.doi.org/10.4082/kjfm.2016.37.3.164  • Korean J Fam Med 2016;37:164-170 Original Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/e2/b5/kjfm-37-164.PMC4891318.pdf
"• The Association between Frailty and Cognition in Elderly Women http://dx.doi.org/10.4082/kjfm.2016.37.3.164www.kjfm.or.kr   165 INTRODUCTION Frailty means that the ability of a person to cope with stress is reduced  and it leads to negative outcomes such as falls, hospitalizations, dis - ability, and deaths.1) Frailty ultimately results in dependence and dis - abilities that are associated with the reduced physiological function.1)  Frailty is an important consideration for the elderly, because it is im - portant to maintain a life of independence and a guaranteed quality of  life for them.",Non-OADS,/arxiv_data1/oa_pdf/e2/b5/kjfm-37-164.PMC4891318.pdf
• The Association between Frailty and Cognition in Elderly Women 166  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.164 the study subjects.,Non-OADS,/arxiv_data1/oa_pdf/e2/b5/kjfm-37-164.PMC4891318.pdf
"• The Association between Frailty and Cognition in Elderly Women http://dx.doi.org/10.4082/kjfm.2016.37.3.164www.kjfm.or.kr   167 number of chronic diseases, and the number of medication taken by  the study participants.",Non-OADS,/arxiv_data1/oa_pdf/e2/b5/kjfm-37-164.PMC4891318.pdf
"• The Association between Frailty and Cognition in Elderly Women 168  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.164 culated by using the equation below, which was made by using multi - variate linear regression.",Non-OADS,/arxiv_data1/oa_pdf/e2/b5/kjfm-37-164.PMC4891318.pdf
"• The Association between Frailty and Cognition in Elderly Women http://dx.doi.org/10.4082/kjfm.2016.37.3.164www.kjfm.or.kr   169 Hence, it will not significantly affect the results of our study.",Non-OADS,/arxiv_data1/oa_pdf/e2/b5/kjfm-37-164.PMC4891318.pdf
• The Association between Frailty and Cognition in Elderly Women 170  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.164 ants.,Non-OADS,/arxiv_data1/oa_pdf/e2/b5/kjfm-37-164.PMC4891318.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/55/kjfm-37-171.PMC4891319.pdf
"Keywords:  Smoking; Cotinine; Surveys and Questionnaires; Self Report; Mass Screening Received: February 28, 2015, Revised: August 21, 2015, Accepted: September 27, 2015 *Corresponding Author:  Cheol Min Lee  Tel: +82-2-2112-5668, Fax: +82-2-2112-5635, E-mail: bigbangx@snuh.orghttp://dx.doi.org/10.4082/kjfm.2016.37.3.171  • Korean J Fam Med 2016;37:171-176 Original Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/17/55/kjfm-37-171.PMC4891319.pdf
"• Self-Reported vs. Urine-Cotinine Verified Smoking 172  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.171 INTRODUCTION Cigarette smoking is a leading risk factor for cancer, cardiovascular,  and pulmonary disorders.",Non-OADS,/arxiv_data1/oa_pdf/17/55/kjfm-37-171.PMC4891319.pdf
• Self-Reported vs. Urine-Cotinine Verified Smoking http://dx.doi.org/10.4082/kjfm.2016.37.3.171www.kjfm.or.kr   173 4) Urine cotinine test Urine samples were collected in plastic cups on the day of check-up.,Non-OADS,/arxiv_data1/oa_pdf/17/55/kjfm-37-171.PMC4891319.pdf
"• Self-Reported vs. Urine-Cotinine Verified Smoking 174  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.171  We analyzed the differences between CV and SR, and the ratios of  CV to SR relative to study variables ( Table 3 ).",OADS,/arxiv_data1/oa_pdf/17/55/kjfm-37-171.PMC4891319.pdf
"• Self-Reported vs. Urine-Cotinine Verified Smoking http://dx.doi.org/10.4082/kjfm.2016.37.3.171www.kjfm.or.kr   175 likely to show discrepancy between SR and CV rates compared to  graduates from graduation school (aOR, 2.33; 95% CI, 1.36–4.01).",Non-OADS,/arxiv_data1/oa_pdf/17/55/kjfm-37-171.PMC4891319.pdf
"• Self-Reported vs. Urine-Cotinine Verified Smoking 176  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.171 status, and formulate interventions to improve response rates.",Non-OADS,/arxiv_data1/oa_pdf/17/55/kjfm-37-171.PMC4891319.pdf
Available from: http://www.nhis.or.kr.,Non-OADS,/arxiv_data1/oa_pdf/17/55/kjfm-37-171.PMC4891319.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/1c/kjfm-37-177.PMC4891320.pdf
"Keywords:  Korean-Mini-Mental Status Examination; Seoul Neuropsychological Screening Battery-II; Sensitivity  and Specificity; Negative Predictive Value; False Positive; False Negative Received: February 28, 2015, Revised: October 8, 2015, Accepted: October 15, 2015 *Corresponding Author:  Hyo-Rim Son  Tel: +82-62-602-6267, Fax: +82-62-602-6982, E-mail: isjbson@naver.comhttp://dx.doi.org/10.4082/kjfm.2016.37.3.177  • Korean J Fam Med 2016;37:177-181 Original Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/b7/1c/kjfm-37-177.PMC4891320.pdf
"• Accuracy of K-MMSE 178  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.177 INTRODUCTION Dementia incorporates a range of deficits, which include executive  dysfunction, impaired judgment, and varying degrees of memory loss.",Non-OADS,/arxiv_data1/oa_pdf/b7/1c/kjfm-37-177.PMC4891320.pdf
• Accuracy of K-MMSE http://dx.doi.org/10.4082/kjfm.2016.37.3.177www.kjfm.or.kr   179 K-MMSE test and SNSB-II result were divided into normal and abnor - mal in 15 percentile standards.,OADS,/arxiv_data1/oa_pdf/b7/1c/kjfm-37-177.PMC4891320.pdf
• Accuracy of K-MMSE 180  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.177 tients belonging to the ‘cognitive impairment’ group had a memory  disorder.,Non-OADS,/arxiv_data1/oa_pdf/b7/1c/kjfm-37-177.PMC4891320.pdf
• Accuracy of K-MMSE http://dx.doi.org/10.4082/kjfm.2016.37.3.177www.kjfm.or.kr   181 2012.,Non-OADS,/arxiv_data1/oa_pdf/b7/1c/kjfm-37-177.PMC4891320.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d2/9f/kjfm-37-182.PMC4891321.pdf
"Keywords:  Dietary Supplements; Health Behavior; Health Promotion Received: August 19, 2015, Revised: September 16, 2015, Accepted: October 7, 2015 *Corresponding Author:  Kyung-Shik Lee  Tel: +82-31-779-0152, Fax: +82-31-779-0169, E-mail: pinealbody@hanmail.nethttp://dx.doi.org/10.4082/kjfm.2016.37.3.182  • Korean J Fam Med 2016;37:182-187 Original Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/d2/9f/kjfm-37-182.PMC4891321.pdf
"• Dietary Supplements and Healthy Habits http://dx.doi.org/10.4082/kjfm.2016.37.3.182www.kjfm.or.kr   183 INTRODUCTION In South Korea, the number of people interested in health has in - creased following recent advancements in medicine and improve - ments in economic status.",Non-OADS,/arxiv_data1/oa_pdf/d2/9f/kjfm-37-182.PMC4891321.pdf
"• Dietary Supplements and Healthy Habits 184  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.182 ≥150 mg/dL or the use of cholesterol lowering medication; (4) serum  high density lipoprotein cholesterol level <40 mg/dL for men and <50  mg/dL for women or the use of cholesterol-lowering medication; or (5)  systolic blood pressure >130 mm Hg or diastolic blood pressure >85  mm Hg or the use of antihypertensive drugs for patients with a history  of hypertension.13)  Dietary supplement usage was assessed using the nutrition survey  conducted by a team of nutritionists.11) Frequent dietary supplement  users were defined as those who had taken vitamins, minerals, or  health functional foods for more than 2 weeks in the past year or more  than once in the past month.",Non-OADS,/arxiv_data1/oa_pdf/d2/9f/kjfm-37-182.PMC4891321.pdf
• Dietary Supplements and Healthy Habits http://dx.doi.org/10.4082/kjfm.2016.37.3.182www.kjfm.or.kr   185 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/d2/9f/kjfm-37-182.PMC4891321.pdf
"• Dietary Supplements and Healthy Habits 186  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.182 health to be normal, and women with dyslipidemia.",Non-OADS,/arxiv_data1/oa_pdf/d2/9f/kjfm-37-182.PMC4891321.pdf
"• Dietary Supplements and Healthy Habits http://dx.doi.org/10.4082/kjfm.2016.37.3.182www.kjfm.or.kr   187 low for more clear analyses regarding associations with health behav - iors and, thus, more relevant implications.",Non-OADS,/arxiv_data1/oa_pdf/d2/9f/kjfm-37-182.PMC4891321.pdf
Available from: http://kosis.kr.9.,Non-OADS,/arxiv_data1/oa_pdf/d2/9f/kjfm-37-182.PMC4891321.pdf
Available from: https://knhanes.cdc.go.kr/knhanes/index.do.,OADS,/arxiv_data1/oa_pdf/d2/9f/kjfm-37-182.PMC4891321.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a3/d0/kjfm-37-188.PMC4891322.pdf
"Keywords:  Metabolic Syndrome; Insulin Resistance; McAuley Index; Koreans Received: August 31, 2014, Revised: January 8, 2016, Accepted: January 11, 2016 *Corresponding Author:  Ji Won Lee  Tel: +82-2-2228-2338, Fax: +82-2-362-2473, E-mail: indi5645@yuhs.achttp://dx.doi.org/10.4082/kjfm.2016.37.3.188  • Korean J Fam Med 2016;37:188-196 Original Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/a3/d0/kjfm-37-188.PMC4891322.pdf
"• Markers of Insulin Resistance in Korean Adults http://dx.doi.org/10.4082/kjfm.2016.37.3.188www.kjfm.or.kr   189 INTRODUCTION Metabolic syndrome (MS) is clinically identified as a cluster of cardio - vascular risk factors and metabolic imbalances such as central obesity,  dyslipidemia, impaired glucose tolerance and dysregulation of blood  pressure.1) MS increases the risk of cardiometabolic diseases, includ - ing type II diabetes and cardiovascular disease.2) Furthermore, the  prevalence of MS is increasing steadily in several Asian countries3) ow- ing to the influence of socioeconomic westernization, resulting in  problems such as increasing obesity4,5) and reduced physical activity.6)  According to data from the Korean National Health and Nutrition Ex - amination Survey (1998–2007), the age-adjusted prevalence of MS in  Korean adults has rapidly increased in recent years, from 24.9% in  1998 to 31.3% in 2007.5) Although the precise mechanism of MS patho - genesis is still unknown, many studies have revealed that insulin resis - tance (IR) and related factors have a central role in the development of  metabolic dysfunction.7) As IR is a central factor in the development of  MS, the detection of MS may provide a suitable model to assess the  risk factors of IR, allowing preventative management of diseases such  as diabetes.",Non-OADS,/arxiv_data1/oa_pdf/a3/d0/kjfm-37-188.PMC4891322.pdf
"• Markers of Insulin Resistance in Korean Adults 190  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.188 mens Medical Solutions, Tarrytown, NY, USA).",Non-OADS,/arxiv_data1/oa_pdf/a3/d0/kjfm-37-188.PMC4891322.pdf
• Markers of Insulin Resistance in Korean Adults http://dx.doi.org/10.4082/kjfm.2016.37.3.188www.kjfm.or.kr   191  The correlations of IR to each index were also assessed.,OADS,/arxiv_data1/oa_pdf/a3/d0/kjfm-37-188.PMC4891322.pdf
• Markers of Insulin Resistance in Korean Adults 192  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.188 DM.,Non-OADS,/arxiv_data1/oa_pdf/a3/d0/kjfm-37-188.PMC4891322.pdf
"• Markers of Insulin Resistance in Korean Adults http://dx.doi.org/10.4082/kjfm.2016.37.3.188www.kjfm.or.kr   193 DISCUSSION Using the diagnosis of MS as a marker of IR, our cross-sectional study  showed that the McAuley index has the best accuracy for screening  uncomplicated IR in Korean adults.",Non-OADS,/arxiv_data1/oa_pdf/a3/d0/kjfm-37-188.PMC4891322.pdf
• Markers of Insulin Resistance in Korean Adults 194  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.188  Several other studies have also identified the McAuley index to be a  more accurate detection method for IR compared with other indices.,Non-OADS,/arxiv_data1/oa_pdf/a3/d0/kjfm-37-188.PMC4891322.pdf
"• Markers of Insulin Resistance in Korean Adults http://dx.doi.org/10.4082/kjfm.2016.37.3.188www.kjfm.or.kr   195 agreement with the results of our study.30) Although many previous  studies have compared the power of MS detection among IR indices,  relatively few studies have assessed an Asian population.",Non-OADS,/arxiv_data1/oa_pdf/a3/d0/kjfm-37-188.PMC4891322.pdf
• Markers of Insulin Resistance in Korean Adults 196  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.188 notypes.,Non-OADS,/arxiv_data1/oa_pdf/a3/d0/kjfm-37-188.PMC4891322.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5b/81/kjfm-37-197.PMC4891323.pdf
"K eywords: Radioactive Iodine; Proptosis; Ptosis; Thyroid Eye Disease; Relative Afferent Pupillary Defect Received: January 14, 2016, Revised: February 4, 2016, Accepted: March 10, 2016 *Corresponding Author: Nur Aqilah Salleh  Tel: +60-167762804, Fax: +60-391456673, E-mail: Aqilahthesisproject@yahoo.comhttp://dx.doi.org/10.4082/kjfm.2016.37.3.197  • Korean J Fam Med 2016;37:197-201 Case Report eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/5b/81/kjfm-37-197.PMC4891323.pdf
• Partial Ptosis and Proptosis in Thyroid Eye Disease 198  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.197 INTRODUCTION Thyroid eye disease (TED) is a chronic inflammatory disease of the eye  that can occur in patients with systemic thyroid disorder.,Non-OADS,/arxiv_data1/oa_pdf/5b/81/kjfm-37-197.PMC4891323.pdf
• Partial Ptosis and Proptosis in Thyroid Eye Disease http://dx.doi.org/10.4082/kjfm.2016.37.3.197www.kjfm.or.kr   199 Magnetic resonance imaging (MRI) of the orbit ( Figure 2 ) revealed  crowding of the orbital apex consistent with thyroid ophthalmopathy.,Non-OADS,/arxiv_data1/oa_pdf/5b/81/kjfm-37-197.PMC4891323.pdf
• Partial Ptosis and Proptosis in Thyroid Eye Disease 200  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.3.197 ophthalmopathy.,Non-OADS,/arxiv_data1/oa_pdf/5b/81/kjfm-37-197.PMC4891323.pdf
"• Partial Ptosis and Proptosis in Thyroid Eye Disease http://dx.doi.org/10.4082/kjfm.2016.37.3.197www.kjfm.or.kr   201 weeks (total period of 12 weeks with total dose of 4,500 mg).",Non-OADS,/arxiv_data1/oa_pdf/5b/81/kjfm-37-197.PMC4891323.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/a8/8d/40261_2016_Article_386.PMC4891385.pdf
Available from: http://www.fda.gov/ downloads/drugs/guidancecomplianceregulatoryinformation/gui- dances/ucm292362.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a8/8d/40261_2016_Article_386.PMC4891385.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/a0/9b/40261_2016_Article_388.PMC4891394.pdf
Available at  http://www.ahcpr.gov/clinic/uspstf/uspsbrca.htm   2.,Non-OADS,/arxiv_data1/oa_pdf/d7/0b/main.PMC4891469.pdf
"a phase I clinical trial evaluating therapeutic, autologous transduced dendritic cell vaccine expressing HER2/neu (http://www.clinicaltrials.gov/ct2/show/NCT01730118).",Non-OADS,/arxiv_data1/oa_pdf/84/db/CCR3-4-549.PMC4891476.pdf
http://www.els.net [doi: 10.1002/9780470015902.,Non-OADS,/arxiv_data1/oa_pdf/59/87/CCR3-4-593.PMC4891486.pdf
"Because of the family predisposition to BCCs, the patient was now offered genetic testing for the Basal CellNevus Syndrome (#109400, http://www.omim.org/), butthe patient declined.",Non-OADS,/arxiv_data1/oa_pdf/8d/e3/CCR3-4-601.PMC4891487.pdf
Available at http://www.nccn.org/ professionals/physician_gls/pdf/nmsc.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8d/e3/CCR3-4-601.PMC4891487.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc) *Correspondence: Dr Y Lu; E-mail: yunxia.lu@ki.se &2016 Cancer Research UK.,Non-OADS,/arxiv_data1/oa_pdf/98/36/bjc2016100a.PMC4891496.pdf
"All rights reserved 0007 – 0920/16 http://creativecommons.org/licenses/by-nc-sa/4.0/LETTER TO THE EDITOR British Journal of Cancer (2016) 114, e12 | doi: 10.1038/bjc.2016.100 www.bjcancer.com | DOI:10.1038/bjc.2016.100 1",Non-OADS,/arxiv_data1/oa_pdf/98/36/bjc2016100a.PMC4891496.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Cancer oxidase ERO1- adrives VEGF production 1234 www.bjcancer.com | DOI:10.1038/bjc.2016.105,Non-OADS,/arxiv_data1/oa_pdf/ce/20/bjc2016105a.PMC4891497.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Use of TCA and risk of glioma 1268 www.bjcancer.com | DOI:10.1038/bjc.2016.109",Non-OADS,/arxiv_data1/oa_pdf/82/dd/bjc2016109a.PMC4891498.pdf
"To the best of our knowledge, thereare two transcript variants of LGR5: one lacking exon 5 (LGR5 D5) and published in the ExPasy UniprotKB-data bank as variant VSP_ 054782, the other lacking exon 8 and published in the same database as variant VSP_037746 (http://www.uniprot.org/uniprot/ O75473).",Non-OADS,/arxiv_data1/oa_pdf/f6/00/bjc2016112a.PMC4891500.pdf
"To verify the exon organisation and alternative splice sites of the variants, we compared the DNA sequences to the genomic sequence of LGR5 registered with the CCDS database (http://www.ncbi.nlm.nih.gov/ CCDS/CcdsBrowse.cgi?REQUE ST=CCDS&GO=MainBrowse& DATA=CCDS9000.1).",OADS,/arxiv_data1/oa_pdf/f6/00/bjc2016112a.PMC4891500.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Transcript variants of LGR5 in colorectal cancer 1260 www.bjcancer.com | DOI:10.1038/bjc.2016.112,Non-OADS,/arxiv_data1/oa_pdf/f6/00/bjc2016112a.PMC4891500.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER BCL-2 family inhibition in leiomyosarcoma 1226 www.bjcancer.com | DOI:10.1038/bjc.2016.117,Non-OADS,/arxiv_data1/oa_pdf/ce/07/bjc2016117a.PMC4891502.pdf
The same was carried out to develop an online calculator: http://www.iricom.es/prognostictools/Cisne/ inicio.aspx.,Non-OADS,/arxiv_data1/oa_pdf/2b/85/bjc2016118a.PMC4891503.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Phase I of DT01 with radiotherapy in melanoma BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.120 1205,Non-OADS,/arxiv_data1/oa_pdf/0f/fe/bjc2016120a.PMC4891504.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Vorinostat-XP in gastric cancer 1190 www.bjcancer.com | DOI:10.1038/bjc.2016.125,Non-OADS,/arxiv_data1/oa_pdf/12/06/bjc2016125a.PMC4891506.pdf
"All rights reserved 0007 – 0920/16 http://creativecommons.org/licenses/by-nc-sa/4.0/LETTER TO THE EDITOR British Journal of Cancer (2016) 114, e8 | doi: 10.1038/bjc.2016.69 www.bjcancer.com | DOI:10.1038/bjc.2016.69 1",Non-OADS,/arxiv_data1/oa_pdf/e4/36/bjc201669a.PMC4891507.pdf
All rights reserved 0007 – 0920/16 http://creativecommons.org/licenses/by-nc-sa/4.0/Letter to the Editor BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.70 3,Non-OADS,/arxiv_data1/oa_pdf/4a/39/bjc201670a.PMC4891508.pdf
"Data were linked by a third party under the custodianship of the DVA, the NSW Ministry of Health and the Cancer Institute NSW, using best practice, probabilistic, and privacy-preserving protocols (Centre for Health Record Linkage (CHeReL), http://www.cherel.org.au/).",OADS,/arxiv_data1/oa_pdf/e2/7f/bjc201675a.PMC4891509.pdf
Available from: http://www.aihw.gov.au/deaths/age-at-death/ (accessed July 2015).,Non-OADS,/arxiv_data1/oa_pdf/e2/7f/bjc201675a.PMC4891509.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER End-of-life health service use and costs in cancer decedents 1302 www.bjcancer.com | DOI:10.1038/bjc.2016.75,Non-OADS,/arxiv_data1/oa_pdf/e2/7f/bjc201675a.PMC4891509.pdf
Available at:http://goo.gl/mcJ0iO (accessed on 17 March 2016).,Non-OADS,/arxiv_data1/oa_pdf/57/de/bjc201677a.PMC4891510.pdf
Available at: http://www.incisivehealth.com/uploads/Saving%20lives%20averting%20costs.pdf(accessed on 27 October 2015).,Non-OADS,/arxiv_data1/oa_pdf/57/de/bjc201677a.PMC4891510.pdf
Available at: https://www.nao.org.uk/wp-content/uploads/2015/01/Progress-improving-cancer-services-and-outcomes-in-England.pdf (accessed on 17 March 2016).,Non-OADS,/arxiv_data1/oa_pdf/57/de/bjc201677a.PMC4891510.pdf
Available at: http://www.nice.org.uk/guidance/ ng12/evidence/full-guidance-65700685 (accessed on 24 August 2015).,Non-OADS,/arxiv_data1/oa_pdf/57/de/bjc201677a.PMC4891510.pdf
Available at: http://www.nuffieldtrust.org.uk/sites/files/nuffield/140602_social_care_for_cancer_survivors_full_report.pdf(accessed on 17 March 2016).,Non-OADS,/arxiv_data1/oa_pdf/57/de/bjc201677a.PMC4891510.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Cost of care for cancer patients in England 1292 www.bjcancer.com | DOI:10.1038/bjc.2016.77",Non-OADS,/arxiv_data1/oa_pdf/57/de/bjc201677a.PMC4891510.pdf
All rights reserved 0007 – 0920/16 http://creativecommons.org/licenses/by-nc-sa/4.0/BRITISH JOURNAL OF CANCER Letter to the Editor 2 www.bjcancer.com | DOI:10.1038/bjc.2016.81,Non-OADS,/arxiv_data1/oa_pdf/a1/99/bjc201681a.PMC4891511.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Meta-analysis of estimates adjusted for adherence 1276 www.bjcancer.com | DOI:10.1038/bjc.2016.90,Non-OADS,/arxiv_data1/oa_pdf/66/4b/bjc201690a.PMC4891513.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Function of ps20 in the prostate stroma 1242 www.bjcancer.com | DOI:10.1038/bjc.2016.91,Non-OADS,/arxiv_data1/oa_pdf/31/fe/bjc201691a.PMC4891514.pdf
"MATLAB 2012b (The MathWorks, Natick, MA, USA) was used for Nucleotyping, whereas survival analyses were carried out in Stata/SE 14.0 (StataCorp, College Station, TX, USA) and R v.3.1.3 (http://www.r-project.org).",OADS,/arxiv_data1/oa_pdf/60/c7/bjc201696a.PMC4891515.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Chromatin changes predict prostate cancer relapse 1250 www.bjcancer.com | DOI:10.1038/bjc.2016.96",Non-OADS,/arxiv_data1/oa_pdf/60/c7/bjc201696a.PMC4891515.pdf
"All residual samples are stored in the Scottish HPV Archive, a national repository and ‘collection of collections’ of cervical samples for use in research http://www.shine.mvm.ed.ac.uk/archive.shtml.",OADS,/arxiv_data1/oa_pdf/70/3e/bjc201697a.PMC4891516.pdf
"There are caveats to our analysis; as immunisation uptake for the complete schedule has been consistently high in Scotland, relatively few women had o3 doses (http://www.isdscotland.org/ Health-Topics/Child-Health/publications/index.asp.)",Non-OADS,/arxiv_data1/oa_pdf/70/3e/bjc201697a.PMC4891516.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)DII and breast cancer incidence and death BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.98 1285,Non-OADS,/arxiv_data1/oa_pdf/41/d0/bjc201698a.PMC4891517.pdf
"All rights reserved 0007 – 0920/16http://creativecommons.org/licenses/by-nc-sa/4.0/LETTER TO THE EDITOR British Journal of Cancer (2016) 114, e11 | doi: 10.1038/bjc.2016.99 www.bjcancer.com | DOI:10.1038/bjc.2016.99 1",Non-OADS,/arxiv_data1/oa_pdf/d6/af/bjc201699a.PMC4891518.pdf
" Annals of Surgical Treatment and Research 297pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.90.6.297 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE An online questionnaire survey on preferred timing for  the diagnosis and management of thyroid carcinoma in  general population in Korea Jin-Woo Park1,2, Jae-Soo Yoo3, Jin-Kyung Yun3, Byoung-Hoon Kim3, Yeon-Woo Noh3, Dong-Ju Kim2 1Department of Surgery, College of Medicine Chungbuk National University, Cheongju, 2Department of Surgery, Chungbuk  National University Hospital, Cheongju, 3Department of Information & Communication Engineering, College of Electrical and  Computer Engineering, Chungbuk National University, Cheongju, Korea INTRODUCTION Early diagnosis and treatment have been emphasized as a key  to control cancer for a long time.",Non-OADS,/arxiv_data1/oa_pdf/20/5f/astr-90-297.PMC4891519.pdf
An online survey was conducted from March 3 to June 3 in  2015 using Google Survey (http://goo.gl/forms/b81yEjqNUA).,OADS,/arxiv_data1/oa_pdf/20/5f/astr-90-297.PMC4891519.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/5f/astr-90-297.PMC4891519.pdf
An online questionnaire survey was conducted from  March 3 to June 3 in 2015 using Google Survey (http://goo.gl/forms/b81yEjqNUA).,OADS,/arxiv_data1/oa_pdf/20/5f/astr-90-297.PMC4891519.pdf
Available from: http://www.nccn.org/ professionals/physician_gls/f_guidelines.,Non-OADS,/arxiv_data1/oa_pdf/20/5f/astr-90-297.PMC4891519.pdf
" Annals of Surgical Treatment and Research 303pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.90.6.303 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Risk factors for conversion to conventional laparoscopic  cholecystectomy in single incision laparoscopic  cholecystectomy Sung Gon Kim, Ju Ik Moon, In Seok Choi, Sang Eok Lee, Nak Song Sung, Ki Won Chun, Hye Yoon Lee,   Dae Sung Yoon, Won Jun Choi Department of Surgery, Konyang University Hospital, Daejeon, Korea INTRODUCTION Laparoscopic cholecystectomy has been recognized as  the gold standard for treatment of benign gallbladder (GB)  diseases [1 ­3].",Non-OADS,/arxiv_data1/oa_pdf/67/e6/astr-90-303.PMC4891520.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/e6/astr-90-303.PMC4891520.pdf
 Annals of Surgical Treatment and Research 309pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.90.6.309 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Who experiences endoscopic retrograde  cholangiopancreatography after laparoscopic  cholecystectomy for symptomatic gallstone disease?,Non-OADS,/arxiv_data1/oa_pdf/c9/68/astr-90-309.PMC4891521.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/68/astr-90-309.PMC4891521.pdf
" Annals of Surgical Treatment and Research 315pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.90.6.315 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE The effects of scalpel, harmonic scalpel and monopolar  electrocautery on the healing of colonic anastomosis  after colonic resection Gökhan Karaca, M. Recep Pekcici, Canan Altunkaya1, Vildan Fidanci2, Aytul Kilinc2, Huseyin Ozer, Ahmet Tekeli3,  Kuzey Aydinuraz4, Osman Guler  Departments of General Surgery, 1Pathology, 2Biochemistry, Ankara Education and Research Hospital, Ankara, 3Yil University,  Faculty of Veterinary, Van, 4Department of General Surgery, Kirikkale University Medical Faculty, Kirikkale, Turkey INTRODUCTION Colonic anastomosis is one of the major prodecures of both  elective and urgent general surgical procedures.",Non-OADS,/arxiv_data1/oa_pdf/68/8e/astr-90-315.PMC4891522.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/8e/astr-90-315.PMC4891522.pdf
"322pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.90.6.322 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Preoperative thrombocytosis predicts prognosis in stage  II colorectal cancer patients Yong Sun Lee, Kwang Wook Suh, Seung Yeop Oh Department of Surgery, Ajou University School of Medicine, Suwon, Korea INTRODUCTION Colorectal cancer (CRC) remains a leading cause of cancer  related death worldwide.",Non-OADS,/arxiv_data1/oa_pdf/e0/b3/astr-90-322.PMC4891523.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/b3/astr-90-322.PMC4891523.pdf
"328pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.90.6.328 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Comparison of perioperative and short-term outcomes  between robotic and conventional laparoscopic surgery  for colonic cancer: a systematic review and meta-analysis Sungwon Lim*, Jin Hee Kim1,*, Se-Jin Baek2, Seon-Hahn Kim2, Seon Heui Lee3 National Evidence-Based Healthcare Collaborating Agency, Seoul, 1Department of Nursing, College of Medicine, Chosun  University, Gwangju, 2Division  of Colorectal Surgery, Department of Surgery, Korea University College of Medicine, Seoul,  3Department of Nursing Science, College of Nursing, Gachon University, Incheon, Korea INTRODUCTION In the last decade, laparoscopic surgery has become popular  in many surgical fields due to its advantages compared to the  open approach, such as less pain, faster recovery/resumption of daily activities, and better cosmesis [1,2].",Non-OADS,/arxiv_data1/oa_pdf/7c/af/astr-90-328.PMC4891524.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/af/astr-90-328.PMC4891524.pdf
Available  from: http://handbook.cochrane.org.,OADS,/arxiv_data1/oa_pdf/7c/af/astr-90-328.PMC4891524.pdf
"340pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.90.6.340 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Thrombophilia in Korean patients with arterial or venous  thromboembolisms Sungbae Kim, Incheol Song, Hyung-Kee Kim, Seung Huh Division of Vascular Surgery, Department of Surgery, Kyungpook National University School of Medicine, Daegu, Korea INTRODUCTION Thrombophilia is a condition that increases the risk of  thromboembolic events via altered hemostasis, shifting the  balance in favor of thrombus formation.",Non-OADS,/arxiv_data1/oa_pdf/af/eb/astr-90-340.PMC4891525.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/af/eb/astr-90-340.PMC4891525.pdf
"346pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.90.6.346 Annals of Surgical Treatment and ResearchCASE REPORT Uncomplicated jejunal diverticulosis with  pneumoperitoneum Jae Young Kwak, Eun Hwa Park, Cheon Soo Park, Ji Hoon Kim, Myeong Sik Han, Jin Ho Kwak Department of Surgery, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea INTRODUCTION Jejunal diverticulosis is a very rare clinical entity, and is  identified in 0.02% to 0.42% of standard radiological studies.",Non-OADS,/arxiv_data1/oa_pdf/e2/bd/astr-90-346.PMC4891526.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e2/bd/astr-90-346.PMC4891526.pdf
"350pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.90.6.350 Annals of Surgical Treatment and ResearchCASE REPORT Isolated cystic duct cyst with associated stones in a  4-month-old boy Joong Kee Youn, Hyejin Kim, Hyun-Young Kim, Sung-Eun Jung Department of Pediatric Surgery, Seoul National University Children’s Hospital, Seoul, Korea INTRODUCTION Choledochal cysts are rare hepatobiliary abnormalities with  an incidence of 1 per 100,000–150,000 in the general population  and 1 in 1,000 in Asia.",Non-OADS,/arxiv_data1/oa_pdf/30/8c/astr-90-350.PMC4891527.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/30/8c/astr-90-350.PMC4891527.pdf
"Our great enterprise of difficult airway management begins  with the implementation of the guidelines in the most accurate manner to manage our patients safely.Editorial Guidelines help us to keep calm  when facing a difficult airway Bon-Nyeo Koo  Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Anesthesia and Pain  Research Institute, Seoul, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/2b/kjae-69-209.PMC4891530.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2016 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Bon-Nyeo Koo, M.D., Ph.D. Department of Anesthesiology and Pain Medicine, Y onsei University College of Medicine, Anesthesia and Pain Research Institute, 50, Y onsei-ro, Seodaemun-gu, Seoul 03722, KoreaTel: 82-2-2228-2422, Fax: 82-2-312-7185E-mail: koobn@yuhs.acORCID: http://orcid.org/0000-0002-3189-1673 Korean J Anesthesiol 2016 June 69(3): 209-210  http://dx.doi.org/10.4097/kjae.2016.69.3.209",Non-OADS,/arxiv_data1/oa_pdf/88/2b/kjae-69-209.PMC4891530.pdf
210 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/88/2b/kjae-69-209.PMC4891530.pdf
"Key Words: Patient-controlled analgesia, Postoperative pain.A new therapeutic option for  postoperative pain management  with oxycodone HCI injection Byung Moon Choi  Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine,  Seoul, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/cb/kjae-69-211.PMC4891531.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2016 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Byung Moon Choi, M.D., Ph.D. Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, KoreaTel: 82-2-3010-1704, Fax: 82-2-3010-6790E-mail: byungmoonchoi7@gmail.comORCID: http://orcid.org/0000-0002-6561-8851 Received: January 5, 2016.",Non-OADS,/arxiv_data1/oa_pdf/64/cb/kjae-69-211.PMC4891531.pdf
Korean J Anesthesiol 2016 June 69(3): 211-218  http://dx.doi.org/10.4097/kjae.2016.69.3.211,Non-OADS,/arxiv_data1/oa_pdf/64/cb/kjae-69-211.PMC4891531.pdf
212 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/64/cb/kjae-69-211.PMC4891531.pdf
213 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL Byung Moon Choi  with the parent drug [19].,Non-OADS,/arxiv_data1/oa_pdf/64/cb/kjae-69-211.PMC4891531.pdf
1)http://app.purduepharma.com/xmlpublishing/pi.aspx?id=o.,Non-OADS,/arxiv_data1/oa_pdf/64/cb/kjae-69-211.PMC4891531.pdf
214 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/64/cb/kjae-69-211.PMC4891531.pdf
"2.1.3; Bionet Co. Ltd., Seoul, Korea, http://www.fit4nm.org/download, last ac-cessed: Aug 27, 2012).",Non-OADS,/arxiv_data1/oa_pdf/64/cb/kjae-69-211.PMC4891531.pdf
"215 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL Byung Moon Choi  ing dose of 2 mg, while unaffected by background infusion of 1  mg/h.",Non-OADS,/arxiv_data1/oa_pdf/64/cb/kjae-69-211.PMC4891531.pdf
216 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/64/cb/kjae-69-211.PMC4891531.pdf
"217 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL Byung Moon Choi  17.5 hours after the end of surgery, and steady-state concentra- tion (1.8 ng/ml) was double the MEAC (1 ng/ml) of fentanyl (Fig.",Non-OADS,/arxiv_data1/oa_pdf/64/cb/kjae-69-211.PMC4891531.pdf
218 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/64/cb/kjae-69-211.PMC4891531.pdf
"Key Words: Biomedical research, Research, Statistical analysis, Statistical errors, Statistics.Avoiding negative reviewer  comments: common statistical  errors in anesthesia journals Sangseok Lee Department of Anesthesiology and Pain Medicine, Sanggye Paik Hospital, Inje University College of Medicine,  Seoul, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/62/kjae-69-219.PMC4891532.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2016 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Sangseok Lee, M.D.",Non-OADS,/arxiv_data1/oa_pdf/4a/62/kjae-69-219.PMC4891532.pdf
"Department of Anesthesiology and Pain Medicine, Sanggye Paik Hospital, Inje University College of Medicine, 1342, Dongil-ro, Nowon-gu, Seoul 01757, KoreaTel: 82-2-950-1171, Fax: 82-2-950-1323E-mail: s2248@paik.ac.krORCID: http://orcid.org/0000-0001-7023-3668 Received: April 4, 2016.",Non-OADS,/arxiv_data1/oa_pdf/4a/62/kjae-69-219.PMC4891532.pdf
Korean J Anesthesiol 2016 June 69(3): 219-226  http://dx.doi.org/10.4097/kjae.2016.69.3.219,Non-OADS,/arxiv_data1/oa_pdf/4a/62/kjae-69-219.PMC4891532.pdf
220 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/4a/62/kjae-69-219.PMC4891532.pdf
"221 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL Sangseok Lee sectional studies provide a snapshot of a disease or condition at  a specific time point; thus, attention should be paid to the infer - ence of disease progression on the basis of the results obtained from these studies.",Non-OADS,/arxiv_data1/oa_pdf/4a/62/kjae-69-219.PMC4891532.pdf
222 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/4a/62/kjae-69-219.PMC4891532.pdf
223 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL Sangseok Lee relationship.,Non-OADS,/arxiv_data1/oa_pdf/4a/62/kjae-69-219.PMC4891532.pdf
224 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/4a/62/kjae-69-219.PMC4891532.pdf
"225 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL Sangseok Lee guidelines such as CONSORT, which includes a flow diagram  and a checklist and which clearly states the types of informa-tion that should be included in an article for reproduction of its experiment.",OADS,/arxiv_data1/oa_pdf/4a/62/kjae-69-219.PMC4891532.pdf
226 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/4a/62/kjae-69-219.PMC4891532.pdf
Available from http://dx.doi.org/10.1080/00031305.2016.1154108 19.,Non-OADS,/arxiv_data1/oa_pdf/4a/62/kjae-69-219.PMC4891532.pdf
"Key Words: Electromyography, Entropy, Pyridostigmine bromide.Effect of neuromuscular blockade  reversal by pyridostigmine on  spectral entropy values during  recovery from desflurane anesthesia: a prospective,  randomized, double-blind,  controlled trial Eugene Kim, Jae Hun Ryu, and Sung Hye Byun Department of Anesthesiology and Pain Medicine, Catholic University of Daegu School of Medicine,  Daegu, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/60/63/kjae-69-227.PMC4891533.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2016 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Sung Hye Byun, M.D.",Non-OADS,/arxiv_data1/oa_pdf/60/63/kjae-69-227.PMC4891533.pdf
"Department of Anesthesiology and Pain Medicine, Catholic University of Daegu School of Medicine, 33, Duryugongwon-ro 17-gil, Nam-gu, Daegu 42472, KoreaTel: 82-53-650-3620, Fax: 82-53-650-4517E-mail: stone0311@cu.ac.krORCID: http://orcid.org/0000-0002-9287-5087 Received: November 27, 2015.",Non-OADS,/arxiv_data1/oa_pdf/60/63/kjae-69-227.PMC4891533.pdf
"Accepted: February 3, 2016.Korean J Anesthesiol 2016 June 69(3): 227-233  http://dx.doi.org/10.4097/kjae.2016.69.3.227",Non-OADS,/arxiv_data1/oa_pdf/60/63/kjae-69-227.PMC4891533.pdf
228 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/60/63/kjae-69-227.PMC4891533.pdf
229 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Kim et al.,OADS,/arxiv_data1/oa_pdf/60/63/kjae-69-227.PMC4891533.pdf
230 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/60/63/kjae-69-227.PMC4891533.pdf
231 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Kim et al.,OADS,/arxiv_data1/oa_pdf/60/63/kjae-69-227.PMC4891533.pdf
232 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/60/63/kjae-69-227.PMC4891533.pdf
"ORCID Eugene Kim, http://orcid.org/0000-0002-1926-4191Sung Hye Byun, http://orcid.org/0000-0002-9287-5087 References 1.",Non-OADS,/arxiv_data1/oa_pdf/60/63/kjae-69-227.PMC4891533.pdf
233 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Kim et al.,OADS,/arxiv_data1/oa_pdf/60/63/kjae-69-227.PMC4891533.pdf
"Key Words: Acupressure, Cough, Dilution technique, Fentanyl.Acupressure versus dilution of  fentanyl to reduce incidence of  fentanyl-induced cough in female  cancer patients: a prospective randomized controlled study Sohan Lal Solanki, Jeson Rajan Doctor, Savi J Kapila,   Raghbirsingh P Gehdoo, and Jigeeshu V Divatia Department of Anesthesiology, Critical Care and Pain, Tata Memorial Center, Mumbai, India CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/91/c8/kjae-69-234.PMC4891534.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2016 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Sohan Lal Solanki, M.D.",Non-OADS,/arxiv_data1/oa_pdf/91/c8/kjae-69-234.PMC4891534.pdf
Korean J Anesthesiol 2016 June 69(3): 234-238  http://dx.doi.org/10.4097/kjae.2016.69.3.234,Non-OADS,/arxiv_data1/oa_pdf/91/c8/kjae-69-234.PMC4891534.pdf
235 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Solanki et al.,OADS,/arxiv_data1/oa_pdf/91/c8/kjae-69-234.PMC4891534.pdf
236 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/91/c8/kjae-69-234.PMC4891534.pdf
237 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Solanki et al.,OADS,/arxiv_data1/oa_pdf/91/c8/kjae-69-234.PMC4891534.pdf
238 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/91/c8/kjae-69-234.PMC4891534.pdf
Available from http://www.acupressure.,Non-OADS,/arxiv_data1/oa_pdf/91/c8/kjae-69-234.PMC4891534.pdf
Available from http://www.herbalshop.com/Acupressure/Acupressure_55.,Non-OADS,/arxiv_data1/oa_pdf/91/c8/kjae-69-234.PMC4891534.pdf
"Key Words: Neostigmine, Neuromuscular monitoring, Rocuronium, Sugammadex.Relationship between first- twitch depression and train-of- four ratio during sugammadex  reversal of rocuronium-induced neuromuscular blockade Kyo Sang Kim, Y ou Na Oh, Tae Y eon Kim, Song Y ee Oh, and Y eong Hun Sin Department of Anesthesiology and Pain Medicine, Hanyang University College of Medicine, Seoul, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/fb/kjae-69-239.PMC4891535.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2016 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Kyo Sang Kim, M.D., Ph.D. Department of Anesthesiology and Pain Medicine, Hanyang University College of Medicine, 222, Wangsimni-ro, Seongdong-gu, Seoul 04763, KoreaTel: 82-2-2290-8680, Fax: 82-2-2299-0742E-mail: kimks@hanyang.ac.krORCID: http://orcid.org/0000-0002-2186-3484 Received: January 13, 2016.",Non-OADS,/arxiv_data1/oa_pdf/66/fb/kjae-69-239.PMC4891535.pdf
Korean J Anesthesiol 2016 June 69(3): 239-243  http://dx.doi.org/10.4097/kjae.2016.69.3.239,Non-OADS,/arxiv_data1/oa_pdf/66/fb/kjae-69-239.PMC4891535.pdf
240 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/66/fb/kjae-69-239.PMC4891535.pdf
241 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Kim et al.,OADS,/arxiv_data1/oa_pdf/66/fb/kjae-69-239.PMC4891535.pdf
242 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/66/fb/kjae-69-239.PMC4891535.pdf
243 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Kim et al.,OADS,/arxiv_data1/oa_pdf/66/fb/kjae-69-239.PMC4891535.pdf
"Key Words: Difficult, Grade, Intubation, Scale, Unexpected.Encountering unexpected difficult  airway: relationship with the  intubation difficulty scale Wonuk Koh, Hajung Kim, Kyongsun Kim, Y oung-Jin Ro, and   Hong-Seuk Y ang Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9f/b9/kjae-69-244.PMC4891536.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2016 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Hong-Seuk Y ang, M.D., Ph.D. Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, KoreaTel: 82-2-3010-3865, Fax: 82-2-470-1363E-mail: hsyang@amc.seoul.kr Received: December 29, 2015.",Non-OADS,/arxiv_data1/oa_pdf/9f/b9/kjae-69-244.PMC4891536.pdf
Korean J Anesthesiol 2016 June 69(3): 244-249  http://dx.doi.org/10.4097/kjae.2016.69.3.244,Non-OADS,/arxiv_data1/oa_pdf/9f/b9/kjae-69-244.PMC4891536.pdf
245 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Koh et al.,OADS,/arxiv_data1/oa_pdf/9f/b9/kjae-69-244.PMC4891536.pdf
246 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/9f/b9/kjae-69-244.PMC4891536.pdf
247 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Koh et al.,OADS,/arxiv_data1/oa_pdf/9f/b9/kjae-69-244.PMC4891536.pdf
248 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/9f/b9/kjae-69-244.PMC4891536.pdf
249 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Koh et al.,Non-OADS,/arxiv_data1/oa_pdf/9f/b9/kjae-69-244.PMC4891536.pdf
"Key Words: General anesthesia, Heart rate variability, QT interval, QTVI, Sevoflurane, Tourniquets.Change of QT variability index  during general anesthesia  In Y oung Huh, Dae-Y oung Kim, Minha Sung, Minhyun Lee, and   Soon Eun Park Department of Anesthesiology and Pain Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/14/kjae-69-250.PMC4891537.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2016 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: In Y oung Huh, M.D., Ph.D. Department of Anesthesiology and Pain Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, 877, Bangeojin-sun hwando-ro, Dong-gu, Ulsan 44033, Korea Tel: 82-52-250-7246, Fax: 82-52-250-7249 E-mail: inyoung_huh@uuh.ulsan.krORCID: http://orcid.org/0000-0003-2760-9898 Received: October 2, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b5/14/kjae-69-250.PMC4891537.pdf
Korean J Anesthesiol 2016 June 69(3): 250-254  http://dx.doi.org/10.4097/kjae.2016.69.3.250,Non-OADS,/arxiv_data1/oa_pdf/b5/14/kjae-69-250.PMC4891537.pdf
251 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Huh et al.,OADS,/arxiv_data1/oa_pdf/b5/14/kjae-69-250.PMC4891537.pdf
252 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/b5/14/kjae-69-250.PMC4891537.pdf
253 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Huh et al.,OADS,/arxiv_data1/oa_pdf/b5/14/kjae-69-250.PMC4891537.pdf
254 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/b5/14/kjae-69-250.PMC4891537.pdf
"Key Words: Cough, Dexamethasone, Hoarseness, Prone position, Sore throat.The prophylactic effect of  dexamethasone on postoperative  sore throat in prone position  surgery Sang Ho Lee, Y oon Chan Lee, Ji Hyeon Lee, So Ron Choi, Seung-Cheol Lee,  Jong Hwan Lee, and Chan Jong Chung Department of Anesthesiology and Pain Medicine, Dong-A University Hospital, Busan, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fd/cf/kjae-69-255.PMC4891538.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2016 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Ji Hyeon Lee, M.D., Ph.D. Department of Anesthesiology and Pain Medicine, Dong-A University Medical Center, 26, Daesingongwon-ro, Seo-gu, Busan 49201, KoreaTel: 82-51-240-5390, Fax: 82-51-247-7819E-mail: jh57@dau.ac.kr This is a thesis for a Master's degree by Sang Ho Lee.",Non-OADS,/arxiv_data1/oa_pdf/fd/cf/kjae-69-255.PMC4891538.pdf
Korean J Anesthesiol 2016 June 69(3): 255-261  http://dx.doi.org/10.4097/kjae.2016.69.3.255,Non-OADS,/arxiv_data1/oa_pdf/fd/cf/kjae-69-255.PMC4891538.pdf
256 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/fd/cf/kjae-69-255.PMC4891538.pdf
257 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Lee et al.,OADS,/arxiv_data1/oa_pdf/fd/cf/kjae-69-255.PMC4891538.pdf
258 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/fd/cf/kjae-69-255.PMC4891538.pdf
259 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Lee et al.,OADS,/arxiv_data1/oa_pdf/fd/cf/kjae-69-255.PMC4891538.pdf
260 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/fd/cf/kjae-69-255.PMC4891538.pdf
261 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Lee et al.,OADS,/arxiv_data1/oa_pdf/fd/cf/kjae-69-255.PMC4891538.pdf
"Key Words: Inflammation, Interleukins, Thiamylal.Thiamylal sodium increased  inflammation and the proliferation  of vascular smooth muscle cells Ryohei Miyazaki1 and Sumio Hoka2 Department of Anesthesiology and Critical Care Medicine, 1Kyushu University Hospital, 2Graduate School of  Medical Sciences, Kyushu University, Fukuoka, Japan CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/29/kjae-69-262.PMC4891539.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2016 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Ryohei Miyazaki, M.D., Ph.D. Department of Anesthesiology and Critical Care Medicine, Kyushu University Hospital, 3-1-1 Maidashi, Higashi-ku, Fukuoka 8128582, Japan Tel: 81-926425714, Fax: 81-926425722E-mail: miyaryou@kuaccm.med.kyushu-u.ac.jp Received: November 6, 2015.",Non-OADS,/arxiv_data1/oa_pdf/4d/29/kjae-69-262.PMC4891539.pdf
Korean J Anesthesiol 2016 June 69(3): 262-269  http://dx.doi.org/10.4097/kjae.2016.69.3.262,Non-OADS,/arxiv_data1/oa_pdf/4d/29/kjae-69-262.PMC4891539.pdf
263 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL Ryohei Miyazaki and Sumio Hoka dium solution (TSS: Citosol)-responsive inflammatory related  genes in a rat VSMC cell line using microarray analysis.,OADS,/arxiv_data1/oa_pdf/4d/29/kjae-69-262.PMC4891539.pdf
264 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/4d/29/kjae-69-262.PMC4891539.pdf
"265 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL Ryohei Miyazaki and Sumio Hoka TSs increases IL-6 production In Vitro  and Ex Vivo VSMCs were incubated with TSS for 24 h. TSS-induced IL-6  production was significantly increased in a dose-dependent manner (Control 16.4 ± 6.5 pg/ml [range: 0.91–31.85 pg/ml];  TSS [10 µM] 119.2 ± 28.4 pg/ml [range: 51.9–186.4 pg/ml], P = 0.145; TSS [30 µM] 194.8 ± 78.1 pg/ml [range: 10.1–379.6 pg/ml], P = 0.015; Fig.",Non-OADS,/arxiv_data1/oa_pdf/4d/29/kjae-69-262.PMC4891539.pdf
266 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/4d/29/kjae-69-262.PMC4891539.pdf
267 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL Ryohei Miyazaki and Sumio Hoka ten causes phlebitis or local necrosis at the injection site.,Non-OADS,/arxiv_data1/oa_pdf/4d/29/kjae-69-262.PMC4891539.pdf
268 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/4d/29/kjae-69-262.PMC4891539.pdf
269 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL Ryohei Miyazaki and Sumio Hoka 9.,Non-OADS,/arxiv_data1/oa_pdf/4d/29/kjae-69-262.PMC4891539.pdf
"Key Words: Bronchial blocker, Hemoptysis, One-lung isolation.Experience of hemostasis in  tracheal bleeding very close to the  carina by the bronchial blocker  -a case report- MinKi Son1, Sangjun Lee2, Sang Hyun Lee1, Taewan Lim1, Soo Kyung Lee2,  and Kook Hyun Lee3 Department of Anesthesiology and Pain Medicine, 1Hallym University Dongtan Sacred Heart Hospital, Hwaseong,  2Hallym University Sacred Heart Hospital, Anyang, 3Seoul National University Hospital, Seoul, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/51/kjae-69-270.PMC4891540.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2016 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Taewan Lim, M.D., Ph.D. Department of Anesthesiology and Pain Medicine, Hallym University Dongtan Sacred Heart Hospital, 7, Keunjaebong-gil, Hwaseong 18450, KoreaTel: 82-31-8086-2283, Fax: 82-31-8086-2029E-mail: ltwhanzo@naver.com Received: July 8, 2015.",Non-OADS,/arxiv_data1/oa_pdf/e9/51/kjae-69-270.PMC4891540.pdf
Korean J Anesthesiol 2016 June 69(3): 270-274  http://dx.doi.org/10.4097/kjae.2016.69.3.270,Non-OADS,/arxiv_data1/oa_pdf/e9/51/kjae-69-270.PMC4891540.pdf
271 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Son et al.,OADS,/arxiv_data1/oa_pdf/e9/51/kjae-69-270.PMC4891540.pdf
272 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/e9/51/kjae-69-270.PMC4891540.pdf
273 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Son et al.,OADS,/arxiv_data1/oa_pdf/e9/51/kjae-69-270.PMC4891540.pdf
274 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/e9/51/kjae-69-270.PMC4891540.pdf
"Anesthetic experience of patient  with isolated left ventricular  noncompaction   -a case report- Doyeon Kim1, Eunhee Kim2, Jong-Hwan Lee1, Chung Su Kim1,   Sangmin Maria Lee1, and Jung Eun Lee1 Department of Anesthesiology and Pain Medicine, 1Samsung Medical Center, 2Seoul National University Hospital,  Seoul, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/76/7f/kjae-69-275.PMC4891541.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2016 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Chung Su Kim, M.D., Ph.D. Department of Anesthesiology and Pain Medicine, Samsung Medical Center, 81, Irwon-ro, Gangnam-gu, Seoul 06351, KoreaTel: 82-2-3410-0369, Fax: 82-2-3410-0361E-mail: kem99@skku.edu Received: January 9, 2015.",Non-OADS,/arxiv_data1/oa_pdf/76/7f/kjae-69-275.PMC4891541.pdf
Korean J Anesthesiol 2016 June 69(3): 275-278  http://dx.doi.org/10.4097/kjae.2016.69.3.275,Non-OADS,/arxiv_data1/oa_pdf/76/7f/kjae-69-275.PMC4891541.pdf
276 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/76/7f/kjae-69-275.PMC4891541.pdf
277 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Kim et al.,OADS,/arxiv_data1/oa_pdf/76/7f/kjae-69-275.PMC4891541.pdf
278 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/76/7f/kjae-69-275.PMC4891541.pdf
"Key Words: One lung ventilation, Perfusion, Thoracic surgery.Severe hypoxemia during carinal  resection in the lateral position  under one-lung ventilation of a  non-dependent lung  -a case report- Chang-Hoon Koo1, Y oo Sun Jung1, Y ong-Hun Lee2, Hyun-Chang Kim3,   Jae-Hyon Bahk1, and Jeong-Hwa Seo1 Department of Anesthesiology and Pain Medicine, 1Seoul National University Hospital, 2Asan Medical Center,  Seoul, 3Keimyung University Dongsan Medical Center, Daegu, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9b/e2/kjae-69-279.PMC4891542.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2016 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Jeong-Hwa Seo, M.D., Ph.D. Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, 101, Daehak-ro, Jongno-gu, Seoul 03080, KoreaTel: 82-2-2072-2467, Fax: 82-2-747-5639E-mail: eongpa@empal.com Received: March 19, 2015.",Non-OADS,/arxiv_data1/oa_pdf/9b/e2/kjae-69-279.PMC4891542.pdf
Korean J Anesthesiol 2016 June 69(3): 279-282  http://dx.doi.org/10.4097/kjae.2016.69.3.279,Non-OADS,/arxiv_data1/oa_pdf/9b/e2/kjae-69-279.PMC4891542.pdf
280 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/9b/e2/kjae-69-279.PMC4891542.pdf
281 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Koo et al.,OADS,/arxiv_data1/oa_pdf/9b/e2/kjae-69-279.PMC4891542.pdf
282 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/9b/e2/kjae-69-279.PMC4891542.pdf
"Key Words: Anesthesia, Congenital heart block, Pregnancy, Sjogren’s syndrome.Anesthetic management of patient  with Sjogren’s syndrome who  underwent cesarean section   -a case report- Na Eun Kim, Jae Hyuk Lee, In Sun Chung, and Jun Y ong Lee Department of Anesthesiology and Pain Medicine, Seoul Medical Center, Seoul, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/1c/kjae-69-283.PMC4891543.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2016 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: In Sun Chung, M.D.",Non-OADS,/arxiv_data1/oa_pdf/d7/1c/kjae-69-283.PMC4891543.pdf
"Department of Anesthesiology and Pain Medicine, Samsung Medical Center, 81, Irwon-ro, Gangnam-gu, Seoul 06351, KoreaTel: 82-2-3410-6589, Fax: 82-2-3410-6626E-mail: anessun123@gmail.comORCID: http://orcid.org/0000-0002-2874-0225  In Sun Chung is now with the Department of Anesthesiology and  Pain Medicine, Samsung Medical Center, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/d7/1c/kjae-69-283.PMC4891543.pdf
Korean J Anesthesiol 2016 June 69(3): 283-286  http://dx.doi.org/10.4097/kjae.2016.69.3.283,Non-OADS,/arxiv_data1/oa_pdf/d7/1c/kjae-69-283.PMC4891543.pdf
284 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/d7/1c/kjae-69-283.PMC4891543.pdf
285 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Kim et al.,OADS,/arxiv_data1/oa_pdf/d7/1c/kjae-69-283.PMC4891543.pdf
286 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/d7/1c/kjae-69-283.PMC4891543.pdf
"Key Words: Cesarean section, Middle East respiratory syndrome coronavirus, Pregnant women.Emergency cesarean section in  an epidemic of the middle east  respiratory syndrome  -a case report- Mi Hye Park1, Hee Ryun Kim1, Duck Hwan Choi1, Ji Hee Sung2, and   Jong Hwa Kim2 Departments of 1Anesthesiology and Pain Medicine, 2Obstetrics and Gynecology, Samsung Medical Center,  Sungkyunwan University School of Medicne, Seoul, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/d4/kjae-69-287.PMC4891544.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2016 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Duck Hwan Choi, M.D., Ph.D. Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50,  Irwon-dong, Gangnam-gu, Seoul 06351, KoreaTel: 82-2-3410-6590, Fax: 82-2-3410-0362E-mail: duckhwanc@gmail.com Received: July 27, 2015.",Non-OADS,/arxiv_data1/oa_pdf/2c/d4/kjae-69-287.PMC4891544.pdf
Korean J Anesthesiol 2016 June 69(3): 287-291  http://dx.doi.org/10.4097/kjae.2016.69.3.287,Non-OADS,/arxiv_data1/oa_pdf/2c/d4/kjae-69-287.PMC4891544.pdf
288 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/2c/d4/kjae-69-287.PMC4891544.pdf
289 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL Park et al.,OADS,/arxiv_data1/oa_pdf/2c/d4/kjae-69-287.PMC4891544.pdf
290 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/2c/d4/kjae-69-287.PMC4891544.pdf
"ORCID Mi Hye Park, http://orcid.org/0000-0002-3760-1067  References 1.",Non-OADS,/arxiv_data1/oa_pdf/2c/d4/kjae-69-287.PMC4891544.pdf
291 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL Park et al.,OADS,/arxiv_data1/oa_pdf/2c/d4/kjae-69-287.PMC4891544.pdf
"After successful resuscitation, the comatose pa-tient was transferred to the neurosurgical intensive care unit and PHBS was confirmed using brain CT. Key Words: Brain swelling, Circulatory collapse, Suction drainage.Cardiac arrest due to intracranial  hypotension following  pseudohypoxic brain swelling  induced by negative suction drainage in a cranioplasty patient  -a case report- Hyun-Soo Moon, Soo Kyung Lee, Su Ryun Kim, and Seon Ju Kim Department of Anesthesiology and Pain Medicine, Hallym University College of Medicine, Anyang, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/02/kjae-69-292.PMC4891545.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2016 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Hyun-Soo Moon, M.D., Ph.D. Department of Anesthesiology and Pain Medicine, Hallym University College of Medicine, 22, Gwanpyeong-ro, 170 beon-gil, Dongan-gu, Anyang 14068, KoreaTel: 82-31-380-3954, Fax: 82-31-380-3954E-mail: hysomoon@yahoo.co.kr Received: February 9, 2015.",Non-OADS,/arxiv_data1/oa_pdf/bf/02/kjae-69-292.PMC4891545.pdf
Korean J Anesthesiol 2016 June 69(3): 292-295  http://dx.doi.org/10.4097/kjae.2016.69.3.292,Non-OADS,/arxiv_data1/oa_pdf/bf/02/kjae-69-292.PMC4891545.pdf
293 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Moon et al.,OADS,/arxiv_data1/oa_pdf/bf/02/kjae-69-292.PMC4891545.pdf
294 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/bf/02/kjae-69-292.PMC4891545.pdf
"ORCID Soo Kyung Lee, http://orcid.org/0000-0002-5732-057X References 1.",Non-OADS,/arxiv_data1/oa_pdf/bf/02/kjae-69-292.PMC4891545.pdf
295 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Moon et al.,OADS,/arxiv_data1/oa_pdf/bf/02/kjae-69-292.PMC4891545.pdf
"Key Words: Air, Catheters, Coronary, Embolism, Renal dialysis.Lethal coronary air embolism  caused by the removal of a double- lumen hemodialysis catheter  -a case report- Sung Ha Mun, Dong Ai An, Hyun Jung Choi, Tae Hee Kim, Jung Woo Pin,  and Dong Chan Ko Department of Anesthesiology and Pain Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/7d/kjae-69-296.PMC4891546.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2016 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Sung Ha Mun, M.D.",Non-OADS,/arxiv_data1/oa_pdf/84/7d/kjae-69-296.PMC4891546.pdf
Korean J Anesthesiol 2016 June 69(3): 296-300  http://dx.doi.org/10.4097/kjae.2016.69.3.296,Non-OADS,/arxiv_data1/oa_pdf/84/7d/kjae-69-296.PMC4891546.pdf
297 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Mun et al.,OADS,/arxiv_data1/oa_pdf/84/7d/kjae-69-296.PMC4891546.pdf
298 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/84/7d/kjae-69-296.PMC4891546.pdf
299 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Mun et al.,OADS,/arxiv_data1/oa_pdf/84/7d/kjae-69-296.PMC4891546.pdf
300 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/84/7d/kjae-69-296.PMC4891546.pdf
"Key Words: Airway management, Bronchoscopy, Tracheostomy.Simply modified percutaneous  tracheostomy using the Cook®  Ciaglia Blue RhinoTM  -a case series- Woosuk Chung, Byung Muk Kim, and Sang-Il Park Department of Anesthesiology and Pain Medicine, Chungnam National University Hospital, Daejeon, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d8/ca/kjae-69-301.PMC4891547.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2016 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Sang-Il Park, M.D.",Non-OADS,/arxiv_data1/oa_pdf/d8/ca/kjae-69-301.PMC4891547.pdf
"Department of Anesthesiology and Pain Medicine, Chungnam National University Hospital, 282, Munhwa-ro, Jung-gu, Daejeon 35015, KoreaTel: 82-42-280-7840, Fax: 82-42-280-7968E-mail: goodlebang@gmail.comORCID: http://orcid.org/0000-0002-2026-6848 Sang-Il Park is now with the Department of Anesthesiology and Pain  Medicine, Y oon's Pain clinic, Daejeon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/d8/ca/kjae-69-301.PMC4891547.pdf
Korean J Anesthesiol 2016 June 69(3): 301-304  http://dx.doi.org/10.4097/kjae.2016.69.3.301,Non-OADS,/arxiv_data1/oa_pdf/d8/ca/kjae-69-301.PMC4891547.pdf
302 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/d8/ca/kjae-69-301.PMC4891547.pdf
303 Online access in http://ekja.orgKOReAN J ANeSTHeSIOL  Chung et al.,OADS,/arxiv_data1/oa_pdf/d8/ca/kjae-69-301.PMC4891547.pdf
304 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/d8/ca/kjae-69-301.PMC4891547.pdf
"Signs and symptoms are equally wide ranging and include intra-operative and postoperative hypotension, associated fall in hematocrit, acute ischemia, distal pulse deficit, bruit, thrill, pul-satile abdominal mass, abdominal pain, expanding hematoma,  Letter to the Editor Iatrogenic iliac arteriovenous  fistula with aortic pseudoaneurysm  formation post lumbar (L4-L5)  laminectomy and pedicular screw fixation Viraj M Shah and Reena Nayar Department of Anaesthesia, St. Johns Medical College and Hospital, Bangalore, India CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/88/1f/kjae-69-305.PMC4891548.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2016 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Corresponding author: Viraj M Shah, M.D.",Non-OADS,/arxiv_data1/oa_pdf/88/1f/kjae-69-305.PMC4891548.pdf
"Department of Anaesthesia, St. Johns Medical College and Hospital, A/1803, Beau Monde, Appasaheb Marathe Road, Mumbai 400025, IndiaTel: 9987714961, Fax: 918025530070E-mail: virajshah86@gmail.comORCID: http://orcid.org/0000-0001-6282-2518  Received: October 28, 2015.",Non-OADS,/arxiv_data1/oa_pdf/88/1f/kjae-69-305.PMC4891548.pdf
Korean J Anesthesiol 2016 June 69(3): 305-306  http://dx.doi.org/10.4097/kjae.2016.69.3.305,Non-OADS,/arxiv_data1/oa_pdf/88/1f/kjae-69-305.PMC4891548.pdf
306 Online access in http://ekja.orgVOL.,Non-OADS,/arxiv_data1/oa_pdf/88/1f/kjae-69-305.PMC4891548.pdf
"We apologize for any inconvenience this mistake may have caused.Erratum Erratum: Heart rate variability as  a predictor of hypotension after  spinal anesthesia in hypertensive  patients  Tae Dong Kweon1, So Y eon Kim1, Sung Ah Cho2, Ji Hoon Kim2,   Y oung Ran Kang2, and Y ang-Sik Shin1 1Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University  College of Medicine, 2Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine,  Seoul, Korea CC This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/6a/kjae-69-307.PMC4891549.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2016 Online access in http://ekja.orgpISSN 2005-6419  •  eISSN 2005-7563 Korean Journal of AnesthesiologyKJA Korean J Anesthesiol 2016 June 69(3): 307 http://dx.doi.org/10.4097/kjae.2016.69.3.307",Non-OADS,/arxiv_data1/oa_pdf/5a/6a/kjae-69-307.PMC4891549.pdf
2003 Dec; 2:532-533. http://icvts.ctsnetjournals.org/cgi/content/full/2/4/53 2.,OADS,/arxiv_data1/oa_pdf/b7/16/main.PMC4891564.pdf
Last accessed 11 Sept. 2006. http://www.acr.org/s_acr/bin.asp?CID=1206&DID=1 1796&DOC=FILE.PDF 26.,OADS,/arxiv_data1/oa_pdf/93/e9/main.PMC4891588.pdf
Last accessed 11 Sept. 2006.http://www.nof.org/osteoporosis/bonemass.htm   27.,Non-OADS,/arxiv_data1/oa_pdf/93/e9/main.PMC4891588.pdf
"http://en.wikipedia.org/wiki/Static_line  (Last accessed  Oct 30, 2006).",Non-OADS,/arxiv_data1/oa_pdf/2e/1c/main.PMC4891589.pdf
"275 Copyright © 2016 The Korean Society of CardiologyKorean Circulation Journal Review Article http://dx.doi.org/10.4070/kcj.2016.46.3.275 Print ISSN 1738-5520 • On-line ISSN 1738-5555 2015 Korean Guidelines for the Management of Dyslipidemia:  Executive Summary (English Translation) Committee for the Korean Guidelines for the Management of Dyslipidemia Received:  February 11, 201 6 / Revision Received:  April 6, 2016 / Accepted:  April 12, 2016 Correspondence:  Chee Jeong Kim, MD, Division of Cardiology, Department of Internal Medicine, Chung-Ang University College of Medicine, 84 Heukseok-ro,  Dongjak-gu, Seoul 06974, Korea  / Tel: 82-2-6299-1398  / Fax: 82-2-822-2769  / E-mail: cjkim@cau.ac.kr * This guideline is translated from “J Lipid Atheroscler 2015;4(1):61-92”.",Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Table of Contents Chapter  1.",Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
"276  Korean Guidelines for the Management of Dyslipidemia http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org followed up for a long term and, at the same time, if the rates  of CVD and death are precisely recorded.",Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org a nation-wide continuous monitoring system, however, recent  research estimated that the annual incidence rate of acute myocardial infarction (AMI) was about 50 cases per 100000 males and about 20 cases per 100000 females.",Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
"278  Korean Guidelines for the Management of Dyslipidemia http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org carotid artery disease, peripheral artery disease (PAD), abdominal  aneurysm, and diabetes, was defined as high risk, according to the revised Korean Guidelines for the Management of Dyslipidemia.",Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org factors is also currently available.,OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
"280  Korean Guidelines for the Management of Dyslipidemia http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org To acquire the triglyceride and LDL cholesterol levels among the  lipid profiles, fasting for at least 9–12 h before venous sampling is  required.",Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org The US NCEP criteria for lipid and lipoprotein levels can be used  to evaluate the performance of a clinical laboratory for testing of  the blood lipid level that is required for the diagnosis and treatment of dyslipidemia.,Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
282  Korean Guidelines for the Management of Dyslipidemia http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org the administration of statins for primary prevention in patients  with a 10-year risk of atherosclerotic CVD (ASCVD) of ≥7.5%.,Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org criteria.,Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
"284  Korean Guidelines for the Management of Dyslipidemia http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org Continued Statins should be immediately prescribed  regardless of the baseline LDL cholesterol concentration in patients with AMI.I A Patients with carotid artery disease (carotid  artery stenosis >50%), abdominal aneurysm,  or diabetes belong to the high-risk group,  and treatment is indicated to be started for primary prevention, if the LDL cholesterol is  ≥100 mg/dL.I A Patients with two or more major risk factors except for LDL cholesterol are classified as  the intermediate-risk group.",Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org Chapter 3.,Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
"286  Korean Guidelines for the Management of Dyslipidemia http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org ESC/EAS guidelines recommend that alcohol consumption should be  limited to 1–2 glasses/day (males: <20–30 g, females: <10–20 g), and even to stop drinking especially in patients with hypertriglyceridemia.",Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org Continued Saturated fatty acid intake should be limited  to <7% of the calorie intake.I A Replacement of saturated fatty acid with   unsaturated fatty acid should be considered, but the N6-polyunsaturated fatty acid intake amount  should be limited within 10% of the total calorie.II B Trans-fatty acid intake should be avoided.",Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
288  Korean Guidelines for the Management of Dyslipidemia http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org the maximum heart rate (=220–age).,Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org medication should be considered if the LDL cholesterol level is ≥130  mg/dL (IIa, B).",Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
"290  Korean Guidelines for the Management of Dyslipidemia http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org Continued If indicated, fibric acid derivative should be  used as drug to control triglycerides.I B If indicated, nicotinic acid should be  considered as drug to control triglycerides.IIa B If indicated, it is reasonable to use omega-3 fatty acid as a drug to control triglycerides.IIa B If the triglyceride level fails to reach the first  target with single-drug therapy, combination  therapy should be considered.IIa C (4) Low HDL cholesterolemia   RecommendationsClass of  recommen- dationLevel of  evidence  The first treatment goal is to control LDL  cholesterol to target level or less.I A To raise HDL cholesterol, nicotinic acid should be considered.",Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org dosage is doubled, the LDL cholesterol level additionally decreases  by 6% in general.",Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
"292  Korean Guidelines for the Management of Dyslipidemia http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org dose/moderate-intensity or high-dose/high-intensity statin that can  reduce the LDL cholesterol level by ≥30–50% from the baseline levels (IIa, A).",Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org multiple comorbid diseases or those with the concomitant use of  cyclosporine, fibrate derivatives, macrolide antibiotics, or several antifungal drugs.",Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
"294  Korean Guidelines for the Management of Dyslipidemia http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org (6) Summary Fibric acid derivatives Dosage and  administrationBezafibrate: 400-600 mg/day, 1-3 times a day, after mealsFenofibrate: 160-200 mg/day, once a day, immedi- ately after a meal  Gemfibrozil: 600-1,200 mg/day, twice a day, 30 min before meals (combination therapy with statin  should be avoided) Follow-up testLipid profile, liver function, blood chemistry, and muscle enzyme tests (when there is unexplainable  muscular pain or muscle weakness) Adverse effectsGastrointestinal disorder, cholesterol gallstone, myopathy ContraindicationsThe absolute contraindications are severe liver  disorder, gall bladder disease, or hypersensitivity   reaction to fibric acid derivatives.",Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org enzymes have been reported.,OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
296  Korean Guidelines for the Management of Dyslipidemia http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org 2) Secondary prevention  Stroke patients have increased risk not only of recurrent stroke  events but also of the development of CVDs such as myocardial  infarction.,Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org cardiovascular mortality than those without diabetes.,Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
"298  Korean Guidelines for the Management of Dyslipidemia http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org 2) Blood lipid screening test  If a blood lipid screening test is conducted in children who have  a history of premature CAD or dyslipidemia, it will lead to missing  30–60% of children with dyslipidemia.",Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org exercise; moreover, education should be aggressively provided to  children and their family.",Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
"300  Korean Guidelines for the Management of Dyslipidemia http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org 2) Treatment General considerations: Heterozygous FH management includes  the lifestyle modifications, lipid-lowering medication, and tests for  atherosclerotic disease.",Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org 4.,Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
Available from: http://www.who.int/gho/ncd/ mortality_morbidity/ncd_total/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
302  Korean Guidelines for the Management of Dyslipidemia http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org health care professionals.,Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin  across doses (STELLAR* Trial).",Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
304  Korean Guidelines for the Management of Dyslipidemia http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org 91.,Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org Committee for the Korean Guidelines for the Man - agement of Dyslipidemia Advisory Committee:  Young-Seol Kim, Hyun Ho Shin,   Moon-Kyu Lee, Hun Tae Chung, Sung Chull Chae  Chairperson:  Young-Bae Park  Vice-Chairperson:  Hyun Chul Lee  Steering Committee:   Chairperson: Chee Jeong KimAssistant Administrator: Jaetaek KimMembers: Kwang-il Kim, Dokyung Kim, Myung-A Kim, Sang-Hyun Kim, Sung-Rae Kim, Yangha Kim, Youngmi Kim, Yong-Jae Kim, Eun Mi Kim, Jae-Ryong Kim, Jongwoo Kim, Hyunwook Kim, Hyeon Chang Kim, Hyo-Soo Kim, Moon Suk Nam, Kyong Soo Park, Joong-Yeol Park, Hyun-Young Park, Sang Hong Baek, Youngkeun Ahn, Yeo-Min Yun, Myoungsook Lee, Sang Hak Lee, Ji-Eun Lee, Hak Chul Jang, Sun Ha Jee, Donghoon Choi, Sung Hee Choi, Young Jin Choi,  Jin Han, Sun-cheol Hong Subcommittee for Evidence Evaluation Chairperson: Joong-Yeol ParkAssistant Administrator: Chang Hee JungMembers: Hyuk-Sang Kwon, Dae Jung Kim, Jae-Ryong Kim, Hyeon Chang Kim, Hyun-Young Park, Kyu Jeung Ahn, Kyungwon Oh, Yeo-Min Yun, Sun Ha Jee, Donghoon Choi, Sung Hee Choi, You-Cheol Hwang Subcommittee for Lifestyle Modification Chairperson: Yangha KimAssistant Administrator: Yoon Jung ParkMembers: Dokyung Kim, Sung-Rae Kim, Young-Joo Kim, Oh Yoen Kim, Woo-shik Kim, Eun Mi Kim, Yongsoon Park, Kee-Ho Song, Yoon  Ju Song, Ki Man Ahn, Myoungsook Lee, Sae Young Jae, Sung Hee Choi Subcommittee for PharmacotherapyChairperson: Sang-Hyun Kim Assistant Administrator: Young Joon Hong Members: Minkyung Kim, Yong-Jae Kim, Jaetaek Kim, Jongwoo Kim, Hyunwook Kim, Sang Hak Lee, Eun-Jung Rhee, Hae-Young Lee, Sang-Ho Jo, Seonghoon Choi, Soon Jun Hong Subcommittee for Editing Chairperson: Myung-A KimAssistant Administrator: Min Kyong MoonMembers: Yoon Jung Park, Kee-Ho Song, Sung-Hee Shin, Sang Hak Lee, Hae-Young Lee, Soo Lim, Chang Hee Jung, Kyung-Hyun Cho, Sang-Ho Jo, Sung Hee Choi, Young Joon HongAuthor Details Kwang-il Kim, MD1, Myung-A Kim, MD1, Min Kyung Kim, MD1,  Sang-Hyun Kim, MD1, Hyo Soo Kim, MD1, Min Kyong Moon, MD1,  Kyong Soo Park, MD1, Young-Bae Park, MD1, Soo Lim, MD1, Sung  Hee Choi, MD1, Hae-Young Lee, MD1, Hak Chul Jang, MD1, Sang- Hak Lee, MD2, Donghoon Choi, MD2, Hyun Cheol Lee, MD2, Hyeon  Chang Kim, MD3, Sun Ha Jee4, Hyun Taek Cheong, MD5, Joong-Yeol  Park, MD5, Chang Hee Jung, MD5, Mun Kyu Lee, MD6, Eun-Jung  Rhee, MD6, Kim, Do Kyung7, Eun Mi Kim8, Soon Jun Hong, MD9,  Soon-Cheol Hong, MD10, Young Seol Kim, MD11, Woo-Sik Kim, MD11,  You-Cheol Hwang, MD11, Kyu Jeong Ahn, MD11, Youngmi Kim, MD12,  Seong-Cheol Chae, MD13, Yeo-Min Yun, MD14, Yangha Kim15, Yoon  Jung Park15, Yong Jae Kim, MD16, Jin Han, MD17, Jongwoo Kim, MD18,  Young-Joo Kim, MD19, Sung-Rae Kim, MD20, Sang Hong Baek, MD20,  Hyuk-Sang Kwon, MD20, Yoon Ju Song21, Hyunwook Kim, MD22,  Moon Suk Nam, MD23, Sung Hee Shin, MD23, Ji-Eun Lee, MD23,  Jaetaek Kim, MD24, Chee Jeong Kim, MD24, Dae Jung Kim, MD25, Oh  Yoen Kim26, Jae-Ryong Kim, MD27, Kyung-Hyun Cho28, Yongsoon  Park29, Gi Ho Song, MD30, Hyun Ho Shin, MD31, Youngkeun Ahn,  MD32, Young Joon Hong, MD32, Myoungsook Lee33, Sae Young Jae34,  Sang-Ho Jo, MD35, Seonghoon Choi, MD35, Young Jin Choi, MD36,  Hyun-Young Park, MD37, Kyungwon Oh37, and Ki Man Ahn38 1Department of Internal Medicine, Seoul National University College  of Medicine, Seoul, 2Department of Internal Medicine, 3Department  of Preventive Medicine and Public Health, Yonsei University College of Medicine, Seoul,  4Department of Public Health Graduate  School, Yonsei University, Seoul, 5Department of Internal Medicine  University of Ulsan College of Medicine, Asan Medical Center, Seoul,  6Department of Internal Medicine, Sungkyunkwan University School  of Medicine, Seoul, 7Department of Sport Medicine, Samsung Medical  Center, Seoul, 8Dietetic Department, Kangbuk Samsung Hospital,  Seoul, 9Department of Internal Medicine, 10Department of Obstetrics  and Gynecology, Korea University College of Medicine, Seoul,  11Department of Internal Medicine, Kyung Hee University School of  Medicine, Seoul, 12Department of Physiology Kyung Hee University  College of Medicine, Seoul, 13Department of Internal Medicine,  Kyungpook National University Hospital, Daegu, 14Department of  Clinical Laboratory Medicine, Konkuk University Medical Center, Seoul,  15Department of Nutritional Science and Food Management,  16Department of Neurology Ewha Womans University College of  Medicine, Seoul, 17Department of Physiology, Inje University College  of Medicine, Busan, 18Department of Family Medicine, 19Department  of Rehabilitation Medicine Inje University College of Medicine, Seoul,  20Department of Internal Medicine, 21Department of Food Science and  Nutrition The Catholic University School of Human Ecology, Seoul,",Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
"306  Korean Guidelines for the Management of Dyslipidemia http://dx.doi.org/10.4070/kcj.2016.46.3.275 www.e-kcj.org 22Department of Internal Medicine, Wonkwang Universilty College of  Medicine, Iksan, 23Department of Internal Medicine, Inha University  School of Medicine, Incheon, 24Department of Internal Medicine,  Chung-Ang University College of Medicine, Seoul, 25Department  of Internal Medicine, Ajou University School of Medicine, Suwon,  26Department of Food Science and Nutrition, Dong-A University,  Busan, 27Department of Biochemistry and Molecular Biology,  28Department of Medical Biotechnology Yeungnam University,  Kyungsan, 29Department of Food and Nutrition, Hanyang University,  Seoul, 30Department of Internal Medicine, Konkuk University Medical  Center, Seoul, 31Department of Internal Medicine, Dankook University  College of Medicine, Cheil General Hospital, Seoul, 32Department of  Internal Medicine, Chonnam National University College of Medicine,  Kwangju, 33Department of Food and Nutrition, Sungshin Women’s  University, Seoul, 34Department of Sport Science, The University of  Seoul, Seoul, 35Department of Internal Medicine, Hallym University  College of Medicine, Chuncheon, 36Department of Internal Medicine,  Sejong General Hospital, Bucheon, 37Centers for Disease Control and  Prevention, Osong, 38Humanworkers, Seoul KoreaParticipant Organizations Health Insurance Review and Assessment ServiceThe Korean Academy of Family Medicine The Korean Society of Hypertension Korean Endocrine Society The Korean Geriatrics Society Korean Diabetes Association Korean Society of Obstetrics and Gynecology Korean Society of Pediatric Endocrinology The Korean Society of Sports Medicine Korean Neurological Association The Korean Society of Nephrology The Korean Society of Cardiology The Korean Society for Preventive Medicine  The Korean Society for Laboratory Medicine  Korean Society for Biochemistry and Molecular Biology Korea Centers for Disease Control and Prevention Korean Society of Epidemiology The Korean Nutrition SocietyKorean Society of Lipidology and Atherosclerosis",Non-OADS,/arxiv_data1/oa_pdf/b3/e0/kcj-46-275.PMC4891593.pdf
Editorial http://dx.doi.org/10.4070/kcj.2016.46.3.307 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Angiotensin Receptor Blocker for Stroke Prevention in Atrial Fibrillation: beyond Blood Pressure Lowering?,Non-OADS,/arxiv_data1/oa_pdf/f4/ad/kcj-46-307.PMC4891594.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f4/ad/kcj-46-307.PMC4891594.pdf
"308  ARB for Stroke Prevention in Atrial Fibrillation http://dx.doi.org/10.4070/kcj.2016.46.3.307 www.e-kcj.org Although this study did not provide additional information about  the role of ARBs in modulating the pro-thrombotic process and  endocardial remodeling, future experiments using a large number of animals and biomarkers based on this study may be informative.",Non-OADS,/arxiv_data1/oa_pdf/f4/ad/kcj-46-307.PMC4891594.pdf
"7) Epidemiological  studies indicate that high PON1 activity is inversely associated with Original Article http://dx.doi.org/10.4070/kcj.2016.46.3.309 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Antioxidative Activity after Rosuvastatin Treatment in Patients  with Stable Ischemic Heart Disease and Decreased High Density  Lipoprotein Cholesterol  Do-Sim Park, MD1, Kyeong Ho Yun, MD2,3, Hyun Young Park, MD3, Sang Jae Rhee, MD2, Nam-Ho Kim, MD2,   Seok Kyu Oh, MD2, and Jin-Won Jeong, MD2 1Department of Laboratory medicine, Wonkwang University Hospital and School of Medicine, Iksan, 2Department of Cardiovascular Medicine, Regional  Cardiocerebrovascular Center, Wonkwang University Hospital, Iksan, 3Institute of Wonkwang Medical Science, Wonkwang University School of Medicine, Iksan, Korea   Background and Objectives: The clinical significance of statin-induced high-density lipoprotein cholesterol (HDL-C) changes is not well known.",Non-OADS,/arxiv_data1/oa_pdf/69/85/kcj-46-309.PMC4891595.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/85/kcj-46-309.PMC4891595.pdf
"310  Antioxidative Effect of Rosuvastatin http://dx.doi.org/10.4070/kcj.2016.46.3.309 www.e-kcj.org the progression of atherosclerosis, and reduction in the incidence  of coronary artery disease.8) In our previous study, we have shown that many patients showed  decreased HDL-C response after statin therapy, although the mean HDL-C of total patients was increased.",Non-OADS,/arxiv_data1/oa_pdf/69/85/kcj-46-309.PMC4891595.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.309 www.e-kcj.org automated paraoxonase activity measurement kit (Mega Tip,  Gaziantep, Turkey) on Hitachi 7600 automatic biochemical analyzer (Hitachi, Tokyo, Japan).",OADS,/arxiv_data1/oa_pdf/69/85/kcj-46-309.PMC4891595.pdf
312  Antioxidative Effect of Rosuvastatin http://dx.doi.org/10.4070/kcj.2016.46.3.309 www.e-kcj.org p=0.010).,Non-OADS,/arxiv_data1/oa_pdf/69/85/kcj-46-309.PMC4891595.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.309 www.e-kcj.org residual risk than chemically measured HDL-C or Apo A1.16) That is,  among placebo-allocated patients, the on-treatment HDL particle  measured by nuclear magnetic resonance spectroscopy and HDL-C had similar inverse association with cardiovascular outcomes.",Non-OADS,/arxiv_data1/oa_pdf/69/85/kcj-46-309.PMC4891595.pdf
314  Antioxidative Effect of Rosuvastatin http://dx.doi.org/10.4070/kcj.2016.46.3.309 www.e-kcj.org receiving statin therapy after acute coronary syndromes: results from  PROVE IT-TIMI 22.,Non-OADS,/arxiv_data1/oa_pdf/69/85/kcj-46-309.PMC4891595.pdf
"This Original Article http://dx.doi.org/10.4070/kcj.2016.46.3.315 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Differential Clinical Implications of High-Degree Atrioventricular Block Complicating ST-Segment Elevation Myocardial Infarction  according to the Location of Infarction in the Era of Primary  Percutaneous Coronary Intervention Kyung Hwan Kim, MD1, Myung Ho Jeong, MD1, Youngkeun Ahn, MD1, Young Jo Kim, MD2, Myeong Chan Cho, MD3,  Wan Kim, MD4, and Other Korea Acute Myocardial Infarction Registry Investigators 1Division of Cardiology, Department of Internal Medicine, Chonnam National University Hospital, Gwangju, 2Division of Cardiology, Department of Internal Medicine,  Yeungnam University Hospital, Daegu, 3Division of Cardiology, Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, 4Division of Cardiology,  Department of Internal Medicine Gwangju Veterans Hospital, Gwangju, Korea  Background and Objectives: The clinical implication of high-degree (second- and third-degree) atrioventricular block (HAVB) complicating  ST-segment elevation myocardial infarction (STEMI) is ripe for investigation in this era of primary percutaneous coronary intervention (PCI).",Non-OADS,/arxiv_data1/oa_pdf/c0/e3/kcj-46-315.PMC4891596.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/e3/kcj-46-315.PMC4891596.pdf
316  High-Degree Atrioventricular Block in ST-Segment Elevation Myocardial Infarction http://dx.doi.org/10.4070/kcj.2016.46.3.315 www.e-kcj.org study enrolled 2073 patients and evaluated the prognostic value  of HAVB in STEMI patients treated with primary PCI.,Non-OADS,/arxiv_data1/oa_pdf/c0/e3/kcj-46-315.PMC4891596.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.315 www.e-kcj.org 1), decreased left ventricular ejection fraction (LVEF), and smoking.",Non-OADS,/arxiv_data1/oa_pdf/c0/e3/kcj-46-315.PMC4891596.pdf
318  High-Degree Atrioventricular Block in ST-Segment Elevation Myocardial Infarction http://dx.doi.org/10.4070/kcj.2016.46.3.315 www.e-kcj.org Results Incidence and baseline characteristics The overall incidence of HAVB was 3.2% (546/17046) in patients  with STEMI treated with primary PCI.,Non-OADS,/arxiv_data1/oa_pdf/c0/e3/kcj-46-315.PMC4891596.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.315 www.e-kcj.org  In the population with anterior wall infarction, the in-hospital  mortality of STEMI patients with HAVB was higher than that of  patients without HAVB (HR=9.821, 95% CI: 4.946-19.503, p<0.001).",Non-OADS,/arxiv_data1/oa_pdf/c0/e3/kcj-46-315.PMC4891596.pdf
"320  High-Degree Atrioventricular Block in ST-Segment Elevation Myocardial Infarction http://dx.doi.org/10.4070/kcj.2016.46.3.315 www.e-kcj.org STEMI, there was no significant difference in long-term survival  between the two groups (Fig.",Non-OADS,/arxiv_data1/oa_pdf/c0/e3/kcj-46-315.PMC4891596.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.315 www.e-kcj.org STEMI patients.,Non-OADS,/arxiv_data1/oa_pdf/c0/e3/kcj-46-315.PMC4891596.pdf
322  High-Degree Atrioventricular Block in ST-Segment Elevation Myocardial Infarction http://dx.doi.org/10.4070/kcj.2016.46.3.315 www.e-kcj.org The mechanism of conduction disturbance in MI is different  according to the location of infarction.,Non-OADS,/arxiv_data1/oa_pdf/c0/e3/kcj-46-315.PMC4891596.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.315 www.e-kcj.org (2013-E63005-01), and The Korean Health Technology R&D Project  (HI13C1527), Ministry of Health & Welfare, Republic of Korea.",Non-OADS,/arxiv_data1/oa_pdf/c0/e3/kcj-46-315.PMC4891596.pdf
"5) Although the statin is a most powerful drug for lowering LDL-C,  the effect of statin on increasing HDL-C and lowering triglyceride Original Article http://dx.doi.org/10.4070/kcj.2016.46.3.324 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Differential Benefit of Statin in Secondary Prevention of Acute  Myocardial Infarction according to the Level of Triglyceride and  High Density Lipoprotein Cholesterol Kyung Hwan Kim, MD1*, Cheol Hwan Kim, MD1*, Myung Ho Jeong, MD1, Youngkeun Ahn, MD1, Young Jo Kim, MD2,  Myeong Chan Cho, MD3, Wan Kim, MD4, Jong Jin Kim,  MD5, and Other Korea Acute Myocardial Infarction Registry  Investigators 1Chonnam National University Hospital, Gwangju, 2Yeungnam University Hospital, Busan, 3Chungbuk National University Hospital, Cheongju, 4Gwangju Veterans Hospital,  Gwangju, 5Kyunghee University College of Medicine, Seoul, Korea  Background and Objectives: The differential benefit of statin according to the state of dyslipidemia has been sparsely investigated.",Non-OADS,/arxiv_data1/oa_pdf/a9/e6/kcj-46-324.PMC4891597.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.324 www.e-kcj.org are modest or suboptimal.,Non-OADS,/arxiv_data1/oa_pdf/a9/e6/kcj-46-324.PMC4891597.pdf
326  Statin in Myocardial Infarction Patients with Dyslipidemia http://dx.doi.org/10.4070/kcj.2016.46.3.324 www.e-kcj.org counts and percentages and continuous variables are expressed as  mean±standard deviation.,OADS,/arxiv_data1/oa_pdf/a9/e6/kcj-46-324.PMC4891597.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.324 www.e-kcj.org Table 1.,OADS,/arxiv_data1/oa_pdf/a9/e6/kcj-46-324.PMC4891597.pdf
328  Statin in Myocardial Infarction Patients with Dyslipidemia http://dx.doi.org/10.4070/kcj.2016.46.3.324 www.e-kcj.org Table 2.,Non-OADS,/arxiv_data1/oa_pdf/a9/e6/kcj-46-324.PMC4891597.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.324 www.e-kcj.org should be initiated and continued in all acute MI patients without  contraindications to its use, a trial evaluated the impact of baseline LDL-C on the efficacy of statin and reported that the benefit of high-intensity statin declines as a function of decreasing baseline LDL-C level.",Non-OADS,/arxiv_data1/oa_pdf/a9/e6/kcj-46-324.PMC4891597.pdf
"330  Statin in Myocardial Infarction Patients with Dyslipidemia http://dx.doi.org/10.4070/kcj.2016.46.3.324 www.e-kcj.org outcomes, are lowering LDL-C level and decreasing systemic  inflammation.4)6) The effect of statin on increasing HDL-C and  decreasing triglyceride is not substantial or optimal.",Non-OADS,/arxiv_data1/oa_pdf/a9/e6/kcj-46-324.PMC4891597.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.324 www.e-kcj.org nicotinic acid and statin provides additional benefit beyond  that attributable to simply lowering LDL-C by statin.,Non-OADS,/arxiv_data1/oa_pdf/a9/e6/kcj-46-324.PMC4891597.pdf
332  Statin in Myocardial Infarction Patients with Dyslipidemia http://dx.doi.org/10.4070/kcj.2016.46.3.324 www.e-kcj.org Conclusion The benefit of statin in secondary prevention was significant in  acute MI patients with low triglyceride and high HDL-C.,Non-OADS,/arxiv_data1/oa_pdf/a9/e6/kcj-46-324.PMC4891597.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.324 www.e-kcj.org Yong Lee, MD, Kee Sik Kim, MD, Jin Yong Hwang, MD, Myeong Chan  Cho, MD, Seok Kyu Oh, MD, Nae Hee Lee, MD, Kyoung Tae Jeong, MD, Seung Jea Tahk, MD, Jang Ho Bae, MD, Seung-Woon Rha, MD, Keum Soo Park, MD, Chong Jin Kim, MD, Kyoo Rok Han, MD, Tae Hoon Ahn, MD, Moo Hyun Kim, MD, Ki Bae Seung, MD, Wook Sung Chung, MD, Ju Young Yang, MD, Chong Yun Rhim, MD, Hyeon Cheol Gwon, MD, Seong Wook Park, MD, Young Youp Koh, MD, Seung Jae Joo, MD, Soo Joong Kim, MD, Dong Kyu Jin, MD, Jin Man Cho, MD, Yang Soo Jang, MD, Jeong Gwan Cho, MD, and Seung Jung Park, MD.",Non-OADS,/arxiv_data1/oa_pdf/a9/e6/kcj-46-324.PMC4891597.pdf
334  Statin in Myocardial Infarction Patients with Dyslipidemia http://dx.doi.org/10.4070/kcj.2016.46.3.324 www.e-kcj.org high levels of apolipoprotein B. N Engl J Med  1990;323:1289-98.,Non-OADS,/arxiv_data1/oa_pdf/a9/e6/kcj-46-324.PMC4891597.pdf
"We aimed to determine whether ARBs can reduce thrombogenicity in tachy-induced AF canine models systemically Original Article http://dx.doi.org/10.4070/kcj.2016.46.3.335 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Effects of Angiotensin-II Receptor Blocker on Inhibition  of Thrombogenicity in a Canine Atrial Fibrillation Model Jong-Il Choi, MD1, Jae Seung Jung, MD2, Min Kyung Kim, MD3, Jaemin Sim, MD1, Jin Seok Kim, MD1,   Hong Euy Lim, MD1, Sang Weon Park, MD1, and Young-Hoon Kim, MD1 1Division of Cardiology, Department of Internal Medicine, 2Department of Thoracic and Cardiovascular Surgery, Korea University College of Medicine, Korea University  Medical Center, Seoul, 3Kim Min Kyung’s Pathology Clinic, Seoul, Korea Background and Objectives: Angiotensin-II receptor blockers (ARBs) are known to reduce the development of atrial fibrillation (AF)  through reverse-remodeling.",Non-OADS,/arxiv_data1/oa_pdf/77/f9/kcj-46-335.PMC4891598.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/f9/kcj-46-335.PMC4891598.pdf
336  Angiotensin-II Receptor Blocker and Thrombogenicity in Atrial Fibrillation http://dx.doi.org/10.4070/kcj.2016.46.3.335 www.e-kcj.org or through reverse-remodeling of the atrium.,Non-OADS,/arxiv_data1/oa_pdf/77/f9/kcj-46-335.PMC4891598.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.335 www.e-kcj.org Histologic examination Hearts were removed at the end of the experiments.,Non-OADS,/arxiv_data1/oa_pdf/77/f9/kcj-46-335.PMC4891598.pdf
338  Angiotensin-II Receptor Blocker and Thrombogenicity in Atrial Fibrillation http://dx.doi.org/10.4070/kcj.2016.46.3.335 www.e-kcj.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/77/f9/kcj-46-335.PMC4891598.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.335 www.e-kcj.org in the control and candesartan groups.,Non-OADS,/arxiv_data1/oa_pdf/77/f9/kcj-46-335.PMC4891598.pdf
340  Angiotensin-II Receptor Blocker and Thrombogenicity in Atrial Fibrillation http://dx.doi.org/10.4070/kcj.2016.46.3.335 www.e-kcj.org mechanisms.,Non-OADS,/arxiv_data1/oa_pdf/77/f9/kcj-46-335.PMC4891598.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.335 www.e-kcj.org determine the atrial rhythm and evaluate whether or not AF was  sustained.,OADS,/arxiv_data1/oa_pdf/77/f9/kcj-46-335.PMC4891598.pdf
342  Angiotensin-II Receptor Blocker and Thrombogenicity in Atrial Fibrillation http://dx.doi.org/10.4070/kcj.2016.46.3.335 www.e-kcj.org 18.,Non-OADS,/arxiv_data1/oa_pdf/77/f9/kcj-46-335.PMC4891598.pdf
"MTWA) and several echocardiographic parameters related with diastolic dysfunction Original Article http://dx.doi.org/10.4070/kcj.2016.46.3.343 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Effects of Trimetazidine on T Wave Alternans  in Stable Coronary Artery Disease Mehmet Yaman, MD1, Uğur Arslan, MD1, Hasan Ali Gümrükçüo ğlu, MD2, Musa Şahin, MD2, Hakkı Şimşek, MD2,   and Serkan Akda ğ, MD2 1Department of Cardiology, Samsun Education and Research Hospital,  Samsun, 2Department of Cardiology,  Van 100.",Non-OADS,/arxiv_data1/oa_pdf/c5/bb/kcj-46-343.PMC4891599.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c5/bb/kcj-46-343.PMC4891599.pdf
344  Trimetazidine in Coronary Artery Disease http://dx.doi.org/10.4070/kcj.2016.46.3.343 www.e-kcj.org clinically show these beneficial effects of trimetazidine.,Non-OADS,/arxiv_data1/oa_pdf/c5/bb/kcj-46-343.PMC4891599.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.343 www.e-kcj.org identified periods of possible TWA using the MMA algorithm, a  time domain-based method that bifurcates the beat stream and generates separate moving average templates for odd versus even beats.",OADS,/arxiv_data1/oa_pdf/c5/bb/kcj-46-343.PMC4891599.pdf
"346  Trimetazidine in Coronary Artery Disease http://dx.doi.org/10.4070/kcj.2016.46.3.343 www.e-kcj.org sampling was positioned between the mitral valve edges, parallel  to ventricular inflow.",Non-OADS,/arxiv_data1/oa_pdf/c5/bb/kcj-46-343.PMC4891599.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.343 www.e-kcj.org systolic functions in both groups (Table 2).,OADS,/arxiv_data1/oa_pdf/c5/bb/kcj-46-343.PMC4891599.pdf
"348  Trimetazidine in Coronary Artery Disease http://dx.doi.org/10.4070/kcj.2016.46.3.343 www.e-kcj.org In a study by Fedorova et al.12) with a beta blocker and trimetazidine  combination treatment, advanced functional class heart failure  patients showed a 59% reduction in E/A ratio after six months follow-up.",Non-OADS,/arxiv_data1/oa_pdf/c5/bb/kcj-46-343.PMC4891599.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.343 www.e-kcj.org Blood Institute Joint National Committee on Prevention, Detection,  Evaluation, and Treatment of High Blood Pressure; National High  Blood Pressure Education Program Coordinating Committee.",Non-OADS,/arxiv_data1/oa_pdf/c5/bb/kcj-46-343.PMC4891599.pdf
"2) Original Article http://dx.doi.org/10.4070/kcj.2016.46.3.350 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Two Distinct Responses of Left Ventricular End-Diastolic Pressure  to Leg-Raise Exercise in Euvolemic Patients with Exertional Dyspnea SeongIl Choi, MD1, Jeung-Hun Shin, MD1, Whan-Cheol Park, MD1, Soon-Gil Kim, MD1, Jinho Shin, MD2,   Young-Hyo Lim, MD2, and Yonggu Lee, MD3 1Department of Cardiology, Department of Internal Medicine, Guri Hospital, College of Medicine, Hanyang University, Guri, 2 Division of Cardiology, Department of Internal  Medicine, Hanyang University College of Medicine, Seoul, 3 Division of Cardiology, Department of Internal Medicine, Seoul SeungAe Hospital, Seoul, Korea  Background and Objectives:  Few studies have invasively assessed diastolic functional reserve and serial changes in left ventricular  hemodynamics in euvolemic patients with exertional dyspnea.",Non-OADS,/arxiv_data1/oa_pdf/cf/84/kcj-46-350.PMC4891600.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/84/kcj-46-350.PMC4891600.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.350 www.e-kcj.org According to recent studies, based on current diagnostic guidelines  issued by the European Society of Cardiology (ESC), HFpEF was diagnosed in 25% to 34% of patients with early HFpEF and in 24% with non-cardiac dyspnea.",Non-OADS,/arxiv_data1/oa_pdf/cf/84/kcj-46-350.PMC4891600.pdf
"352  Left Ventricular Hemodynamics in Euvolemic Patients with Exertional Dyspnea  http://dx.doi.org/10.4070/kcj.2016.46.3.350 www.e-kcj.org disease, chronic liver disease, or cancer or if they had evidence of  chronic obstructive pulmonary disease, frequent atrial or ventricular arrhythmias (ectopic focus>6 beats/minutes or atrial fibrillation), or chronic kidney disease.",Non-OADS,/arxiv_data1/oa_pdf/cf/84/kcj-46-350.PMC4891600.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.350 www.e-kcj.org EKG Pre-aLVDP Pre-aLVDP Pre-aLVDPLVSBP LVSBP LVSBP LVEDP LVEDP LVEDPLVDBPLV dP/dt LV dP/dt LV dP/dtHeart rate Heart rate LVDBP LVDBPLV pressureQRS PQRS P PQRS Fig.,Non-OADS,/arxiv_data1/oa_pdf/cf/84/kcj-46-350.PMC4891600.pdf
354  Left Ventricular Hemodynamics in Euvolemic Patients with Exertional Dyspnea  http://dx.doi.org/10.4070/kcj.2016.46.3.350 www.e-kcj.org ∆LVEDP_frequent≤0 mmHg ∆LVEDP_frequent>0 mmHg Total LVEDP_frequent (mmHg)30 252015 10 0 p30 p60 p90 p120 p150 p180 a0 a30 a60 a90 a120 a150 a180 R60 R120 R18018.219.4* 19.4* 19.3* 19.8*19.119.7*20.0*22.6*†24.1*†24.6*†25.8*†27.4*†27.9*† 23.0*† 19.9* 18.8†LVEDP (mmHg) Time (seconds)18.519.5*25.0*† 24.0*† 23.1*† 22.9*† 21.7*† 19.7* 19.4* 18.919.4* 19.1* 19.2* 19.1* 18.0 17.218.018.4* 18.4* 18.2* 18.2* 18.4* 18.4*18.7* 18.5*‡ 17.5‡ 17.3†‡ 16.6†‡ 14.3*†‡18.6*‡ 17.917.5†24.9*† 22.0*† Fig.,Non-OADS,/arxiv_data1/oa_pdf/cf/84/kcj-46-350.PMC4891600.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.350 www.e-kcj.org who had smoked at least 400 cigarettes during their lifetime were  classified as ex-smokers or as current smokers on the basis of current smoking status.,Non-OADS,/arxiv_data1/oa_pdf/cf/84/kcj-46-350.PMC4891600.pdf
"356  Left Ventricular Hemodynamics in Euvolemic Patients with Exertional Dyspnea  http://dx.doi.org/10.4070/kcj.2016.46.3.350 www.e-kcj.org Measurement of left ventricular hemodynamic parameters LV hemodynamic function was assessed using heart rate (HR),  LV systolic BP (LVSBP), LV diastolic BP (LVDBP), LVEDP, and rate  of LV pressure change (dP/dt).",OADS,/arxiv_data1/oa_pdf/cf/84/kcj-46-350.PMC4891600.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.350 www.e-kcj.org LV hemodynamic parameters were defined using the same system  and format.,OADS,/arxiv_data1/oa_pdf/cf/84/kcj-46-350.PMC4891600.pdf
"358  Left Ventricular Hemodynamics in Euvolemic Patients with Exertional Dyspnea  http://dx.doi.org/10.4070/kcj.2016.46.3.350 www.e-kcj.org intraobserver and interobserver variability for the e/e´ ratio ranged  from 0.81 to 0.90, which was relatively excellent.",Non-OADS,/arxiv_data1/oa_pdf/cf/84/kcj-46-350.PMC4891600.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.350 www.e-kcj.org To examine possible confounding-adjusted correlations between  echocardiographic measurements and the LVEDP response to ALR, we entered age, sex, and other clinically important variables in a multivariate logistic regression analysis as independent variables.",OADS,/arxiv_data1/oa_pdf/cf/84/kcj-46-350.PMC4891600.pdf
360  Left Ventricular Hemodynamics in Euvolemic Patients with Exertional Dyspnea  http://dx.doi.org/10.4070/kcj.2016.46.3.350 www.e-kcj.org activity.,Non-OADS,/arxiv_data1/oa_pdf/cf/84/kcj-46-350.PMC4891600.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.350 www.e-kcj.org Model for predicting the pattern of left ventricular   end-diastolic pressure response during active leg-raise On univariate analysis, we found that age, sex, dP/dt, A wave,  septal e´ wave, septal e/e´ ratio, lateral e/e´ ratio, and mean e/e´ ratio  were all significantly associated with the pattern of LVEDP response during ALR (p<0.05) (Table 6).",OADS,/arxiv_data1/oa_pdf/cf/84/kcj-46-350.PMC4891600.pdf
362  Left Ventricular Hemodynamics in Euvolemic Patients with Exertional Dyspnea  http://dx.doi.org/10.4070/kcj.2016.46.3.350 www.e-kcj.org of the LVEDP response to ALR.,Non-OADS,/arxiv_data1/oa_pdf/cf/84/kcj-46-350.PMC4891600.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.350 www.e-kcj.org study, the effect of leg-raise exercise on LV hemodynamics or DFR  was not sufficient to establish a cause–effect relation or underlying mechanisms.",OADS,/arxiv_data1/oa_pdf/cf/84/kcj-46-350.PMC4891600.pdf
Supplementary Materials  The online-only Data Supplement is available with this article at  http://dx.doi.org/10.4070/kcj.2016.46.3.350.,Non-OADS,/arxiv_data1/oa_pdf/cf/84/kcj-46-350.PMC4891600.pdf
364  Left Ventricular Hemodynamics in Euvolemic Patients with Exertional Dyspnea  http://dx.doi.org/10.4070/kcj.2016.46.3.350 www.e-kcj.org nonobstructive hypertrophic cardiomyopathy.,Non-OADS,/arxiv_data1/oa_pdf/cf/84/kcj-46-350.PMC4891600.pdf
"9) BPV  has the potential to be a strong predictor of stroke, independent Original Article http://dx.doi.org/10.4070/kcj.2016.46.3.365 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Higher Blood Pressure Variability in White Coat Hypertension;  from the Korean Ambulatory Blood Pressure Monitoring Registry In Sook Kang, MD1, Wook Bum Pyun, MD1, Jinho Shin, MD2, Sang-Hyun Ihm, MD3, Ju Han Kim, MD4,   Sungha Park, MD5, Kwang-Il Kim, MD6, Woo-Shik Kim, MD7, Soon Gil Kim, MD2, and Gil Ja Shin, MD1 1Department of Internal Medicine, School of Medicine, Ewha Womans University, Seoul, 2Department of Internal Medicine, College of Medicine, Hanyang University,  Seoul, 3Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, 4Department of Internal Medicine, School of Medicine, Chonnam  University, Gwangju, 5Department of Internal Medicine, School of Medicine, Yonsei University, Seoul, 6Department of Internal Medicine, School of Medicine, Seoul  National University, Seongnam, 7Department of Internal Medicine, School of Medicine Kyung Hee University, Seoul, Korea Background and Objectives: Blood pressure variability (BPV) was recently shown to be a risk factor of stroke.",Non-OADS,/arxiv_data1/oa_pdf/30/5e/kcj-46-365.PMC4891601.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/30/5e/kcj-46-365.PMC4891601.pdf
"366  White Coat Hypertension and Blood Pressure Variability http://dx.doi.org/10.4070/kcj.2016.46.3.365 www.e-kcj.org of mean systolic BP.11-13) Increased large artery stiffness and left  ventricular mass can be present in subjects with high BPV.14)15)  WCH may be a marker of a reaction to stress, such as a visit  to the doctor’s office that manifests with a BP surge and results  in BPV.16) The purpose of this study is to evaluate the relationship  between WCH and BPV.",Non-OADS,/arxiv_data1/oa_pdf/30/5e/kcj-46-365.PMC4891601.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.365 www.e-kcj.org diastolic BP≥85 mmHg.,OADS,/arxiv_data1/oa_pdf/30/5e/kcj-46-365.PMC4891601.pdf
368  White Coat Hypertension and Blood Pressure Variability http://dx.doi.org/10.4070/kcj.2016.46.3.365 www.e-kcj.org 24.3±3.3 kg/m2.,Non-OADS,/arxiv_data1/oa_pdf/30/5e/kcj-46-365.PMC4891601.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.365 www.e-kcj.org MHT group had higher office BP values than the NT group, and  the SHT group had higher office BP values than the WCH group (p<0.001).",OADS,/arxiv_data1/oa_pdf/30/5e/kcj-46-365.PMC4891601.pdf
370  White Coat Hypertension and Blood Pressure Variability http://dx.doi.org/10.4070/kcj.2016.46.3.365 www.e-kcj.org values compared to the other two groups.,Non-OADS,/arxiv_data1/oa_pdf/30/5e/kcj-46-365.PMC4891601.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.365 www.e-kcj.org nighttime diastolic BPV between the WCH and SHT groups showing  a statistically significant difference (7.9±0.4 vs. 8.7±0.3, p=0.002, Table 4).",OADS,/arxiv_data1/oa_pdf/30/5e/kcj-46-365.PMC4891601.pdf
"372  White Coat Hypertension and Blood Pressure Variability http://dx.doi.org/10.4070/kcj.2016.46.3.365 www.e-kcj.org displays differences between races.29)30) All participants in the  current study were Korean, and the results therefore cannot be  generalized to other ethnic groups.",Non-OADS,/arxiv_data1/oa_pdf/30/5e/kcj-46-365.PMC4891601.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.365 www.e-kcj.org and 24-hour blood pressure and heart rate variability.,OADS,/arxiv_data1/oa_pdf/30/5e/kcj-46-365.PMC4891601.pdf
"In previous studies, BP was either sequentially measured, 3-7) simultaneously  measured with two devices,8-10) or measured only once.6)10)11)  In addition, most studies were conducted for patients with cardiovascular diseases, 5)6)8)11-13) with only a few targeting the  general populations.3)9)14) Thus, the objective of this study was to  examine inter-arm difference in BP among the general population of Koreans and to identify associated factors.Original Article http://dx.doi.org/10.4070/kcj.2016.46.3.374 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Inter-Arm Difference in Brachial Blood Pressure  in the General Population of Koreans Bo Mi Song, MPH1,2, Hyeon Chang Kim, MD2,3, Jee-Seon Shim, PhD2, Myung Ha Lee, PhD2, and Dong Phil Choi, PhD2,4 1Department of Public Health, Yonsei University Graduate School, Seoul, 2Cardiovascular and Metabolic Disease Etiology Research Center, 3Department of Preventive  Medicine, Yonsei University College of Medicine, Seoul, 4National Academy of Agricultural Science, Rural Development Administration, Jeonju, Korea Background and Objectives: We investigated the inter-arm difference in blood pressure of the general Korean population to identify  associated factors.Subjects and Methods: A total of 806 participants aged 30 to 64 years without history of major cardiovascular disease were analyzed in this cross-sectional study.",Non-OADS,/arxiv_data1/oa_pdf/d6/b9/kcj-46-374.PMC4891602.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/b9/kcj-46-374.PMC4891602.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.374 www.e-kcj.org Subjects and Methods Study population  Data from the Cardiovascular and Metabolic Disease Etiology  Research Center (CMERC) cohort that began in 2013 were analyzed  in this study.,OADS,/arxiv_data1/oa_pdf/d6/b9/kcj-46-374.PMC4891602.pdf
376  Inter-Arm Difference in Brachial Blood Pressure http://dx.doi.org/10.4070/kcj.2016.46.3.374 www.e-kcj.org their mid-arm circumference.,OADS,/arxiv_data1/oa_pdf/d6/b9/kcj-46-374.PMC4891602.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.374 www.e-kcj.org Statistical analysis Differences in general characteristics and variables of interest  between men and women were evaluated.,OADS,/arxiv_data1/oa_pdf/d6/b9/kcj-46-374.PMC4891602.pdf
378  Inter-Arm Difference in Brachial Blood Pressure http://dx.doi.org/10.4070/kcj.2016.46.3.374 www.e-kcj.org difference in DBP was only independently associated with BMI.,OADS,/arxiv_data1/oa_pdf/d6/b9/kcj-46-374.PMC4891602.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.374 www.e-kcj.org participants with an absolute inter-arm SBP difference≥10 mmHg  was 9.1%.,OADS,/arxiv_data1/oa_pdf/d6/b9/kcj-46-374.PMC4891602.pdf
380  Inter-Arm Difference in Brachial Blood Pressure http://dx.doi.org/10.4070/kcj.2016.46.3.374 www.e-kcj.org The prevalence of a large inter-arm difference in BP in this  study was lower than that in previous studies.3)14) This might be  due to differences in study populations and methods used for BP  measurement.,Non-OADS,/arxiv_data1/oa_pdf/d6/b9/kcj-46-374.PMC4891602.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.374 www.e-kcj.org sequentially instead of simultaneously (RR: 2.2; 95% CI: 1.4–3.6)  and when performing only one BP measurement was used instead of multiple measurements (RR, 2.0; 95% CI, 1.1–3.8).",OADS,/arxiv_data1/oa_pdf/d6/b9/kcj-46-374.PMC4891602.pdf
382  Inter-Arm Difference in Brachial Blood Pressure http://dx.doi.org/10.4070/kcj.2016.46.3.374 www.e-kcj.org difference at the last single measurement (Supplementary Table 2  in the online-only Data Supplement).,OADS,/arxiv_data1/oa_pdf/d6/b9/kcj-46-374.PMC4891602.pdf
Supplementary Materials The online-only Data Supplement is available with this article at  http://dx.doi.org/10.4070/kcj.2016.46.3.374.,Non-OADS,/arxiv_data1/oa_pdf/d6/b9/kcj-46-374.PMC4891602.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.374 www.e-kcj.org 10.,Non-OADS,/arxiv_data1/oa_pdf/d6/b9/kcj-46-374.PMC4891602.pdf
"6) This has led to the speculation Original Article http://dx.doi.org/10.4070/kcj.2016.46.3.384 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Medication Adherence and the Occurrence of Complications  in Patients with Newly Diagnosed Hypertension Hyun-Jin Kim, PhD1, Seok-Jun Yoon, MD2, In-Hwan Oh, MD3, Jae Hee Lim, MS3, and Young Ae Kim, PhD4 1Department of Rehabilitation Standard & Policy, Korea National Rehabilitation Research Institute, Seoul, 2Department of Preventive Medicine, Korea University College  of Medicine, Seoul, 3Department of Preventive Medicine, Kyung Hee University College of Medicine, Seoul, 4Cancer Policy Branch, National Cancer Control Institute,  National Cancer Center, Goyang, Korea Background and Objectives:  In this retrospective cohort study, we sought to elucidate the relationship between medication adherence  (MA) and the incidence of complications in patients with newly diagnosed hypertension.",Non-OADS,/arxiv_data1/oa_pdf/01/f5/kcj-46-384.PMC4891603.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/01/f5/kcj-46-384.PMC4891603.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.384 www.e-kcj.org that MA and anti-hypertensive pharmacological treatments may  be useful in preventing the occurrence of complications and in successfully controlling blood pressure.,Non-OADS,/arxiv_data1/oa_pdf/01/f5/kcj-46-384.PMC4891603.pdf
"386  Medication Adherence and Complication of Hypertension http://dx.doi.org/10.4070/kcj.2016.46.3.384 www.e-kcj.org of the first prescription, since this time period was similar to that in  which the MA was measured.",Non-OADS,/arxiv_data1/oa_pdf/01/f5/kcj-46-384.PMC4891603.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.384 www.e-kcj.org based on sex, age, type of health insurance coverage, main types  and locations of medical institutions, CCI scores, past history of hospitalization, and past history of diabetes mellitus, MPR mean and standard deviation were analyzed using Student’s t-test and ANOVA.",OADS,/arxiv_data1/oa_pdf/01/f5/kcj-46-384.PMC4891603.pdf
388  Medication Adherence and Complication of Hypertension http://dx.doi.org/10.4070/kcj.2016.46.3.384 www.e-kcj.org Table 1.,Non-OADS,/arxiv_data1/oa_pdf/01/f5/kcj-46-384.PMC4891603.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.384 www.e-kcj.org year, the risk of developing complications was 1.20 and 1.80 times  higher, respectively.",Non-OADS,/arxiv_data1/oa_pdf/01/f5/kcj-46-384.PMC4891603.pdf
390  Medication Adherence and Complication of Hypertension http://dx.doi.org/10.4070/kcj.2016.46.3.384 www.e-kcj.org Table 3.,Non-OADS,/arxiv_data1/oa_pdf/01/f5/kcj-46-384.PMC4891603.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.384 www.e-kcj.org Discussion In the present study, MA was relatively higher in men compared  to women as well as among the 50-59 year-old age group.",Non-OADS,/arxiv_data1/oa_pdf/01/f5/kcj-46-384.PMC4891603.pdf
392  Medication Adherence and Complication of Hypertension http://dx.doi.org/10.4070/kcj.2016.46.3.384 www.e-kcj.org There are several limitations to the current study.,Non-OADS,/arxiv_data1/oa_pdf/01/f5/kcj-46-384.PMC4891603.pdf
Supplementary Materials The online-only Data Supplement is available with this article at  http://dx.doi.org/10.4070/kcj.2016.46.3.384.,Non-OADS,/arxiv_data1/oa_pdf/01/f5/kcj-46-384.PMC4891603.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.384 www.e-kcj.org Health Policy Res  2012;1:21.,Non-OADS,/arxiv_data1/oa_pdf/01/f5/kcj-46-384.PMC4891603.pdf
"13-16)Original Article http://dx.doi.org/10.4070/kcj.2016.46.3.394 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Obesity and Hypertension in Association with Diastolic Dysfunction Could Reduce Exercise Capacity JinShil Kim, PhD1, Myeong Gun Kim, MD2, SeWon Kang, PhD3, Bong Roung Kim, MD4, Min Young Baek, MD2,   Yae Min Park, MD2,5, and Mi-Seung Shin, MD2,5 1Gachon University College of Nursing, Incheon, 2Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, 3Dongseoi University College of  Nursing, Pusan, 4Department of Internal Medicine, Seoul Medical Center, Seoul, 5Gachon University College of Medicine, Incheon, Korea  Background and Objectives: Empirical evidence is lacking on the cumulative disease burden of obesity and hypertension and its impact on  cardiac function and exercise capacity.",Non-OADS,/arxiv_data1/oa_pdf/08/fa/kcj-46-394.PMC4891604.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/08/fa/kcj-46-394.PMC4891604.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.394 www.e-kcj.org The impact of weight burden on the development of cardiovascular  disease remains strongly linked to the structural and functional  changes in the left ventricle (LV), which becomes overstrained by the concomitant presence of obesity and hypertension causing progressive cardiac dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/08/fa/kcj-46-394.PMC4891604.pdf
"396  Obesity, Hypertension, and Exercise Capacity http://dx.doi.org/10.4070/kcj.2016.46.3.394 www.e-kcj.org SBP, DBP, and heart rate.23)  Statistical analysis SPSS for Windows version 16.0 (SPSS Inc., Chicago, IL, USA) was  used for data analysis.",Non-OADS,/arxiv_data1/oa_pdf/08/fa/kcj-46-394.PMC4891604.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.394 www.e-kcj.org E/A ratio was a significant predictor of greater METs (ß=0.37,  p=0.013), accounting for 29% of the variance in METs (Table 3).",OADS,/arxiv_data1/oa_pdf/08/fa/kcj-46-394.PMC4891604.pdf
"398  Obesity, Hypertension, and Exercise Capacity http://dx.doi.org/10.4070/kcj.2016.46.3.394 www.e-kcj.org Table 2.",Non-OADS,/arxiv_data1/oa_pdf/08/fa/kcj-46-394.PMC4891604.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.394 www.e-kcj.org were observed between the obese hypertensive patients compared  with their counterparts.,Non-OADS,/arxiv_data1/oa_pdf/08/fa/kcj-46-394.PMC4891604.pdf
"400  Obesity, Hypertension, and Exercise Capacity http://dx.doi.org/10.4070/kcj.2016.46.3.394 www.e-kcj.org short-term treadmill walking program or an exercise and weight  loss intervention in obese persons with metabolic syndrome.24)27)28)  Diastolic function parameters showed particular improvement in association with weight reduction in persons with severe obesity.",Non-OADS,/arxiv_data1/oa_pdf/08/fa/kcj-46-394.PMC4891604.pdf
Available from http://www.cdc.gov/minorityhealth/CHDIR/2011/FactSheets/Hypertension.pdf.,Non-OADS,/arxiv_data1/oa_pdf/08/fa/kcj-46-394.PMC4891604.pdf
Available from http://www.mw.go.kr/front_new/al/ sal0301vw.jsp?PAR_MENU_ID=04 &MENU_ID=0403 &CONT_ SEQ=279051 &page=1.,OADS,/arxiv_data1/oa_pdf/08/fa/kcj-46-394.PMC4891604.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.394 www.e-kcj.org study: comparison between immediate and delayed intervention  groups.,Non-OADS,/arxiv_data1/oa_pdf/08/fa/kcj-46-394.PMC4891604.pdf
Available from: http://stat.mw.go.kr/front/statData/majorIdctView.jsp?menuId=17 &guidSeq=112 &ctgr=F 00001.,OADS,/arxiv_data1/oa_pdf/08/fa/kcj-46-394.PMC4891604.pdf
"Original Article http://dx.doi.org/10.4070/kcj.2016.46.3.402 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Levosimendan Reduces Lung Injury in a Canine Model  of Cardiopulmonary Bypass Junbo Feng, MD1, Haiyuan Liu, MD2, Jiayi Chen, MD1, Jiyuan Wang, MD1, Zhuang Liu, MD1, and Shenglin Ge, MD1 1The First Ward of Cardiovascular Surgery Department of the First Affiliated Hospital of Anhui Medical University, 2The Oncology Department of the Hefei Second People’s  Hospital, Hefei, China  Background and Objectives: To explore the lung-protective effect of levosimendan (LS) during cardiopulmonary bypass in a canine model  by determining the wet/dry weight (W/D) ratio of lung tissue, malonaldehyde (MDA) and superoxide dismutase (SOD) concentrations, and performing a histological evaluation.",Non-OADS,/arxiv_data1/oa_pdf/ac/d0/kcj-46-402.PMC4891605.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/d0/kcj-46-402.PMC4891605.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.402 www.e-kcj.org Materials and Methods Materials Animals  A total of 32 healthy canines of body weight 12±1.94 kg were  selected for this study without gender restriction (Animal Experiment  Center, Anhui Medical University).",Non-OADS,/arxiv_data1/oa_pdf/ac/d0/kcj-46-402.PMC4891605.pdf
404  Pulmonary Protective Effects of Levosimendan in Cardiopulmonary Bapass http://dx.doi.org/10.4070/kcj.2016.46.3.402 www.e-kcj.org Measurements of malonaldehyde and superoxide dismutase  Stored lung tissues were thawed and made into tissue  homogenates for determination of MDA and SOD concentrations  in accordance with the manufacturer’s instructions.,Non-OADS,/arxiv_data1/oa_pdf/ac/d0/kcj-46-402.PMC4891605.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.402 www.e-kcj.org adjustment.,Non-OADS,/arxiv_data1/oa_pdf/ac/d0/kcj-46-402.PMC4891605.pdf
406  Pulmonary Protective Effects of Levosimendan in Cardiopulmonary Bapass http://dx.doi.org/10.4070/kcj.2016.46.3.402 www.e-kcj.org exudate were present in groups C and LSIV.,Non-OADS,/arxiv_data1/oa_pdf/ac/d0/kcj-46-402.PMC4891605.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.402 www.e-kcj.org groups in which LS was administered, which indicated that LS can  protect lung tissues.",Non-OADS,/arxiv_data1/oa_pdf/ac/d0/kcj-46-402.PMC4891605.pdf
"The patient took aspirin (300 mg) and clopidogrel (300 Case Report http://dx.doi.org/10.4070/kcj.2016.46.3.408 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Abdominal Wall Hematoma as a Rare Complication  following Percutaneous Coronary Intervention In Tae Moon, MD1, Jeong Hun Shin, MD1, Young Seok Sohn, MD1, Ji Young Lee, MD1, Hwan Cheol Park, MD1,   Sung Il Choi, MD1, Soon Gil Kim, MD1, and Ji Young Oh, MD2 1Division of Cardiology, Department of Internal Medicine, 2Department of Radiology, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri,  Korea Abdominal wall hematoma is a rare but potentially serious vascular complication that may develop after coronary angiographic procedures.",Non-OADS,/arxiv_data1/oa_pdf/f8/7f/kcj-46-408.PMC4891606.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/7f/kcj-46-408.PMC4891606.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.408 www.e-kcj.org mg) loading dose 12 hours before the procedure.,Non-OADS,/arxiv_data1/oa_pdf/f8/7f/kcj-46-408.PMC4891606.pdf
"410  Abdominal Wall Hematoma after Percutaneous Coronary Intervention http://dx.doi.org/10.4070/kcj.2016.46.3.408 www.e-kcj.org Discussion Abdominal wall hematoma is a rare but potentially serious vascular  complication that may develop after cardiac and peripheral angiographic  procedures.1) Predisposing factors include increased sheath size,  repeat or multiple punctures of the artery, concomitant use of anticoagulants, advanced age, being female, and hypertension.",Non-OADS,/arxiv_data1/oa_pdf/f8/7f/kcj-46-408.PMC4891606.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.408 www.e-kcj.org Soc 2009;57:2375-6.,OADS,/arxiv_data1/oa_pdf/f8/7f/kcj-46-408.PMC4891606.pdf
"Given the patient’s age, possible inflammatory adhesion around  the dissection, absence of dilation of the internal artery, and the desire to minimize the risks of colon ischemia, buttock claudication, and impotence, we proceeded with an attempt at endovascular dissection repair with an MFSG.Case Report http://dx.doi.org/10.4070/kcj.2016.46.3.412 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Preservation of Internal Iliac Artery after Endovascular Repair  of Common Iliac Artery Dissection Using Modified Fenestrated Stent Graft Binshan Zha, MD, Huagang Zhu, MD, Bin Liu, MD, Yusheng Ye, MD, and Jun Li, MD Department of Vascular Surgery, First Affiliated Hospital of Anhui Medical University, Hefei, China Standard endovascular repair of iliac/aortoiliac pathologies can lead to complications, such as buttock claudication, colon ischemia and  erectile dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/7c/f9/kcj-46-412.PMC4891607.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/f9/kcj-46-412.PMC4891607.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.412 www.e-kcj.org Device modification  The modified graft was created using a 16 mm×13 mm×80 mm  Endurant stent graft (Medtronic, Minneapolis, MN, USA).",Non-OADS,/arxiv_data1/oa_pdf/7c/f9/kcj-46-412.PMC4891607.pdf
414  Preservation IIA Using Modified Fenestrated Stent Grafts http://dx.doi.org/10.4070/kcj.2016.46.3.412 www.e-kcj.org fluoroscopy and adjusting the longitudinal radiopaque marker to  the level of the internal iliac artery.,Non-OADS,/arxiv_data1/oa_pdf/7c/f9/kcj-46-412.PMC4891607.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.412 www.e-kcj.org pathologies have been reported.4) The current report presents our  first clinical use of an MFSG for preservation of the internal iliac  artery.,Non-OADS,/arxiv_data1/oa_pdf/7c/f9/kcj-46-412.PMC4891607.pdf
416  Preservation IIA Using Modified Fenestrated Stent Grafts http://dx.doi.org/10.4070/kcj.2016.46.3.412 www.e-kcj.org 2.,Non-OADS,/arxiv_data1/oa_pdf/7c/f9/kcj-46-412.PMC4891607.pdf
"Three years ago, he had also presented with CLI in the same leg, for which, femoropopliteal bypass surgery using an 8-mm Hemashield graft, as well as popliteal artery stenting, Case Report http://dx.doi.org/10.4070/kcj.2016.46.3.417 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Endovascular Treatment of Multilevel Chronic Total Occlusion  Using a Stent Puncture Technique in Buerger’s Disease Jung-Hee Lee, MD, Young-Guk Ko, MD, and Donghoon Choi, MD Division of Cardiology, Yonsei University College of Medicine, Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, Korea   We reported a patient with Buerger’s disease who presented with critical limb ischemiawith prior recurrent occlusions after multiple  surgical and endovascular treatments.",Non-OADS,/arxiv_data1/oa_pdf/8a/55/kcj-46-417.PMC4891608.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8a/55/kcj-46-417.PMC4891608.pdf
418  Endovascular Treatment Using Stent Puncture http://dx.doi.org/10.4070/kcj.2016.46.3.417 www.e-kcj.org were performed.,Non-OADS,/arxiv_data1/oa_pdf/8a/55/kcj-46-417.PMC4891608.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.417 www.e-kcj.org a reattempt to crack the occluded in-stent segment in the popliteal  artery (Fig.,Non-OADS,/arxiv_data1/oa_pdf/8a/55/kcj-46-417.PMC4891608.pdf
420  Endovascular Treatment Using Stent Puncture http://dx.doi.org/10.4070/kcj.2016.46.3.417 www.e-kcj.org suitable.,Non-OADS,/arxiv_data1/oa_pdf/8a/55/kcj-46-417.PMC4891608.pdf
"However, the pro-brain natriuretic peptide was elevated to 13095 pg/mL.Case Report http://dx.doi.org/10.4070/kcj.2016.46.3.421 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Reversal of Pacing-Induced Cardiomyopathy by Normal QRS Axis Pacing Ji Hyun Yang, MD, Ju Youn Kim, MD, Sung-Hwan Kim, MD, and Yong-Seog Oh, MD Division of Cardiology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea Right ventricular apical pacing has been a commonly used method for placement of permanent pacemaker, but it is known to be  associated with ventricular dyssynchrony and may lead to heart failure.",Non-OADS,/arxiv_data1/oa_pdf/ff/64/kcj-46-421.PMC4891609.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ff/64/kcj-46-421.PMC4891609.pdf
422  Normal QRS Axis Pacing http://dx.doi.org/10.4070/kcj.2016.46.3.421 www.e-kcj.org The patient was transferred to a general medical ward.,Non-OADS,/arxiv_data1/oa_pdf/ff/64/kcj-46-421.PMC4891609.pdf
http://dx.doi.org/10.4070/kcj.2016.46.3.421 www.e-kcj.org lead came off from the ventricular wall with ease.,Non-OADS,/arxiv_data1/oa_pdf/ff/64/kcj-46-421.PMC4891609.pdf
424  Normal QRS Axis Pacing http://dx.doi.org/10.4070/kcj.2016.46.3.421 www.e-kcj.org 6.,Non-OADS,/arxiv_data1/oa_pdf/ff/64/kcj-46-421.PMC4891609.pdf
"However, 2 weeks before his admission, he developed sudden onset headache, dizziness and nausea and was Case Report http://dx.doi.org/10.4070/kcj.2016.46.3.425 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Non-Bacterial Thrombotic Endocarditis in a Patient  with Rheumatoid Arthritis Jung-Hye Choi, MD1, Jeong-Eun Park, MD1, Jang-Young Kim, MD2, and Taeyoung Kang, MD1 1Department of Rheumatology, 2Department of Cardiology, Yonsei University Wonju College of Medicine, Wonju, Korea Rheumatoid arthritis (RA) is frequently associated with various extra-joint complications.",Non-OADS,/arxiv_data1/oa_pdf/93/89/kcj-46-425.PMC4891610.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/89/kcj-46-425.PMC4891610.pdf
426  Non-Bacterial Thrombotic Endocarditis in a Rheumatoid Arthritis Patient http://dx.doi.org/10.4070/kcj.2016.46.3.425 www.e-kcj.org admitted to the rheumatology clinic in our hospital.,Non-OADS,/arxiv_data1/oa_pdf/93/89/kcj-46-425.PMC4891610.pdf
"http://dx.doi.org/10.4070/kcj.2016.46.3.425 www.e-kcj.org numerous reports on the relationship between NBTE and a variety of  different inflammatory states, particularly malignancy.4) A definite  diagnosis can be made pathologically by the demonstration of platelet thrombi on surgical specimens.",Non-OADS,/arxiv_data1/oa_pdf/93/89/kcj-46-425.PMC4891610.pdf
"428  Non-Bacterial Thrombotic Endocarditis in a Rheumatoid Arthritis Patient http://dx.doi.org/10.4070/kcj.2016.46.3.425 www.e-kcj.org erythematosus, NBTE does not correlate with disease activity.16) In  the present RA case, arthritic activity was not higher around the  time of the cardiovascular event.",Non-OADS,/arxiv_data1/oa_pdf/93/89/kcj-46-425.PMC4891610.pdf
"Letter to the Editor http://dx.doi.org/10.4070/kcj.2016.46.3.429 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Sympathetic Activity Index Should Be Kept in Mind  When Assessing Autonomic Tonus Mehmet Dogan, MD1, Zekeriya Arslan, MD2, and Haluk Un, MD2 1Department of Cardiology, Mevki Military Hospital, Ankara, 2Department of Cardiology, Gulhane Military Medical Academy, Haydarpasa Training Hospital, Istanbul,  Turkey Received:  October 27, 2015 Accepted:  December 1, 2015 Correspondence:  Mehmet Dogan, MD, Irfan Bastug Street,   Altindag Ankara, TurkeyTel: 90-530-5928277E-mail:  mehmetdoganmd@yahoo.com • The authors have no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/54/9a/kcj-46-429.PMC4891611.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/9a/kcj-46-429.PMC4891611.pdf
430  Sympathetic Activity Index in Autonomic Tonus http://dx.doi.org/10.4070/kcj.2016.46.3.429 www.e-kcj.org My colleague and I appreciated the comments of Doctor Mehmet  regarding the sympathetic activity in patients with idiopathic  ventricular premature complexes (VPCs).,Non-OADS,/arxiv_data1/oa_pdf/54/9a/kcj-46-429.PMC4891611.pdf
"Letter to the Editor http://dx.doi.org/10.4070/kcj.2016.46.3.431 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Apelin Levels in Patients with Coronary Artery Ectasia Sevket Balta, MD, Cengiz Ozturk, MD, Mustafa Demir, MD, and Ali Osman Yildirim, MD Department of Cardiology, Gulhane Medical Academy, Ankara, Turkey Received:  November  23, 2015 Revision Received:  December 12, 2015 Accepted:  December 17, 2015 Correspondence:  Sevket Balta, MD, Department of Cardiology, Gulhane  Medical Academy, Tevfik Saglam St., 06018 Etlik-Ankara, TurkeyTel: 90-312-3044281, Fax: 90-312-3044250E-mail: drsevketb@gmail.com  • The authors have no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/f5/52/kcj-46-431.PMC4891612.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f5/52/kcj-46-431.PMC4891612.pdf
"432 Copyright © 2016 The Korean Society of CardiologyKorean Circulation Journal Erratum http://dx.doi.org/10.4070/kcj.2016.46.3.432 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Korean Circ J 2016;46:169-178http://dx.doi.org/10.4070/kcj.2016.46.2.169 In the article, “Psychiatric Characteristics of the Cardiac Outpatients with Chest Pain” in Volume 46(2), page 169-178, the first author’s name was misspelled.",Non-OADS,/arxiv_data1/oa_pdf/c9/ab/kcj-46-432.PMC4891613.pdf
"Saunders, Philadelphia 1997, pp 74-88. http://www.amazon.com/Internal-Derangements-Joints -Emphasis-Imaging/dp/0721667600/sr=1-6/qid=1162 339352/ref=sr_1_6/002-3754009-0014440?ie=UTF8& s=books )  9.",Non-OADS,/arxiv_data1/oa_pdf/c8/f0/main.PMC4891622.pdf
Available from: http://www.cdc.gov/obesity/ data/facts.html 4.,OADS,/arxiv_data1/oa_pdf/a9/11/OSP4-2-136.PMC4891700.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Infection Ecology and Epidemiology 2016, 6: 31465 - http://dx.doi.org/10.3402/iee.v6.31465 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/1a/56/IEE-6-31465.PMC4891966.pdf
"2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31465 - http://dx.doi.org/10.3402/iee.v6.31465",Non-OADS,/arxiv_data1/oa_pdf/1a/56/IEE-6-31465.PMC4891966.pdf
"Summary of ELISA and FRNT results Sample ELISAaFRNTbPUUV SEOV DOBV SAAV TULV 14 0.929 50 B50 B50 B50 B50 85 0.974 200 B50 B50 B50 B100 87 0.570 B50 NT NT NT 250 89 1.358 50 B50 B50 B50 200 91 0.973 200 50 50 50 200 96 0.763 50 B50 B50 B50 50 164 0.967 200 B50 B50 B50 NT 174 2.207 200 B50 B50 B50 200 181 1.677 200 B50 50 50 200 183 0.410 B50 NT NT NT 250 PUUV pos.c1.00 640 NT B40 B40 NT PUUV neg.c0.00 B50 NT B40 B40 NT TULV pos.dNT 80 40 40 NT 1280 TULV neg.dNT B40 B40 B40 NT B40 NT, not tested;aOD, optical density at 405nm, adjusted to the positive control /C301.00;bFRNT end-point titer;chuman PUUV convalescent and negative control sera;dMicrotus arvalis TULV control sera.Hantavirus in Sweden Citation: Infection Ecology and Epidemiology 2016, 6: 31465 - http://dx.doi.org/10.3402/iee.v6.31465 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/1a/56/IEE-6-31465.PMC4891966.pdf
doi: http://dx.doi.org/10.1099/vir.0.000076 8.,Non-OADS,/arxiv_data1/oa_pdf/1a/56/IEE-6-31465.PMC4891966.pdf
"4 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31465 - http://dx.doi.org/10.3402/iee.v6.31465",Non-OADS,/arxiv_data1/oa_pdf/1a/56/IEE-6-31465.PMC4891966.pdf
Infect Ecol Epidemiol 2015; 5: 27215. doi: http://dx.doi.org/10.3402/iee.v5.,Non-OADS,/arxiv_data1/oa_pdf/1a/56/IEE-6-31465.PMC4891966.pdf
"J Virol 1994; 68: 7833 /C19.Hantavirus in Sweden Citation: Infection Ecology and Epidemiology 2016, 6: 31465 - http://dx.doi.org/10.3402/iee.v6.31465 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/1a/56/IEE-6-31465.PMC4891966.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all no n-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Infection Ecology and Epidemiology 2016, 6: 31374 - http://dx.doi.org/10.3402/iee.v6.31374 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/20/12/IEE-6-31374.PMC4891970.pdf
"The age distribution is representative and shows thatKarolina Gullsby and Ka ˚re Bondeson 2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31374 - http://dx.doi.org/10.3402/iee.v6.31374",OADS,/arxiv_data1/oa_pdf/20/12/IEE-6-31374.PMC4891970.pdf
"The blue line without melting point corresponds to a negative sample with no ampliﬁcation of M. pneumoniae DNA.No detection of macrolide-resistant M. pneumoniae Citation: Infection Ecology and Epidemiology 2016, 6: 31374 - http://dx.doi.org/10.3402/iee.v6.31374 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/20/12/IEE-6-31374.PMC4891970.pdf
"New Microbes New Infect 2015; 6: 22 /C19.Karolina Gullsby and Ka ˚re Bondeson 4 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31374 - http://dx.doi.org/10.3402/iee.v6.31374",Non-OADS,/arxiv_data1/oa_pdf/20/12/IEE-6-31374.PMC4891970.pdf
Available from: https://www.folkhalsomyndigheten.se/pageﬁles/20281/Swedres-Svarm-2014-14027.pdf [cited 19 April 2016].,Non-OADS,/arxiv_data1/oa_pdf/20/12/IEE-6-31374.PMC4891970.pdf
"Antimicrob Agents Chemother 2014; 58: 1034 /C18.No detection of macrolide-resistant M. pneumoniae Citation: Infection Ecology and Epidemiology 2016, 6: 31374 - http://dx.doi.org/10.3402/iee.v6.31374 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/20/12/IEE-6-31374.PMC4891970.pdf
"The Barmer GEK is one of the largest statutory insurance companies and provides health insurance for 8.7 million people (about 10% of the entire German population, see http://www.barmer-gek.de ).",Non-OADS,/arxiv_data1/oa_pdf/01/d1/TONEUJ-10-15.PMC4891984.pdf
"[http://dx.doi.org/10.1111/j.1600-0404.2009.01250.x] [PMID: 19832773] [4] Trenkwalder C, Schwarz J, Gebhard J, et al.",OADS,/arxiv_data1/oa_pdf/01/d1/TONEUJ-10-15.PMC4891984.pdf
"[http://dx.doi.org/10.1001/archneur.1995.00540340109020] [PMID: 7575219] [5] Muangpaisan W, Petcharat C, Srinonprasert V. Prevalence of potentially reversible conditions in dementia and mild cognitive impairment in a geriatric clinic.",Non-OADS,/arxiv_data1/oa_pdf/01/d1/TONEUJ-10-15.PMC4891984.pdf
"[http://dx.doi.org/10.1111/j.1447-0594.2011.00728.x] [PMID: 21794050] [6] Klassen BT, Ahlskog JE.",OADS,/arxiv_data1/oa_pdf/01/d1/TONEUJ-10-15.PMC4891984.pdf
"[http://dx.doi.org/10.1212/WNL.0b013e31822f02f5] [PMID: 21849644] [7] Cabral D, Beach TG, Vedders L, et al.",OADS,/arxiv_data1/oa_pdf/01/d1/TONEUJ-10-15.PMC4891984.pdf
"[http://dx.doi.org/10.1016/j.jalz.2010.12.008] [8] Brean A, Eide PK.",OADS,/arxiv_data1/oa_pdf/01/d1/TONEUJ-10-15.PMC4891984.pdf
"[http://dx.doi.org/10.1111/j.1600-0404.2007.00982.x] [PMID: 18205881] [9] Tanaka N, Yamaguchi S, Ishikawa H, Ishii H, Meguro K. Prevalence of possible idiopathic normal-pressure hydrocephalus in Japan: the Osaki-Tajiri project.",Non-OADS,/arxiv_data1/oa_pdf/01/d1/TONEUJ-10-15.PMC4891984.pdf
"[http://dx.doi.org/10.1159/000186501] [PMID: 19096225] [10] Hiraoka  K,  Meguro  K,  Mori  E.  Prevalence  of  idiopathic  normal-pressure  hydrocephalus  in  the  elderly  population  of  a  Japanese  rural community.",Non-OADS,/arxiv_data1/oa_pdf/01/d1/TONEUJ-10-15.PMC4891984.pdf
"[http://dx.doi.org/10.2176/nmc.48.197] [PMID: 18497491] [11] Marmarou A, Young HF, Aygok GA.",Non-OADS,/arxiv_data1/oa_pdf/01/d1/TONEUJ-10-15.PMC4891984.pdf
"[http://dx.doi.org/10.3171/foc.2007.22.4.2] [PMID: 17613187] [12] Tisell M, Höglund M, Wikkelsø C. National and regional incidence of surgery for adult hydrocephalus in Sweden.",OADS,/arxiv_data1/oa_pdf/01/d1/TONEUJ-10-15.PMC4891984.pdf
"[http://dx.doi.org/10.1111/j.1600-0404.2005.00451.x] [PMID: 16008530] [13] Jaraj D, Rabiei K, Marlow T, Jensen C, Skoog I, Wikkelsø C. Prevalence of idiopathic normal-pressure hydrocephalus.",OADS,/arxiv_data1/oa_pdf/01/d1/TONEUJ-10-15.PMC4891984.pdf
[http://dx.doi.org/10.1212/WNL.0000000000000342] [PMID: 24682964] © Lemcke et al.,OADS,/arxiv_data1/oa_pdf/01/d1/TONEUJ-10-15.PMC4891984.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/01/d1/TONEUJ-10-15.PMC4891984.pdf
"[http://dx.doi.org/10.4103/0970-4388.19010] [PMID: 16327143] [6] Ramaglia L, Morgese F, Pighetti M, Saviano R. Odontogenic keratocyst and uterus bicornis in nevoid basal cell carcinoma syndrome: case report and literature review.",Non-OADS,/arxiv_data1/oa_pdf/46/78/TODENTJ-10-117.PMC4891985.pdf
"[http://dx.doi.org/10.1016/j.tripleo.2005.08.009] [PMID: 16876065] [7] Chirapathomsakul D, Sastravaha P, Jansisyanont P. A review of odontogenic keratocysts and the behavior of recurrences.",OADS,/arxiv_data1/oa_pdf/46/78/TODENTJ-10-117.PMC4891985.pdf
[http://dx.doi.org/10.1016/j.tripleo.2005.03.023] [PMID: 16360602] [8] Shear M. The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm?,Non-OADS,/arxiv_data1/oa_pdf/46/78/TODENTJ-10-117.PMC4891985.pdf
"[http://dx.doi.org/10.1016/S1368-8375(01)00065-3] [PMID: 11978543] [9] Freitas DQ, Tempest LM, Sicoli E, Lopes-Neto FC.",Non-OADS,/arxiv_data1/oa_pdf/46/78/TODENTJ-10-117.PMC4891985.pdf
"[http://dx.doi.org/10.1259/dmfr/26194891] [PMID: 17082341] [10] Hyun HK, Hong SD, Kim JW.",OADS,/arxiv_data1/oa_pdf/46/78/TODENTJ-10-117.PMC4891985.pdf
"[http://dx.doi.org/10.1016/j.tripleo.2009.04.030] [PMID: 19615649] [11] Maurette PE, Jorge J, de Moraes M. Conservative treatment protocol of odontogenic keratocyst: a preliminary study.",OADS,/arxiv_data1/oa_pdf/46/78/TODENTJ-10-117.PMC4891985.pdf
"[http://dx.doi.org/10.1016/j.joms.2005.11.007] [PMID: 16487797] [12] Prakash R, Verma S, Agarwal N, et al.",OADS,/arxiv_data1/oa_pdf/46/78/TODENTJ-10-117.PMC4891985.pdf
"[http://dx.doi.org/10.1136/bcr-2013-010409 ] [PMID: 3702894 ] [13] Deboni MC, Brozoski MA, Traina AA, Acay RR, Naclério-Homem MdaG.",Non-OADS,/arxiv_data1/oa_pdf/46/78/TODENTJ-10-117.PMC4891985.pdf
[http://dx.doi.org/10.1590/S1678-77572012000200025 ] [PMID: 22666848 ] [14] Kumar  V.  Conservative  surgical  approach  to  aggressive  benign  odontogenic  neoplasm:  a  report  of  three  cases.,Non-OADS,/arxiv_data1/oa_pdf/46/78/TODENTJ-10-117.PMC4891985.pdf
"[http://dx.doi.org/10.5125/jkaoms.2015.41.1.37 ] [PMID: 25741467 ] [15] Singh M, Gupta KC.",OADS,/arxiv_data1/oa_pdf/46/78/TODENTJ-10-117.PMC4891985.pdf
"[http://dx.doi.org/10.5005/jp-journals-10005-1199 ] [PMID: 25206202 ] [17] Chaudhary S, Sinha A, Barua P, Mallikarjuna R. Keratocystic odontogenic tumour (KCOT) misdiagnosed as a dentigerous cyst.",Non-OADS,/arxiv_data1/oa_pdf/46/78/TODENTJ-10-117.PMC4891985.pdf
"[http://dx.doi.org/10.5037/jomr.2010.1307 ] [PMID: 24421977 ] [23] Giuliani M, Grossi GB, Lajolo C, Bisceglia M, Herb KE.",OADS,/arxiv_data1/oa_pdf/46/78/TODENTJ-10-117.PMC4891985.pdf
"[http://dx.doi.org/10.1016/j.joms.2005.10.013 ] [PMID: 16413905 ] [24] Zhou H, Hou R, Ma Q, et al.",OADS,/arxiv_data1/oa_pdf/46/78/TODENTJ-10-117.PMC4891985.pdf
"[http://dx.doi.org/10.1016/j.joms.2011.12.021 ] [PMID: 22330329 ] [25] Ramesh RS, Manjunath S, Ustad TH, Pais S, Shivakumar K. Unicystic ameloblastoma of the mandible-an unusual case report and review of literature.",Non-OADS,/arxiv_data1/oa_pdf/46/78/TODENTJ-10-117.PMC4891985.pdf
"[http://dx.doi.org/10.1186/1758-3284-2-1 ] [PMID: 20157425 ] [26] Park SH, Kim NK, Kim KH, et al.",OADS,/arxiv_data1/oa_pdf/46/78/TODENTJ-10-117.PMC4891985.pdf
"[http://dx.doi.org/10.4103/0976-237X.91804 ] [PMID: 22346168 ] [29] Güler N, Sençift K, Demirkol O.",Non-OADS,/arxiv_data1/oa_pdf/46/78/TODENTJ-10-117.PMC4891985.pdf
"[http://dx.doi.org/10.1100/2012/680397 ] [30] Hellstein J, Hopkins T, Morgan T. The history and mystery of Carnoy’s solution: an assessment of the need for chloroform.",Non-OADS,/arxiv_data1/oa_pdf/46/78/TODENTJ-10-117.PMC4891985.pdf
"[http://dx.doi.org/10.1016/j.tripleo.2006.12.055 ] [31] Carneiro JT, Guerreiro Rodrigues Couto AP, Dias Carreira AS.",OADS,/arxiv_data1/oa_pdf/46/78/TODENTJ-10-117.PMC4891985.pdf
"[http://dx.doi.org/10.1016/j.jcms.2012.01.017 ] [PMID: 22421467 ] [32] Mizokami F, Murasawa Y, Furuta K, Isogai Z. Iodoform gauze removes necrotic tissue from pressure ulcer wounds by fibrinolytic activity.",OADS,/arxiv_data1/oa_pdf/46/78/TODENTJ-10-117.PMC4891985.pdf
"[http://dx.doi.org/10.1248/bpb.b11-00016 ] [PMID: 22791151 ] [33] Freedman M, Stassen LF.",OADS,/arxiv_data1/oa_pdf/46/78/TODENTJ-10-117.PMC4891985.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/78/TODENTJ-10-117.PMC4891985.pdf
"[http://dx.doi.org/10.1016/0002-9416(84)90063-0 ] [PMID: 6584033 ] [2] Hägg U, Pancherz H. Dentofacial orthopaedics in relation to chronological age, growth period and skeletal development.",Non-OADS,/arxiv_data1/oa_pdf/d7/e1/TODENTJ-10-99.PMC4891986.pdf
"[http://dx.doi.org/10.1093/ejo/10.3.169 ] [PMID: 3181295 ] [3] Petrovic A, Stutzmann J, Lavergne J.",OADS,/arxiv_data1/oa_pdf/d7/e1/TODENTJ-10-99.PMC4891986.pdf
"[http://dx.doi.org/10.1016/0002-9416(85)90126-5 ] [PMID: 3863486 ] [6] Tanner JM, Healy M, Goldstein N, Cameron N. Assessment of Skeletal Maturity and Prediction of Adult Height (TW3 method).",Non-OADS,/arxiv_data1/oa_pdf/d7/e1/TODENTJ-10-99.PMC4891986.pdf
[http://dx.doi.org/10.1016/0002-9416(76)90143-3 ] [PMID: 179326 ] [9] Fishman LS.,OADS,/arxiv_data1/oa_pdf/d7/e1/TODENTJ-10-99.PMC4891986.pdf
"[http://dx.doi.org/10.1016/S0889-5406(95)70157-5 ] [PMID: 7817962 ] [11] Baccetti T, Franchi L, McNamara JA Jr. An improved version of the cervical vertebral maturation (CVM) method for the assessment of mandibular growth.",Non-OADS,/arxiv_data1/oa_pdf/d7/e1/TODENTJ-10-99.PMC4891986.pdf
"[http://dx.doi.org/10.1016/0002-9416(80)90226-2 ] [PMID: 6928087 ] [15] Coutinho S, Buschang PH, Miranda F. Relationships between mandibular canine calcification stages and skeletal maturity.",Non-OADS,/arxiv_data1/oa_pdf/d7/e1/TODENTJ-10-99.PMC4891986.pdf
"[http://dx.doi.org/10.1016/S0889-5406(05)81728-7 ] [PMID: 8362788 ] [16] Franchi L, Baccetti T, De Toffol L, Polimeni A, Cozza P. Phases of the dentition for the assessment of skeletal maturity: a diagnostic performance study.",Non-OADS,/arxiv_data1/oa_pdf/d7/e1/TODENTJ-10-99.PMC4891986.pdf
"[http://dx.doi.org/10.1016/j.ajodo.2006.02.040 ] [PMID: 18331939 ] [17] Perinetti G, Contardo L, Gabrieli P, Baccetti T, Di Lenarda R. Diagnostic performance of dental maturity for identification of skeletal maturation phase.",Non-OADS,/arxiv_data1/oa_pdf/d7/e1/TODENTJ-10-99.PMC4891986.pdf
"[http://dx.doi.org/10.1093/ejo/cjr027 ] [PMID: 21345927 ] [18] Baccetti T, Franchi L, McNamara JA.",OADS,/arxiv_data1/oa_pdf/d7/e1/TODENTJ-10-99.PMC4891986.pdf
[http://dx.doi.org/10.1053/j.sodo.2005.04.005 ] [19] Nolla CM.,OADS,/arxiv_data1/oa_pdf/d7/e1/TODENTJ-10-99.PMC4891986.pdf
[http://dx.doi.org/10.14219/jada.archive.1989.0162 ] [PMID: 2738249 ],OADS,/arxiv_data1/oa_pdf/d7/e1/TODENTJ-10-99.PMC4891986.pdf
"[http://dx.doi.org/10.1007/s00414-005-0047-9 ] [PMID: 16283352 ] [23] Mörnstad H, Reventlid M, Teivens A.",OADS,/arxiv_data1/oa_pdf/d7/e1/TODENTJ-10-99.PMC4891986.pdf
[http://dx.doi.org/10.1093/ejo/cji010 ] [PMID: 15947233 ] [27] Al-Emran S. Dental age assessment of 8.5 to 17 Year-old Saudi children using Demirjian’s method.,Non-OADS,/arxiv_data1/oa_pdf/d7/e1/TODENTJ-10-99.PMC4891986.pdf
"[http://dx.doi.org/10.1258/msl.2011.011021 ] [PMID: 22399027 ] [29] Yan J, Lou X, Xie L, Yu D, Shen G, Wang Y.",Non-OADS,/arxiv_data1/oa_pdf/d7/e1/TODENTJ-10-99.PMC4891986.pdf
"[http://dx.doi.org/10.1371/journal.pone.0084672 ] [PMID: 24367690 ] [30] Demirjian A, Buschang PH, Tanguay R, Patterson DK.",Non-OADS,/arxiv_data1/oa_pdf/d7/e1/TODENTJ-10-99.PMC4891986.pdf
[http://dx.doi.org/10.1016/0002-9416(85)90070-3 ] [PMID: 3864376 ] [31] Helm S. Relationship between dental and skeletal maturation in Danish schoolchildren.,Non-OADS,/arxiv_data1/oa_pdf/d7/e1/TODENTJ-10-99.PMC4891986.pdf
"[http://dx.doi.org/10.1093/ejo/cjq031 ] [PMID: 20558591 ] [36] Kumar S, Singla A, Sharma R, Virdi MS, Anupam A, Mittal B. Skeletal maturation evaluation using mandibular second molar calcification stages.",Non-OADS,/arxiv_data1/oa_pdf/d7/e1/TODENTJ-10-99.PMC4891986.pdf
"[http://dx.doi.org/10.2319/051611-334.1 ] [PMID: 21899377 ] [37] Engström C, Engström H, Sagne S. Lower third molar development in relation to skeletal maturity and chronological age.",Non-OADS,/arxiv_data1/oa_pdf/d7/e1/TODENTJ-10-99.PMC4891986.pdf
"[http://dx.doi.org/10.1542/peds.110.5.911 ] [PMID: 12415029 ] Received: April 9, 2015 Revised: December 7, 2015 Accepted: December 30, 2015 © Litsas and Lucchese; Licensee Bentham Open.",Non-OADS,/arxiv_data1/oa_pdf/d7/e1/TODENTJ-10-99.PMC4891986.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/e1/TODENTJ-10-99.PMC4891986.pdf
"[http://dx.doi.org/10.1111/j.1600-0765.1986.tb01467.x ] [PMID: 2942661 ] [2] Blomlöf J, Lindskog S. Periodontal tissue-vitality after different etching modalities.",OADS,/arxiv_data1/oa_pdf/98/25/TODENTJ-10-109.PMC4891987.pdf
[http://dx.doi.org/10.1111/j.1600-051X.1995.tb00178.x ] [PMID: 7560225 ] [3] Fluoride in water now reaches 70% of Americans 2008.,Non-OADS,/arxiv_data1/oa_pdf/98/25/TODENTJ-10-109.PMC4891987.pdf
"[http://dx.doi.org/10.4103/0970-9290.32423 ] [PMID: 17502711 ] [5] Vandana KL, George P, Cobb CM.",Non-OADS,/arxiv_data1/oa_pdf/98/25/TODENTJ-10-109.PMC4891987.pdf
"[http://dx.doi.org/10.1111/j.1600-0722.2006.00267.x ] [PMID: 16460346 ] [7] Blomlof J, Blomlof LB, Lindskog SF.",OADS,/arxiv_data1/oa_pdf/98/25/TODENTJ-10-109.PMC4891987.pdf
"[http://dx.doi.org/10.1111/j.1600-0765.1978.tb00164.x ] [PMID: 148504 ] [9] Isik AG, Tarim B, Hafez AA, Yalçin FS, Onan U, Cox CF.",Non-OADS,/arxiv_data1/oa_pdf/98/25/TODENTJ-10-109.PMC4891987.pdf
"[http://dx.doi.org/10.1902/jop.2000.71.2.219 ] [PMID: 10711612 ] [10] Vandana L, Sadanand K, Cobb Charles M, Desai R. Effects of tetracycline, EDTA and citric acid application on fluorosed dentin and cementum surfaces: an in vitro  study.",Non-OADS,/arxiv_data1/oa_pdf/98/25/TODENTJ-10-109.PMC4891987.pdf
"[http://dx.doi.org/10.2174/1876503300902010088 ] [11] Hanes PJ, O’Brien NJ, Garnick JJ.",Non-OADS,/arxiv_data1/oa_pdf/98/25/TODENTJ-10-109.PMC4891987.pdf
"[http://dx.doi.org/10.1111/j.1600-051X.1991.tb00107.x ] [PMID: 1960235 ] [12] Desai V, Cherian G, George JP.",OADS,/arxiv_data1/oa_pdf/98/25/TODENTJ-10-109.PMC4891987.pdf
[http://dx.doi.org/10.1111/j.1600-051X.1997.tb00234.x ] [PMID: 9378828 ],Non-OADS,/arxiv_data1/oa_pdf/98/25/TODENTJ-10-109.PMC4891987.pdf
"[http://dx.doi.org/10.1902/jop.1992.63.4.303 ] [PMID: 1573544 ] [15] Lasho DJ, O’Leary TJ, Kafrawy AH.",OADS,/arxiv_data1/oa_pdf/98/25/TODENTJ-10-109.PMC4891987.pdf
"[http://dx.doi.org/10.1902/jop.1983.54.4.210 ] [PMID: 6406665 ] [16] Chahal GS, Chhina K, Chhabra V, Bhatnagar R, Chahal A.",OADS,/arxiv_data1/oa_pdf/98/25/TODENTJ-10-109.PMC4891987.pdf
"[http://dx.doi.org/10.4103/0972-124X.128196 ] [PMID: 24744541 ] [17] Harpreet SG, Anil Y, Prashant N. A comparative evaluation of the efficacy of Citric Acid, Ethylene Diamine Tetra Acetic Acid (EDTA) and Tetracycline Hydrochloride as root biomodification agents: An in vitro  SEM study.",OADS,/arxiv_data1/oa_pdf/98/25/TODENTJ-10-109.PMC4891987.pdf
"[http://dx.doi.org/10.1902/jop.1976.47.9.497 ] [PMID: 1067403 ] [19] Ririe CM, Crigger M, Selvig KA.",OADS,/arxiv_data1/oa_pdf/98/25/TODENTJ-10-109.PMC4891987.pdf
[http://dx.doi.org/10.1111/j.1600-0765.1980.tb00287.x ] [PMID: 6448289 ] [20] Vandana KL.,OADS,/arxiv_data1/oa_pdf/98/25/TODENTJ-10-109.PMC4891987.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/98/25/TODENTJ-10-109.PMC4891987.pdf
"[http://dx.doi.org/10.1212/WNL.50.5_Suppl_5.S1 ] [PMID: 9750897 ] [2] Trompetto C, Avanzino L, Bove M, Buccolieri A, Uccelli A, Abbruzzese G. Investigation of paroxysmal dystonia in a patient with multiple sclerosis: a transcranial magnetic stimulation study.",Non-OADS,/arxiv_data1/oa_pdf/82/2b/TONEUJ-10-9.PMC4891988.pdf
"[http://dx.doi.org/10.1016/j.clinph.2007.09.123 ] [PMID: 18042426 ] [3] Bonev VI, Gledhill RF.",OADS,/arxiv_data1/oa_pdf/82/2b/TONEUJ-10-9.PMC4891988.pdf
"[http://dx.doi.org/10.1046/j.1468-1331.2002.00440.x ] [PMID: 12220384 ] [4] Fragoso YD, Araujo MG, Branco NL.",Non-OADS,/arxiv_data1/oa_pdf/82/2b/TONEUJ-10-9.PMC4891988.pdf
"[http://dx.doi.org/10.1016/S0303-8467(05)80011-3 ] [PMID: 1660380 ] [6] Tranchant C, Bhatia KP, Marsden CD.",OADS,/arxiv_data1/oa_pdf/82/2b/TONEUJ-10-9.PMC4891988.pdf
"[http://dx.doi.org/10.1002/mds.870100403 ] [PMID: 7565820 ] [7] Marsden CD, Obeso JA, Zarranz JJ, Lang AE.",OADS,/arxiv_data1/oa_pdf/82/2b/TONEUJ-10-9.PMC4891988.pdf
"[http://dx.doi.org/10.1093/brain/108.2.463 ] [PMID: 4005532 ] [8] Pettigrew LC, Jankovic J. Hemidystonia: a report of 22 patients and a review of the literature.",OADS,/arxiv_data1/oa_pdf/82/2b/TONEUJ-10-9.PMC4891988.pdf
"[http://dx.doi.org/10.1136/jnnp.48.7.650 ] [PMID: 4031909 ] [9] Ostermann PO, Westerberg CE.",OADS,/arxiv_data1/oa_pdf/82/2b/TONEUJ-10-9.PMC4891988.pdf
"[http://dx.doi.org/10.1093/brain/98.2.189 ] [PMID: 1148814 ] [10] Caccia MR, McComas AJ, Upton AR, Blogg T. Cutaneous reflexes in small muscles of the hand.",Non-OADS,/arxiv_data1/oa_pdf/82/2b/TONEUJ-10-9.PMC4891988.pdf
"[http://dx.doi.org/10.1136/jnnp.36.6.960 ] [PMID: 4272546 ] [11] Shahani BT, Younge RR.",Non-OADS,/arxiv_data1/oa_pdf/82/2b/TONEUJ-10-9.PMC4891988.pdf
"[http://dx.doi.org/10.1159/000394170 ] [12] Inghilleri M, Cruccu G, Argenta M, Polidori L, Manfredi M. Silent period in upper limb muscles after noxious cutaneous stimulation in man.",Non-OADS,/arxiv_data1/oa_pdf/82/2b/TONEUJ-10-9.PMC4891988.pdf
"[http://dx.doi.org/10.1016/S0924-980X(97)96579-6 ] [PMID: 9152203 ] [13] Kranz H, Adorjani C, Baumgartner G. The effect of nociceptive cutaneous stimuli on human motoneurons.",OADS,/arxiv_data1/oa_pdf/82/2b/TONEUJ-10-9.PMC4891988.pdf
"[http://dx.doi.org/10.1093/brain/96.3.571 ] [PMID: 4355272 ] [14] Shefner JM, Logigian EL.",OADS,/arxiv_data1/oa_pdf/82/2b/TONEUJ-10-9.PMC4891988.pdf
"[http://dx.doi.org/10.1002/mus.880160306 ] [PMID: 8446125 ] [15] Uncini A, Kujirai T, Gluck B, Pullman S. Silent period induced by cutaneous stimulation.",OADS,/arxiv_data1/oa_pdf/82/2b/TONEUJ-10-9.PMC4891988.pdf
[http://dx.doi.org/10.1016/0168-5597(91)90023-Q ] [PMID: 1718720 ] [16] Leis AA.,OADS,/arxiv_data1/oa_pdf/82/2b/TONEUJ-10-9.PMC4891988.pdf
"[http://dx.doi.org/10.1016/0168-5597(94)90152-X ] [PMID: 7529695 ] [17] Leis AA, Ross MA, Emori T, Matsue Y, Saito T. The silent period produced by electrical stimulation of mixed peripheral nerves.",OADS,/arxiv_data1/oa_pdf/82/2b/TONEUJ-10-9.PMC4891988.pdf
[http://dx.doi.org/10.1002/mus.880141211 ] [PMID: 1837332 ] [18] Floeter MK.,OADS,/arxiv_data1/oa_pdf/82/2b/TONEUJ-10-9.PMC4891988.pdf
"[http://dx.doi.org/10.1002/mus.10447 ] [PMID: 14506711 ] [19] Leis AA, Kofler M, Ross MA.",OADS,/arxiv_data1/oa_pdf/82/2b/TONEUJ-10-9.PMC4891988.pdf
"[http://dx.doi.org/10.1002/mus.880151209 ] [PMID: 1470199 ] [20] Pullman SL, Ford B, Elibol B, Uncini A, Su PC, Fahn S. Cutaneous electromyographic silent period findings in brachial dystonia.",Non-OADS,/arxiv_data1/oa_pdf/82/2b/TONEUJ-10-9.PMC4891988.pdf
[http://dx.doi.org/10.1212/WNL.46.2.503 ] [PMID: 8614522 ],Non-OADS,/arxiv_data1/oa_pdf/82/2b/TONEUJ-10-9.PMC4891988.pdf
"[http://dx.doi.org/10.1136/jnnp.36.3.334 ] [PMID: 4268362 ] [23] Stetkarova I, Kofler M, Leis AA.",OADS,/arxiv_data1/oa_pdf/82/2b/TONEUJ-10-9.PMC4891988.pdf
[http://dx.doi.org/10.1016/S1388-2457(00)00486-7 ] [PMID: 11137664 ] © Cogez et al.,OADS,/arxiv_data1/oa_pdf/82/2b/TONEUJ-10-9.PMC4891988.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/2b/TONEUJ-10-9.PMC4891988.pdf
"11,17Immunoglobulin sequences were analyzed using the IgBLAST tool18on the NCBI website (http://www.ncbi.nlm.nih.gov/projects/igblast) or theIMGT/V-QUEST tool available at the International ImMu-noGeneTics information system (IMGT) website (http://www.imgt.org).",OADS,/arxiv_data1/oa_pdf/a2/e0/ACN3-3-443.PMC4891998.pdf
2015; Available at:https://www.R-project.org (accessed March 2016) 24.,Non-OADS,/arxiv_data1/oa_pdf/a2/e0/ACN3-3-443.PMC4891998.pdf
Available from: http://www.diabetesincontrol.com/ new-encapsulated-beta-cell-replacement-therapy-for-type-1- diabetes/ .,Non-OADS,/arxiv_data1/oa_pdf/25/3a/IJMR-143-267.PMC4892071.pdf
Available from:  http://globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/33/a5/IJMR-143-308.PMC4892077.pdf
( http://www.ncbi.nlm.nih.gov/nuccore/DQ431198 ) PHAREPHAN et al: PREV ALENCE OF α-THALASSAEMIA GENOTYPES IN PREGNANCY  317,OADS,/arxiv_data1/oa_pdf/37/48/IJMR-143-315.PMC4892078.pdf
"Available from: http://www.who.int/ mediacentre/factsheets/fs999/en/index.html , accessed on  January 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/33/a3/IJMR-143-323.PMC4892079.pdf
Dent Clin North Am 2005; 49(3): 517-32. v-vi [http://dx.doi.org/10.1016/j.cden.2005.03.003 ] [PMID: 15978239 ] [2] Haynes DR.,Non-OADS,/arxiv_data1/oa_pdf/ff/07/TODENTJ-10-131.PMC4892129.pdf
[http://dx.doi.org/10.1007/s10787-006-0006-1 ] [PMID: 17093901 ] [3] Peri-implant mucositis and peri-implantitis: a current understanding of their diagnoses and clinical implications.,Non-OADS,/arxiv_data1/oa_pdf/ff/07/TODENTJ-10-131.PMC4892129.pdf
"[http://dx.doi.org/10.1902/jop.2013.134001 ] [PMID: 23537178 ] [4] Mombelli A, Lang NP.",Non-OADS,/arxiv_data1/oa_pdf/ff/07/TODENTJ-10-131.PMC4892129.pdf
"[http://dx.doi.org/10.1111/j.1600-0757.1998.tb00124.x ] [PMID: 10337314 ] [5] Sanz M, Chapple IL.",OADS,/arxiv_data1/oa_pdf/ff/07/TODENTJ-10-131.PMC4892129.pdf
"[http://dx.doi.org/10.1111/j.1600-051X.2011.01837.x ] [PMID: 22533957 ] [6] Berglundh T, Zitzmann NU, Donati M. Are peri-implantitis lesions different from periodontitis lesions?",Non-OADS,/arxiv_data1/oa_pdf/ff/07/TODENTJ-10-131.PMC4892129.pdf
[http://dx.doi.org/10.1111/j.1600-051X.2010.01672.x ] [PMID: 21323715 ] [7] Armitage GC.,OADS,/arxiv_data1/oa_pdf/ff/07/TODENTJ-10-131.PMC4892129.pdf
[http://dx.doi.org/10.1046/j.0906-6713.2002.003427.x ] [PMID: 14717858 ] [8] Brill N. Gingival conditions related to flow of tissue fluid into gingival pockets.,Non-OADS,/arxiv_data1/oa_pdf/ff/07/TODENTJ-10-131.PMC4892129.pdf
[http://dx.doi.org/10.3109/00016356009043875 ] [9] Cimasoni G. Crevicular fluid updated.,OADS,/arxiv_data1/oa_pdf/ff/07/TODENTJ-10-131.PMC4892129.pdf
"[http://dx.doi.org/10.1111/j.1600-0757.1995.tb00035.x ] [PMID: 9567929 ] [11] Barros SP, Williams R, Offenbacher S, Morelli T. Gingival crevicular fluid as a source of biomarkers for periodontitis.",Non-OADS,/arxiv_data1/oa_pdf/ff/07/TODENTJ-10-131.PMC4892129.pdf
"[http://dx.doi.org/10.1111/prd.12107 ] [PMID: 26662482 ] [12] Ustün K, Alptekin NO.",Non-OADS,/arxiv_data1/oa_pdf/ff/07/TODENTJ-10-131.PMC4892129.pdf
"[http://dx.doi.org/10.1093/ejo/cjq172 ] [PMID: 21273285 ] [15] Lachmann S, Kimmerle-Müller E, Axmann D, Scheideler L, Weber H, Haas R. Associations between peri-implant crevicular fluid volume, concentrations of crevicular inflammatory mediators, and composite IL-1A -889 and IL-1B +3954 genotype.",OADS,/arxiv_data1/oa_pdf/ff/07/TODENTJ-10-131.PMC4892129.pdf
"[http://dx.doi.org/10.1111/j.1600-0501.2006.01322.x ] [PMID: 17348886 ] [16] Bhardwaj S, Prabhuji ML.",Non-OADS,/arxiv_data1/oa_pdf/ff/07/TODENTJ-10-131.PMC4892129.pdf
"[http://dx.doi.org/10.5051/jpis.2013.43.5.233 ] [PMID: 24236246 ] [17] Tözüm TF, Akman AC, Yamalik N, et al.",OADS,/arxiv_data1/oa_pdf/ff/07/TODENTJ-10-131.PMC4892129.pdf
"J Periodontal Res [http://dx.doi.org/10.1111/jre.12354 ] [PMID: 26774043 ] [19] Zitzmann NU, Berglundh T. Definition and prevalence of peri-implant diseases.",OADS,/arxiv_data1/oa_pdf/ff/07/TODENTJ-10-131.PMC4892129.pdf
"[http://dx.doi.org/10.1111/j.1600-051X.2008.01274.x ] [PMID: 18724856 ] [20] Ferreira SD, Silva GL, Cortelli JR, Costa JE, Costa FO.",OADS,/arxiv_data1/oa_pdf/ff/07/TODENTJ-10-131.PMC4892129.pdf
"[http://dx.doi.org/10.1111/j.1600-051X.2006.01001.x ] [PMID: 17092244 ] [21] Eickholz P, Grotkamp FL, Steveling H, Mühling J, Staehle HJ.",OADS,/arxiv_data1/oa_pdf/ff/07/TODENTJ-10-131.PMC4892129.pdf
"[http://dx.doi.org/10.1034/j.1600-0501.2001.012002153.x ] [PMID: 11251665 ] [22] Andrade R, Espinoza M, Gómez EM, Espinoza JR, Cruz E. Intra- and inter-examiner reproducibility of manual probing depth.",OADS,/arxiv_data1/oa_pdf/ff/07/TODENTJ-10-131.PMC4892129.pdf
"[http://dx.doi.org/10.1590/S1806-83242012000100010 ] [PMID: 22344339 ] [23] Atici K, Yamalik N, Eratalay K, Etikan I.",Non-OADS,/arxiv_data1/oa_pdf/ff/07/TODENTJ-10-131.PMC4892129.pdf
"[http://dx.doi.org/10.1902/jop.1998.69.10.1155 ] [PMID: 9802716 ] [24] Hultin M, Gustafsson A, Hallström H, Johansson LA, Ekfeldt A, Klinge B. Microbiological findings and host response in patients with peri- implantitis.",OADS,/arxiv_data1/oa_pdf/ff/07/TODENTJ-10-131.PMC4892129.pdf
"[http://dx.doi.org/10.1034/j.1600-0501.2002.130402.x ] [PMID: 12175371 ] [25] Behneke A, Behneke N, d’Hoedt B, Wagner W. Hard and soft tissue reactions to ITI screw implants: 3-year longitudinal results of a prospective study.",OADS,/arxiv_data1/oa_pdf/ff/07/TODENTJ-10-131.PMC4892129.pdf
"[http://dx.doi.org/10.1111/j.1600-0501.2010.02044.x ] [PMID: 21121958 ] [30] Wassall RR, Preshaw PM.",OADS,/arxiv_data1/oa_pdf/ff/07/TODENTJ-10-131.PMC4892129.pdf
"[http://dx.doi.org/10.1111/prd.12109 ] [PMID: 26662483 ] [31] Golubovic V, Mihatovic I, Becker J, Schwarz F. Accuracy of cone-beam computed tomography to assess the configuration and extent of ligature-induced peri-implantitis defects.",OADS,/arxiv_data1/oa_pdf/ff/07/TODENTJ-10-131.PMC4892129.pdf
[http://dx.doi.org/10.1007/s10006-012-0320-2 ] [PMID: 22476693 ] Bevilacqua et al; Licensee Bentham Open.,OADS,/arxiv_data1/oa_pdf/ff/07/TODENTJ-10-131.PMC4892129.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ff/07/TODENTJ-10-131.PMC4892129.pdf
"[http://dx.doi.org/10.1016/j.vaccine.2011.03.042] [PMID: 21447314] [3] Sumida SM, Truitt DM, Kishko MG, et al.",OADS,/arxiv_data1/oa_pdf/1f/3b/TOVJ-10-10.PMC4892130.pdf
"[http://dx.doi.org/10.1128/JVI.78.6.2666-2673.2004] [PMID: 14990686] [4] Sumida SM, Truitt DM, Lemckert AA, et al.",OADS,/arxiv_data1/oa_pdf/1f/3b/TOVJ-10-10.PMC4892130.pdf
"Baltimore, Md : 1950 [http://dx.doi.org/10.4049/jimmunol.174.11.7179] [5] Lasaro MO, Ertl HC.",Non-OADS,/arxiv_data1/oa_pdf/1f/3b/TOVJ-10-10.PMC4892130.pdf
"[http://dx.doi.org/10.1038/mt.2009.130] [6] Zeng Q, Han J, Zhao D, Gong T, Zhang Z, Sun X.",OADS,/arxiv_data1/oa_pdf/1f/3b/TOVJ-10-10.PMC4892130.pdf
"Ad5H3 Chimera-Based Vaccination Approach The Open Virology Journal, 2016, Volume 10   19 [http://dx.doi.org/10.1038/nature04721] [PMID: 16625206] [8] Xin KQ, Jounai N, Someya K, et al.",Non-OADS,/arxiv_data1/oa_pdf/1f/3b/TOVJ-10-10.PMC4892130.pdf
"[http://dx.doi.org/10.1038/sj.gt.3302590] [PMID: 16079886] [9] Wu H, Dmitriev I, Kashentseva E, Seki T, Wang M, Curiel DT.",OADS,/arxiv_data1/oa_pdf/1f/3b/TOVJ-10-10.PMC4892130.pdf
"[http://dx.doi.org/10.1128/JVI.76.24.12775-12782.2002] [PMID: 12438602] [10] Short JJ, Rivera AA, Wu H, et al.",OADS,/arxiv_data1/oa_pdf/1f/3b/TOVJ-10-10.PMC4892130.pdf
"[http://dx.doi.org/10.1158/1535-7163.MCT-10-0332] [PMID: 20736345] [11] Sharma A, Krause A, Xu Y, Sung B, Wu W, Worgall S. Adenovirus-based vaccine with epitopes incorporated in novel fiber sites to induce protective immunity against Pseudomonas aeruginosa.",Non-OADS,/arxiv_data1/oa_pdf/1f/3b/TOVJ-10-10.PMC4892130.pdf
"[http://dx.doi.org/10.1371/journal.pone.0056996] [PMID: 23437292] [12] Palma C, Overstreet MG, Guedon JM, et al.",OADS,/arxiv_data1/oa_pdf/1f/3b/TOVJ-10-10.PMC4892130.pdf
"[http://dx.doi.org/10.1016/j.vaccine.2010.12.040] [PMID: 21199707] [13] Gu L, Li ZC, Krendelchtchikov A, Krendelchtchikova V, Wu H, Matthews QL.",OADS,/arxiv_data1/oa_pdf/1f/3b/TOVJ-10-10.PMC4892130.pdf
"[http://dx.doi.org/10.1371/journal.pone.0060347] [PMID: 23555957] [14] Matthews QL, Fatima A, Tang Y, et al.",OADS,/arxiv_data1/oa_pdf/1f/3b/TOVJ-10-10.PMC4892130.pdf
"[http://dx.doi.org/10.1371/journal.pone.0011815] [PMID: 20676400] [15] Farrow AL, Rachakonda G, Gu L, et al.",OADS,/arxiv_data1/oa_pdf/1f/3b/TOVJ-10-10.PMC4892130.pdf
"[http://dx.doi.org/10.1371/journal.pntd.0003089] [PMID: 25144771] [16] Tian X, Su X, Li X, et al.",OADS,/arxiv_data1/oa_pdf/1f/3b/TOVJ-10-10.PMC4892130.pdf
"[http://dx.doi.org/10.1371/journal.pone.0041381] [PMID: 22848478] [17] Xue C, Tian X, Li X, Zhou Z, Su X, Zhou R. Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon.",OADS,/arxiv_data1/oa_pdf/1f/3b/TOVJ-10-10.PMC4892130.pdf
"[http://dx.doi.org/10.1016/j.virusres.2014.01.027] [PMID: 24518297] [18] Gu L, Krendelchtchikova V, Krendelchtchikov A, Oster RA, Fujihashi K, Matthews QL.",OADS,/arxiv_data1/oa_pdf/1f/3b/TOVJ-10-10.PMC4892130.pdf
"[http://dx.doi.org/10.1186/1743-422X-11-112] [PMID: 24935650] [19] Gahéry-Ségard H, Farace F, Godfrin D, et al.",OADS,/arxiv_data1/oa_pdf/1f/3b/TOVJ-10-10.PMC4892130.pdf
"[http://dx.doi.org/10.1128/JVI.06254-11] [PMID: 22072776] [21] Bradley RR, Maxfield LF, Lynch DM, Iampietro MJ, Borducchi EN, Barouch DH.",Non-OADS,/arxiv_data1/oa_pdf/1f/3b/TOVJ-10-10.PMC4892130.pdf
"[http://dx.doi.org/10.1128/JVI.06165-11] [PMID: 22072746] [22] Qiu H, Li X, Tian X, et al.",OADS,/arxiv_data1/oa_pdf/1f/3b/TOVJ-10-10.PMC4892130.pdf
"[http://dx.doi.org/10.1128/JVI.07076-11] [PMID: 22623776] [23] Ge J, Wang X, Tian M, et al.",OADS,/arxiv_data1/oa_pdf/1f/3b/TOVJ-10-10.PMC4892130.pdf
"[http://dx.doi.org/10.1016/j.vaccine.2014.01.020] [PMID: 24486349] [24] Kim EH, Park HJ, Han GY, et al.",OADS,/arxiv_data1/oa_pdf/1f/3b/TOVJ-10-10.PMC4892130.pdf
"[http://dx.doi.org/10.1128/JVI.00823-14] [PMID: 24920793] [25] Xu L, He D, Li Z, et al.",OADS,/arxiv_data1/oa_pdf/1f/3b/TOVJ-10-10.PMC4892130.pdf
"[http://dx.doi.org/10.7150/thno.7457] [PMID: 24669278] [26] Dupuy  LC,  Richards  MJ,  Ellefsen  B,  et  al.",OADS,/arxiv_data1/oa_pdf/1f/3b/TOVJ-10-10.PMC4892130.pdf
"[http://dx.doi.org/10.1128/CVI.00030-11] [PMID: 21450977] [27] Baden LR, Walsh SR, Seaman MS, et al.",OADS,/arxiv_data1/oa_pdf/1f/3b/TOVJ-10-10.PMC4892130.pdf
"[http://dx.doi.org/10.1093/infdis/jiu217] [PMID: 24719474] [28] Zhou ZC, Liang HX, Li T, et al.",OADS,/arxiv_data1/oa_pdf/1f/3b/TOVJ-10-10.PMC4892130.pdf
"[http://dx.doi.org/10.1186/1743-422X-5-98] [PMID: 18718011] [30] Wang TL, Ling M, Shih IM, et al.",OADS,/arxiv_data1/oa_pdf/1f/3b/TOVJ-10-10.PMC4892130.pdf
"[http://dx.doi.org/10.1038/sj.gt.3301160] [PMID: 10822298] [31] Geutskens SB, van der Eb MM, Plomp AC, et al.",OADS,/arxiv_data1/oa_pdf/1f/3b/TOVJ-10-10.PMC4892130.pdf
[http://dx.doi.org/10.1038/sj.gt.3301251] [PMID: 10981668] © Gu et al.,OADS,/arxiv_data1/oa_pdf/1f/3b/TOVJ-10-10.PMC4892130.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/3b/TOVJ-10-10.PMC4892130.pdf
[http://dx.doi.org/10.3109/17453678108991776 ] [PMID: 7246093 ] [2] Lazzara R. Dental implant system design and potential impact on the establishment and sustainability of aesthetics J Impl Reconstruct Dent Edit  2012;  19:  117-29.,Non-OADS,/arxiv_data1/oa_pdf/9a/b8/TODENTJ-10-139.PMC4892131.pdf
Available  from:  http://www.biomet3i.com/Resource%20Center/Clinical%20Information/JIRD%20Editorial %20Implants%20System%20Design%20and%20Its%20Potential%20Impact%20on%20the%20Establishment%20and%20Sustainability%20 of%20Aesthetics_ART1185.pdf [3] Davies JE.,Non-OADS,/arxiv_data1/oa_pdf/9a/b8/TODENTJ-10-139.PMC4892131.pdf
"[http://dx.doi.org/10.1034/j.1600-0501.2000.011006530.x ] [PMID: 11168246 ] [5] Trisi P, Lazzara R, Rao W, Rebaudi A. Bone-implant contact and bone quality: evaluation of expected and actual bone contact on machined and osseotite implant surfaces.",OADS,/arxiv_data1/oa_pdf/9a/b8/TODENTJ-10-139.PMC4892131.pdf
"[http://dx.doi.org/10.1111/j.1600-0501.2004.01082.x ] [PMID: 15248872 ] [7] Lazzara RJ, Testori T, Trisi P, Porter SS, Weinstein RL.",OADS,/arxiv_data1/oa_pdf/9a/b8/TODENTJ-10-139.PMC4892131.pdf
"[http://dx.doi.org/10.1002/jbm.820250708 ] [PMID: 1918105 ] [9] Wennerberg A, Albrektsson T, Lindhe J.",OADS,/arxiv_data1/oa_pdf/9a/b8/TODENTJ-10-139.PMC4892131.pdf
"[http://dx.doi.org/10.1007/978-1-4613-0491-3 ] [11] Joy D, Romig A Jr, Goldstein J.",Non-OADS,/arxiv_data1/oa_pdf/9a/b8/TODENTJ-10-139.PMC4892131.pdf
"[http://dx.doi.org/10.1002/jbm.820250708 ] [PMID: 1918105 ] [16] Wennerberg A, Albrektsson T, Andersson B, Krol JJ.",OADS,/arxiv_data1/oa_pdf/9a/b8/TODENTJ-10-139.PMC4892131.pdf
"[http://dx.doi.org/10.1034/j.1600-0501.1995.060103.x ] [PMID: 7669864 ] [17] Orsini G, Assenza B, Scarano A, Piattelli M, Piattelli A.",OADS,/arxiv_data1/oa_pdf/9a/b8/TODENTJ-10-139.PMC4892131.pdf
"[http://dx.doi.org/10.1034/j.1600-0501.1998.090102.x ] [PMID: 9590940 ] [19] Wennerberg A, Ektessabi A, Albrektsson T, Johansson C, Andersson B.",OADS,/arxiv_data1/oa_pdf/9a/b8/TODENTJ-10-139.PMC4892131.pdf
"[http://dx.doi.org/10.1902/jop.2005.76.11.1972 ] [PMID: 16274318 ] [23] Ibañez JC, Tahhan MJ, Zamar JA.",Non-OADS,/arxiv_data1/oa_pdf/9a/b8/TODENTJ-10-139.PMC4892131.pdf
"[http://dx.doi.org/10.1902/jop.2003.74.11.1575 ] [PMID: 14682653 ] [24] Romanos GE, Testori T, Degidi M, Piattelli A. Histologic and histomorphometric findings from retrieved, immediately occlusally loaded implants in humans.",OADS,/arxiv_data1/oa_pdf/9a/b8/TODENTJ-10-139.PMC4892131.pdf
"[http://dx.doi.org/10.1902/jop.2005.76.11.1823 ] [PMID: 16274300 ] [25] Trisi P, Lazzara R, Rebaudi A, Rao W, Testori T, Porter SS.",Non-OADS,/arxiv_data1/oa_pdf/9a/b8/TODENTJ-10-139.PMC4892131.pdf
"[http://dx.doi.org/10.1902/jop.2003.74.7.945 ] [PMID: 12931756 ] [26] Salvi GE, Gallini G, Lang NP.",OADS,/arxiv_data1/oa_pdf/9a/b8/TODENTJ-10-139.PMC4892131.pdf
"[http://dx.doi.org/10.1111/j.1600-0501.2004.01014.x ] [PMID: 15008926 ] [27] Veis A, Trisi P, Tsirlis A, et al.",OADS,/arxiv_data1/oa_pdf/9a/b8/TODENTJ-10-139.PMC4892131.pdf
"[http://dx.doi.org/10.1111/j.1600-0501.2004.01004.x ] [PMID: 14731177 ] [28] Zetterqvist L, Feldman S, Rotter B, et al.",OADS,/arxiv_data1/oa_pdf/9a/b8/TODENTJ-10-139.PMC4892131.pdf
"[http://dx.doi.org/10.1902/jop.2009.090492 ] [PMID: 20367092 ] [29] Juodzbalys G, Sapragoniene M, Wennerberg A.",OADS,/arxiv_data1/oa_pdf/9a/b8/TODENTJ-10-139.PMC4892131.pdf
[http://dx.doi.org/10.1111/j.1600-0501.2009.01883.x ] [PMID: 20666791 ] © Sezin et al.,OADS,/arxiv_data1/oa_pdf/9a/b8/TODENTJ-10-139.PMC4892131.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/b8/TODENTJ-10-139.PMC4892131.pdf
"[http://dx.doi.org/10.1038/sj.bdj.4808449 ] [PMID: 8024869 ] [2] Morris HF, Manz M, Stoffer W, Weir D. Casting alloys: the materials and “The Clinical Effects”.",Non-OADS,/arxiv_data1/oa_pdf/05/94/TODENTJ-10-124.PMC4892132.pdf
"[http://dx.doi.org/10.1016/S0022-3913(98)70137-4 ] [PMID: 9760369 ] [4] Sharp B, Morton D, Clark AE.",OADS,/arxiv_data1/oa_pdf/05/94/TODENTJ-10-124.PMC4892132.pdf
"[http://dx.doi.org/10.1067/mpr.2000.111497 ] [PMID: 11125348 ] [5] Suzuki T, Takahashi H, Arksornnukit M, Oda N, Hirano S. Bonding properties of heat-polymerized denture base resin to Ti-6Al-7Nb alloy.",OADS,/arxiv_data1/oa_pdf/05/94/TODENTJ-10-124.PMC4892132.pdf
"[http://dx.doi.org/10.4012/dmj.24.530 ] [PMID: 16445014 ] [6] Ishii T, Koizumi H, Tanoue N, Naito K, Yamashita M, Matsumura H. Effect of alumina air-abrasion on mechanical bonding between an acrylic resin and casting alloys.",OADS,/arxiv_data1/oa_pdf/05/94/TODENTJ-10-124.PMC4892132.pdf
"[http://dx.doi.org/10.2334/josnusd.51.161 ] [PMID: 19550081 ] [7] Freitas AP, Francisconi PA. Effect of a metal primer on the bond strength of the resin-metal interface.",OADS,/arxiv_data1/oa_pdf/05/94/TODENTJ-10-124.PMC4892132.pdf
"[http://dx.doi.org/10.1590/S1678-77572004000200006 ] [PMID: 21365132 ] [8] Silveira de Araújo C, Incerti da Silva T, Ogliari FA, Meireles SS, Piva E, Demarco FF.",Non-OADS,/arxiv_data1/oa_pdf/05/94/TODENTJ-10-124.PMC4892132.pdf
[http://dx.doi.org/10.1016/j.dental.2006.06.007 ] [PMID: 16876240 ] [10] Kourtis SG.,OADS,/arxiv_data1/oa_pdf/05/94/TODENTJ-10-124.PMC4892132.pdf
"[http://dx.doi.org/10.1016/S0022-3913(97)70117-3 ] [PMID: 9260130 ] [11] Sarafianou A, Seimenis I, Papadopoulos T. Effectiveness of different adhesive primers on the bond strength between an indirect composite resin and a base metal alloy.",Non-OADS,/arxiv_data1/oa_pdf/05/94/TODENTJ-10-124.PMC4892132.pdf
"[http://dx.doi.org/10.1016/S0022-3913(08)60086-4 ] [PMID: 18456049 ] [12] Yanagida H, Tanoue N, Ide T, Matsumura H. Evaluation of two dual-functional primers and a tribochemical surface modification system applied to the bonding of an indirect composite resin to metals.",OADS,/arxiv_data1/oa_pdf/05/94/TODENTJ-10-124.PMC4892132.pdf
"[http://dx.doi.org/10.1007/s10266-009-0103-x ] [PMID: 19639453 ] [13] Matsuda Y, Yanagida H, Ide T, Matsumura H, Tanoue N. Bond strength of poly(methyl methacrylate) denture base material to cast titanium and cobalt-chromium alloy.",OADS,/arxiv_data1/oa_pdf/05/94/TODENTJ-10-124.PMC4892132.pdf
"[http://dx.doi.org/10.1016/j.jdent.2005.05.002 ] [PMID: 15994000 ] [16] Sahafi A, Peutzfeld A, Asmussen E, Gotfredsen K. Effect of surface treatment of prefabricated posts on bonding of resin cement.",OADS,/arxiv_data1/oa_pdf/05/94/TODENTJ-10-124.PMC4892132.pdf
"[http://dx.doi.org/10.1016/S0300-5712(96)00023-1 ] [PMID: 9175359 ] [19] Vojvodic D, Jerolimov V, Celebic A, Catovic A.",OADS,/arxiv_data1/oa_pdf/05/94/TODENTJ-10-124.PMC4892132.pdf
"[http://dx.doi.org/10.1111/j.1532-849X.2000.00030.x ] [PMID: 11074026 ] [21] Kim JY, Pfeiffer P, Niedermeier W. Effect of laboratory procedures and thermocycling on the shear bond strength of resin-metal bonding systems.",OADS,/arxiv_data1/oa_pdf/05/94/TODENTJ-10-124.PMC4892132.pdf
"[http://dx.doi.org/10.1016/S0022-3913(03)00261-0 ] [PMID: 12886212 ] [22] Di Francescantonio M, de Oliveira MT, Garcia RN, Romanini JC, da Silva NR, Giannini M. Bond strength of resin cements to Co-Cr and Ni- Cr metal alloys using adhesive primers.",OADS,/arxiv_data1/oa_pdf/05/94/TODENTJ-10-124.PMC4892132.pdf
"[http://dx.doi.org/10.1111/j.1532-849X.2009.00534.x ] [PMID: 20002979 ] [23] Radhi A, Juszczyk AS, Curtis RV, Sherriff M, Radford DR, Clark RK.",OADS,/arxiv_data1/oa_pdf/05/94/TODENTJ-10-124.PMC4892132.pdf
"[http://dx.doi.org/10.1179/bjo.21.1.33 ] [PMID: 8199163 ] [25] Kuntman  A,  Baysal  B.  Estimation  of  thermodynamic  parameters  for  poly(ethyl  methacrylate)/isopropyl  alcohol  system  from  intrinsic viscosity measurements.",OADS,/arxiv_data1/oa_pdf/05/94/TODENTJ-10-124.PMC4892132.pdf
"[http://dx.doi.org/10.1016/0032-3861(93)90060-N ] [26] Zinelis S, Tsetsekou A, Papadopoulos T. Thermal expansion and microstructural analysis of experimental metal-ceramic titanium alloys.",Non-OADS,/arxiv_data1/oa_pdf/05/94/TODENTJ-10-124.PMC4892132.pdf
[http://dx.doi.org/10.1016/S0022-3913(03)00493-1 ] [PMID: 14564287 ] © Al Jabbari et al.,OADS,/arxiv_data1/oa_pdf/05/94/TODENTJ-10-124.PMC4892132.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/94/TODENTJ-10-124.PMC4892132.pdf
"[http://dx.doi.org/10.1513/AnnalsATS.201303-067OC] [PMID: 24102151] [2] Prevots DR, Marras TK.",Non-OADS,/arxiv_data1/oa_pdf/48/82/TORMJ-10-20.PMC4892172.pdf
"[http://dx.doi.org/10.1016/j.ccm.2014.10.002] [PMID: 25676516] [3] Prevots DR, Shaw PA, Strickland D, et al.",OADS,/arxiv_data1/oa_pdf/48/82/TORMJ-10-20.PMC4892172.pdf
"[http://dx.doi.org/10.1164/rccm.201002-0310OC] [PMID: 20538958] [4] Simons S, van Ingen J, Hsueh PR, et al.",OADS,/arxiv_data1/oa_pdf/48/82/TORMJ-10-20.PMC4892172.pdf
[http://dx.doi.org/10.3201/eid170310060] [PMID: 21392422] [5] Sakatani M. The non-tuberculous mycobacteriosis.,Non-OADS,/arxiv_data1/oa_pdf/48/82/TORMJ-10-20.PMC4892172.pdf
"[http://dx.doi.org/10.1183/09031936.00140007] [PMID: 18515557] [7] Winthrop KL, McNelley E, Kendall B, et al.",OADS,/arxiv_data1/oa_pdf/48/82/TORMJ-10-20.PMC4892172.pdf
"[http://dx.doi.org/10.1164/rccm.201003-0503OC] [PMID: 20508209] [8] Hayashi  M,  Takayanagi  N,  Kanauchi  T,  Miyahara  Y,  Yanagisawa  T,  Sugita  Y.  Prognostic  factors  of  634  HIV-negative  patients  with Mycobacterium avium complex lung disease.",OADS,/arxiv_data1/oa_pdf/48/82/TORMJ-10-20.PMC4892172.pdf
"[http://dx.doi.org/10.1164/rccm.201107-1203OC] [PMID: 22199005] [9] Tamura A, Hebisawa A, Sagara Y, et al.",OADS,/arxiv_data1/oa_pdf/48/82/TORMJ-10-20.PMC4892172.pdf
"[http://dx.doi.org/10.1097/JTO.0b013e31825abd49] [PMID: 22699888] [11] Tamura A, Shimada M, Matsui Y, et al.",OADS,/arxiv_data1/oa_pdf/48/82/TORMJ-10-20.PMC4892172.pdf
"[http://dx.doi.org/10.2169/internalmedicine.49.2686] [PMID: 20075571] [12] Tanaka E, Amitani R, Niimi A, Suzuki K, Murayama T, Kuze F. Yield of computed tomography and bronchoscopy for the diagnosis of Mycobacterium avium complex pulmonary disease.",OADS,/arxiv_data1/oa_pdf/48/82/TORMJ-10-20.PMC4892172.pdf
"[http://dx.doi.org/10.1164/ajrccm.155.6.9196113] [PMID: 9196113] [13] Sugihara E, Hirota N, Niizeki T, et al.",OADS,/arxiv_data1/oa_pdf/48/82/TORMJ-10-20.PMC4892172.pdf
[http://dx.doi.org/10.1007/s10156-003-0267-1] [PMID: 14691654] [14] Statistics of tuberculosis 2012.,Non-OADS,/arxiv_data1/oa_pdf/48/82/TORMJ-10-20.PMC4892172.pdf
"[http://dx.doi.org/10.1016/S0195-6701(97)90183-3] [PMID: 9364262] [16] Griffith DE, Aksamit T, Brown-Elliott BA, et al.",OADS,/arxiv_data1/oa_pdf/48/82/TORMJ-10-20.PMC4892172.pdf
"[http://dx.doi.org/10.1164/rccm.200604-571ST] [PMID: 17277290] [17] Han XY, Tarrand JJ, Infante R, Jacobson KL, Truong M. Clinical significance and epidemiologic analyses of Mycobacterium avium  and Mycobacterium intracellulare among patients without AIDS.",OADS,/arxiv_data1/oa_pdf/48/82/TORMJ-10-20.PMC4892172.pdf
"[http://dx.doi.org/10.1128/JCM.43.9.4407-4412.2005] [PMID: 16145084] [18] Hosoda C, Hagiwara E, Shinohara T, et al.",OADS,/arxiv_data1/oa_pdf/48/82/TORMJ-10-20.PMC4892172.pdf
"[http://dx.doi.org/10.1097/JTO.0b013e318265a7ef] [PMID: 22895136] [20] Middleton AM, Chadwick MV, Nicholson AG, et al.",OADS,/arxiv_data1/oa_pdf/48/82/TORMJ-10-20.PMC4892172.pdf
"[http://dx.doi.org/10.1046/j.1365-2958.2000.02137.x] [PMID: 11069663] [21] Fujita J, Ohtsuki Y, Shigeto E, et al.",OADS,/arxiv_data1/oa_pdf/48/82/TORMJ-10-20.PMC4892172.pdf
"[http://dx.doi.org/10.1016/S0954-6111(03)00120-3] [PMID: 12924521] [22] West JB, Dollery CT. Distribution of blood flow and ventilation-perfusion ratio in the lung, measured with radioactive carbon dioxide.",OADS,/arxiv_data1/oa_pdf/48/82/TORMJ-10-20.PMC4892172.pdf
"[http://dx.doi.org/10.1016/S0003-4975(03)01015-4] [PMID: 14602308] [24] Brenner DR, Boffetta P, Duell EJ, et al.",OADS,/arxiv_data1/oa_pdf/48/82/TORMJ-10-20.PMC4892172.pdf
[http://dx.doi.org/10.1093/aje/kws151] [PMID: 22986146] [25] Friedrich G. Periphere Lungenkrebse auf dem Borden pleu-ranaher Narben.,OADS,/arxiv_data1/oa_pdf/48/82/TORMJ-10-20.PMC4892172.pdf
"[http://dx.doi.org/10.1007/BF02595199] [26] Bobba RK, Holly JS, Loy T, Perry MC.",Non-OADS,/arxiv_data1/oa_pdf/48/82/TORMJ-10-20.PMC4892172.pdf
"[http://dx.doi.org/10.1016/j.cllc.2011.03.011] [PMID: 21663856] [27] Tamura A, Hebisawa A, Sagara Y, et al.",OADS,/arxiv_data1/oa_pdf/48/82/TORMJ-10-20.PMC4892172.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/82/TORMJ-10-20.PMC4892172.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.GENETIC TESTING AND MOLECULAR BIOMARKERS Volume 20, Number 6, 2016Mary Ann Liebert, Inc.Pp.",Non-OADS,/arxiv_data1/oa_pdf/a4/a6/gtmb.2016.0014.PMC4892196.pdf
1 Frameshift SLC22A5 05:131705708 G/A p.G15E 20 Missense 1.00 22.1 -6.77 SLC26A2 05:149360744 G/A p.G530S 13 Missense 1.00 27.6 -5.9 SMPD1 11:006415539 C/T p.P533L 20 Missense 1.00 11.6 -7.18 STXBP2 19:007710082 G/C c.1247-1G >C 8 Splice site TBCE 01:235599092 T/G p.L257* 7 Nonsense TYK2 19:010469975 A/C p.I684S 14 Missense 1.00 28.8 -5.13 UNC13D 17:073832671 C/T p.R427Q 8 Missense 1.00 35.0 -3.2 VLDLR 09:002648286 G/A p.R634H 16 Missense 1.00 35.0 -4.93 ZNF469 16:088497233 G/T p.E1091* 11 Nonsense aAdditional details on each variant reported in this study can be accessed at http://research.genepeeks.comDEFICIENCY OF DONOR CARRIER SCREENING 281,Non-OADS,/arxiv_data1/oa_pdf/a4/a6/gtmb.2016.0014.PMC4892196.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, dis-tribution, and reproduction in any medium, provided the original author(s) and the source are credited.",Non-OADS,/arxiv_data1/oa_pdf/9c/e6/tmj.2015.0166.PMC4892212.pdf
"Available at https://tm.knet.ca/files/FINAL_KOETS_AR_2014-15.pdf (last accessed October 22, 2015).",Non-OADS,/arxiv_data1/oa_pdf/9c/e6/tmj.2015.0166.PMC4892212.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.Photomedicine and Laser Surgery Volume 34, Number 6, 2016Mary Ann Liebert, Inc.Pp.",Non-OADS,/arxiv_data1/oa_pdf/ef/b2/pho.2016.4094.PMC4892223.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f6/b6/cmar-8-067.PMC4892292.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Cancer Management and Research 2016:8 67–76Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  67ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CMAR.S102383Treatment patterns, health state, and health care  resource utilization of patients with radioactive  iodine refractory differentiated thyroid cancer andrew g gianoukakis1 natalia M Flores2 Corey l Pelletier3 anna Forsythe3 gregory R Wolfe2 Matthew h Taylor4 1Division of endocrinology and  Metabolism, harbor-UC la Medical  Center, The University of California,   los angeles, 2health Outcomes  Research, Kantar health, Foster City,   Ca, 3global Value and access, eisai,   inc., Woodcliff lakes, nJ, 4Division of  hematology and Medical Oncology,   Oregon health and science University,   Portland, OR, Usa Correspondence: natalia M Flores   health Outcomes Research, Kantar  health, 393 Vintage Park Drive, suite 100,   Foster City, C a 94404, Usa   T el +1 650 403 7057   email natalia.flores@kantarhealth.co mBackground:  Patients with differentiated thyroid cancer (DTC) often respond well to treatment  but some become refractory to radioactive iodine (RAI) treatment, and treatment options are  limited.",Non-OADS,/arxiv_data1/oa_pdf/f6/b6/cmar-8-067.PMC4892292.pdf
Available from: http://www.cancer.org/Cancer/ThyroidCancer/ DetailedGuide/thyroid-cancer-key-statistics .,Non-OADS,/arxiv_data1/oa_pdf/f6/b6/cmar-8-067.PMC4892292.pdf
Available from: http://eco.iarc.fr/eucan/Cancer.,Non-OADS,/arxiv_data1/oa_pdf/f6/b6/cmar-8-067.PMC4892292.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/f6/b6/cmar-8-067.PMC4892292.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f6/b6/cmar-8-067.PMC4892292.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2d/8c/dddt-10-1807.PMC4892293.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 1807–1815Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1807Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10640 6 synthesis, activity, and docking study of  phenylthiazole acids as potential agonists of PP arγ liang Ma1,* Taijin Wang2,* Min shi1 haoyu Ye2 1Department of n ephrology, Kidney  research institute, 2state Key  laboratory of Biotherapy and cancer  center/ collaborative innovation  center of Biotherapy, West china  hospital, West china Medical school  of sichuan University, chengdu,   People’s republic of china *These authors contributed equally  to this workAbstract:  Peroxisome proliferator-activated receptor gamma (PPAR γ) is a ligand-mediated  transcription factor playing key roles in glucose and lipid homeostasis, and PPAR γ ligands pos - sess therapeutic potential in these as well as other areas.",Non-OADS,/arxiv_data1/oa_pdf/2d/8c/dddt-10-1807.PMC4892293.pdf
"PPAR γ agonists TZDs have  also been potential drug leads to develop potent and safe drug candidates, especially  antidiabetic drug RSG.5,12–14 This study describes a series of small-molecule phenylthiazole acids that have  been synthesized and investigated for agonistic activity by a convenient fluorescence correspondence: liang Ma Division of nephrology, Kidney research  institute, West china hospital, West  china Medical school of sichuan  University, no 37 guoxue Xiang,  chengdu 610041, People’s republic  of china Tel +86 28 8516 4167 email l iang_m@scu.edu.c n  haoyu Ye state Key laboratory of Biotherapy and  cancer center, West china hospital,  West china Medical school of sichuan  University, chengdu 610041, People’s  republic of china email yhy1984_hb@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Ma et al Running head recto: Phenylthiazole acids as potential PPAR γ agonists DOI: http://dx.doi.org/10.2147/DDDT.S106406",Non-OADS,/arxiv_data1/oa_pdf/2d/8c/dddt-10-1807.PMC4892293.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/2d/8c/dddt-10-1807.PMC4892293.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2d/8c/dddt-10-1807.PMC4892293.pdf
2012. https://www.vectorlabs.com/  Vector Laboratories 39.,Non-OADS,/arxiv_data1/oa_pdf/48/26/emss-68238.PMC4892350.pdf
Available from http://globocan.iarc.fr/ Default.aspx 84.,Non-OADS,/arxiv_data1/oa_pdf/48/26/emss-68238.PMC4892350.pdf
Available from  http://eu-cancer.iarc.fr/ 85.,Non-OADS,/arxiv_data1/oa_pdf/48/26/emss-68238.PMC4892350.pdf
It can be accessed at http://api-geospatial.vertnet-portal.appspot.com/geospatial and is already im-plemented in the VertNet data portal for quality reporting.,OADS,/arxiv_data1/oa_pdf/6e/4f/btw057.PMC4892415.pdf
Source code is freely available under GPL license from http://www.github.com/vertnet/api-geospatial.,OADS,/arxiv_data1/oa_pdf/6e/4f/btw057.PMC4892415.pdf
", 2014 ) for providing seam- less access via portals such as VertNet (http://www.vertnet.org)and the Global Biodiversity Information Facility (http://www.gbif.org).",Non-OADS,/arxiv_data1/oa_pdf/6e/4f/btw057.PMC4892415.pdf
2 Implementation 2.1 Input methods The API currently accepts two request methods and is located at:http://api-geospatial.vertnet-portal.appspot.com/geospatial.,OADS,/arxiv_data1/oa_pdf/6e/4f/btw057.PMC4892415.pdf
"1755 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/4f/btw057.PMC4892415.pdf
"One of these data sets is the country admin-istrative boundaries, extracted from the Global AdministrativeAreas database (http://www.gadm.org).",OADS,/arxiv_data1/oa_pdf/6e/4f/btw057.PMC4892415.pdf
The other data set is the collection of expert range maps com- piled by the International Union for the Conservation of Nature(http://www.iucnredlist.org).,Non-OADS,/arxiv_data1/oa_pdf/6e/4f/btw057.PMC4892415.pdf
"For a full list, see source code API documentation (http://bit.ly/1NkNDde).",Non-OADS,/arxiv_data1/oa_pdf/6e/4f/btw057.PMC4892415.pdf
"Just as a simple example, one could download a set of records from the GBIF API (http://www.gbif.org/developer/occurrence) and, without modification, pass the result tothe Geospatial Quality API to get the same record structure plus thequality flags.",OADS,/arxiv_data1/oa_pdf/6e/4f/btw057.PMC4892415.pdf
This provides an easy-to-read re- port per record for data consumers (http://vertnet.org/resources/spatialqualitytabguide.html).,OADS,/arxiv_data1/oa_pdf/6e/4f/btw057.PMC4892415.pdf
Available online at http://www.gbif.org/orc/?doc_id ¼1262.1756 J.Otegui and R.P.Guralnick,Non-OADS,/arxiv_data1/oa_pdf/6e/4f/btw057.PMC4892415.pdf
Available online at http://www.gbif.org/orc/?doc_id ¼1229.,Non-OADS,/arxiv_data1/oa_pdf/6e/4f/btw057.PMC4892415.pdf
"Accessible online at http://www.gbif.org/resource/80623.Johnson,N.F.",Non-OADS,/arxiv_data1/oa_pdf/6e/4f/btw057.PMC4892415.pdf
Availability and Implementation :A general implementation of our approach can be found under: https://github.com/SchulzLab/KREATION.Supplementary information: Supplementary data are available at Bioinformatics online.,Non-OADS,/arxiv_data1/oa_pdf/b1/29/btw217.PMC4892416.pdf
"1670 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b1/29/btw217.PMC4892416.pdf
"For measuring the difference in misassemblies between multi- kmer assembly (say T multi) and single- kmer assembly (say Tsingle)w e define: misassembly rate ¼observed expected(5) where, observed ¼#misassemblies in Tmulti jTmultij; (6) expected ¼#misassemblies in Tsingle jTsinglej: (7) 2.6 Data retrieval and preprocessing All datasets were downloaded from the SRA (http://www.ncbi.nlm.",OADS,/arxiv_data1/oa_pdf/b1/29/btw217.PMC4892416.pdf
", 2011 , SRR309265) and 60M, 101bp paired-end reads from IMR90 cell lines from ENCODE (http://genome.ucsc.edu/cgi-bin/hgFileUi?g¼wgEncodeCshlLongRnaSeq).",OADS,/arxiv_data1/oa_pdf/b1/29/btw217.PMC4892416.pdf
We believe that KREATIONwith the misassembly filters will be useful for the community andimplemented the mentioned ideas in a software that currently sup-ports the de novo assemblers tested in this work (https://github.com/ SchulzLab/KREATION).,Non-OADS,/arxiv_data1/oa_pdf/b1/29/btw217.PMC4892416.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/a2/11/10.1177_2325967116647724.PMC4892430.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/12/df/10.1177_2048004016652514.PMC4892624.pdf
2The new aspirin dosing: a patient-centric trial assessing beneﬁts and long-term eﬀectiveness(http://theaspirinstudy.org) study has been planned todetermine the optimal aspirin dose that is associated with maximum anti-ischemic beneﬁt and minimal bleeding risk.,Non-OADS,/arxiv_data1/oa_pdf/12/df/10.1177_2048004016652514.PMC4892624.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies the paper on The Journal of Antibiotics website (http://www.nature.com/ja)Anti-obesity activities of the marine γ-pyrone compounds TK o y a m a et al 351 The Journal of Antibiotics",Non-OADS,/arxiv_data1/oa_pdf/d1/31/ja201619a.PMC4892692.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/c5/fiw095.PMC4892715.pdf
One Codex is a web-based program that uses a differ- ent technique to BLAST and MG-RAST to classify sequences (https://onecodex.com/ ).,OADS,/arxiv_data1/oa_pdf/d6/c5/fiw095.PMC4892715.pdf
"The simulated metagenome was also annotated using Megablast, a faster variation of BLAST, to provide a control and so that MEGAN, MG-RAST and One Codex could be compared to astandardinsequenceannotation.ComparingtheMEGAN,MG- RAST and One Codex annotations to the Megablast annotations will quantify the accuracy of these programs for annotating se- quencesfromorganismswhosegenomesarestoredintheNCBI databases.METHODOLOGY Metagenome simulation A simulated metagenome, hereafter Simmet, was created using NeSSM (Jia et al.2013), comprising the complete NCBI bacterialgenomedatabase( ftp://ftp.ncbi.nlm.nih.gov/genomes/ Bacteria/all.fna.tar.gz , May 2013 collection, accessed on 29/04/14).",OADS,/arxiv_data1/oa_pdf/d6/c5/fiw095.PMC4892715.pdf
"Analysis The Simmet metagenome file was annotated with Megablast (available from: http://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE TYPE =BlastDocs&DOC TYPE =Download) as a control, using a reference database of the genomes used to create Simmet.",OADS,/arxiv_data1/oa_pdf/d6/c5/fiw095.PMC4892715.pdf
The NCBI nucleotide database (updated 17/11/2014) ( ftp://ftp.ncbi.nlm.nih.gov/blast/db/ )w a s also used to assess the annotation performance of Megablast.,OADS,/arxiv_data1/oa_pdf/d6/c5/fiw095.PMC4892715.pdf
"25,30,25,40,45,50,55and60bp.ThemaximumE-valuestested were as follows: 1-e−1,1 - e−5,1 - e−10and 1-e−15.A s i d ef r o mt e s t - ing,defaultparameterswereused:60%,15bpand1-e−5,respec- tively,forminimumidentifycut-off,minimumalignmentlength and maximum E-value.The sequence IDs and annotations were extracted from the Megablast results ( https://github.com/sandyjmacdonald/ blastparser), and full taxonomic lineages were generated for each sequence using the NCBI taxonomy database (available from:ftp://ftp.ncbi.nlm.nih.gov/pub/taxonomy/; NCBI database",OADS,/arxiv_data1/oa_pdf/d6/c5/fiw095.PMC4892715.pdf
"2011,https://github.com/najoshi/sickle (18 May 2016, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/d6/c5/fiw095.PMC4892715.pdf
"Secondary out-comes assessed in the review were resource use, adverseevents (AEs) and quality of life of patients with UC or CDtreated with a biologic agent; these outcomes and further details on treatment patterns are reported in full detail inSupplementary digital content 1, http://links.lww.com/ EJGH/A23 .",Non-OADS,/arxiv_data1/oa_pdf/83/35/meg-27-804.PMC4892747.pdf
"Search terms and systematic review methodology, including inclusion and exclusion criteria, are provided as Supplemental digital content 2, http://links.lww.com/ EJGH/A24 .",Non-OADS,/arxiv_data1/oa_pdf/83/35/meg-27-804.PMC4892747.pdf
"The questionnaire was administered as an online survey (see Supplemental digital content 3, http://links.lww.com/EJGH/A25 ).",OADS,/arxiv_data1/oa_pdf/83/35/meg-27-804.PMC4892747.pdf
"1; identi ﬁed publications listed within Supplemental digital content 1,http://links.lww.com/EJGH/A23 ), 24 were identi ﬁed for UC, 76 for CD, 15 for IBD combined (both UC and CD)andﬁve for IBD unspeci ﬁed (UC, CD or indeterminate).",OADS,/arxiv_data1/oa_pdf/83/35/meg-27-804.PMC4892747.pdf
"There wassome evidence to suggest that treatment failure (as mea-sured by the proportion of patients undergoing doseescalation) was higher at second-line biologic treatmentcompared with ﬁrst-line biologic treatment (see Tables S1 and S2, Supplemental digital content 1, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/83/35/meg-27-804.PMC4892747.pdf
"overall costs (see Tables S3 –S5, Supplemental digital con- tent 1, http://links.lww.com/EJGH/A23 ).",Non-OADS,/arxiv_data1/oa_pdf/83/35/meg-27-804.PMC4892747.pdf
"The details of and a brief narrative review of the literature for these outcomes are provided inSupplemental digital content 1, http://links.lww.com/ EJGH/A23 .",Non-OADS,/arxiv_data1/oa_pdf/83/35/meg-27-804.PMC4892747.pdf
Available at: http://www.ema.europa.eu/docs/en_GB/docu ment_library/EPAR_-_Product_Information/human/000240/ WC500050888.pdf .,Non-OADS,/arxiv_data1/oa_pdf/83/35/meg-27-804.PMC4892747.pdf
Available at: http://www.ema.europa.eu/docs/en_GB/document_ library/EPAR_-_Product_Information/human/000481/WC500050870.pdf.,Non-OADS,/arxiv_data1/oa_pdf/83/35/meg-27-804.PMC4892747.pdf
Available at: http://www.ema.europa.eu/docs/en_GB/document_ library/EPAR_-_Product_Information/human/001037/WC500069763.pdf.,Non-OADS,/arxiv_data1/oa_pdf/83/35/meg-27-804.PMC4892747.pdf
Available at: http://www.ema.europa.eu/docs/en_GB/docu ment_library/EPAR_-_Product_Information/human/000992/WC500052368.pdf .,Non-OADS,/arxiv_data1/oa_pdf/83/35/meg-27-804.PMC4892747.pdf
Available at: http://www.access data.fda.gov/drugsatfda_docs/label/2013/125104s840s847s889lbl.,Non-OADS,/arxiv_data1/oa_pdf/83/35/meg-27-804.PMC4892747.pdf
Available at: http://www.nice.org.uk/guidance/gid-tag450/docu ments/ulcerative-colitis-moderate-to-severely-active-vedolizumab- ﬁnal- scope-postreferral2 .,Non-OADS,/arxiv_data1/oa_pdf/83/35/meg-27-804.PMC4892747.pdf
Available at: http://www.nice.org.uk/guidance/gid-tag461/documents/crohns-disease-moderate-to-severe-vedolizumab-ﬁ nal-scope2 .,Non-OADS,/arxiv_data1/oa_pdf/83/35/meg-27-804.PMC4892747.pdf
Available at: http://www.nice.org.uk/arti cle/pmg9 .,Non-OADS,/arxiv_data1/oa_pdf/83/35/meg-27-804.PMC4892747.pdf
Available at: https://www.rcplondon.ac.uk/projects/biologics .,Non-OADS,/arxiv_data1/oa_pdf/83/35/meg-27-804.PMC4892747.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/c5/aww074.PMC4892754.pdf
Available at: http://www.ema.europa.eu/ema/index.jsp?curl =pages/ medicines/human/medicines/000899/human_med_000793.jsp&mid = WC0b01ac058001d124 .,Non-OADS,/arxiv_data1/oa_pdf/f9/2d/mej-23-224.PMC4892758.pdf
Available at: http://www.nccn.org .,Non-OADS,/arxiv_data1/oa_pdf/07/b2/meg-28-493.PMC4892768.pdf
"55,66,68,69 Unconventional response patterns have also been observed in patients with lung cancer or RCC receiving PD-1 pathway inhibitors.56,64,65,70These atypical responses have led to the development of modiﬁed response criteria called immune-related response criteria (Supplemental Table 1, Supplemental Digital Content 1, http://links.lww.com/AJCO/A110 67,68,71).",Non-OADS,/arxiv_data1/oa_pdf/f2/b0/coc-39-98.PMC4892769.pdf
Available at: http://www.clinical trials.gov.,Non-OADS,/arxiv_data1/oa_pdf/f2/b0/coc-39-98.PMC4892769.pdf
"32(3) : 173-181 (2016) http://dx.doi.org/10.5423/PPJ.OA.12.2015.0263  pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal *Corresponding author.Phone) +82-63-238-4668, FAX) +82-63-238-4654E-mail) jinhyung@korea.kr cc This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/99/ppj-32-173.PMC4892813.pdf
"32(3) : 182-189 (2016) http://dx.doi.org/10.5423/PPJ.OA.12.2015.0268 pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal *Corresponding author.Phone) +82-41-530-1288, FAX) +82-41-530-3085E-mail) sy14@sch.ac.kr cc This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/72/ca/ppj-32-182.PMC4892814.pdf
culmorum  isolates  and two reference strains were deposited in GenBank (http://www.ncbi.nlm.nih.gov/) under the accession num-bers listed in Table 2.,OADS,/arxiv_data1/oa_pdf/72/ca/ppj-32-182.PMC4892814.pdf
32(3) : 190-200 (2016) http://dx.doi.org/10.5423/PPJ.OA.10.2015.0208  pISSN 1598-2254   eISSN 2093-9280,Non-OADS,/arxiv_data1/oa_pdf/12/fe/ppj-32-190.PMC4892815.pdf
Microarray  analysis was performed according to the CustomArrayTM  12K microarray protocol provided by CombiMatrix (CombiMatrix Corp.; http://www.combimatrix.com).,OADS,/arxiv_data1/oa_pdf/12/fe/ppj-32-190.PMC4892815.pdf
"After data extraction (https://webapps.combimatrix.com), the background was calculated for individual samples using factory-built controls with low intensities (lowest intensity, 5–30%) and the median signal intensities were  calculated for subtraction.",OADS,/arxiv_data1/oa_pdf/12/fe/ppj-32-190.PMC4892815.pdf
"The sequence of each gene was obtained from the Xoo KACC10331 database (http:// www.ncbi.nlm.nih.gov), and used for primer design by IDT (Integrated DNA Technologies, https://eu.idtdna.com/Primerquest/Home/Index).",OADS,/arxiv_data1/oa_pdf/12/fe/ppj-32-190.PMC4892815.pdf
"32(3) : 201-208 (2016) http://dx.doi.org/10.5423/PPJ.OA.10.2015.0210 pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal *Corresponding author.Phone) +98-(0)21-44868536, FAX) +98-(0)21-44868550E-mail) agolnaraghi@yahoo.com cc This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/92/ppj-32-201.PMC4892816.pdf
"32(3) : 209-215 (2016) http://dx.doi.org/10.5423/PPJ.OA.11.2015.0250 pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal *Corresponding author.Phone) +98-2129904068, FAX) +98-2122431783E-mail) m_farzaneh@sbu.ac.ir cc This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/11/ppj-32-209.PMC4892817.pdf
"32(3) : 216-227 (2016) http://dx.doi.org/10.5423/PPJ.OA.11.2015.0235 pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal *Corresponding author.Phone) +82-2-450-3727, FAX) +82-2-450-3726E-mail) scchun@konkuk.ac.kr cc This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/28/ppj-32-216.PMC4892818.pdf
"When  means and errors were presented in the graph, the image was digitized, and Dexter (GA VO data center) software was used to estimate the values (http://dc.zah.uni-heidel - berg.de/sdexter/).",OADS,/arxiv_data1/oa_pdf/34/28/ppj-32-216.PMC4892818.pdf
"The plants were classified by using the PLANTS database of the USDA, Natural Resources Conservation Service (http://plants.usda.gov/java/).",OADS,/arxiv_data1/oa_pdf/34/28/ppj-32-216.PMC4892818.pdf
"The plants were classified by using the PLANTS database of the USDA, Natural Resources Con-servation Service (http://plants.usda.gov/java/).",OADS,/arxiv_data1/oa_pdf/34/28/ppj-32-216.PMC4892818.pdf
"32(3) : 228-241 (2016) http://dx.doi.org/10.5423/PPJ.OA.10.2015.0218 pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal *Corresponding author.Phone) +82-55-772-1326, FAX) +82-55-772-1329E-mail) yrchung@gnu.ac.kr cc This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/57/c9/ppj-32-228.PMC4892819.pdf
"32(3) : 242-250 (2016) http://dx.doi.org/10.5423/PPJ.OA.08.2015.0162pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal *Corresponding author.Phone) +82-31-750-4763, FAX) +82-31-750-8573E-mail) jkpark@gachon.ac.kr cc This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/01/24/ppj-32-242.PMC4892820.pdf
"32(3) : 251-259 (2016) http://dx.doi.org/10.5423/PPJ.OA.01.2016.0015pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal *Corresponding author.Phone) +82-54-820-5507, FAX) +82-54-820-6320E-mail) yongbac@anu.ac.kr cc This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/99/54/ppj-32-251.PMC4892821.pdf
32(3) : 260-265 (2016) http://dx.doi.org/10.5423/PPJ.NT.09.2015.0183  pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal Note Open Access,Non-OADS,/arxiv_data1/oa_pdf/96/59/ppj-32-260.PMC4892822.pdf
32(3) : 266-272 (2016) http://dx.doi.org/10.5423/PPJ.NT.12.2015.0273pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal †These authors contributed equally to this work as first authors.,Non-OADS,/arxiv_data1/oa_pdf/47/bf/ppj-32-266.PMC4892823.pdf
"32(3) : 273-280 (2016) http://dx.doi.org/10.5423/PPJ.NT.12.2015.0274  pISSN 1598-2254   eISSN 2093-9280 ©The Korean Society of Plant PathologyThe Plant Pathology Journal *Corresponding author.Phone) +82-62-530-2071, FAX) +82-62-530-0208E-mail) yckimyc@jnu.ac.kr cc This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/14/ppj-32-273.PMC4892824.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/db/32/ott-9-3197.PMC4892826.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3197–3204OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3197Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10424 1 Delineation of radiation therapy target volumes for  patients with postoperative glioblastoma: a review Fen Zhao1,2,* Minghuan Li1,2,* Li Kong1,2 Guoli Zhang1,2 Jinming Yu1,2 1Department of Radiation Oncology,   Shandong Cancer Hospital and  institute, Shandong Academy of  Medical Sciences, 2Key Laboratory  of Radiation Oncology Shandong  Province, Jinan, Shandong, People’s  Republic of China *These authors contributed equally  to this workAbstract:  Glioblastoma is the most aggressive and lethal primary malignancy of the brain,  and radiotherapy (RT) is a fundamental part of its treatment.",Non-OADS,/arxiv_data1/oa_pdf/db/32/ott-9-3197.PMC4892826.pdf
"The introduction of computerized tomography (CT) and  magnetic resonance imaging (MRI) has contributed largely to improve the accuracy of  tumor delineation.7 The three-dimensional (3D) conformal radiation technique makes  partial-brain irradiation for glioma possible and reduces neurotoxicity.8 Co-registration  of pre- and postoperative MRI with planning CT images is normally used to determine Correspondence: Jinming Yu Department of Radiation Oncology,  Shandong Cancer Hospital and institute,  440 Jiyan Road, Jinan 250117, Shandong,  People’s Republic of China Tel +86 531 8798 4729 Fax +86 531 8798 4079 email chinasdyjm@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Zhao et al Running head recto: Target volume delineation for GBM DOI: http://dx.doi.org/10.2147/OTT.S104241",Non-OADS,/arxiv_data1/oa_pdf/db/32/ott-9-3197.PMC4892826.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/db/32/ott-9-3197.PMC4892826.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/db/32/ott-9-3197.PMC4892826.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/dd/0b/ott-9-3181.PMC4892827.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3181–3185OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3181Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9512 8 clinical features and treatment of squamous cell  carcinoma of the breast Ximei Zhang1 Baozhong Zhang1 Fenglin Zang2 lujun Zhao1 Zhiyong Yuan1 Ping Wang1 1Department of radiation Oncology,   2Department of Pathology, cancer  institute and hospital, Tianjin Medical  University, Tianjin, People’s republic  of chinaObjectives:  Data on breast squamous cell carcinoma (SCC) are rare.",Non-OADS,/arxiv_data1/oa_pdf/dd/0b/ott-9-3181.PMC4892827.pdf
"Since nine cases were diagnosed before  the correspondence: Ximei Zhang Department of radiation Oncology,  cancer institute and hospital, Tianjin  Medical University, huanhuxi road,  hexi District, Tianjin 300060, People’s  republic of china Tel +86 22 2334 1131 Fax +86 22 2334 1405 email xiangrikuigirl@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhang et al Running head recto: Clinical features and treatment of breast SCC DOI: http://dx.doi.org/10.2147/OTT.S95128",Non-OADS,/arxiv_data1/oa_pdf/dd/0b/ott-9-3181.PMC4892827.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/dd/0b/ott-9-3181.PMC4892827.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/0b/ott-9-3181.PMC4892827.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f8/35/tcrm-12-831.PMC4892828.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 831–850Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  831Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S7036 3How does the efficacy and safety of Oralair®  compare to other products on the market?",Non-OADS,/arxiv_data1/oa_pdf/f8/35/tcrm-12-831.PMC4892828.pdf
"After a century of subcu - taneous (SC) applications, the sublingual (SL) route has been of growing importance Correspondence: Désirée Larenas- Linnemann Hospital Médica Sur, Allergy Section,  Torre 2, cons.602, Puente de Piedra  150, Colony Toriello Guerra, Delegation  Tlalpan, 14050 México City, México Tel +52 55 5171 2248 email marlar1@prodigy.net.m x Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Larenas-Linnemann Running head recto: The comparative efficacy and safety of Oralair® DOI: http://dx.doi.org/10.2147/TCRM.S70363 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/f8/35/tcrm-12-831.PMC4892828.pdf
Or use: http://youtu.be/5lgvBIDNsA kvideo abstract,Non-OADS,/arxiv_data1/oa_pdf/f8/35/tcrm-12-831.PMC4892828.pdf
"Retrieved November 16, 2012 from http://work-learning.com/effect_sizes.ht m. X values represent trials where there were  no parameters of importance to report in the corresponding column.",OADS,/arxiv_data1/oa_pdf/f8/35/tcrm-12-831.PMC4892828.pdf
"Retrieved November 16, 2012 from http://work-learning.com/effect_sizes.ht m. X values represent trials where there were  no parameters of importance to report in the corresponding column.",OADS,/arxiv_data1/oa_pdf/f8/35/tcrm-12-831.PMC4892828.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/f8/35/tcrm-12-831.PMC4892828.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f8/35/tcrm-12-831.PMC4892828.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c4/28/ott-9-3259.PMC4892829.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3259–3267OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3259Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9744 4anti-colorectal cancer effect of interleukin-2  and interferon- β fusion gene driven by  carcinoembryonic antigen promoter Yan Wang Mengchun Wang Yan li Department of gastroenterology,   shengjing hospital of china Medical  University, shenyang, People’s  republic of chinaAbstract:  This study was designed to investigate the antitumor effects of combined  interleukin-2/interferon- β-based gene therapy in colorectal cancer.",Non-OADS,/arxiv_data1/oa_pdf/c4/28/ott-9-3259.PMC4892829.pdf
"The benefits of these  combined cytokines are encouraging.15 A former study has demonstrated that IFN and  IL-2 induce lymphokine-activated killer activity synergistically, further enhancing the correspondence: Yan li Department of gastroenterology,  shengjing hospital of china Medical  University, 36 sanhao street, shenyang  110004, People’s republic of china Tel/fax +86 24 2389 6615 email wangy9@sj-hospital.or g Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Wang et al Running head recto: The antitumor effect of IL-2/IFN- β DOI: http://dx.doi.org/10.2147/OTT.S97444",Non-OADS,/arxiv_data1/oa_pdf/c4/28/ott-9-3259.PMC4892829.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c4/28/ott-9-3259.PMC4892829.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/28/ott-9-3259.PMC4892829.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d0/0d/ott-9-3249.PMC4892830.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3249–3257OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3249Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10490 4Meta-analysis of associations of interleukin-28B  polymorphisms rs8099917 and rs12979860  with development of hepatitis virus-related  hepatocellular carcinoma Yu Zhang* Shao-Liang Zhu* Jie Chen* Le-Qun Li Department of Hepatobiliary Surgery,   Affiliated Tumor Hospital of Guangxi  Medical University, Nanning, People’s  Republic of China *These authors contributed equally  to this workBackground:  This meta-analysis aimed to assess available evidence on possible associations  of interleukin-28B polymorphisms rs8099917 and rs12979860 with development of hepatitis  virus-related hepatocellular carcinoma (HCC).",Non-OADS,/arxiv_data1/oa_pdf/d0/0d/ott-9-3249.PMC4892830.pdf
"Keywords:  interleukin-28B, polymorphisms, hepatitis virus-related hepatocellular carcinoma,  meta-analysis Introduction Hepatocellular carcinoma (HCC) is one of the most common causes of cancer-related  mortality worldwide.1 It is well known that infection with hepatitis B virus (HBV) Correspondence: Le-Qun Li Department of Hepatobiliary Surgery,  Affiliated Tumor Hospital of Guangxi  Medical University, No 71, He Di Road,  Nanning 530021, People’s Republic  of China Tel +86 771 533 0855 Fax +86 771 531 2000 email lilequn2016@aliyun.co m Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Zhang et al Running head recto: IL28B polymorphisms and hepatitis virus-related HCC DOI: http://dx.doi.org/10.2147/OTT.S104904",Non-OADS,/arxiv_data1/oa_pdf/d0/0d/ott-9-3249.PMC4892830.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/d0/0d/ott-9-3249.PMC4892830.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/0d/ott-9-3249.PMC4892830.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5c/46/ott-9-3187.PMC4892831.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3187–3195OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3187Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S8435 6Profile of nivolumab in the treatment of metastatic  squamous non-small-cell lung cancer Yvonne Le Ang1 Joline SJ Lim1,2 Ross A Soo1–3 1Department of Haematology- Oncology, National University Cancer  Institute, National University Health  System, 2Cancer Science institute  of Singapore, National University of  Singapore, Singapore; 3Department  of Surgery, University of Western  Australia, Perth, wA, AustraliaAbstract:  Until recently, the prognosis and treatment of patients with advanced-stage squamous  cell lung cancers have been limited.",Non-OADS,/arxiv_data1/oa_pdf/5c/46/ott-9-3187.PMC4892831.pdf
"Advances in the understanding of  the interaction between the immune system and tumors have led to the development of  programmed death-1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitors targeting  the immune checkpoint pathway.2 The standard first-line therapy for SCC is a platinum-based doublet chemotherapy  without pemetrexed.3–5 More recently, a second-generation platinum derivative,  nedaplatin, in combination with docetaxel, improved outcomes compared to cisplatin/ docetaxel as first-line treatment in advanced-stage SCC, with an overall survival (OS)  benefit of 13 vs 11.4 months (hazard ratio [HR] 0.81, 90% confidence interval [CI]  0.67–0.98).6 In a Phase III trial comparing weekly nab-paclitaxel with carboplatin vs  3-weekly sb-paclitaxel with carboplatin, on subset analysis in SCC, the response rate  with nab-paclitaxel and sb-paclitaxel was 41% and 24%, respectively.7 In the Phase  III SQUIRE study, patients with SCC were randomized to cisplatin and gemcitabine  with or without necitumumab, a second-generation recombinant human IgG1 EGFR Correspondence: Ross A Soo Department of Haematology-Oncology,  National University Cancer institute,  National University Health System,  1E Kent Ridge Road, NUHS Tower Block  Level 7, 119228 Singapore email ross_soo@nuhs.edu.s g Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Ang et al Running head recto: Nivolumab in the treatment of metastatic squamous NSCLC DOI: http://dx.doi.org/10.2147/OTT.S84356",Non-OADS,/arxiv_data1/oa_pdf/5c/46/ott-9-3187.PMC4892831.pdf
"Available  from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnounce - ments/ucm436534.ht m. Accessed December 1, 2015.",Non-OADS,/arxiv_data1/oa_pdf/5c/46/ott-9-3187.PMC4892831.pdf
"Available from: http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements /ucm466413.ht m. Accessed December 1, 2015.38.",Non-OADS,/arxiv_data1/oa_pdf/5c/46/ott-9-3187.PMC4892831.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/5c/46/ott-9-3187.PMC4892831.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/46/ott-9-3187.PMC4892831.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9c/e3/ott-9-3223.PMC4892832.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3223–3232OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3223Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10572 5cholesterol biosynthesis inhibitor r O 48-8071  suppresses growth of hormone-dependent and  castration-resistant prostate cancer cells Yayun liang1 Benford Mafuvadze1 Johannes D aebi2 salman M hyder1 1Dalton cardiovascular research  center and Department of  Biomedical sciences, University  of Missouri-columbia, columbia,   MO, Usa; 2Medicinal chemistry,   roche Pharma research and  early Development (preD),   roche innovation center Basel,   F hoffmann-la roche ltd., Basel,   switzerlandAbstract:  Standard treatment for primary prostate cancer includes systemic exposure to  chemotherapeutic drugs that target androgen receptor or antihormone therapy (chemical castration);  however, drug-resistant cancer cells generally emerge during treatment, limiting the continued use  of systemic chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/9c/e3/ott-9-3223.PMC4892832.pdf
"Keywords:  prostate cancer, cholesterol biosynthesis inhibitor, cell viability, xenograft, castration  resistant Introduction Despite concerted efforts to develop new strategies for preventing and treating  prostate cancer, almost 240,000 new cases are reported each year in the US and  more than 28,000 males die of the disease annually.1 In addition, prostate cancer is  associated with significant physical burden, including bowel, urinary, and sexual dys - function in early-stage disease and painful bony lesions in more advanced cancers.2,3  Most deaths from prostate cancer occur due to complications that arise following  metastasis from the primary tumor to other tissues and organs, a process dependent correspondence: salman M hyder Dalton cardiovascular research center,  University of Missouri-columbia,  134 research Park Drive, columbia,  MO 65211, Usa Tel +1 573 882 1261 Fax +1 573 884 4232 email hyders@missouri.ed u Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Liang et al Running head recto: Cholesterol biosynthesis inhibitor suppresses prostate cancer cell growth DOI: http://dx.doi.org/10.2147/OTT.S105725",Non-OADS,/arxiv_data1/oa_pdf/9c/e3/ott-9-3223.PMC4892832.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/9c/e3/ott-9-3223.PMC4892832.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/e3/ott-9-3223.PMC4892832.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6f/5a/tcrm-12-851.PMC4892833.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 851–860Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  851Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S10763 5 The role of inflammation in cardiovascular  diseases: the predictive value of neutrophil– lymphocyte ratio as a marker in peripheral  arterial disease Feliciano Chanana Paquissi Department of Medicine, Clínica  Girassol, Luanda, AngolaAbstract:  Peripheral arterial disease (PAD) is an important manifestation of atherosclerosis,  with increasing prevalence worldwide.",Non-OADS,/arxiv_data1/oa_pdf/6f/5a/tcrm-12-851.PMC4892833.pdf
"Keywords:  neutrophil–lymphocyte ratio, peripheral arterial disease, inflammation, cardiovas - cular diseases, biomarkers Introduction Peripheral arterial disease (PAD) is an important manifestation of atherosclerosis,  which affects .202 million people worldwide,1 and is associated with cardiovas - cular events,2 with increased all-cause and cardiovascular mortality.3,4 PAD, despite  the advances registered in its treatment, still has a worse prognosis compared with  coronary artery disease (CAD)5 by various factors, including the high rate of in- stent restenosis, which occurs with an important contribution of the inflammatory  response.6,7 These negative outcomes have brought in sight the need of biomarkers  as predictors of outcomes to ensure better risk stratification, proper selection of treat - ment approaches, and, if necessary, additional multitarget approaches (such as the  endovascular brachytherapy).8 In recent years, the literature has highlighted the value of systemic inflamma - tion as an important element in the development, progression, and prognosis of  atherosclerosis.9,10 It is worth to mention that PAD is the atherosclerotic manifestation  that shows the greater relationship with systemic inflammation.11 Several inflamma - tory markers have been shown to be useful in clinical studies on risk stratification and  prognosis of patients with PAD,12,13 as well as in those with disease in other vascular  beds as cerebral and coronary.14–16Correspondence: Feliciano Chanana  Paquissi Department of Medicine, Clínica Girassol,  Street Comandante Gika number 225,  Luanda, Angola Tel +55 119 4997 5972 Fax +24 422 6698 218 email fepaquissi@gmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Paquissi Running head recto: Studies on the role of inflammatory biomarkers in cardiovascular outcomes DOI: http://dx.doi.org/10.2147/TCRM.S107635",Non-OADS,/arxiv_data1/oa_pdf/6f/5a/tcrm-12-851.PMC4892833.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/6f/5a/tcrm-12-851.PMC4892833.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/5a/tcrm-12-851.PMC4892833.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/46/d4/ott-9-3233.PMC4892834.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3233–3247OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3233Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10605 5 The efficiency and safety of trastuzumab and  lapatinib added to neoadjuvant chemotherapy  in Her2-positive breast cancer patients:  a randomized meta-analysis Zhe-ling chen Yan-Wei shen shu-Ting li chun-li li ling-Xiao Zhang Jiao Yang Meng lv Ya-Yun lin Xin Wang Jin Yang Department of Medical Oncology,   The First affiliated hospital of Xi’an  Jiaotong University, Xi’an, shaanxi,   People’s Republic of ChinaBackground:  The addition of human epidermal growth factor receptor 2 (Her2) therapies to  neoadjuvant chemotherapy (NAC) during treatment of Her2-positive breast cancer has been  proposed as an effective way to improve the prognosis.",Non-OADS,/arxiv_data1/oa_pdf/46/d4/ott-9-3233.PMC4892834.pdf
"Keywords:  breast cancer, trastuzumab, lapatinib, human epidermal growth factor receptor,  neoadjuvant, pathologically complete response Introduction The overexpression of human epidermal growth factor receptor 2 (Her2) can be found  in 15%–20% of breast cancer patients, which is associated with significantly shortened correspondence: Jin Yang Department of Medical Oncology,  The First Affiliated Hospital of Xi’an  Jiaotong University, no 277 Yanta West  road, Xi’an, shaanxi 710061, People’s  Republic of China Tel +86 29 8532 3422 Fax +86 29 8532 3422 email 1473106133@qq.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Chen et al Running head recto: Trastuzumab and lapatinib with NAC for breast cancer DOI: http://dx.doi.org/10.2147/OTT.S106055",Non-OADS,/arxiv_data1/oa_pdf/46/d4/ott-9-3233.PMC4892834.pdf
"All the analyses and graphs were obtained using RevMan  5.3 (The Nordic Cochrane Centre, The Cochrane Collabora - tion, Copenhagen, Denmark, https://tech.cochrane.or g).",OADS,/arxiv_data1/oa_pdf/46/d4/ott-9-3233.PMC4892834.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/46/d4/ott-9-3233.PMC4892834.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/46/d4/ott-9-3233.PMC4892834.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fd/33/ott-9-3067.PMC4892835.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3067–3076OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3067Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9686 1restoration of mir-20a expression suppresses  cell proliferation, migration, and invasion in  hepg2 cells guang shun chen ning Zhou Jie-Qun li Ting li Zhong-Qiang Zhang Zhong-Zhou si Department of Organ Transplantation  and general surgery, The second  Xiangya hospital, central south  University, changsha, People’s  republic of chinaObjective:  To study microRNA (miR)-20a expression in hepatocellular carcinoma (HCC) and  its effects on the proliferation, migration, and invasion of HepG2.",Non-OADS,/arxiv_data1/oa_pdf/fd/33/ott-9-3067.PMC4892835.pdf
"It is generally believed that HCC correspondence: Zhong-Zhou si Department of Organ Transplantation  and general surgery, The second Xiangya  hospital, central south University, 139  renmin road, changsha 410011, hunan  Province, People’s republic of china Tel +86 731 8529 5108 email sizhongzhou0921@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Chen et al Running head recto: miR-20a expression and HCC DOI: http://dx.doi.org/10.2147/OTT.S96861",Non-OADS,/arxiv_data1/oa_pdf/fd/33/ott-9-3067.PMC4892835.pdf
"Abbreviations:  mir, microrna; nc, negative control.compared to the blank group, an obviously less number of  cells in miR-20a mimics groups passed through the high- magnification invasion chamber, with invasion inhibition  rate of 51.4% (0.501 times that of the blank group, P0.01),  while there was no obvious difference between the NC and  blank groups ( P0.05) (Figure 6).Bioinformatics prediction and verification  of fluorescence report vector for target  gene of mir-20a Bioinformatics software Target Scan ( http://www.targetscan.",OADS,/arxiv_data1/oa_pdf/fd/33/ott-9-3067.PMC4892835.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/fd/33/ott-9-3067.PMC4892835.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fd/33/ott-9-3067.PMC4892835.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ed/61/opth-10-1001.PMC4892836.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1001–1006Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1001Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10490 1 Valved versus nonvalved cannula small-gauge pars  plana vitrectomy for repair of retinal detachments  with grade C proliferative vitreoretinopathy Patrick Oellers sandra stinnett Paul hahn Duke eye Center, Duke University  school of Medicine, Durham, nC, UsaPurpose:  Valved cannulas are a recent addition to small-gauge pars plana vitrectomy (PPV)  and provide stable intraocular fluidics.",Non-OADS,/arxiv_data1/oa_pdf/ed/61/opth-10-1001.PMC4892836.pdf
"Proliferative vitreoretinopathy (PVR) is the most common etiology for recurrent  retinal detachment (RD).2 The pathophysiology leading to PVR formation is not fully  understood but thought to be at least partially inflammation mediated in a process Correspondence: Paul hahn Duke eye Center, Duke University  school of Medicine, DUMC Box 3802,  Durham, nC 27710, Usa Tel +1 919 684 5631 email paulhahn@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Oellers et al Running head recto: Valved vs nonvalved PPV for RD-Grade C PVR repair DOI: http://dx.doi.org/10.2147/OPTH.S104901",Non-OADS,/arxiv_data1/oa_pdf/ed/61/opth-10-1001.PMC4892836.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ed/61/opth-10-1001.PMC4892836.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ed/61/opth-10-1001.PMC4892836.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a5/7a/ijn-11-2417.PMC4892837.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2417–2429International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2417OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10246 7chimeric hBcag virus-like particles presenting a  HPV 16 E7 epitope significantly suppressed tumor  progression through preventive or therapeutic  immunization in a Tc-1-grafted mouse model Xiaojie chu1–3,* Yang li1–3,* Qiong long1–3 Ye Xia1–3 Yufeng Yao1–3 Wenjia sun1–3 Weiwei huang1–3 Xu Yang1–3 cunbao liu1–3 Yanbing Ma1–3 1Laboratory of Molecular Immunology,   Institute of Medical Biology, Chinese  Academy of Medical Science & Peking  Union Medical college, 2Yunnan Key  Laboratory of Vaccine Research &  Development on severe Infectious  Disease, 3Yunnan engineering  research center of Vaccine research  and Development on severe  Infectious Disease, Kunming, People’s  republic of china *These authors contributed equally  to this workBackground:  Therapeutic human papillomavirus (HPV) vaccines are currently being developed.",Non-OADS,/arxiv_data1/oa_pdf/a5/7a/ijn-11-2417.PMC4892837.pdf
"Recently, three commercially available prophylactic HPV  vaccines, which are virus-like particles (VLPs) composed of major capsid protein L1, correspondence: Yanbing Ma Laboratory of Molecular Immunology,  Institute of Medical Biology, Chinese  Academy of Medical Sciences & Peking  Union Medical college, 935 Jiaoling road,  Kunming 650118, People’s republic of  china Tel +86 871 6833 9287 Fax +86 871 6833 4483 email mayanbing1969@hotmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Chu et al Running head recto: Chimeric VLPs suppressed tumor progression in mice DOI: http://dx.doi.org/10.2147/IJN.S102467",Non-OADS,/arxiv_data1/oa_pdf/a5/7a/ijn-11-2417.PMC4892837.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a5/7a/ijn-11-2417.PMC4892837.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a5/7a/ijn-11-2417.PMC4892837.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f0/cd/opth-10-993.PMC4892838.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 993–1000Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  993Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10588 0The acute phase of inflammatory response  involved in the wound-healing process after  excimer laser treatment Mirko resan1,2 Miroslav Vukosavljevic1,2 Danilo Vojvodic2,3  Brigitte Pajic-eggspuehler4 Bojan Pajic2,4–6 1eye Clinic, Military Medical academy,   Belgrade, serbia; 2Faculty of Medicine  of the Military Medical academy,   University of Defense, Belgrade,   serbia; 3Department for Clinical  and experimental immunology,   institute for Medical research,   Military Medical academy, Belgrade,   serbia; 4eye Clinic O rasis , swiss eye  research Foundation, reinach ag,   switzerland; 5Department of Physics,   Faculty of science, University of  novi sad, novi sad, serbia; 6Division  of Ophthalmology, Department of  Clinical neurosciences, University  hospitals of geneva, switzerlandPurpose:  To evaluate the participation of proinflammatory cytokines in the acute phase of  corneal wound-healing response after excimer laser treatment.",Non-OADS,/arxiv_data1/oa_pdf/f0/cd/opth-10-993.PMC4892838.pdf
"Both methods involve  excimer laser treatments that result in photoablative effects to correct existing Correspondence: Bojan Pajic eye Clinic Orasis, swiss eye  research Foundation, Titlisstrasse 44,  5734 reinach, switzerland Tel +41 627 656 080 email bpajic@datacomm.c h Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Resan et al Running head recto: Inflammatory response after excimer laser treatment DOI: http://dx.doi.org/10.2147/OPTH.S105880",Non-OADS,/arxiv_data1/oa_pdf/f0/cd/opth-10-993.PMC4892838.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f0/cd/opth-10-993.PMC4892838.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/cd/opth-10-993.PMC4892838.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/31/98/jbm-7-107.PMC4892839.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/31/98/jbm-7-107.PMC4892839.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Development of paroxysmal nocturnal  hemoglobinuria in CALR-positive  myeloproliferative neoplasm Yarden S Fraiman1,2 Nathan Cuka3 Denise Batista3 Milena Vuica-Ross3 Alison R Moliterno4 1Department of Pediatrics, Harvard  Medical School, 2Department of  Pediatrics, Boston University School  of Medicine, Boston, MA, 3Department  of Pathology, 4Division of Hematology,   Department of Medicine, The Johns  Hopkins University School of  Medicine, Baltimore, MD, USA Correspondence: Alison R Moliterno   Division of Hematology, Department  of Medicine, Johns Hopkins University  School of Medicine, Traylor 912,  720 Rutland Avenue, Baltimore,  MD 21205, USA   T el +1 410 614 6360   Fax +1 410 614 0854   Email amoliter@jhmi.ed uAbstract:  Paroxysmal nocturnal hemoglobinuria (PNH), a disease characterized by intravascular  hemolysis, thrombosis, and bone marrow failure, is associated with mutations in the PIG-A  gene,  resulting in a deficiency of glycosylphosphatidylinositol-anchored proteins.",Non-OADS,/arxiv_data1/oa_pdf/31/98/jbm-7-107.PMC4892839.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal-of-blood-medicine-journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/31/98/jbm-7-107.PMC4892839.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/31/98/jbm-7-107.PMC4892839.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/55/92/ijn-11-2359.PMC4892840.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2359–2367International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2359OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9881 5Preparation of liposomal amiodarone and  investigation of its cardiomyocyte-targeting ability  in cardiac radiofrequency ablation rat model Ying Zhuge1,* Zhi-Feng Zheng1,* Mu-Qing Xie2 lin li2 Fang Wang1 Feng gao2,3 1Department of cardiology, shanghai  First People’s hospital of Nanjing  Medical University, 2Department of  Pharmaceutics, school of Pharmacy,   3shanghai Key laboratory of  Functional Materials chemistry,   east china University of science  and Technology, shanghai, People’s  republic of china *These authors contributed equally  to this workAbstract:  The objective of this study was to develop an amiodarone hydrochloride  (ADHC)-loaded liposome (ADHC-L) formulation and investigate its potential for cardiomyo - cyte targeting after cardiac radiofrequency ablation (CA) in vivo.",Non-OADS,/arxiv_data1/oa_pdf/55/92/ijn-11-2359.PMC4892840.pdf
"Among  these antiarrhythmic drugs, amiodarone hydrochloride (ADHC) is widely used  to enhance the efficiency and reduce the side effects in CA operation for patients  with cardiac arrhythmia.correspondence: Fang Wang Department of cardiology, shanghai First  People’s hospital of Nanjing Medical  University, 100 haining road, hongkou  District, shanghai 200080, People’s  republic of china Tel +86 21 6324 0090 email 1838750550@qq.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Zhuge et al Running head recto: Liposomal cardiomyocyte-targeting ability in CA DOI: http://dx.doi.org/10.2147/IJN.S98815",Non-OADS,/arxiv_data1/oa_pdf/55/92/ijn-11-2359.PMC4892840.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/55/92/ijn-11-2359.PMC4892840.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/55/92/ijn-11-2359.PMC4892840.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2c/2c/ijn-11-2443.PMC4892848.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2443–2450International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2443OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10429 2Efficacy of HIV antiviral polyanionic carbosilane  dendrimer g2-s16 in the presence of semen rafael ceña-Diez1–4,* Pilar garcía-Broncano1–5,* Francisco Javier de la  Mata4,6 rafael gómez4,6 Mª Ángeles Muñoz- Fernández1–4 1hospital general Universitario  gregorio Marañon, 2Instituto de  Investigación sanitaria gregorio  Marañon, 3Spanish HIV HGM Biobank,   4Networking Research Center  on Bioengineering, Biomaterials  and Nanomedicine (cIBer-BBN),   5Laboratory of Viral Infection and  Immunity, National Center of  Microbiology, Health Institute of  carlos III, Majadahonda, 6Department  of Organic Chemistry and Inorganic  Chemistry, University of Alcalá, Alcalá  de henares, Madrid, spain *These authors contributed equally  to this workAbstract:  The development of a safe and effective microbicide to prevent the sexual  transmission of human immunodeficiency virus (HIV)-1 is urgently needed.",Non-OADS,/arxiv_data1/oa_pdf/2c/2c/ijn-11-2443.PMC4892848.pdf
"We studied whether this effect can be observed  in our G2-S16 anionic carbosilane dendrimer, which has been in a preclinical phase  as an anti-HIV microbicide.correspondence: Mª Ángeles  Muñoz-Fernández hospital general Universitario gregorio  Marañon, C/Dr Esquerdo 46, 28007  Madrid, spain Tel +34 915 868 565 email mmunoz.hgugm@gmail.co m;  mmunoz.hgugm@salud.madrid.or g Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Ceña-Diez et al Running head recto: Polyanionic carbosilane dendrimer G2-S16 DOI: http://dx.doi.org/10.2147/IJN.S104292",Non-OADS,/arxiv_data1/oa_pdf/2c/2c/ijn-11-2443.PMC4892848.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/2c/2c/ijn-11-2443.PMC4892848.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/2c/ijn-11-2443.PMC4892848.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/67/e0/ott-9-3205.PMC4892849.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3205–3212OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3205Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9946 1Clinicopathological significance of claudin 4  expression in gastric carcinoma: a systematic  review and meta-analysis Xiaowan chen1,* Junhua Zhao1,* ailin li1,2 Peng gao1 Jingxu sun1 Y ongxi song1 Jingjing liu1 Ping chen1 Zhenning Wang1 1Department of Surgical Oncology  and general surgery, 2Department of  Radiation Oncology, First Hospital of  china Medical University, shenyang,   People’s Republic of China *These authors contributed equally  to this workBackground:  The prognostic significance of claudin 4 (CLDN4) in patients with gastric  cancer (GC) is controversial.",Non-OADS,/arxiv_data1/oa_pdf/67/e0/ott-9-3205.PMC4892849.pdf
"Claudins are located at the most apical component of intercellular cell–cell junc - tions, where they establish cell polarity.3 Claudin 4 (CLDN4) is a member of claudin  family, which consists of 209 amino acids and encodes four putative transmembrane  segments.4,5 Gress et al6 firstly reported that CLDN4 overexpression occurs in pancreatic correspondence: Zhenning Wang Department of Surgical Oncology and  General Surgery, First Hospital of China  Medical University, 155 north nanjing  street, heping District, shenyang 110001,  People’s Republic of China Tel +86 24 8328 3556 Fax +86 24 8328 3556 email josieon826@sina.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Chen et al Running head recto: Significance of CLDN4 expression in GC DOI: http://dx.doi.org/10.2147/OTT.S99461",OADS,/arxiv_data1/oa_pdf/67/e0/ott-9-3205.PMC4892849.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/67/e0/ott-9-3205.PMC4892849.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/67/e0/ott-9-3205.PMC4892849.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3d/ab/ott-9-3153.PMC4892850.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3153–3162OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3153Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10067 8anti-egFr-irgD recombinant protein conjugated  silk fibroin nanoparticles for enhanced tumor  targeting and antitumor efficiency Xinyu Bian* Puyuan Wu* huizi sha hanqing Qian Qing Wang lei cheng Yang Yang Mi Yang Baorui liu comprehensive cancer center  of Drum-Tower Hospital, Medical  School of Nanjing University, Clinical  Cancer Institute of Nanjing University,   Nanjing, People’s Republic of China *These authors contributed equally  to this workAbstract:  In this study, we report a novel kind of targeting with paclitaxel (PTX)-loaded silk  fibroin nanoparticles conjugated with iRGD–EGFR nanobody recombinant protein (anti-EGFR- iRGD).",Non-OADS,/arxiv_data1/oa_pdf/3d/ab/ott-9-3153.PMC4892850.pdf
"Meanwhile,  the impaired lymphatic drainage of tumor limits the clearance of these particles and  causes their enhanced retention.3 However, many clinical outcomes have indicated that EPR is not as reliable to  ensure tumor targeting of NPs as previously proved by preclinical studies, which correspondence: Baorui liu comprehensive cancer center  of Drum-Tower Hospital, Medical  School of Nanjing University, Clinical  Cancer Institute of Nanjing University,  Zhongshan Road 321, Nanjing 210008,  People’s Republic of China Tel +86 25 83105082 email baoruiliu@nju.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Bian et al Running head recto: Anti–EGFR-siRGD recombinant protein conjugated NPs for oncotherapy DOI: http://dx.doi.org/10.2147/OTT.S100678",Non-OADS,/arxiv_data1/oa_pdf/3d/ab/ott-9-3153.PMC4892850.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/3d/ab/ott-9-3153.PMC4892850.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3d/ab/ott-9-3153.PMC4892850.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c8/1b/mder-9-131.PMC4892851.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c8/1b/mder-9-131.PMC4892851.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Medical Devices: Evidence and Research 2016:9 131–137Medical Devices: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress 131 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S105899 Human factors validation study of 3 mg  sumatriptan autoinjector, for migraine patients Elimor Brand-Schieber1  Sagar Munjal1  Rajesh Kumar1  Anthony D Andre2  Will Valladao2  Margarita Ramirez2 1Dr.",Non-OADS,/arxiv_data1/oa_pdf/c8/1b/mder-9-131.PMC4892851.pdf
"5,6  Recent studies in migraine patients have found that patients are well aware of these Correspondence: Anthony D Andre   Interface Analysis Associates, 1821  Saratoga Avenue, Suite 200, Saratoga, CA 95070, USA Email 800usability@gmail.comJournal name: Medical Devices: Evidence and Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Brand-Schieber et alRunning head recto: DFN-11 autoinjector validationDOI: http://dx.doi.org/10.2147/MDER.S105899",Non-OADS,/arxiv_data1/oa_pdf/c8/1b/mder-9-131.PMC4892851.pdf
"Medical Devices: Evidence and Research 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/medical-devices-evidence-and-research-journalMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology, research, and expert opinion supporting the use and application of   medical devices in the diagnosis, monitoring, treatment and management of clinical conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/c8/1b/mder-9-131.PMC4892851.pdf
Available from: https://gsksource.com/pharma/content/dam/GlaxoSmithKline/US/en/Prescribing_Information/Imitrex_   Injection/pdf/IMITREX-INJECTION-PI-PPI-PIL-COMBINED.PDF .,Non-OADS,/arxiv_data1/oa_pdf/c8/1b/mder-9-131.PMC4892851.pdf
Available from: http://www.fda.gov/downloads/MedicalDevices/./UCM259760.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c8/1b/mder-9-131.PMC4892851.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on Experimental & Molecular Medicin e website (http://www.nature.com/emm)Neuroprotective role of CB2 receptors in a PD model YC Chung et al 10 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/35/8c/emm2015100a.PMC4892852.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on Experime ntal & Molecular Medicine website (http://www.nature.com/emm)Functional role of CHMP5 in TCR signaling SM WI et al 9 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/57/90/emm2015102a.PMC4892854.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies the paper on Experime ntal & Molecular Medicine website (http://www.nature.com/emm)Isoproterenol increases HDAC6 expression JA Lim and Y-S Juhnn 11 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/fc/39/emm201598a.PMC4892858.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/71/ff/ott-9-3171.PMC4892859.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3171–3179OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3171Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9415 1risk model in stage iB1-iiB cervical cancer with  positive node after radical hysterectomy Zhilan chen,1,2,* Kecheng  huang,1,* Zhiyong lu,1,3 song  Deng,1,4 Jiaqiang Xiong,1 Jia  huang,1 Xiong li,5 Fangxu  Tang,1 Zhihao Wang,6 haiying  sun,1 lin Wang,1 shasha Zhou,1  Xiaoli Wang,1 Yao Jia,1 Ting  hu,1 Juan gui,7 Dongyi Wan,1  Ding Ma,1 shuang li,1 shixuan  Wang1 1Department of Obstetrics and gynecology,   T ongji hospital, T ongji Medical college,   huazhong University of science and  T echonology, Wuhan, 2Department of  Obstetrics and gynecology, Wuhan  general hospital of guangzhou Military  command, Wuhan, 3hubei Key laboratory  of embryonic stem cell research, Tai-he  hospital, hubei University of Medicine,   shiyan, hubei, 4Department of Obstetrics  and gynecology, University hospital of  hubei University for nationalities, enshi,   hubei, 5Department of Obstetrics and  gynecology, Wuhan central hospital,   Wuhan, 6Department of Pathology  and Pathophysiology, Key laboratory  of Ministry of education of china for  neurological Disorders, huazhong  University of science and T echonology,   Wuhan, 7Department of Obstetrics and  gynecology, renmin hospital, Wuhan  University, Wuhan, People’s republic  of china *These authors contributed equally  to this workAbstract:  The purpose of this study was to identify risk factors in patients with surgically treated  node-positive IB1-IIB cervical cancer and to establish a risk model for disease-free survival  (DFS) and overall survival (OS).",Non-OADS,/arxiv_data1/oa_pdf/71/ff/ott-9-3171.PMC4892859.pdf
"The recommendations made when pelvic LNM are found remain controversial.correspondence: shuang li;   shixuan Wang Department of gynecology & Obstetrics,  Tongji hospital, Tongji Medical college,  huazhong University of science and  Technology, 1095 Jiefang anv Wuhan, hubei  430030, People’s republic of china Tel +86 27 8366 3078 Fax +86 27 8366 3078 email lee5190008@126.co m;  sxwang2012@hotmail.co mJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Chen et al Running head recto: Risk model for cervical cancer DOI: http://dx.doi.org/10.2147/OTT.S94151",Non-OADS,/arxiv_data1/oa_pdf/71/ff/ott-9-3171.PMC4892859.pdf
Materials and methods Patients The patients were selected from the database from January  2002 to December 2008 ( https://clinicaltrials.go v;  NCT01267851).,OADS,/arxiv_data1/oa_pdf/71/ff/ott-9-3171.PMC4892859.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/71/ff/ott-9-3171.PMC4892859.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/ff/ott-9-3171.PMC4892859.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1f/44/jpr-9-311.PMC4892860.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).The Italian Consensus Conference on Pain in  Neurorehabilitation: rationale and methodology Stefano Tamburin1 Stefano Paolucci2 Francesca Magrinelli1 Massimo Musicco2,3 Giorgio Sandrini4,5 On behalf of the Italian  Consensus Conference on  Pain in Neurorehabilitation  (ICCPN) 1Department of Neurological,   Biomedical and Movement Sciences,   University of Verona, Verona, 2Santa  Lucia Foundation, IRCCS, Rome,   3Institute of Biomedical Technologies  (IBT) National Research Council  of Italy (CNR), Segrate, Milan,   4C.",Non-OADS,/arxiv_data1/oa_pdf/1f/44/jpr-9-311.PMC4892860.pdf
"Available from: http://www.snlg-iss.it/cms/files/ manuale_ metodologico_consensus_0.pd f. Accessed August 10, 2015.",Non-OADS,/arxiv_data1/oa_pdf/1f/44/jpr-9-311.PMC4892860.pdf
"Available from http://store.elsevier.com/embas e. Accessed August 10,  2015.",Non-OADS,/arxiv_data1/oa_pdf/1f/44/jpr-9-311.PMC4892860.pdf
"Available  from https://clinicaltrials.gov/ct2/hom e. Accessed August 10, 2015.",Non-OADS,/arxiv_data1/oa_pdf/1f/44/jpr-9-311.PMC4892860.pdf
Available from: http://www.cebm.net/index.aspx?o =5653.,Non-OADS,/arxiv_data1/oa_pdf/1f/44/jpr-9-311.PMC4892860.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/1f/44/jpr-9-311.PMC4892860.pdf
Visit  http://www.dovepress.com/testimonials.php to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/44/jpr-9-311.PMC4892860.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/84/49/ijn-11-2397.PMC4892861.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2397–2406International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2397RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S10527 4 Pericyte-targeting drug delivery and tissue  engineering eunah Kang1 Jong wook Shin2 1School of Chemical engineering and  Material Science, 2Division of Allergic  and Pulmonary Medicine, Department  of Internal Medicine, College of  Medicine, Chung-Ang University,   Dongjak-Gu, Seoul, South KoreaAbstract:  Pericytes are contractile mural cells that wrap around the endothelial cells of  capillaries and venules.",Non-OADS,/arxiv_data1/oa_pdf/84/49/ijn-11-2397.PMC4892861.pdf
"Paracrine signal modulation between PCs and Correspondence: eunah Kang School of Chemical engineering and  Material Science, Chung-Ang University,  221 Heukseok-Dong, Dongjak-Gu, Seoul,  South Korea Tel +82 2 820 6684 email eakangek@cau.ac.k r  Jong wook Shin Department of Internal Medicine, Division  of Allergic and Pulmonary Medicine,  College of Medicine, Chung-Ang  University, 221 Heukseok-Dong,  Dongjak-Gu, Seoul, South Korea Tel +82 2 6299 1407 Fax +82 2 6299 1448 email basthma@cau.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Kang and Shin Running head recto: Pericytes-targeting drug delivery and tissue engineering DOI: http://dx.doi.org/10.2147/IJN.S105274",Non-OADS,/arxiv_data1/oa_pdf/84/49/ijn-11-2397.PMC4892861.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/84/49/ijn-11-2397.PMC4892861.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/84/49/ijn-11-2397.PMC4892861.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b9/a8/ott-9-3213.PMC4892862.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 3213–3221OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3213Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9832 2The evaluative value of sema3c and MFn2  co-expression detected by immunohistochemistry  for prognosis in hepatocellular carcinoma patients  after hepatectomy Xu Feng1,* Kelei Zhu1,2,* Jinghua liu1 Jiang chen1 Jiacheng Tang3 Yuelong liang1 renan Jin1 Xiao liang1 Xiujun cai1,3 1Department of general surgery,   sir run run shaw hospital, Zhejiang  University, hangzhou, 2Department  of general surgery, Yinzhou People’s  hospital, ningbo, 3Key lab of surgery  of Zhejiang Province, sir run run  shaw hospital, Zhejiang University,   hangzhou, Zhejiang, People’s  republic of china *These authors contributed equally  to this workBackground:  The ability to evaluate the prognosis of hepatocellular carcinoma (HCC)  following hepatectomy using biological markers is of great importance.",Non-OADS,/arxiv_data1/oa_pdf/b9/a8/ott-9-3213.PMC4892862.pdf
"It has been shown to have high  level of expression in various types of tumor cells; a correlation between its expression  and tumor development and progression has been reported.5,6 It can promote tumor correspondence: Xiujun cai Department of general surgery, sir run  run shaw hospital, Zhejiang University,  3rd Qingchun east road, hangzhou,  Zhejiang 310016, People’s republic of  china Tel/fax +86 571 8600 6605 email cxjzu@zju.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Feng et al Running head recto: Evaluative value of Sema3C and MFN2 co-expression DOI: http://dx.doi.org/10.2147/OTT.S98322",Non-OADS,/arxiv_data1/oa_pdf/b9/a8/ott-9-3213.PMC4892862.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/b9/a8/ott-9-3213.PMC4892862.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/a8/ott-9-3213.PMC4892862.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4a/ea/ijn-11-2431.PMC4892864.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 2431–2442International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  2431OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10167 3Bone regenerating effect of surface-functionalized  titanium implants with sustained-release  characteristics of strontium in ovariectomized rats Vincent Offermanns1 Ole Zoffmann andersen2 gregor riede1 Inge hald andersen3 Klaus Pagh almtoft3 søren sørensen3 Michael sillassen2 christian sloth Jeppesen3 Michael rasse1 Morten Foss2 Frank Kloss1 1Department of cranio-, Maxillofacial  and Oral surgery, Medical University  Innsbruck, Innsbruck, austria;   2Interdisciplinary Nanoscience  center (iN aNO), Faculty of science  and T echnology, aarhus University,   aarhus, Denmark; 3Tribology centre,   Danish T echnological Institute, aarhus,   DenmarkAbstract:  Since strontium (Sr) is known for its anabolic and anticatabolic effect on bone,  research has been focused on its potential impact on osseointegration.",Non-OADS,/arxiv_data1/oa_pdf/4a/ea/ijn-11-2431.PMC4892864.pdf
"The concept of osseointegration is among the key factors for a successful long-term  implant survival, and the resulting interface between bone and metal is responsible for  the present-day high success rate of medical implants.10,11 In decrepit bone, implant  failure is, however, expected to increase, similar to the currently used ovariecto - mized animal model, where the procedures involved in preparing the model induce correspondence: Vincent Offermanns Department of cranio-, Maxillofacial  and Oral surgery, Medical University  Innsbruck, anichstrasse 35, 6020  Innsbruck, austria Tel +43 512 504 24373 email vincent.offermanns@i-med.ac.a t Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Offermanns et al Running head recto: Bone regenerating effect of surface functionalized titanium implants DOI: http://dx.doi.org/10.2147/IJN.S101673",Non-OADS,/arxiv_data1/oa_pdf/4a/ea/ijn-11-2431.PMC4892864.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/4a/ea/ijn-11-2431.PMC4892864.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4a/ea/ijn-11-2431.PMC4892864.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/4.0/Antibodies against G-protein –coupled receptors MJ oa n dS TJ u n g 9 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/8c/c3/emm2015105a.PMC4892866.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on Experimental & Molecular Medicin e website (http://www.nature.com/emm)Extracellular vesicles in the urine of pregnant women JY Yoo et al 8 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/90/15/emm2015110a.PMC4892867.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on Experime ntal & Molecular Medicine website (http://www.nature.com/emm)Gingival stem cell in CBG hydrogel for regeneration SR Rao et al 11 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/46/7e/emm2015113a.PMC4892868.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on Experimental & Molecular Medicin e website (http://www.nature.com/emm)Resveratrol blocks Akt and UPR in neuroblastoma RM Graham et al 12 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/9f/e0/emm2015116a.PMC4892869.pdf
"We are currentlydeveloping a new diagnostic kit and portable machine (FRENDSystem at http://www.nanoentek.com) to accurately measureconcentrations of ORM1, ORM2 and sCD14 in a drop of urine within 10 min (Supplementary Figure 3).",Non-OADS,/arxiv_data1/oa_pdf/bb/8a/emm2015120a.PMC4892870.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies the paper on Experimental & Molecular Medicin e website (http://www.nature.com/emm)Urinary biomarkers for RA Y-J Park et al 8 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/bb/8a/emm2015120a.PMC4892870.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on Experime ntal & Molecular Medicine website (http://www.nature.com/emm)ERRγas a potential therapeutic target in HCC J-H Kim et al 7 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/d3/16/emm2015115a.PMC4892874.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/Editorial 2 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/68/c2/emm2015119a.PMC4892875.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/4.0/Overview of hepatic glucose metabolism H-S Han et al 10 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/b1/d8/emm2015122a.PMC4892876.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on Experime ntal & Molecular Medicine website (http://www.nature.com/emm)Myeloid deletion of SIRT1 suppresses CIA SJ Woo et al 9 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/d7/cc/emm2015124a.PMC4892877.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on Experime ntal & Molecular Medicine website (http://www.nature.com/emm)ANT2 shRNA downregulates miR-19a and miR-96 in HCC SH Baik et al 7 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/99/38/emm2015126a.PMC4892878.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/Chronic stress accelerates periodontitis HL u et al 10 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/b9/9a/emm2015127a.PMC4892879.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/STEP mediates morphine-induced behavioral response Y-J Kim et al 10 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/18/4f/emm20161a.PMC4892880.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Crosstalk between heart and peripheral organs in HF JWS Jahng et al 11 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/6c/73/emm201620a.PMC4892881.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/Brain control of metabolism ER o h et al 12 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/13/cb/emm20164a.PMC4892882.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/Pancreatic regulation of glucose homeostasis PV Röder et al 19 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/0c/bd/emm20166a.PMC4892884.pdf
Modi ﬁed from GWAS catalog (https://www.ebi.ac.uk/gwas/).,OADS,/arxiv_data1/oa_pdf/a0/40/emm20167a.PMC4892885.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-sa/4.0/Genetics and epigenetics of T2DM SH Kwak and KS Park 8 Experimental & Molecular Medicine",Non-OADS,/arxiv_data1/oa_pdf/a0/40/emm20167a.PMC4892885.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Resting state fMRIFunctional connectivityBrain tumorSurvivor 1.,Non-OADS,/arxiv_data1/oa_pdf/52/9c/main.PMC4893013.pdf
http://dx.doi.org/10.1016/j.nicl.2016.02.010 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/9c/main.PMC4893013.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/52/9c/main.PMC4893013.pdf
"Brie ﬂy, subject order independent group ICA (SOI-GICA) was conducted for all 32 participants using theinfomax algorithm ( Bell and Sejnowski, 1995 )a n dt h ep r o g r a m (http://www.nitrc.org/projects/cogicat )(Zhang et al., 2010 ) Each calcu- lation was done with a randomized initial value and a different subject order.",Non-OADS,/arxiv_data1/oa_pdf/52/9c/main.PMC4893013.pdf
The graphical presentations of the FCs in each group and their signi ﬁcant differences between the two groups were generated using BrainNet Viewer ( http://www.nitrc.org/projects/bnv).,OADS,/arxiv_data1/oa_pdf/52/9c/main.PMC4893013.pdf
These statistically signiﬁcant differences were graphically displayed using The BrainNet Viewer ( http://www.nitrc.org/projects/bnv ).,OADS,/arxiv_data1/oa_pdf/52/9c/main.PMC4893013.pdf
The images were prepared with the BrainNet Viewer ( http://www.nitrc.org/projects/bnv ).,OADS,/arxiv_data1/oa_pdf/52/9c/main.PMC4893013.pdf
"Voxel size = 3 × 3 × 3. dBrodmann's area, double checked with the xjview software (( http://www.alivelearn.net/xjview/ ).",OADS,/arxiv_data1/oa_pdf/52/9c/main.PMC4893013.pdf
Images were prepared with the BrainNet Viewer ( http://www.nitrc.org/projects/bnv ).,OADS,/arxiv_data1/oa_pdf/52/9c/main.PMC4893013.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: ADHD Structural MRIMultimodal analysisGray matterWhite matter 1.,Non-OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.1016/j.nicl.2016.03.0052213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
"We extracted cortical thickness and areal expansion estimates using Freesurfer v5.3 software (http://surfer.nmr.mgh.harvard.edu/; (Dale et al., 1999; Fischl et al., 1999 )).",OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
"Each participant's T1-weigthed scan was normalized to Montreal Neurological Institute (MNI) 152 standard space, bias-ﬁ eld corrected and segmented into gray matter, white matter, and cerebro- spinal ﬂuid using the uni ﬁed procedure of the VBM 8.1 toolbox (http://dbm.neuro.uni-jena.de/vbm/ )i nS P M 8( http://www.",Non-OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.1097/CHI.0b013e3181b395c0 (PubMed PMID: 19730275; PubMed Central PMCID: PMC2891193).,OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/ 10.1001/jamapsychiatry.2014.3162 (PubMed PMID: 25785435).,OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.1111/j.1600-0447.2011.,Non-OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.1001/archpsyc.63.7.795 (PubMed PMID: 16818869; PubMed Central PMCID: PMC2367150).,OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.1176/appi.ajp.164.4.647 (PubMed PMID: 17403979).,OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.1176/appi.ajp.2011.,Non-OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/ 10.1016/j.neubiorev.2012.01.003S0149-7634(12)00010-3 [pii].,OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
"Beneﬁts of multi-modal fusion analysis on a large-scale dataset: life-span patterns of inter-subject variability in cortical morphometry and white matter microstructure.NeuroImage 63 (1), 365– 380. http://dx.doi.org/10.1016/j.neuroimage.2012.06.038 (PubMed PMID: 22750721).",OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.1007/s00787-014-0573-4 Epub 2014/07/12.,Non-OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
2011a;11:54. http://dx.doi.org/ 10.1186/1471-244X-11-541471-244X-11-54 [pii].,OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
BMC Psychiatry.2011b;11:55. http://dx.doi.org/10.1186/1471-244X-11-551471-244X-11-55 [pii].,Non-OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.1097/00004583-199707000-00021 (S0890-8567(09)62555-7 [ pii]; Epub 1997/07/01.,Non-OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.1006/ nimg.1998.0395 (PubMed PMID: 9931268).,OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.1093/cercor/bhm225 (PubMed PMID: 18079129; PubMed Cen- tral PMCID: PMC2474454).,OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.1006/nimg.2000.0582 .,OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
NeuroImage.2001;14(1):21 –36.http://dx.doi.org/10.1006/nimg.2001.0786 .,OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
2005;24(12):1548 –65.http://dx.doi.org/10.1109/ Tmi.2005.857652 .,Non-OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.1006/nimg.,OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.1016/j.neuroimage.2006.02.024 (PubMed PMID: 16624579).,OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.1002/mrm.10609 (Epub 2003/10/31.,Non-OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.1016/S0006-3495(94)80775-1 (S0006-3495(94)80775-1 [ pii]; Epub 1994/01/01.,OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/ 10.1016/j.neuroimage.2004.10.043 (PubMed PMID: 15734364).,OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.1017/S1355617709090481 (PubMed PMID: 19402919; PubMed Central PMCID: PMC3075072).,OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.1016/j.jaac.2015.05.014 (PubMed PMID: 26210335).,OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.1016/j.jaac.2014.05.001 (e3; PubMed PMID: 24954828).,OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.1016/j.jpsychires.2010.04.,OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/ 10.1038/sj.mp.4001649 (PubMed PMID: 15724142).,OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.1002/hbm.21058 (Epub 2010/05/ 25.,Non-OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.1146/annurev.ne.09.030186.002041 (Epub 1986/01/01.,Non-OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.1016/j.tics.,OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
"191 (1), 31 –35.http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.1001/archgenpsychiatry.2011.117 (PubMed PMID: 22065528; PubMed Central PMCID: PMC3554238).,OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.1371/journal.pone.0048286 (PubMed PMID: 23239964; PubMed Central PMCID: PMC3519773).,OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/ 10.1176/appi.ajp.2010.10070948 (PubMed PMID: 21324949).,OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.1111/j.,Non-OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.1093/brain/awq203 (PubMed PMID: 20688814; PubMed Central PMCID: PMC3291528).,OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
"9 (2), 60 –68.http://dx.doi.org/10.1016/j.tics.2004.12.008 (PubMed PMID: 15668098).367 W. Francx et al.",OADS,/arxiv_data1/oa_pdf/3c/76/main.PMC4893015.pdf
"This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Persistent developmental stutteringfMRI Speech perception Functional lateralizationSignal correlated noise Introduction As humans, we spend much of our day communicating with our peers through spoken language.",Non-OADS,/arxiv_data1/oa_pdf/f0/69/main.PMC4893016.pdf
http://dx.doi.org/10.1016/j.nicl.2016.02.017 2213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f0/69/main.PMC4893016.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/69/main.PMC4893016.pdf
"Data preprocessing and analysis of fMRI data were performed using mrVista ( http://web.stanford.edu/group/vista/ cgi-bin/wiki/index.php/MrVista ), running on Matlab 7.11 (The Mathworks, Nattick, MA).",OADS,/arxiv_data1/oa_pdf/f0/69/main.PMC4893016.pdf
(Version 5.2.21. retrieved 29 March 2011 from http://www.praat.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/69/main.PMC4893016.pdf
http://www.samhsa.gov/Work force/Annapolis/WorkforceActionPlan.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c0/c9/10488_2009_Article_254.PMC4893055.pdf
"Thus, unilat - eral occlusion of the MCA will often result in restricted blood Molecular Vision  2016; 22:575-588 <http://www.molvis.org/molvis/v 22/575> Received 23 August 2015 | Accepted 2 June 2016 | Published 4 June 2016© 2016 Molecular Vision 575Early retinal inflammatory biomarkers in the middle cerebral  artery occlusion model of ischemic stroke Rodney M. Ritzel,1 Sarah J. Pan,1 Rajkumar Verma,1 John Wizeman,1 Joshua Crapser,1 Anita R. Patel,1  Richard Lieberman,1 Royce Mohan,1 Louise D. McCullough2 (The first two authors contributed equally to this work) 1Neuroscience Department, University of Connecticut Health Center, Farmington, CT; 2Neurology Department, University of  Texas Health Science Center at Houston, Houston, TX Purpose:  The transient middle cerebral artery occlusion (MCAO) model of stroke is one of the most commonly used  models to study focal cerebral ischemia.",Non-OADS,/arxiv_data1/oa_pdf/5e/a2/mv-v22-575.PMC4893077.pdf
Molecular Vision  2016; 22:575-588 <http://www.molvis.org/molvis/v 22/575> © 2016 Molecular Vision  576flow to the ipsilateral retina in rodents and humans.,Non-OADS,/arxiv_data1/oa_pdf/5e/a2/mv-v22-575.PMC4893077.pdf
"Molecular Vision  2016; 22:575-588 <http://www.molvis.org/molvis/v 22/575> © 2016 Molecular Vision  577Research Labs, Inc., Pleasanton, CA).",Non-OADS,/arxiv_data1/oa_pdf/5e/a2/mv-v22-575.PMC4893077.pdf
Molecular Vision  2016; 22:575-588 <http://www.molvis.org/molvis/v 22/575> © 2016 Molecular Vision  578significantly differ between the sham and stroke (or ipsilat - eral and contralateral) groups as previously shown [ 16-18].,Non-OADS,/arxiv_data1/oa_pdf/5e/a2/mv-v22-575.PMC4893077.pdf
Molecular Vision  2016; 22:575-588 <http://www.molvis.org/molvis/v 22/575> © 2016 Molecular Vision  579 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/5e/a2/mv-v22-575.PMC4893077.pdf
"Molecular Vision  2016; 22:575-588 <http://www.molvis.org/molvis/v 22/575> © 2016 Molecular Vision  580MCAO (Figure 4B, p = 0.001).",Non-OADS,/arxiv_data1/oa_pdf/5e/a2/mv-v22-575.PMC4893077.pdf
"Molecular Vision  2016; 22:575-588 <http://www.molvis.org/molvis/v 22/575> © 2016 Molecular Vision  581the injured eye, implies that microglia play an important role  in mediating the inflammatory response after ocular stroke.",Non-OADS,/arxiv_data1/oa_pdf/5e/a2/mv-v22-575.PMC4893077.pdf
Molecular Vision  2016; 22:575-588 <http://www.molvis.org/molvis/v 22/575> © 2016 Molecular Vision  582necessary to facilitate subsequent recovery processes that  restore homeostasis and visual restoration.,Non-OADS,/arxiv_data1/oa_pdf/5e/a2/mv-v22-575.PMC4893077.pdf
"Molecular Vision  2016; 22:575-588 <http://www.molvis.org/molvis/v 22/575> © 2016 Molecular Vision  583deficits in retinal function after MCAO were transient with  moderate occlusion duration, and thus unlikely to confound  behavioral tests that require visual cues beyond 9 days [ 6].",Non-OADS,/arxiv_data1/oa_pdf/5e/a2/mv-v22-575.PMC4893077.pdf
Molecular Vision  2016; 22:575-588 <http://www.molvis.org/molvis/v 22/575> © 2016 Molecular Vision  584CD45hiCD11b+Ly6C+ perivascular macrophages exhibited  comparably greater phagocytic activity under normal condi - tions compared to resident retinal microglia.,Non-OADS,/arxiv_data1/oa_pdf/5e/a2/mv-v22-575.PMC4893077.pdf
"Molecular Vision  2016; 22:575-588 <http://www.molvis.org/molvis/v 22/575> © 2016 Molecular Vision  585ACKNOWLEDGMENTS This work was supported by National Institutes of Health  grants R21NS076293 (Louise D. McCullough) and  F31NS083244 (Rodney M. Ritzel), and an AHA postdoctoral  fellowship (Raj Verma).",Non-OADS,/arxiv_data1/oa_pdf/5e/a2/mv-v22-575.PMC4893077.pdf
Molecular Vision  2016; 22:575-588 <http://www.molvis.org/molvis/v 22/575> © 2016 Molecular Vision  58622.,Non-OADS,/arxiv_data1/oa_pdf/5e/a2/mv-v22-575.PMC4893077.pdf
Molecular Vision  2016; 22:575-588 <http://www.molvis.org/molvis/v 22/575> © 2016 Molecular Vision  587rat retina following transient ischemia.,Non-OADS,/arxiv_data1/oa_pdf/5e/a2/mv-v22-575.PMC4893077.pdf
"Molecular Vision  2016; 22:575-588 <http://www.molvis.org/molvis/v 22/575> © 2016 Molecular Vision  588Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R.",Non-OADS,/arxiv_data1/oa_pdf/5e/a2/mv-v22-575.PMC4893077.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/jmedgenet-2015-103398).,Non-OADS,/arxiv_data1/oa_pdf/3f/05/jmedgenet-2015-103398.PMC4893078.pdf
"22 23The initial alignment was checked by hand in Geneious V .7.1.4 ( http://www.geneious.com) for anomalies thatmight be attributed to gene model errors rather than actualTable 1 Distribution of cases and controls by age, race/ethnicity and study centre Case –control mutation screening for rare variants in nine moderate-risk genes Case –control SNP genotyping for 18 BCAC SNPs Distributions Case % Control % Case % Control % Age range, years ≤30 106 8.2 67 6.0 97 7.8 61 5.8 31–35 319 24.6 171 15.3 300 24.3 157 14.9 36–10 433 33.4 238 21.2 409 33.1 220 20.8 41–45 439 33.9 203 18.1 430 34.8 183 17.3 46–50 0 0 230 20.5 0 0 225 21.3 51–55 0 0 212 18.9 0 0 211 20.0 Race/ethnicity Caucasian 840 64.8 967 86.3 788 63.8 904 85.5East Asian 202 15.6 71 6.3 193 15.6 70 6.6Latina 158 12.2 47 4.2 158 12.8 47 4.5Recent African Ancestry 97 7.5 36 3.2 97 7.9 36 3.4 Study centre BCFR-Australia 588 45.4 522 46.6 551 44.6 472 44.7BCFR-Canada 299 23.1 463 41.3 284 23.0 499 42.5BCFR-Northern California 410 31.6 136 12.1 401 32.4 136 12.9 Total 1297 1121 1236 1057 Subjects were excluded from mutation-screening if performance was poor; percentage data are the total number of cases on control DNA in the category i ndicated that met the mutation-screening quality control standards.BCAC, Breast Cancer Association Consortium; BCFR, Breast Cancer Family Registry.",Non-OADS,/arxiv_data1/oa_pdf/3f/05/jmedgenet-2015-103398.PMC4893078.pdf
"Potential anomalies were corrected by ref- erence to, and gene reprediction from, genomic DNA sequenceavailable on the UCSC genome browser (http://genome.ucsc.edu).",OADS,/arxiv_data1/oa_pdf/3f/05/jmedgenet-2015-103398.PMC4893078.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Abkevich V, Zharkikh A, Deffenbaugh AM, Frank D, Chen Y, Shattuck D, Skolnick MH, Gutin A, Tavtigian SV.",Non-OADS,/arxiv_data1/oa_pdf/3f/05/jmedgenet-2015-103398.PMC4893078.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Villegas VM, Hess DJ, Wildner A, et al.",Non-OADS,/arxiv_data1/oa_pdf/27/88/bjophthalmol-2015-307211.PMC4893080.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Deladoey J, Ruel J, Giguère Y, et al.",Non-OADS,/arxiv_data1/oa_pdf/52/76/archdischild-2015-309529.PMC4893081.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/archdischild-2015-308424).,Non-OADS,/arxiv_data1/oa_pdf/13/6c/archdischild-2015-308424.PMC4893082.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 http://www.hscic.gov.uk/catalogue/PUB12566/ hospepis-stat-admi-diag-2012-12-3-tab.xlsx (accessed 30 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/13/6c/archdischild-2015-308424.PMC4893082.pdf
http://www.hscic.gov.uk/hes (accessed 30 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/13/6c/archdischild-2015-308424.PMC4893082.pdf
http://www.dhsspsni.gov.uk/index/statistics.htm (accessed 30 Jul 2015).,OADS,/arxiv_data1/oa_pdf/13/6c/archdischild-2015-308424.PMC4893082.pdf
http://www.infoandstats.wales.nhs.uk/ (accessed 30 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/13/6c/archdischild-2015-308424.PMC4893082.pdf
2014. http://www.nice.org.uk/guidance/cg176 (accessed 30 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/13/6c/archdischild-2015-308424.PMC4893082.pdf
2014. https://www.gov.uk/government/uploads/ system/uploads/attachment_data/ ﬁle/322210/Reducing_unintentional_injuries_in_ and_around_the_home_among_children_under_ ﬁve_years.pdf (accessed 30 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/13/6c/archdischild-2015-308424.PMC4893082.pdf
2012. https://www.gov.uk/government/uploads/system/uploads/attachment_ data/ ﬁle/9066/reported-road-casualties-in-great-britain-main-results-2011.pdf (accessed 30 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/13/6c/archdischild-2015-308424.PMC4893082.pdf
"35 TARNLET report 2014. https://www.tarn.ac.uk (accessed 6 January 2015).36 Hawley CA, Ward AB, Magnay AR, et al.",Non-OADS,/arxiv_data1/oa_pdf/13/6c/archdischild-2015-308424.PMC4893082.pdf
2012. http://www.nhs.uk/ NHSEngland/AboutNHSservices/Emergencyandurgentcareservices/Documents/2012/ map-of-major-trauma-centres-2012.pdf (accessed 30 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/13/6c/archdischild-2015-308424.PMC4893082.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ bjophthalmol-2015-307000).,OADS,/arxiv_data1/oa_pdf/ec/0a/bjophthalmol-2015-307000.PMC4893083.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Ishida N, Odani-Kawabata N, Shimazaki A, et al.",Non-OADS,/arxiv_data1/oa_pdf/ec/0a/bjophthalmol-2015-307000.PMC4893083.pdf
https://www.nice.org.uk/guidance/cg85 (accessed 31 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/ec/0a/bjophthalmol-2015-307000.PMC4893083.pdf
2011. http://www.aoa.org/documents/optometrists/CPG-9.pdf (accessed 31 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/ec/0a/bjophthalmol-2015-307000.PMC4893083.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/0.,Non-OADS,/arxiv_data1/oa_pdf/e3/7c/bjophthalmol-2015-307249.PMC4893084.pdf
"RETAIN (registered at http://www.ClinicalT rials.gov; NCT01171976) adhered to the tenets of the Declaration ofHelsinki, the International Conference on Harmonisation andGood Clinical Practice guidelines.",Non-OADS,/arxiv_data1/oa_pdf/e3/7c/bjophthalmol-2015-307249.PMC4893084.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Klein R, Klein BE, Moss SE.",Non-OADS,/arxiv_data1/oa_pdf/e3/7c/bjophthalmol-2015-307249.PMC4893084.pdf
2013. http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/000715/WC500043546.pdf http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000715/WC500043546.pdf (accessed 15 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/e3/7c/bjophthalmol-2015-307249.PMC4893084.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ bjophthalmol-2015-306823).,OADS,/arxiv_data1/oa_pdf/03/3c/bjophthalmol-2015-306823.PMC4893085.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Klaassen I, Van Noorden CJ, Schlingemann RO.",Non-OADS,/arxiv_data1/oa_pdf/03/3c/bjophthalmol-2015-306823.PMC4893085.pdf
Table 2 Mutations of patients with MPS VII in the survey (n=6)* Amino acid change † ExonDegree of conservation ‡Amino acid change † ExonDegree of conservation ‡ Population/ethnicityPresentation of the disease Phenotype p.D50Y 1 2 p.L565V 11 4 American/ African-AmericanEarly onset (in utero) Severe p.D89G 2 4 p.D362N 7 1 American/Caucasian Early onset (in utero) Normal§ p.V99M 2 1 p.W289X 5 2 American/Hispanic Early onset (at birth) Severe with severe MR p.L176F 3 1 p.L176F 3 1 Mexican-American/ HispanicEarly onset (at birth) Severe with moderate MR p.R382C 7 1 p.R382C 7 1 Japanese/Asian Early onset (1 – 3 years)Mild with MR p.P408S 7 2 p.P415L 7 5 Mexican-American/ HispanicEarly onset (at birth) Moderate with severe MR *More extensive data on mutations in MPS VII is available in references.28–32 †The methionine encoded by the translation initiation site (start codon) is numbered as residue 1 (http://www.hgvs.org/mutnomen).,Non-OADS,/arxiv_data1/oa_pdf/5a/46/jmedgenet-2015-103322.PMC4893087.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Sly WS, Quinton BA, McAlister WH, Rimoin DL.",Non-OADS,/arxiv_data1/oa_pdf/5a/46/jmedgenet-2015-103322.PMC4893087.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 http://www.unicef.org/infobycountry/sierraleone_statistics.htlm 2 Kingham TB, Kamara TB, Cherian MN et al.",Non-OADS,/arxiv_data1/oa_pdf/e9/b9/jramc-2015-000582.PMC4893089.pdf
"4 http://apps.who.int/ebola/current-situation/ebola-situation-report-7-october-2015 5 Kilmarx PH, Clarke KR, Dietz PM et al.",Non-OADS,/arxiv_data1/oa_pdf/e9/b9/jramc-2015-000582.PMC4893089.pdf
6 http://www.who.int/hrh/documents/21may2015_web_ ﬁnal.pdf 7 Case De ﬁnition recommendations for Ebola or Marburg virus disease.,Non-OADS,/arxiv_data1/oa_pdf/e9/b9/jramc-2015-000582.PMC4893089.pdf
"August 2014. http://www.who.int/ebola/ebolacasede ﬁntion 8 de Villiers FPR, Sawyerr TN, de Villiers GK.",Non-OADS,/arxiv_data1/oa_pdf/e9/b9/jramc-2015-000582.PMC4893089.pdf
"2014. http://www.aho.afro.who.int/pro ﬁles_information/ index.php/Sierra_Leone:Civil_registration_and_vital_statistics_systems 14 Delamou A, Hammonds RM, Caluwaerts S et al.",Non-OADS,/arxiv_data1/oa_pdf/e9/b9/jramc-2015-000582.PMC4893089.pdf
"http://www.unfpa.org/news/ ebola-wiping-out-gains-safe-motherhoodwww.who/int/csr …/publications 16 Fasina FO, Shittu A, Lazarus D et al.",Non-OADS,/arxiv_data1/oa_pdf/e9/b9/jramc-2015-000582.PMC4893089.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Team WER.,Non-OADS,/arxiv_data1/oa_pdf/27/b2/jramc-2015-000562.PMC4893094.pdf
https://extranet.who.int/ebolafmt/sites/default/ ﬁles/documents/Sierra Leone Ebola Treatment Centre pocket guide 15 Dec 2014(1).pdf (accessed 15Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/27/b2/jramc-2015-000562.PMC4893094.pdf
http://apps.who.int/iris/bitstream/10665/137410/ 1/WHO_EVD_Guidance_PPE_14.1_eng.pdf (accessed 15 Sep 2015).,OADS,/arxiv_data1/oa_pdf/27/b2/jramc-2015-000562.PMC4893094.pdf
http://www.who.int/csr/resources/publications/ebola/ebola-case-de ﬁnition-contact-en.pdf (accessed 15 Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/27/b2/jramc-2015-000562.PMC4893094.pdf
EBOLA OUTBREAK UPDATES 20 March 2015. http://health.gov.sl/wp-content/uploads/2015/03/Ebola-Update-March-20-2015.pdf (accessed 15 Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/27/b2/jramc-2015-000562.PMC4893094.pdf
"To view, please visit the journal online (http://dx.doi.org/10.1136/annrheumdis-2015-207628).",Non-OADS,/arxiv_data1/oa_pdf/35/b1/annrheumdis-2015-207628.PMC4893095.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Emery P, Breedveld F, van der Heijde D, et al.",Non-OADS,/arxiv_data1/oa_pdf/35/b1/annrheumdis-2015-207628.PMC4893095.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/annrheumdis-2015-207919).,Non-OADS,/arxiv_data1/oa_pdf/de/6e/annrheumdis-2015-207919.PMC4893096.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/Table 3 Summary of TEAEs (safety population) n (%)Lesinurad 200 mg+allopurinol (n=46)Lesinurad 400 mg+allopurinol (n=42)Lesinurad 600 mg+allopurinol (n=48)Pooled lesinurad (n=136)Placebo+allopurinol (n=72) ≥1 TEAE 21 (45.7) 20 (47.6) 26 (54.2) 67 (49.3) 33 (45.8) ≥1 treatment-related TEAE 1 (2.2) 5 (11.9) 5 (10.4) 11 (8.1) 9 (12.5) ≥1 S A E 0000 0 D e a t h 0000 0 Discontinuation due to TEAE 0 1 (2.4) 2 (4.2) 3 (2.2) 1 (1.4)Specific TEAEs* Gout flare 10 (21.7) 13 (31) 15 (31.3) 38 (27.9) 15 (20.8) Arthralgia 3 (6.5) 1 (2.4) 2 (4.2) 6 (4.4) 4 (5.6)Headache 3 (6.5) 2 (4.8) 1 (2.1) 6 (4.4) 1 (1.4) Nasopharyngitis 4 (8.7) 0 1 (2.1) 5 (3.7) 1 (1.4) Tendonitis 2 (4.3) 0 1 (2.1) 3 (2.2) 0Lipase increased 0 2 (4.8) 0 2 (1.5) 1 (1.4) URI 0 0 2 (4.2) 2 (1.5) 0 Urticaria 0 0 2 (4.2) 2 (1.5) 0Diarrhoea 1 (2.2) 1 (2.4) 0 2 (1.5) 3 (4.2) Haematuria 0 1 (2.4) 0 1 (0.7) 3 (4.2) Back pain 0 1 (2.4) 0 1 (0.7) 2 (2.8)Dizziness 1 (2.2) 0 0 1 (0.7) 2 (2.8) Fatigue 0 1 (2.4) 0 1 (0.7) 2 (2.8) Myalgia 0 1 (2.4) 0 1 (0.7) 0Nausea 0000 2 (2.8) *Reported in ≥1 patient in any group.,Non-OADS,/arxiv_data1/oa_pdf/de/6e/annrheumdis-2015-207919.PMC4893096.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/annrheumdis-2015-208279).,Non-OADS,/arxiv_data1/oa_pdf/c5/d1/annrheumdis-2015-208279.PMC4893099.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Firestein GS.,Non-OADS,/arxiv_data1/oa_pdf/c5/d1/annrheumdis-2015-208279.PMC4893099.pdf
Allthe inclusion and exclusion criteria can be found on the clinical.trial.gov web site (http://clinicaltrials.gov/show/NCT01295736).Patients receiving bosentan at enrolment could enter the studyprovided the dose of bosentan had been stable for at least1 month before inclusion.,Non-OADS,/arxiv_data1/oa_pdf/15/2a/annrheumdis-2014-207001.PMC4893100.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Ferri C, Valentini G, Cozzi F, et al.",Non-OADS,/arxiv_data1/oa_pdf/15/2a/annrheumdis-2014-207001.PMC4893100.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ annrheumdis-2014-206785).,OADS,/arxiv_data1/oa_pdf/e8/e0/annrheumdis-2014-206785.PMC4893102.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Gerlag DM, Raza K, van Baarsen LG, et al.",Non-OADS,/arxiv_data1/oa_pdf/e8/e0/annrheumdis-2014-206785.PMC4893102.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/annrheumdis-2015-208052).,Non-OADS,/arxiv_data1/oa_pdf/b6/e7/annrheumdis-2015-208052.PMC4893103.pdf
"Correspondence to Professor Tsutomu Takeuchi,Division of Rheumatology, Department of Internal Medicine, Keio UniversitySchool of Medicine, 35Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan; tsutake@z5.keio.jp Received 10 June 2015 Revised 6 October 2015Accepted 27 October 2015 Published Online First 19 November 2015 ▸http://dx.doi.org/10.1136/ annrheumdis-2015-208863 To cite: Takeuchi T, Tanaka Y, Ishiguro N, et al.",Non-OADS,/arxiv_data1/oa_pdf/b6/e7/annrheumdis-2015-208052.PMC4893103.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Scott DL, Wolfe F, Huizinga TW.",Non-OADS,/arxiv_data1/oa_pdf/b6/e7/annrheumdis-2015-208052.PMC4893103.pdf
"A Food andDrug (FDA) Arthritis Advisory Committeemeeting held in February 2016 to discuss CT-P13recommended approval of CT-P13 for all indica-tions of the reference product (including extrapo-lated indications for Ps, PsA and in ﬂammatory bowel disease (IBD)) by a 21 to 3 vote, followingstrong positive guidance from the agency ’s brief- ing document (http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ArthritisAdvi soryCommittee/UCM484859.",Non-OADS,/arxiv_data1/oa_pdf/83/15/annrheumdis-2016-209166.PMC4893105.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 European Medicines Agency.,Non-OADS,/arxiv_data1/oa_pdf/83/15/annrheumdis-2016-209166.PMC4893105.pdf
Biosimilars: Questions and Answers Regarding Implementation of the Biologics Price Competition and Innovation Act of 2009:Guidance for Industry; April 2015. http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM444661.pdf (accessed 18 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/83/15/annrheumdis-2016-209166.PMC4893105.pdf
2009. http://www.who.int/biologicals/areas/biological_therapeutics/ BIOTHERAPEUTICS_FOR_WEB_22APRIL2010.pdf (accessed 3 Sep 2015).,OADS,/arxiv_data1/oa_pdf/83/15/annrheumdis-2016-209166.PMC4893105.pdf
2010. http://www.hc-sc.gc.ca/dhp-mps/alt_formats/pdf/brgtherap/applic-demande/guides/seb-pbu/seb-pbu-2010- eng.pdf (accessed 7 Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/83/15/annrheumdis-2016-209166.PMC4893105.pdf
2009. http://www.nihs.go.jp/ dbcb/TEXT/yakusyokushinsahatu-0304007.pdf (Japanese language only).,Non-OADS,/arxiv_data1/oa_pdf/83/15/annrheumdis-2016-209166.PMC4893105.pdf
"30 September, 2014. http://www.pharmatimes.com/article/14-09-30/ over_700_biosimilars_now_in_development_worldwide_report.aspx#ixzz3 ﬂma1lfd (accessed 6 Oct 2015).",Non-OADS,/arxiv_data1/oa_pdf/83/15/annrheumdis-2016-209166.PMC4893105.pdf
2004. http://www.ich.org/ ﬁleadmin/Public_Web_Site/ ICH_Products/Guidelines/Quality/Q5E/Step4/Q5E_Guideline.pdf (accessed 13 Dec 2015).,OADS,/arxiv_data1/oa_pdf/83/15/annrheumdis-2016-209166.PMC4893105.pdf
http://www.biosimilarz.com/?page_id=242 (accessed 18 Aug 2015).,OADS,/arxiv_data1/oa_pdf/83/15/annrheumdis-2016-209166.PMC4893105.pdf
"18 Woodcock J. Biosimilars Implementation: Testimony of Janet Woodcock MD Before the Committee on Energy and Commerce Subcommittee on Heath, United States House of Representatives; February 4 2016. http://docs.house.gov/meetings/IF/IF14/20160204/104408/HHRG-114-IF14-Wstate-WoodcockJ-20160204.pdf (accessed12 Feb 2016).",Non-OADS,/arxiv_data1/oa_pdf/83/15/annrheumdis-2016-209166.PMC4893105.pdf
http://www.ema.europa.eu/docs/en_GB/document_ library/Scienti ﬁc_guideline/2012/06/WC500128686.pdf (accessed 18 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/83/15/annrheumdis-2016-209166.PMC4893105.pdf
Biosimilars: Additional Questions and Answers Regarding Implementation of the Biologics Price Competition and Innovation Act of2009 Guidance for Industry; May 2015. http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM273001.pdf (accessed 18 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/83/15/annrheumdis-2016-209166.PMC4893105.pdf
Guidance for Industry Reference Product Exclusivity for Biological Products Filed Under Section 351(a) of the PHS Act; August 2014. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM407844.pdf (accessed 18 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/83/15/annrheumdis-2016-209166.PMC4893105.pdf
"Brie ﬁng slides for FDA ODAC meeting Han 7th, 2015. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeeting 980 Dörner T, et al.Ann Rheum Dis 2016; 75:974–982.",Non-OADS,/arxiv_data1/oa_pdf/83/15/annrheumdis-2016-209166.PMC4893105.pdf
Non-proprietary Naming of Biological Products — Guidance for Industry; August 2015. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM459987.pdf (accessed6 Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/83/15/annrheumdis-2016-209166.PMC4893105.pdf
2015. http://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/125553Orig1s000SumR.pdf (accessed 18 Aug 2015).,OADS,/arxiv_data1/oa_pdf/83/15/annrheumdis-2016-209166.PMC4893105.pdf
https://clinicaltrials.gov/ct2/show/NCT02148640?,Non-OADS,/arxiv_data1/oa_pdf/83/15/annrheumdis-2016-209166.PMC4893105.pdf
"The challenges of nomenclature —INN, biosimilars and biological quali ﬁers.GaBI 2015;4. http://gabi-journal.net/the-challenges-of-nomenclature-inn- biosimilars-and-biological-quali ﬁers.html 49 Vermeer NS, Straus SM, Mantel-Teeuwisse AK, et al.",OADS,/arxiv_data1/oa_pdf/83/15/annrheumdis-2016-209166.PMC4893105.pdf
http://www.pmda.go.jp/drugs/ 2014/P201400086/530191000_22600AMX00758_A100_1.pdf (Japaneselanguage only).,Non-OADS,/arxiv_data1/oa_pdf/83/15/annrheumdis-2016-209166.PMC4893105.pdf
http://www.hc-sc.gc.ca/ dhp-mps/prodpharma/sbd-smd/drug-med/sbd_smd_2014_in ﬂectra_159493-eng.php (accessed 4 Nov 2015).,OADS,/arxiv_data1/oa_pdf/83/15/annrheumdis-2016-209166.PMC4893105.pdf
http://www.hc-sc.gc.ca/ dhp-mps/prodpharma/sbd-smd/drug-med/sbd_smd_2014_remsima_160195-eng.,Non-OADS,/arxiv_data1/oa_pdf/83/15/annrheumdis-2016-209166.PMC4893105.pdf
2015. https://www.tga.gov.au/book/extrapolation-indications (accessed 7 Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/83/15/annrheumdis-2016-209166.PMC4893105.pdf
"CBO publication/41646, November 2007. http://www.cbo.gov/sites/default/ ﬁles/ 11-13-lt-health.pdf (accessed 9 Sep 2015).",OADS,/arxiv_data1/oa_pdf/83/15/annrheumdis-2016-209166.PMC4893105.pdf
https://kouseikyoku.mhlw.go.jp/tokaihokuriku/iryo_hoken/yakka/ documents/0230.pdf (Japanese language only).,Non-OADS,/arxiv_data1/oa_pdf/83/15/annrheumdis-2016-209166.PMC4893105.pdf
http://www.lisnorway.no (Norweigan language only).,Non-OADS,/arxiv_data1/oa_pdf/83/15/annrheumdis-2016-209166.PMC4893105.pdf
NICE technology appraisal guidance[TA130] Published date: October 2007.http://www.nice.org.uk/guidance/ta130/chapter/4-Evidence-and-interpretation#consideration-of-the-evidence (accessed 6 Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/83/15/annrheumdis-2016-209166.PMC4893105.pdf
http://www.eular.org/ myUploadData/ ﬁles/Biosimilars_2015.pdf (accessed 9 Sep 2015).,OADS,/arxiv_data1/oa_pdf/83/15/annrheumdis-2016-209166.PMC4893105.pdf
http://www.ema.europa.eu/ ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000360.jsp(accessed 3 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/83/15/annrheumdis-2016-209166.PMC4893105.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Karlson EW, Deane K. Environmental and gene-environment interactions and risk of rheumatoid arthritis.",Non-OADS,/arxiv_data1/oa_pdf/4b/29/annrheumdis-2015-208278.PMC4893106.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Smith WS, Lev MH, English JD, et al.",Non-OADS,/arxiv_data1/oa_pdf/58/8f/neurintsurg-2015-011744.PMC4893107.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Shah VA, et al.J NeuroIntervent Surg 2016; 8:568 –570.",Non-OADS,/arxiv_data1/oa_pdf/9b/cb/neurintsurg-2015-011763.PMC4893108.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Holbrook A, Schulman S, Witt DM, et al.",Non-OADS,/arxiv_data1/oa_pdf/82/4a/emermed-2015-204891.PMC4893109.pdf
"http://bidocs.boehringer-ingelheim.com/BIWebAccess/ViewServlet.ser?docBase=renetnt&folderPath=/Prescribing%20Information/PIs/Pradaxa/Pradaxa.pdf 24 van Ryn J, Stangier J, Haertter S, et al.",OADS,/arxiv_data1/oa_pdf/82/4a/emermed-2015-204891.PMC4893109.pdf
2012. http://packageinserts.bms.com/pi/pi_eliquis.pdf (accessed 21 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/82/4a/emermed-2015-204891.PMC4893109.pdf
2010. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterialsDrugs/CardiovascularandRenalDrugsAdvisoryCommittee/ UCM226009.pdf (accessed 21 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/82/4a/emermed-2015-204891.PMC4893109.pdf
"http://us.boehringer-ingelheim.com/news_events/press_releases/press_release_archive/2014/06-26-14-boehringer-ingelheim-investigational-antidote-pradaxa-dabigatran-etexilate-mesylate-fda- breakthrough-therapy-designation.html 72 Vandana M, Michael K, Genmin L, et al, eds.",Non-OADS,/arxiv_data1/oa_pdf/82/4a/emermed-2015-204891.PMC4893109.pdf
[Webpage] 2013. http://investors.portola.com/phoenix.zhtml?,Non-OADS,/arxiv_data1/oa_pdf/82/4a/emermed-2015-204891.PMC4893109.pdf
"http://www.portola.com/clinical-development/andexanet-alfa-prt4445-fxa-inhibitor-antidote/ 80 Morishima Y, Kamisato C. Laboratory measurements of the oral direct factor Xa inhibitor edoxaban: comparison of prothrombin time, activated partialthromboplastin time, and thrombin generation assay.",Non-OADS,/arxiv_data1/oa_pdf/82/4a/emermed-2015-204891.PMC4893109.pdf
"To view thisﬁle please visit the journal online (http://dx.doi.org/10.1136/annrheumdis-2015- 207963) 1NIHR Wellcome Trust Clinical Research Facility, UniversityHospital Southampton, Southampton, UK 2INIBIC-Hospital Universitario A Coruña, Galicia, Spain 3Bakers ﬁeld Dermatology, Bakers ﬁeld, California, USA 4University of Massachusetts Medical School, Worcester,Massachusetts, USA 5Reumatika Centrum Reumatologi, Warszawa,Poland 6West Tennessee Research Institute, Jackson, Tennessee, USA 7Celgene Corporation, Summit, New Jersey, USA 8Combined Rheumatology Practice, University ofNew South Wales, Kogarah,New South Wales, Australia Correspondence to Dr Christopher J Edwards, University HospitalSouthampton NHS FoundationTrust, Mailpoint 218, Southampton General Hospital, Tremona Road, SouthamptonSO16 6YD, UK;cedwards@soton.ac.uk.",Non-OADS,/arxiv_data1/oa_pdf/d5/b5/annrheumdis-2015-207963.PMC4893110.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Gladman DD, Antoni C, Mease P, et al.",Non-OADS,/arxiv_data1/oa_pdf/d5/b5/annrheumdis-2015-207963.PMC4893110.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/annrheumdis-2015-208267).,Non-OADS,/arxiv_data1/oa_pdf/8c/ce/annrheumdis-2015-208267.PMC4893111.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Baker JF, Ostergaard M, Emery P, et al.",Non-OADS,/arxiv_data1/oa_pdf/8c/ce/annrheumdis-2015-208267.PMC4893111.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Wesseling C, Crowe J, Hogstedt C, et al., eds.",Non-OADS,/arxiv_data1/oa_pdf/18/8b/oemed-2016-103555.PMC4893112.pdf
8 https://www.osha.gov/dts/osta/otm/otm_iii/otm_iii_4.html (accessed 5 Jan 2016).,OADS,/arxiv_data1/oa_pdf/18/8b/oemed-2016-103555.PMC4893112.pdf
31 https://www.youtube.com/watch?v=6bLA8LjqJow (accessed 5 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/18/8b/oemed-2016-103555.PMC4893112.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/oemed-2015-103177).,Non-OADS,/arxiv_data1/oa_pdf/2c/a6/oemed-2015-103177.PMC4893113.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Binder-Foucard F, Belot A, Delafosse P, et al.Estimation nationale de l ’incidence et de la mortalité par cancer en France entre 1980 et 2012.",Non-OADS,/arxiv_data1/oa_pdf/2c/a6/oemed-2015-103177.PMC4893113.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/gutjnl-2014-308513).,Non-OADS,/arxiv_data1/oa_pdf/88/48/gutjnl-2014-308513.PMC4893115.pdf
"The research was approved bythe CLTR (http://www.cltr.org/), which was authorised as the only national livertransplantation registry in Mainland China by the Ministry of Health in May 2008.",Non-OADS,/arxiv_data1/oa_pdf/88/48/gutjnl-2014-308513.PMC4893115.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Venook AP, Papandreou C, Furuse J, et al.",Non-OADS,/arxiv_data1/oa_pdf/88/48/gutjnl-2014-308513.PMC4893115.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/gutjnl-2015-309184).,Non-OADS,/arxiv_data1/oa_pdf/0f/16/gutjnl-2015-309184.PMC4893116.pdf
"Correspondence to Dr Patricia Lepage, INRA,Domaine de Vilvert, Jouy-en-Josas 78350, France; patricia.lepage@jouy.inra.fr Received 13 January 2015 Revised 16 October 2015 Accepted 1 November 2015 Published Online First1 December 2015 ▸http://dx.doi.org/10.1136/ gutjnl-2015-311015 To cite: Mondot S, Lepage P, Seksik P, et al.",Non-OADS,/arxiv_data1/oa_pdf/0f/16/gutjnl-2015-309184.PMC4893116.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Cosnes J, Gower-Rousseau C, Seksik P, et al.",Non-OADS,/arxiv_data1/oa_pdf/0f/16/gutjnl-2015-309184.PMC4893116.pdf
"http://cran.r-project.org/doc/Rnews/Rnews_2004-1.pdf 27 Csardi G, Nepusz T. The igraph software package for complex network research.",OADS,/arxiv_data1/oa_pdf/0f/16/gutjnl-2015-309184.PMC4893116.pdf
"InterJournal 2006;Complex Sy:1695. http://igraph.sf.net 28 Friedman J, Alm EJ.",Non-OADS,/arxiv_data1/oa_pdf/0f/16/gutjnl-2015-309184.PMC4893116.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/injuryprev-2015-041750).,Non-OADS,/arxiv_data1/oa_pdf/1d/a9/injuryprev-2015-041750.PMC4893118.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 World Health Organisation.,Non-OADS,/arxiv_data1/oa_pdf/1d/a9/injuryprev-2015-041750.PMC4893118.pdf
"Geneva: World Health Organisation, 2014. http://apps.who.int/iris/bitstream/10665/143893/1/9789241564786_eng.pdf?ua=1&ua=1 (accessed 22 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/1d/a9/injuryprev-2015-041750.PMC4893118.pdf
http://onlinelibrary.wiley.com/doi/ 10.1002/14651858.CD001047/pdf (accessed 22 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/1d/a9/injuryprev-2015-041750.PMC4893118.pdf
"Working Paper 2012 –07, Special Series on Child Injury No 2 Florence: UNICEF Ofﬁce of Research, 2012. http://www.unicef-irc.org/publications/pdf/drowning.pdf (accessed 1 Jun 2015).",Non-OADS,/arxiv_data1/oa_pdf/1d/a9/injuryprev-2015-041750.PMC4893118.pdf
"Sydney: Australian Water Safety Council, 2008. http://www.watersafety.com.au/Portals/0/AWSC%20Stragegy%202012-15/AWSC%20Strategy%202008-2011/Australian% 20Water%20Safety%20Strategy%202008-11.pdf (accessed 25 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/1d/a9/injuryprev-2015-041750.PMC4893118.pdf
"Sydney: Australian Water Safety Council, 2012. http://www.watersafety.com.au/Portals/0/AWSC%20Stragegy%202012-15/AWSC_Strategy2012_Brochure%20-%20Lowres.",Non-OADS,/arxiv_data1/oa_pdf/1d/a9/injuryprev-2015-041750.PMC4893118.pdf
"Sydney, 2008. http://www.watersafety.com.au/Reports.aspx (accessed 28 May 2015).",Non-OADS,/arxiv_data1/oa_pdf/1d/a9/injuryprev-2015-041750.PMC4893118.pdf
Secondary NHMRC additional levels of evidence and grades for recommendations for developers of guidelines 2005. http://www.nhmrc.,Non-OADS,/arxiv_data1/oa_pdf/1d/a9/injuryprev-2015-041750.PMC4893118.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/gutjnl-2014-308323).,Non-OADS,/arxiv_data1/oa_pdf/44/f4/gutjnl-2014-308323.PMC4893119.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Kaser A, Zeissig S, Blumberg RS.",Non-OADS,/arxiv_data1/oa_pdf/44/f4/gutjnl-2014-308323.PMC4893119.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Maguire BJ, Hunting KL, Guidotti TL, et al.",Non-OADS,/arxiv_data1/oa_pdf/6c/81/injuryprev-2015-041785.PMC4893120.pdf
2015. http://www.bls.gov/cpi/ (accessed Jun 2015).,Non-OADS,/arxiv_data1/oa_pdf/6c/81/injuryprev-2015-041785.PMC4893120.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ References 1.Roth DE .,Non-OADS,/arxiv_data1/oa_pdf/4e/bf/ebmed-2016-110392.PMC4893122.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ gutjnl-2014-308003).,OADS,/arxiv_data1/oa_pdf/16/58/gutjnl-2014-308003.PMC4893125.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Lavanchy D. Evolving epidemiology of hepatitis C virus.,Non-OADS,/arxiv_data1/oa_pdf/16/58/gutjnl-2014-308003.PMC4893125.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1B a t a l d e n P , Davidoff F .",Non-OADS,/arxiv_data1/oa_pdf/cf/0d/bmjqs-2015-005086.PMC4893130.pdf
"London: The Health Foundation, 2015. http://www.health.org.uk/sites/default/files/TheHabitsOfAnImprover.pdf (accessed 25 Nov 2015).",Non-OADS,/arxiv_data1/oa_pdf/cf/0d/bmjqs-2015-005086.PMC4893130.pdf
"London: Royal Academy of Engineering, 2013. http://www.raeng.org.uk/publications/reports/thinking-like-an-engineer-implications-full-report.pdf (accessed25 Nov 2015).",Non-OADS,/arxiv_data1/oa_pdf/cf/0d/bmjqs-2015-005086.PMC4893130.pdf
"London: City & Guilds, 2012. http://www.skillsdevelopment.org/PDF/How-to-teach-vocational-education.pdf (accessed 21 Nov2015).",Non-OADS,/arxiv_data1/oa_pdf/cf/0d/bmjqs-2015-005086.PMC4893130.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/thoraxjnl-2015-207782).,Non-OADS,/arxiv_data1/oa_pdf/70/e1/thoraxjnl-2015-207782.PMC4893131.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 EuroQol G. EuroQol--a new facility for the measurement of health-related quality of life.Health Policy 1990;16:199 –208.,Non-OADS,/arxiv_data1/oa_pdf/70/e1/thoraxjnl-2015-207782.PMC4893131.pdf
"London: NICE, 4 Apr 2013. https://www.nice.org.uk/article/pmg9/resources/non-guidance-guide-to-the-methods-of-technology-appraisal-2013-pdf 3 Canavan JL, Kaliaraju D, Nolan CM, et al.",Non-OADS,/arxiv_data1/oa_pdf/70/e1/thoraxjnl-2015-207782.PMC4893131.pdf
"2014; http://www.slideshare.net/OHENews/ohe-seminar-5-l-value-set-oct2014 15 Vestbo J, Hurd SS, Agusti AG, et al.",OADS,/arxiv_data1/oa_pdf/70/e1/thoraxjnl-2015-207782.PMC4893131.pdf
"2006. http://www.inahta.org/wp-content/themes/inahta/img/AboutHTA_Guidelines_for_the_Economic_Evaluation_of_Health_Technologies.pdf 30 Lin FJ, Pickard AS, Krishnan JA, et al.",Non-OADS,/arxiv_data1/oa_pdf/70/e1/thoraxjnl-2015-207782.PMC4893131.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Dick R, Hootman JM, Agel J, et al.",Non-OADS,/arxiv_data1/oa_pdf/19/e4/bjsports-2015-094847.PMC4893132.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Schroeder C, Gibson L, Nordström C, et al.",Non-OADS,/arxiv_data1/oa_pdf/c3/30/jclinpath-2015-203526.PMC4893134.pdf
"18 For this review, the PubMed database was used tosearch for relevant literature (http://www.ncbi.nlm.nih.gov/pubmed).",OADS,/arxiv_data1/oa_pdf/81/15/jech-2015-206274.PMC4893135.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Hertzman C. The biological embedding of early experience and its effects on health in adulthood.,Non-OADS,/arxiv_data1/oa_pdf/81/15/jech-2015-206274.PMC4893135.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ To cite Broadbent A, Hwang S-sik.",Non-OADS,/arxiv_data1/oa_pdf/51/bf/jech-2015-206567.PMC4893137.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Bensalah K, Patard JJ.",Non-OADS,/arxiv_data1/oa_pdf/6e/b5/jclinpath-2015-202881.PMC4893138.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Nwaneri C, Cooper H, Bowen-Jones D. Mortality in type 2 diabetes mellitus: magnitude of the evidence from a systematic review and meta-analysis.",Non-OADS,/arxiv_data1/oa_pdf/71/05/jech-2015-206702.PMC4893140.pdf
http://apps.who.int/classi ﬁcations/icd10/ browse/2015/en (accessed 18 Sep 2015).,OADS,/arxiv_data1/oa_pdf/71/05/jech-2015-206702.PMC4893140.pdf
"Hospital Standardised Mortality Ratios: Quarterly HSMR Release, 26 February 2013. http://www.isdscotland.org/Health-Topics/ Quality-Improvement/Publications/2013 –02-26/2013-02-26-HSMR-Report.pdf (accessed 18 Sep 2015).",Non-OADS,/arxiv_data1/oa_pdf/71/05/jech-2015-206702.PMC4893140.pdf
"http://www.isdscotland.org/Products-and-Services/Terminology-Services/ Clinical-Coding-Guidelines/Docs/Coding%20Guidelines%20No.%2021,% 20November%202007.pdf (accessed 18 Sep 2015).",Non-OADS,/arxiv_data1/oa_pdf/71/05/jech-2015-206702.PMC4893140.pdf
http://www.scotland.gov.uk/Resource/Doc/933/0115249.pdf (accessed 18 Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/71/05/jech-2015-206702.PMC4893140.pdf
2015. http://www.diabetesinscotland.org.uk/Publications/SDS2014.pdf (accessed 18 Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/71/05/jech-2015-206702.PMC4893140.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Euro-Peristat project with SCPE and EUROCAT.,Non-OADS,/arxiv_data1/oa_pdf/f1/7d/jech-2015-207013.PMC4893141.pdf
http://appsso.eurostat.,Non-OADS,/arxiv_data1/oa_pdf/f1/7d/jech-2015-207013.PMC4893141.pdf
"2008. http://www.europeristat.com 5 Joseph KS, Liu S, Rouleau J, et al.I nﬂuence of de ﬁnition based versus pragmatic birth registration on international comparisons of perinatal and infant mortality:population based retrospective study.",Non-OADS,/arxiv_data1/oa_pdf/f1/7d/jech-2015-207013.PMC4893141.pdf
2011. http://www.rijksoverheid.nl/ documenten-en-publicaties/rapporten/2013/04/24/perinatale-audit-de-voortgang.html A terme sterfte 2011 (accessed 19 Feb 2015).,Non-OADS,/arxiv_data1/oa_pdf/f1/7d/jech-2015-207013.PMC4893141.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Gysels M, Higginson IJ.",Non-OADS,/arxiv_data1/oa_pdf/a8/f6/bmjspcare-2015-000879.PMC4893143.pdf
Department of Health 2013. https://www.gov.uk/government/publications/review-of-liverpool-care-pathway-for-dying-patients Last accessed 27 September 2015.,Non-OADS,/arxiv_data1/oa_pdf/a8/f6/bmjspcare-2015-000879.PMC4893143.pdf
"http://hee.nhs.uk/wp-content/uploads/sites/321/2013/05/29257_2900971_Delivering_Accessible.pdf Last accessed 27September 2015 11 Carey I, Shouls S, Bristowe K, et al.",Non-OADS,/arxiv_data1/oa_pdf/a8/f6/bmjspcare-2015-000879.PMC4893143.pdf
"2012. http://webarchive.nationalarchives.gov.uk/20130718121128/http:/endoflifecare.nhs.uk/search-resources/resources-search/publications/imported-publications/transforming-end-of-life-care-in-acute-hospitals.aspx 14 Robinson V , Fleming J, Carey I, et al.",Non-OADS,/arxiv_data1/oa_pdf/a8/f6/bmjspcare-2015-000879.PMC4893143.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/jnnp-2015-310853) For numbered af ﬁliations see end of article.,Non-OADS,/arxiv_data1/oa_pdf/b4/d9/jnnp-2015-310853.PMC4893146.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Schievink WI, Meyer FB, Atkinson JL, et al.",Non-OADS,/arxiv_data1/oa_pdf/b4/d9/jnnp-2015-310853.PMC4893146.pdf
2010. http://www.efsumb.org/ecmus/2011%20Guidelines% 20for%20the%20safe%20use%20of%20Diagnostic%20Ultrasound%20Equipment.pdf (accessed Mar 2013).,Non-OADS,/arxiv_data1/oa_pdf/b4/d9/jnnp-2015-310853.PMC4893146.pdf
http://www.fda.gov/ Radiation-EmittingProducts/RadiationEmittingProductsandProcedures/ MedicalImaging/ucm115357.htm (accessed Mar 2013).,OADS,/arxiv_data1/oa_pdf/b4/d9/jnnp-2015-310853.PMC4893146.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/jech- 2015-206547).,OADS,/arxiv_data1/oa_pdf/21/b0/jech-2015-206547.PMC4893147.pdf
"METHODS Study population Our study is based on the Uppsala Birth Cohort Multigenerational Study (UBCoS Multigen) (http://www.chess.su.se/ubcosmg/), which contains all live births at the UppsalaUniversity Hospital, Sweden, between 1915 and 1929.",Non-OADS,/arxiv_data1/oa_pdf/21/b0/jech-2015-206547.PMC4893147.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Marmot M, Friel S, Bell R, et al.",Non-OADS,/arxiv_data1/oa_pdf/21/b0/jech-2015-206547.PMC4893147.pdf
Available at: http://www.oecd- ilibrary.org/social-issues-migration-health/health-at-a-glance-2003_health_glance-2003-en.,Non-OADS,/arxiv_data1/oa_pdf/21/b0/jech-2015-206547.PMC4893147.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/c7/ba/ircmj-18-04-23418.PMC4893410.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/57/62/ircmj-18-04-29548.PMC4893411.pdf
Available  from: https://tel.archives-ouvertes.fr/tel-00878236.,Non-OADS,/arxiv_data1/oa_pdf/57/62/ircmj-18-04-29548.PMC4893411.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/f6/e4/ircmj-18-04-29615.PMC4893412.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/ca/hepatmon-16-04-33881.PMC4893413.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/85/a7/ircmj-18-04-35483.PMC4893414.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/b7/hepatmon-16-04-37089.PMC4893415.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCom - mercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial us - ages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/48/91/ircmj-18-04-23664.PMC4893422.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fd/ed/ircmj-18-04-35412.PMC4893425.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8a/ff/ircmj-18-04-35050.PMC4893426.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/76/3a/TOAIDJ-10-14.PMC4893501.pdf
"[http://dx.doi.org/10.1186/1471-2458-3-14 ] [PMID: 12667263 ] [4] Hosegood V, Vanneste A, Timæus IM.",Non-OADS,/arxiv_data1/oa_pdf/a0/33/TOAIDJ-10-24.PMC4893502.pdf
"[http://dx.doi.org/10.1097/00002030-200403050-00011 ] [5] Hosegood V, McGrath N, Herbst K, Timæus IM.",Non-OADS,/arxiv_data1/oa_pdf/a0/33/TOAIDJ-10-24.PMC4893502.pdf
Available at: http://www.unaids.org/sites/default/files/en/media/unaids/contentassets/documents/ factsheet/2014/20140716_FactSheet_en.pdf  2015 [Accessed on 9th February]; [8] Lusaka: Census of Population and Housing Preliminary Report.,Non-OADS,/arxiv_data1/oa_pdf/a0/33/TOAIDJ-10-24.PMC4893502.pdf
Available at: http://www.aau.org/sites/default/files/AAUBP-report.pdf [19] The Copperbelt University CBU ART Monthly HIR 72 Register 2014.,Non-OADS,/arxiv_data1/oa_pdf/a0/33/TOAIDJ-10-24.PMC4893502.pdf
"[http://dx.doi.org/10.1002/14651858.CD009468.pub2 ] [PMID: 23076959 ] [23] Weinhardt LS, Carey MP, Johnson BT, Bickham NL.",Non-OADS,/arxiv_data1/oa_pdf/a0/33/TOAIDJ-10-24.PMC4893502.pdf
"[http://dx.doi.org/10.2105/AJPH.89.9.1397 ] [PMID: 10474559 ] [24] Johnson V, Leach B, Beardon H, Covey M, Miskelly C. Love Sex and Young People: Learning from our peer educators how to be a youth- centred organisation.",Non-OADS,/arxiv_data1/oa_pdf/a0/33/TOAIDJ-10-24.PMC4893502.pdf
"[http://dx.doi.org/10.1016/S0140-6736(12)61959-X ] [PMID: 23683639 ] [26] Weiss HA, Quigley MA, Hayes RJ.",OADS,/arxiv_data1/oa_pdf/a0/33/TOAIDJ-10-24.PMC4893502.pdf
"[http://dx.doi.org/10.1097/00002030-200010200-00018 ] [27] Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.",Non-OADS,/arxiv_data1/oa_pdf/a0/33/TOAIDJ-10-24.PMC4893502.pdf
"[http://dx.doi.org/10.1371/journal.pmed.0020298 ] [PMID: 16231970 ] [28] Bailey RC, Moses S, Parker CB, et al.",OADS,/arxiv_data1/oa_pdf/a0/33/TOAIDJ-10-24.PMC4893502.pdf
"[http://dx.doi.org/10.1016/S0140-6736(07)60312-2 ] [PMID: 17321310 ] [29] Gray RH, Kigozi G, Serwadda D, et al.",OADS,/arxiv_data1/oa_pdf/a0/33/TOAIDJ-10-24.PMC4893502.pdf
"[http://dx.doi.org/10.1016/S0140-6736(07)60313-4 ] [PMID: 17321311 ] Received: March 16, 2015 Revised: June 12, 2015 Accepted: July 28, 2015 © Sanjobo et al.",OADS,/arxiv_data1/oa_pdf/a0/33/TOAIDJ-10-24.PMC4893502.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/33/TOAIDJ-10-24.PMC4893502.pdf
"1 To date, 10 causal genes have been identi ﬁed for USH: MYO7A (USH1B), USH1C (USH1C), CDH23 (USH1D), PCDH15 (USH1F), USH1G (USH1G) and CIB2 (USH1J) for USH1; USH2A (USH2A), GPR98 (USH2C) and DFNB31 (USH2D) for USH2; and CLRN1 (USH3A) for USH3 (Hereditary Hearing Loss Homepage; http://hereditaryhearingloss.org).",Non-OADS,/arxiv_data1/oa_pdf/59/90/jhg2015168a.PMC4893503.pdf
"12 To predict the pathogenicity of missense variants, the following functional prediction software included in ANNOVAR was used: Sorting Intolerant from Tolerant (SIFT; http://sift.jcvi.org/), Polymorphism Phenotyping (PolyPhen2;http://genetics.bwh.harvard.edu/pph2/), LRT (http://www.genetics.wustl.edu/jﬂab/lrt_query.html) and MutationTaster (http://www.mutationtaster.org/).",OADS,/arxiv_data1/oa_pdf/59/90/jhg2015168a.PMC4893503.pdf
"However, since mutations among these genes could have resulted in non-syndromic HL as well as USH1 (Hereditary Hearing Loss Homepage; http://hereditaryhearingloss.org), a careful differentialdiagnosis was crucial.",Non-OADS,/arxiv_data1/oa_pdf/59/90/jhg2015168a.PMC4893503.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by- nc-nd/4.0/F r e q u e n c yo fU S H 1i nd e a fc h i l d r e n HY o s h i m u r a et al 422 Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/59/90/jhg2015168a.PMC4893503.pdf
"[http://dx.doi.org/10.4314/eamj.v78i8.8986 ] [PMID: 11921557 ] [3] Ronald AR, Ndinya-Achola JO, Plummer FA, et al.",OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
"[http://dx.doi.org/10.4314/eamj.v82i1.9293 ] [PMID: 16122111 ] [6] Wamai RG, Morris BJ, Bailis SA, et al.",OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
"[http://dx.doi.org/10.1186/1758-2652-14-49 ] [PMID: 22014096 ] [7] Haac BE, Charles AG, Matoga M, LaCourse SM, Nonsa D, Hosseinipour M. HIV testing and epidemiology in a hospital-based surgical cohort in Malawi.",Non-OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
"[http://dx.doi.org/10.1007/s00268-013-2096-4 ] [PMID: 23652356 ] [8] Cacala SR, Mafana E, Thomson SR, et al.",OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
"[http://dx.doi.org/10.1186/1743-422X-10-171 ] [PMID: 23721493 ] [11] Kapembwa KC, Goldman JD, Lakhi S, et al.",OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
[http://dx.doi.org/10.4103/0974-777X.83534 ] [PMID: 21887060 ] [12] Bayley AC.,Non-OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
[http://dx.doi.org/10.1002/bjs.1800770806 ] [PMID: 2203506 ] [13] Hunter DJ.,OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
"[http://dx.doi.org/10.1097/00001648-199301000-00012 ] [PMID: 8420583 ] [14] Stanley MA, Winder DM, Sterling JC, Goon PK.",Non-OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
"[http://dx.doi.org/10.1186/1471-2407-12-398 ] [PMID: 22958276 ] [15] Naidoo NG, Beningfield SJ.",Non-OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
"[http://dx.doi.org/10.1007/s002640050074 ] [PMID: 8872550 ] [17] Islam J, Clarke DL, Thomson SR.",Non-OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
"[http://dx.doi.org/10.3834/uij.1944-5784.2013.02.06 ] [20] Dua RS, Wajed SA, Winslet MC.",Non-OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
"[http://dx.doi.org/10.1308/003588407X183436 ] [PMID: 17535610 ] [21] Bowa K, Malyangu E, Wood C, Angelleti P. A pilot study to compare HIV status and cervical and penile pathology among couples attending the urology unit at UTH.",Non-OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
[http://dx.doi.org/10.1097/QAI.0000000000000259 ] [PMID: 25117962 ] [26] Loefler I.,OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
[http://dx.doi.org/10.1258/jrsm.95.10.516 ] [PMID: 12356980 ] [27] Bayley AC.,OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
[http://dx.doi.org/10.1002/bjs.1800770806 ] [PMID: 2203506 ] [28] Watters D A K. Severe peritoneal sepsis.,Non-OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
"[http://dx.doi.org/10.1007/s002640050074 ] [PMID: 8872550 ] [30] Elem B, Ranjan P. Impact of immunodeficiency virus (HIV) on Fournier’s gangrene: observations in Zambia.",Non-OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
"[http://dx.doi.org/10.1302/0301-620X.93B5.26081 ] [PMID: 21511935 ] [34] Saltzman DJ, Williams RA, Gelfand DV, Wilson SE.",OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
"[http://dx.doi.org/10.1001/archsurg.140.10.961 ] [PMID: 16230546 ] [35] Cacala SR, Mafana E, Thomson SR, Smith A.",Non-OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
"[http://dx.doi.org/10.1308/003588406X83050 ] [PMID: 16460640 ] [36] Crabtree KL, Wojcicki JM, Minhas V, et al.",OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
"[http://dx.doi.org/10.1158/1055-9965.EPI-13-0730 ] [PMID: 24296855 ] [37] Lavy C, Tindall A, Steinlechner C, Mkandawire N, Chimangeni S. Surgery in Malawi - a national survey of activity in rural and urban hospitals.",Non-OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
"[http://dx.doi.org/10.1308/003588407X209329 ] [PMID: 17959015 ] [38] Mkandawire N, Ngulube C, Lavy C. Orthopaedic clinical officer program in Malawi: a model for providing orthopaedic care.",Non-OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
"[http://dx.doi.org/10.1007/s11999-008-0366-5 ] [PMID: 18633684 ] [39] Chalya  PL,  Ssentongo  R,  Kakande  I.  HIV  seroprevalence  and  its  effect  on  outcome  of  moderate  to  severe  burn  injuries:  A  Ugandan experience.",Non-OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
[http://dx.doi.org/10.1186/1752-2897-5-8 ] [PMID: 21658212 ] [40] Anon.,Non-OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
"[http://dx.doi.org/10.1097/00002030-199506000-00009 ] [PMID: 7662197 ] [42] Gumodoka B, Favot I, Berege ZA, Dolmans WM.",Non-OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
[http://dx.doi.org/10.1080/09540120701583787 ] [PMID: 18351477 ] [46] Fink AJ.,Non-OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
"[http://dx.doi.org/10.1056/NEJM198610303151818 ] [PMID: 3762636 ] [47] Bailey RC, Moses S, Parker CB, et al.",OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
"[http://dx.doi.org/10.1016/S0140-6736(07)60312-2 ] [PMID: 17321310 ] [48] Donoval BA, Landay AL, Moses S, et al.",OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
"[http://dx.doi.org/10.1309/JVHQVDJDYKM58EPH ] [PMID: 16613341 ] Received: February 27, 2015 Revised: July 9, 2015 Accepted: October 12, 2015 © Bowa et al.",Non-OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/f9/TOAIDJ-10-16.PMC4893540.pdf
"[http://dx.doi.org/10.1056/NEJMoa1507198 ] [PMID: 26193126 ] [2] Piot P, Abdool Karim SS, Hecht R, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1016/S0140-6736(15)60658-4 ] [PMID: 26117719 ] [3] Lundgren JD, Babiker AG, Gordin F, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1056/NEJMoa1506816 ] [PMID: 26192873 ] [4] Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.",Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1371/journal.pmed.0020298 ] [PMID: 16231970 ] [5] Bailey RC, Moses S, Parker CB, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
[http://dx.doi.org/10.1016/S0140-6736(07)60312-2 ] [PMID: 17321310 ],OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1016/S0140-6736(07)60313-4 ] [PMID: 17321311 ] [7] Guay LA, Musoke P, Fleming T, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1016/S0140-6736(99)80008-7 ] [PMID: 10485720 ] [8] Cohen MS, Chen YQ, McCauley M, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1056/NEJMoa1105243 ] [PMID: 21767103 ] [9] Anderson SJ, Cherutich P, Kilonzo N, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1016/S0140-6736(14)61053-9 ] [PMID: 25042235 ] [10] Maartens G, Celum C, Lewin SR. HIV infection: epidemiology, pathogenesis, treatment, and prevention.",Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1016/S0140-6736(14)60164-1 ] [PMID: 24907868 ] [11] Jones A, Cremin I, Abdullah F, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
[http://dx.doi.org/10.1016/S0140-6736(13)62230-8 ] [PMID: 24740087 ] [12] Joint United Nations Programme on HIV/AIDS (UNAIDS).,Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1126/science.1228160 ] [PMID: 23430656 ] [14] Herbst AJ, Cooke GS, Bärnighausen T, KanyKany A, Tanser F, Newell ML.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.2471/BLT.08.058982 ] [PMID: 19876542 ] [15] Mossong J, Grapsa E, Tanser F, Bärnighausen T, Newell ML.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1097/01.aids.0000432475.14992.da ] [PMID: 23842131 ] [16] Nsanzimana S, Remera E, Kanters S, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1016/S2214-109X(14)70364-X ] [PMID: 25701995 ] [17] Bor J, Herbst AJ, Newell ML, Bärnighausen T. Increases in adult life expectancy in rural South Africa: valuing the scale up of HIV treatment.",Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1126/science.1230413 ] [PMID: 23430655 ] [18] Mills EJ, Bakanda C, Birungi J, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1097/QAD.0b013e32834564e9 ] [PMID: 21330903 ] [19] Mills EJ, Bakanda C, Birungi J, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.7326/0003-4819-155-4-201108160-00358 ] [PMID: 21768555 ] [20] Marston M, Michael D, Wringe A, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1111/j.1365-3156.2011.02924.x ] [PMID: 22943380 ] [21] Reniers G, Slaymaker E, Nakiyingi-Miiro J, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1097/QAD.0000000000000496 ] [PMID: 25406756 ] [22] Buse K, Hawkes S. Health in the sustainable development goals: ready for a paradigm shift?",Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1186/s12992-015-0098-8 ] [PMID: 25890267 ] [23] Joint United Nations Programme on HIV/AIDS (UNAIDS) Global report: UNAIDS report on the global AIDS epidemic, Available at www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf  2013  [15 January  2015];  ISBN  978-92-9253-032-7, [24] Abdool Karim SS, Abdool Karim Q, Baxter C. Antibodies for HIV prevention in young women.",Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1097/COH.0000000000000147 ] [PMID: 25700207 ] [25] Halperin DT, Mugurungi O, Hallett TB, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
[http://dx.doi.org/10.1371/journal.pmed.1000414 ] [PMID: 21346807 ] [26] Leclerc-Madlala S. Age disparate and intergenerational sex in southern Africa: the dynamics of hypervulnerability.,Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"44   The Open AIDS Journal, 2016, Volume 10 Kharsany and Karim [http://dx.doi.org/10.1097/01.aids.0000341774.86500.53 ] [PMID: 19033752 ] [27] Leclerc PM, Garenne M. Commercial sex and HIV transmission in mature epidemics: a study of five African countries.",Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1258/ijsa.2008.008099 ] [PMID: 18824616 ] [28] Pettifor A, O’Brien K, Macphail C, Miller WC, Rees H. Early coital debut and associated HIV risk factors among young women and men in South Africa.",Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
[http://dx.doi.org/10.1363/3508209 ] [PMID: 19620092 ] [29] Peltzer K. Early sexual debut and associated factors among in school adolescents in eight African countries.,Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1111/j.1651-2227.2010.01874.x ] [PMID: 20491706 ] [30] Zuma K, Setswe G, Ketye T, Mzolo T, Rehle T, Mbelle N. Age at sexual debut: a determinant of multiple partnership among South African youth.",Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1371/journal.pone.0001001 ] [PMID: 17912340 ] [32] Smith AD, Tapsoba P, Peshu N, Sanders EJ, Jaffe HW.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1016/S0140-6736(09)61118-1 ] [PMID: 19616840 ] [33] Dunkle  KL,  Jewkes  RK,  Murdock  DW,  Sikweyiya  Y,  Morrell  R.  Prevalence  of  consensual  male-male  sex  and  sexual  violence,  and associations with HIV in South Africa: a population based cross sectional study.",Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1371/journal.pmed.1001472 ] [PMID: 23853554 ] [34] Sanders  EJ,  Okuku  HS,  Smith  AD,  et  al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1097/QAD.0b013e32835b0f81 ] [PMID: 23079811 ] [35] Bowring AL, Luhmann N, Pont S, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1016/j.drugpo.2012.08.005 ] [PMID: 23036650 ] [36] Petersen Z, Myers B, van Hout MC, Plüddemann A, Parry C. Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1186/1477-7517-10-13 ] [PMID: 23957896 ] [37] Baral S, Beyrer C, Muessig K, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
[http://dx.doi.org/10.1016/S1473-3099(12)70066-X ] [PMID: 22424777 ] [38] Editorial : HIV : science and stigma.,Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1016/S0140-6736(14)61193-4 ] [PMID: 25042217 ] [39] Jewkes R, Sikweyiya Y, Morrell R, Dunkle K. The relationship between intimate partner violence, rape and HIV amongst South African men: a cross sectional study.",Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1371/journal.pone.0024256 ] [PMID: 21935392 ] [40] Kouyoumdjian FG, Calzavara LM, Bondy SJ, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1097/QAD.0b013e32835fd851 ] [PMID: 23925380 ] [41] Wilson D, Halperin DT.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
[http://dx.doi.org/10.1016/S0140-6736(08)60883-1 ] [PMID: 18687462 ] [42] Joint  United  Nations  Programme  on  HIV/AIDS  (UNAIDS)  and  World  Health  Organization  Practical  Guidelines  for  Intensifying  HIV Prevention.,Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1007/s11904-013-0155-y ] [PMID: 23456730 ] [44] Lowndes C, Alary M, Belleau M, Kofi Bosu W, Frédéric Kintin D, Asonye Nnorom J, et al.",Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
[http://dx.doi.org/10.1111/aji.12039 ] [PMID: 23216606 ] [46] Abdool Karim SS.,Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
[http://dx.doi.org/10.1038/474029a ] [PMID: 21637237 ],Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1016/S1473-3099(13)70066-5 ] [PMID: 23726798 ] [48] Redd AD, Mullis CE, Serwadda D, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1093/infdis/jis325 ] [PMID: 22675216 ] [49] Cuadros DF, Awad SF, Abu-Raddad LJ.",Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1186/1476-072X-12-28 ] [PMID: 23692994 ] [50] Grabowski MK, Lessler J, Redd AD, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1371/journal.pmed.1001610 ] [PMID: 24595023 ] [51] Tanser F, Bärnighausen T, Cooke GS, Newell ML.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1093/ije/dyp148 ] [PMID: 19261659 ] [52] Shisana O, Rehle T, Simbayi LC, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"The 2012 National Antenatal Sentinel HIV and Herpes Simplex type-2 prevalence Survey, South Africa 2014; Available at http://www.health-e.org.za/wp-content/uploads/2014/05/ASHIVHerp_Report2014_22May2014.pdf  2014 [Accessed on 30 June]; [54] Aliyu MH, Varkey P, Salihu HM, Iliyasu Z, Abubakar IS.",Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1186/1471-2334-14-285 ] [PMID: 24886573 ] [56] Novitsky V, Bussmann H, Logan A, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1371/journal.pone.0080589 ] [PMID: 24349005 ] [57] Grabowski MK, Redd AD.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1097/COH.0000000000000040 ] [PMID: 24384502 ] [58] Kharsany AB, Buthelezi TJ, Frohlich JA, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1089/aid.2014.0110 ] [PMID: 25077861 ] [59] Chirinda W, Peltzer K. Correlates of inconsistent condom use among youth aged 18-24 years in South Africa.",Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.2989/17280583.2013.877912 ] [PMID: 25391572 ] [60] Smith J, Nyamukapa C, Gregson S, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
[http://dx.doi.org/10.1371/journal.pone.0088378 ] [PMID: 24558387 ] [61] Hattori MK.,Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1017/S0021932013000680 ] [PMID: 24405964 ] [62] Johnson LF, Hallett TB, Rehle TM, Dorrington RE.",Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1098/rsif.2011.0826 ] [PMID: 22258551 ] [63] Garnett GP, White PJ, Ward H. Fewer partners or more condoms?",Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1136/sti.2008.029850 ] [PMID: 18799491 ] [64] Bock NN, Nadol P, Rogers M, Fenley MA, Moore J, Miller B. Provider-initiated HIV testing and counseling in TB clinical settings: tools for program implementation.",Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1080/09540120903254005 ] [PMID: 20397075 ] [66] Leon NH, Colvin CJ, Lewin S, Mathews C, Jennings K. Provider-initiated testing and counselling for HIV - from debate to implementation.",Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1097/QAI.0b013e31818a6cb5 ] [PMID: 18931624 ] [69] Williams BG, Lloyd-Smith JO, Gouws E, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1371/journal.pmed.0030262 ] [PMID: 16822094 ] [70] Montague C, Ngcobo N, Mahlase G, et al.",Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1371/journal.pone.0096468 ] [PMID: 24788339 ] [71] Ashengo TA, Hatzold K, Mahler H, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1371/journal.pone.0083642 ] [PMID: 24801882 ] [72] Mwandi Z, Murphy A, Reed J, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1371/journal.pmed.1001130 ] [PMID: 22140365 ] [73] Curran K, Njeuhmeli E, Mirelman A, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
[http://dx.doi.org/10.1371/journal.pmed.1001129 ] [PMID: 22140364 ] [74] Ramjee G. Microbicide research: current and future directions.,Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1097/COH.0b013e32833a9f66 ] [PMID: 20543607 ] [75] Padian NS, van der Straten A, Ramjee G, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1016/S0140-6736(07)60950-7 ] [PMID: 17631387 ] [76] McCormack S, Ramjee G, Kamali A, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1016/S0140-6736(10)61086-0 ] [PMID: 20851460 ] [77] Guffey MB, Richardson B, Husnik M, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1136/sextrans-2014-051537 ] [PMID: 24898857 ] [78] Abdool Karim SS, Richardson BA, Ramjee G, et al.",Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1097/QAD.0b013e32834541d9 ] [PMID: 21330907 ] [79] Skoler-Karpoff  S,  Ramjee  G,  Ahmed  K,  et  al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1016/S0140-6736(08)61842-5 ] [PMID: 19059048 ] [80] Van Damme L, Govinden R, Mirembe FM, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1056/NEJMoa0707957 ] [PMID: 18669425 ] [81] Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1126/science.1193748 ] [PMID: 20643915 ] [82] Marrazzo JM, Ramjee G, Richardson BA, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1056/NEJMoa1402269 ] [PMID: 25651245 ] [83] Rees H, Delany-Moretlwe SA, Lombard C, Baron D, Panchia R, Myer L. FACTS 001 Phase III Trial of Pericoital Tenofovir 1% Gel for HIV Prevention in Women Conference on Retroviruses and Opportunitic Infections (CROI).",Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1056/NEJMoa1202614 ] [PMID: 22784040 ] [85] Thigpen MC, Kebaabetswe PM, Paxton LA, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1056/NEJMoa1110711 ] [PMID: 22784038 ] [86] Baeten JM, Donnell D, Ndase P, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1056/NEJMoa1108524 ] [PMID: 22784037 ] [87] McCormack  S,  Dunn  D.  Pragmatic  Open-Label  Randomised  Trial  of  Preexposure  Prophylaxis:  The  PROUD  Study  In:  Conference  on Retroviruses and Opportunistic Infections (CROI) 2015; February 23-26; Seattle, Washington.",Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1056/NEJMoa1506110 ] [90] Nel A, Kapiga S, Bekker L-G, Devlin B, Borremans M. Safety and Efficacy of Dapivirine Vaginal Ring for HIV-1 Prevention in African Women Conference on Retroviruses and Opportunistic Infections (CROI) 2016 [Accessed: 5 March 2016]; February 22–25, 2016; Boston, Massachusetts.",Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1007/82_2013_330 ] [PMID: 23695725 ] [92] Masson L, Passmore JA, Liebenberg LJ, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
[http://dx.doi.org/10.1093/cid/civ298 ] [PMID: 25900168 ] [93] Karim SS.,OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1016/S0140-6736(13)61140-X ] [PMID: 23769217 ] [94] Grant RM, Lama JR, Anderson PL, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1056/NEJMoa1011205 ] [PMID: 21091279 ] [95] Grosskurth H, Mosha F, Todd J, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1016/S0140-6736(95)91380-7 ] [PMID: 7658778 ] [96] Donnell D, Baeten JM, Kiarie J, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1016/S0140-6736(10)60705-2 ] [PMID: 20537376 ] [97] Hayes R, Ayles H, Beyers N, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
[http://dx.doi.org/10.1186/1745-6215-15-57 ] [PMID: 24524229 ] [98] World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"National Consolidated Guidelines for the Prevention of Mother-to-Child Transmission of HIV (PMTCT)  and  the  managemnet  of  HIV  in  Children,  Adolescents  and  Adults  http://www.sahivsoc.org/upload/documents/ART%20 Guidelines%2015052015.pdf  2015  [Accessed  10  June  2015]; [102] MacCarthy S, Hoffmann M, Ferguson L, et al.",Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.7448/IAS.18.1.19395 ] [PMID: 25735869 ] [103] Eaton JW, Johnson LF, Salomon JA, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1371/journal.pmed.1001245 ] [PMID: 22802730 ] [104] Estill J, Egger M, Johnson LF, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1371/journal.pone.0057611 ] [PMID: 23469035 ] [105] Hallett TB, Baeten JM, Heffron R, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1371/journal.pmed.1001123 ] [PMID: 22110407 ] [106] Cori A, Ayles H, Beyers N, et al.",OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"48   The Open AIDS Journal, 2016, Volume 10 Kharsany and Karim [http://dx.doi.org/10.1371/journal.pone.0084511 ] [PMID: 24454728 ] [107] Vermund SH, Fidler SJ, Ayles H, Beyers N, Hayes RJ.",Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1097/QAI.0b013e318299c3f4 ] [PMID: 23764639 ] Received: May 21, 2015 Revised: September 18, 2015 Accepted: October 08, 2015 © Kharsany and Karim; Licensee Bentham Open.",Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/68/94/TOAIDJ-10-34.PMC4893541.pdf
"[http://dx.doi.org/10.1037/a0012756 ] [2] Sheeran P, Gollwitzer PM, Bargh JA.",Non-OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
"[http://dx.doi.org/10.1037/a0029203 ] [PMID: 22888816 ] [3] Houston E, McKirnan D, Cervone D, Johnson MS, Sandfort TGM.",OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
"[http://dx.doi.org/10.1177/0095798403259243 ] [5] Fagbami O, Oluwasanjo A, Fitzpatrick C, Fairchild R, Shin A, Donato A.",Non-OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
"[http://dx.doi.org/10.2174/1874613601509010045 ] [PMID: 26157537 ] [6] Orlando M, Burnam MA, Beckman R, et al.",OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
"[http://dx.doi.org/10.1002/mpr.125 ] [PMID: 12459797 ] [7] Thrasher AD, Earp JA, Golin CE, Zimmer CR.",OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
"[http://dx.doi.org/10.1097/QAI.0b013e3181845589 ] [PMID: 18667919 ] [8] Wagner GJ, Goggin K, Remien RH, et al.",OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
"[http://dx.doi.org/10.1007/s12160-011-9295-8 ] [PMID: 21818528 ] [9] Bongers KC, Dijksterhuis A. Consciousness as a trouble shooting device?",Non-OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
[http://dx.doi.org/10.1016/j.cpr.2010.05.002 ] [PMID: 20538393 ] [11] Beck JS.,OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
"[http://dx.doi.org/10.1097/00126334-200202011-00002 ] [PMID: 11832696 ] [13] Chesney MA, Farmer P, Leandre F, Malow R, Starace F. Human immunodeficiency virus and acquired immunodeficiency syndrome.",Non-OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
"[http://dx.doi.org/10.2174/1874613601206010213 ] [PMID: 23056163 ] [15] de Bruin M, Viechtbauer W, Schaalma HP, Kok G, Abraham C, Hospers HJ.",OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
"[http://dx.doi.org/10.1001/archinternmed.2009.536 ] [PMID: 20142568 ] [16] Nosek BA, Hawkins CB, Frazier RS.",Non-OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
"[http://dx.doi.org/10.1016/j.tics.2011.01.005 ] [PMID: 21376657 ] [17] Greenwald AG, Banaji MR.",OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
"[http://dx.doi.org/10.1037/0033-295X.102.1.4 ] [PMID: 7878162 ] [18] Kruskal JB, Wish M. Multidimensional scaling.",OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
"[http://dx.doi.org/10.1177/0265407503206001 ] [21] Jones LE, Koehly LM.",Non-OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
"[http://dx.doi.org/10.1186/1471-2458-12-587 ] [PMID: 22853824 ] [23] Cacioppo JT, von Hippel W, Ernst JM.",OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
"[http://dx.doi.org/10.1037/0022-006X.65.6.928 ] [PMID: 9420354 ] [24] Stacy AW, Newcomb MD, Ames SL.",Non-OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
"[http://dx.doi.org/10.1023/A:1005577132666 ] [PMID: 11039159 ] [25] Chesney MA, Ickovics JR, Chambers DB, et al.",OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
"[http://dx.doi.org/10.1080/09540120050042891 ] [PMID: 10928201 ] [26] Williams GC, Freedman Z, Deci EL.",OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
"[http://dx.doi.org/10.1037/0278-6133.17.3.269 ] [PMID: 9619477 ] [28] Willey C, Redding C, Stafford J, et al.",OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
"[http://dx.doi.org/10.1016/S0149-2918(00)80058-2 ] [PMID: 10945512 ] [29] de Leeuw J, Heiser WJ.",OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
"[http://dx.doi.org/10.1080/17437190701485852 ] [31] Dijksterhuis A, Aarts H. Control, consciousness, and agency.",Non-OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
"[http://dx.doi.org/10.1371/journal.pone.0011068 ] [PMID: 20548786 ] [34] Dieffenbach CW, Fauci AS.",Non-OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
"[http://dx.doi.org/10.1001/jama.2009.828 ] [PMID: 19509386 ] [35] Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG.",OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
"[http://dx.doi.org/10.1016/S0140-6736(08)61697-9 ] [PMID: 19038438 ] [36] Metsch LR, Pereyra M, Messinger S, et al.",OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
"[http://dx.doi.org/10.1086/590153 ] [PMID: 18624629 ] [37] Montaner JS, Lima VD, Barrios R, et al.",OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
[http://dx.doi.org/10.1016/S0140-6736(10)60936-1 ] [PMID: 20638713 ] [38] Office  of  National  AIDS  Policy  (ONAP).,Non-OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
"National  HIV/AIDS  strategy  for  the  United  States;  2010,  Available  at: http://www.whitehouse.gov/sites/default/files/uploads/NHAS.pdf.",Non-OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
"[http://dx.doi.org/10.1016/S0140-6736(11)60877-5 ] [PMID: 21763938 ] [40] Brown KW, Ryan RM.",OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
[http://dx.doi.org/10.1037/0022-3514.84.4.822 ] [PMID: 12703651 ] © Houston et al.,Non-OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9b/5a/TOAIDJ-10-83.PMC4893623.pdf
"Literature  searches  were  conducted  on  PubMed (http://www.ncbi.nlm.nih.gov/pubmed )  using  the  following  Medical  Subject  Headings  (MeSH):  homosexuality, bisexuality, transgendered persons, South Africa, and HIV.",OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
[http://dx.doi.org/10.1007/s10447-005-3188-0 ] [8] Graziano KJ.,Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
[http://dx.doi.org/10.1037/1099-9809.10.3.302 ] [PMID: 15311981 ] [9] Graziano KJ.,Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1080/21528586.2004.10419119 ] [10] Mkhize N, Bennett J, Reddy V, Moletsane R. The country we want to live in: Hate crimes and homophobia in the lives of black lesbian South Africans.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1097/01.aids.0000194128.97640.07 ] [PMID: 16284463 ] [12] Rawstorne P, Digiusto E, Worth H, Zablotska I.",OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
[http://dx.doi.org/10.1007/s10508-007-9206-z ] [PMID: 17690971 ] [13] Beyrer C. HIV epidemiology update and transmission factors: risks and risk contexts-16th International AIDS Conference epidemiology plenary.,Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
[http://dx.doi.org/10.1086/512371 ] [PMID: 17342654 ],OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
[http://dx.doi.org/10.1016/S1473-3099(12)70315-8 ] [PMID: 23260128 ] [15] McIntyre JA.,OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1136/sti.2009.041640 ] [PMID: 20332365 ] [16] Sallar AM, Somda DA.",OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1007/s12119-011-9094-1 ] [17] Lane T, Mogale T, Struthers H, McIntyre J, Kegeles SM.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
[http://dx.doi.org/10.1136/sti.2008.031567 ] [PMID: 19028941 ] [18] Johnson CA.,Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1080/09581599808402919 ] [20] Lane T, Shade SB, McIntyre J, Morin SF.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1007/s10461-008-9389-x ] [PMID: 18392672 ] [21] Rispel LC, Metcalf CA, Cloete A, Reddy V, Lombard C. HIV prevalence and risk practices among men who have sex with men in two South African cities.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1097/QAI.0b013e318211b40a ] [PMID: 21297480 ] [22] Baral S, Sifakis F, Cleghorn F, Beyrer C. Elevated risk for HIV infection among men who have sex with men in low- and middle-income countries 2000-2006: a systematic review.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1371/journal.pmed.0040339 ] [PMID: 18052602 ] [23] Sanders EJ, Graham SM, Okuku HS, et al.",OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
[http://dx.doi.org/10.1097/QAD.0b013e3282f2704a ] [PMID: 18025888 ] [24] Gueboguo C. SIDA et homosexualité (s) en Afrique In: analyse des communications de prévention.,Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1136/sti.2008.031500 ] [PMID: 19028940 ] [26] Smith AD, Tapsoba P, Peshu N, Sanders EJ, Jaffe HW.",OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1016/S0140-6736(09)61118-1 ] [PMID: 19616840 ] [27] Makofane K, Gueboguo C, Lyons D, Sandfort T. Men who have sex with men inadequately addressed in African AIDS National Strategic Plans.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1080/17441692.2012.749503 ] [PMID: 23252398 ] [28] Cloete A, Simbayi LC, Rehle T, et al.",OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1097/QAI.0b013e31823d8693 ] [PMID: 22227488 ] [30] Dunkle  KL,  Jewkes  RK,  Murdock  DW,  Sikweyiya  Y,  Morrell  R.  Prevalence  of  consensual  male-male  sex  and  sexual  violence,  and associations with HIV in South Africa: a population based cross-sectional study.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1371/journal.pmed.1001472 ] [PMID: 23853554 ] [31] Imrie J, Hoddinott G, Fuller S, Oliver S, Newell ML.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
[http://dx.doi.org/10.1007/s10461-012-0356-1 ] [PMID: 23196857 ] [32] Johnson CA.,Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
[http://dx.doi.org/10.2307/25605310 ] [39] McKenna N. On the margins: men who have sex with men and HIV in the developing world.,Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1080/13691058.2011.610902 ] [PMID: 21972785 ] [41] Matebeni Z, Reddy V, Sandfort T, Southey-Swartz I.",OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
[http://dx.doi.org/10.1080/13691050802541674 ] [PMID: 19234951 ] [43] Richardson D. The social construction of immunity: HIV risk perception and prevention among lesbians and bisexual women.,Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1080/136910500300859 ] [44] Richters J, Prestage G, Schneider K, Clayton S. Do women use dental dams?",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1071/SH09072 ] [PMID: 20465981 ] [45] Schick V, Rosenberger JG, Herbenick D, Reece M. Sexual behaviour and risk reduction strategies among a multinational sample of women who have sex with women.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1136/sextrans-2011-050404 ] [PMID: 22563015 ] [46] Muzny CA, Harbison HS, Pembleton ES, Hook EW, Austin EL.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
[http://dx.doi.org/10.1071/SH12106 ] [PMID: 23369280 ] [47] CDC HIV AIDS Surveill Rep 2007; 1-55.,Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1300/J155v04n03_03 ] [49] Xu F, Sternberg MR, Markowitz LE.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1136/sti.79.2.147 ] [PMID: 12690139 ] [51] Diamant AL, Schuster MA, McGuigan K, Lever J. Lesbians’ sexual history with men: implications for taking a sexual history.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1001/archinte.159.22.2730 ] [PMID: 10597764 ] [52] Fethers K, Marks C, Mindel A, Estcourt CS.",OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1136/sti.76.5.345 ] [PMID: 11141849 ] [53] Lewis RJ, Milletich RJ, Kelley ML, Woody A.",OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1016/j.avb.2012.02.004 ] [54] Nath D, Mthathi S. We'll Show You You're a Woman Violence and discrimination against black lesbians and transgender men in South Africa:.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1007/s10461-007-9299-3 ] [PMID: 17694429 ] [57] Baggaley RF, White RG, Boily MC.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
[http://dx.doi.org/10.1093/ije/dyq057 ] [PMID: 20406794 ],OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
[http://dx.doi.org/10.1080/19540120512331325680 ] [PMID: 15763714 ] [59] Sevelius J. There’s no pamphlet for the kind of sex I have: HIV-related risk factors and protective behaviors among transgender men who have sex with nontransgender men.,Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
[http://dx.doi.org/10.1016/j.jana.2009.06.001 ] [PMID: 19732698 ] [60] Xavier J BJ.,OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.2105/AJPH.91.6.915 ] [PMID: 11392934 ] [62] Sugano E, Nemoto T, Operario D. The impact of exposure to transphobia on HIV risk behavior in a sample of transgendered women of color in San Francisco.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1007/s10461-005-9040-z ] [PMID: 16362237 ] [63] Bockting WO, Knudson G, Goldberg JM.",OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1300/J485v09n03_03 ] [64] Beyrer C, Baral SD, van Griensven F, et al.",OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1016/S0140-6736(12)60821-6 ] [PMID: 22819660 ] [65] Lane T, Osmand T, Marr A, et al.",OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1371/journal.pone.0111063 ] [PMID: 25401785 ] [66] Lane T, Raymond HF, Dladla S, et al.",OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1007/s10461-009-9598-y ] [PMID: 19662523 ] [67] Burrell E, Mark D, Grant R, Wood R, Bekker LG.",OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1071/SH09090 ] [PMID: 20465978 ] [68] Baral S, Burrell E, Scheibe A, Brown B, Beyrer C, Bekker LG.",OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"BMC Public Health 2011;11:766 [http://dx.doi.org/10.1186/1471-2458-11-766 ] [69] Nyoni JE, Ross MW.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1080/09540121.2012.699671 ] [PMID: 22788911 ] [70] Sheehy M, Tun W, Vu L, Adebajo S, Obianwu O, Karlyn A.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1080/09540121.2013.802281 ] [PMID: 23742663 ] [71] Jewkes R, Dunkle K, Nduna M, et al.",OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1093/ije/dyl217 ] [PMID: 17030525 ] [72] Eaton  LA,  Pitpitan  EV,  Kalichman  SC,  et  al.",OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1007/s10508-013-0077-1 ] [PMID: 23519592 ] [73] Arnold MP, Struthers H, McIntyre J, Lane T. Contextual correlates of per partner unprotected anal intercourse rates among MSM in Soweto, South Africa.",OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1007/s10461-012-0324-9 ] [PMID: 23054039 ] [74] Sandfort T, Yi H, Knox J, Reddy V. Sexual partnership types as determinant of HIV risk in South African MSM: an event-level cluster analysis.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1007/s10461-012-0294-y ] [PMID: 22956229 ] [75] Jobson G, de Swardt G, Rebe K, Struthers H, McIntyre J. HIV risk and prevention among men who have sex with men (MSM) in peri-urban townships in Cape Town, South Africa.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1007/s10461-012-0328-5 ] [PMID: 23054040 ] [76] Heusser S, Elkonin D. Childhood sexual abuse and HIV sexual-risk behaviour among men who have sex with men in South Africa.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1177/0081246313516258 ] [77] Nel JA, Yi H, Sandfort TG, Rich E. HIV-untested men who have sex with men in South Africa: the perception of not being at risk and fear of being tested.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"HIV Risk Among MSM, WSW, and LGBT Populations in South Africa The Open AIDS Journal, 2016, Volume 10    63 [http://dx.doi.org/10.1007/s10461-012-0329-4 ] [PMID: 23054041 ] [78] Stephenson R, Rentsch C, Sullivan P. High levels of acceptability of couples-based HIV testing among MSM in South Africa.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1007/s10461-012-0293-z ] [PMID: 22961498 ] [80] Knox J, Sandfort T, Yi H, Reddy V, Maimane S. Social vulnerability and HIV testing among South African men who have sex with men.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1258/ijsa.2011.010350 ] [PMID: 22174050 ] [81] Knox J, Reddy V, Kaighobadi F, Nel D, Sandfort T. Communicating HIV status in sexual interactions: assessing social cognitive constructs, situational factors, and individual characteristics among South African MSM.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1007/s10461-012-0337-4 ] [PMID: 23065127 ] [82] Wagenaar BH, Sullivan PS, Stephenson R. HIV knowledge and associated factors among internet-using men who have sex with men (MSM) in South Africa and the United States.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1371/journal.pone.0032915 ] [PMID: 22427908 ] [83] Tun W, Kellerman S, Maimane S, et al.",OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1007/s10461-011-9948-4 ] [PMID: 21484279 ] [85] Rispel LC, Metcalf CA, Cloete A, Moorman J, Reddy V. You become afraid to tell them that you are gay: health service utilization by men who have sex with men in South African cities.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1057/jphp.2011.29 ] [PMID: 21730987 ] [86] Cloete A, Simbayi LC, Kalichman SC, Strebel A, Henda N. Stigma and discrimination experiences of HIV-positive men who have sex with men in Cape Town, South Africa.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1080/09540120701842720 ] [PMID: 18608067 ] [87] Tucker A, de Swardt G, Struthers H, McIntyre J.",OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1007/s10461-012-0287-x ] [PMID: 22903420 ] [88] Tucker A, Liht J, de Swardt G, et al.",OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1080/09540121.2013.859652 ] [PMID: 24295155 ] [89] Parry C, Petersen P, Carney T, Dewing S, Needle R. Rapid assessment of drug use and sexual HIV risk patterns among vulnerable drug-using populations in Cape Town, Durban and Pretoria, South Africa.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1080/17290376.2008.9724909 ] [PMID: 18979044 ] [90] Parry C, Petersen P, Dewing S, et al.",OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1016/j.drugalcdep.2007.12.005 ] [PMID: 18242881 ] [91] Sandfort TG, Baumann LR, Matebeni Z, Reddy V, Southey-Swartz I.",OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1371/journal.pone.0053552 ] [PMID: 23326452 ] [92] Cloete A, Sanger N, Simbayi LC.",OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1097/INF.0b013e31828b28f1 ] [PMID: 23838741 ] [94] Thurston IB, Dietrich J, Bogart LM, et al.",OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
[http://dx.doi.org/10.2105/AJPH.2013.301865 ] [PMID: 24832149 ] [95] Teunis N. Same-sex sexuality in Africa: A case study from Senegal.,Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1023/A:1011335129358 ] [96] Murray SO, Roscoe W. Studies in African homosexualities.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1080/09540253.2011.645021 ] [99] Grossman AH, D’Augelli AR.",OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"[http://dx.doi.org/10.1521/suli.2007.37.5.527 ] [PMID: 17967119 ] [100] UNAIDS action framework: Universal access for men who have sex with men, and transgender people 2009.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/TOAIDJ-10-49.PMC4893624.pdf
[http://dx.doi.org/10.1007/s10461-014-0832-x ] [PMID: 24986599 ] [2] WHO.,Non-OADS,/arxiv_data1/oa_pdf/80/25/TOAIDJ-10-78.PMC4893625.pdf
"Geneva: Available from: http://www.who.int/hiv/pub/guidelines/arv/2013/en/  [cited 2015 10 July]; [3] Cohen MS, Chen YQ, McCauley M, et al.",Non-OADS,/arxiv_data1/oa_pdf/80/25/TOAIDJ-10-78.PMC4893625.pdf
[http://dx.doi.org/10.1056/NEJMoa1105243 ] [PMID: 21767103 ] [4] Govender P. Survey reveals shock teen pregnancy figures.,Non-OADS,/arxiv_data1/oa_pdf/80/25/TOAIDJ-10-78.PMC4893625.pdf
[http://dx.doi.org/10.1056/NEJMp068153 ] [PMID: 16914699 ] [8] South Africa.,Non-OADS,/arxiv_data1/oa_pdf/80/25/TOAIDJ-10-78.PMC4893625.pdf
[http://dx.doi.org/10.1371/journal.pone.0079772 ] [PMID: 24312185 ] [11] The South African Pharmacy Council.,Non-OADS,/arxiv_data1/oa_pdf/80/25/TOAIDJ-10-78.PMC4893625.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/80/25/TOAIDJ-10-78.PMC4893625.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)MOF is required for stress response BN Sheikh et al 2710 Oncogene (2016) 2698 –2710 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/d6/44/onc2015335a.PMC4893634.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)Structural centrosome aberrations in mammospheres D Schnerch and EA Nigg 2722 Oncogene (2016) 2711 –2722 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/50/57/onc2015332a.PMC4893635.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/0b/rjw095.PMC4893651.pdf
"package for R software29was carried out on the normalized, log-transformed metabolite data for both urine and serum.The resulting network was displayed with VisANT software (http://visant.bu.edu/, Boston University).",OADS,/arxiv_data1/oa_pdf/dc/ad/ctg201626a.PMC4893679.pdf
URL https://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/dc/ad/ctg201626a.PMC4893679.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Clinical and Trans lational Gastroenterology website ( http://www.nat ure.com/ctg)Metabolic Response to ERCP Lusczek et al.",Non-OADS,/arxiv_data1/oa_pdf/dc/ad/ctg201626a.PMC4893679.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Clinical and Tr anslational Gastroenterology websit e (http://www.nature.com/ctg)Comparative Analysis of Whole-Gut Lavage Fluid and Pancreatic Juice Rocker et al.",Non-OADS,/arxiv_data1/oa_pdf/2b/48/ctg201627a.PMC4893680.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Analytic Morphomics Predicts Survival in HCC Singal et al.",Non-OADS,/arxiv_data1/oa_pdf/d1/a2/ctg201631a.PMC4893682.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Clinical and Trans lational Gastroenterology website ( http://www.nat ure.com/ctg)Effects of Rifaximin in Nonconstipated IBS Acosta et al.",Non-OADS,/arxiv_data1/oa_pdf/f5/80/ctg201632a.PMC4893683.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/4.0/Translational Medicine: Bench to Bedside 3 Clinical and Translational Gastroenterology",Non-OADS,/arxiv_data1/oa_pdf/e4/0c/ctg201633a.PMC4893684.pdf
"[http://dx.doi.org/10.1007/s10508-006-9151-2] [PMID: 17380374] [2] Gómez CA, Mason B, Alvarado NJ.",Non-OADS,/arxiv_data1/oa_pdf/02/82/TOAIDJ-10-104.PMC4893685.pdf
"[http://dx.doi.org/10.1037/11109-006] [3] Yeo TE, Ng YL.",Non-OADS,/arxiv_data1/oa_pdf/02/82/TOAIDJ-10-104.PMC4893685.pdf
"[http://dx.doi.org/10.1080/09540121.2015.1093597] [PMID: 26444390] [4] Silverthorne ZA, Quinsey VL.",Non-OADS,/arxiv_data1/oa_pdf/02/82/TOAIDJ-10-104.PMC4893685.pdf
"[http://dx.doi.org/10.1023/A:1001886521449] [PMID: 10763429] [5] Gobrogge  KL,  Perkins  PS,  Baker  JH,  Balcer  KD,  Breedlove  SM,  Klump  KL.",OADS,/arxiv_data1/oa_pdf/02/82/TOAIDJ-10-104.PMC4893685.pdf
[http://dx.doi.org/10.1007/s10508-007-9216-x] [PMID: 17674179] [6] Glaser BG.,Non-OADS,/arxiv_data1/oa_pdf/02/82/TOAIDJ-10-104.PMC4893685.pdf
[http://dx.doi.org/10.1007/s11199-007-9376-0] [9] Sandelowski M. The problem of rigor in qualitative research.,Non-OADS,/arxiv_data1/oa_pdf/02/82/TOAIDJ-10-104.PMC4893685.pdf
"[http://dx.doi.org/10.1097/00012272-198604000-00005] [PMID: 3083765] [10] Simon W, Gagnon JH.",OADS,/arxiv_data1/oa_pdf/02/82/TOAIDJ-10-104.PMC4893685.pdf
[http://dx.doi.org/10.1007/BF01542219] [PMID: 3718206] [11] Cho BH.,Non-OADS,/arxiv_data1/oa_pdf/02/82/TOAIDJ-10-104.PMC4893685.pdf
[http://dx.doi.org/10.1007/s11195-009-9122-3] [14] Taywaditep KJ.,Non-OADS,/arxiv_data1/oa_pdf/02/82/TOAIDJ-10-104.PMC4893685.pdf
[http://dx.doi.org/10.1300/J082v42n01_01] [PMID: 11991561] [15] Jung M. Immigrant workers’ knowledge of HIV/AIDS and their sexual risk behaviors: A respondent-driven sampling survey in South Korea.,Non-OADS,/arxiv_data1/oa_pdf/02/82/TOAIDJ-10-104.PMC4893685.pdf
"[http://dx.doi.org/10.1007/s11195-011-9245-1] [16] Jung M. Sexual, behavioral, and social characteristics of female sex workers and their risk of sexually transmitted infections: In South Korea.",Non-OADS,/arxiv_data1/oa_pdf/02/82/TOAIDJ-10-104.PMC4893685.pdf
[http://dx.doi.org/10.1007/s11195-012-9261-9] [17] Dong-Jin S. Mapping the vicissitudes of homosexual identities in South Korea.,Non-OADS,/arxiv_data1/oa_pdf/02/82/TOAIDJ-10-104.PMC4893685.pdf
"[http://dx.doi.org/10.1300/J082v40n03_04] [PMID: 11386339] [18] Ellingson S, Laumann EO, Paik A, Mahay J.",OADS,/arxiv_data1/oa_pdf/02/82/TOAIDJ-10-104.PMC4893685.pdf
[http://dx.doi.org/10.7208/chicago/9780226470337.003.0001] [19] Cho SP.,Non-OADS,/arxiv_data1/oa_pdf/02/82/TOAIDJ-10-104.PMC4893685.pdf
"[http://dx.doi.org/10.1080/00224490903244575] [PMID: 21322176] [21] Taylor V, Kaminsk E, Dugan K. From the Bowery to the Castro: Communities, identities, and movements.",Non-OADS,/arxiv_data1/oa_pdf/02/82/TOAIDJ-10-104.PMC4893685.pdf
[http://dx.doi.org/10.4135/9781848608269.n8] © Minsoo Jung; Licensee Bentham Open.,Non-OADS,/arxiv_data1/oa_pdf/02/82/TOAIDJ-10-104.PMC4893685.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/82/TOAIDJ-10-104.PMC4893685.pdf
"[http://dx.doi.org/10.1007/s12529-014-9397-3 ] [PMID: 24604206 ] [2] Collier  P,  Sterck  O,  Manning  R.  The  moral  and  fiscal  implications  of  anti-retroviral  therapies  for  HIV  in  Africa.",Non-OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
Available  at  : http://www.csae.ox.ac.uk/workingpapers/pdfs/csae-wps-2015-05.pdf .,Non-OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
Available  at: http://www.unaids.org/sites/default/files/media_asset/UNAIDS_FastTrack_highlights_en.pdf [5] UNAIDS.,Non-OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
Available  at:  http://reliefweb.int/sites/reliefweb.int/ files/resources/aids-at-30.pdf,Non-OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
"[http://dx.doi.org/10.1186/2052-3211-7-3 ] [PMID: 25848543 ] [7] Denton PW, Estes JD, Sun Z, et al.",OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
"[http://dx.doi.org/10.1371/journal.pmed.0050016 ] [PMID: 18198941 ] [8] Wilson D, Taaffe J, Fraser-Hurt N, Gorgens M. The economics, financing and implementation of HIV treatment as prevention: what will it take to get there?",Non-OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
[http://dx.doi.org/10.2989/16085906.2014.943254 ] [PMID: 25174628 ] [9] UNAIDS.,Non-OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
"Available at: http://www.unaids.org/sites/default/files/media_asset/ JC2686_WAD2014report_en.pdf [10] Estill J, Salazar-Vizcaya L, Blaser N, Egger M, Keiser O.",OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
"[http://dx.doi.org/10.1371/journal.pone.0119299 ] [PMID: 25793531 ] [11] Solem CT, Snedecor SJ, Khachatryan A, et al.",OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
"[http://dx.doi.org/10.1371/journal.pone.0098152 ] [PMID: 24866200 ] [12] Stevens W, Gous N, Ford N, Scott LE.",OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
[http://dx.doi.org/10.1186/s12916-014-0173-7 ] [PMID: 25197773 ] [13] Institute of Medicine of the National Academies.,Non-OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
Available at: http://www.iom.edu/Reports/2010/ Preparing-for-the-Future-of-HIVAIDS-in-Africa-A-Shared- Responsibility.aspx [14] Institute of Health Metrics Evaluation.,Non-OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
Available  at:  http://www.healthmetricsandevaluation.org/publications/policy-report/financing_global_health_ 2010_IHME [15] Henry J. Kaiser Family Foundation/UNAIDS.,Non-OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
Available  at: http://www.unaids.org/en/media/unaids/contentassets/documents/  document/2013/09/20130923_KFF_UNAIDS_Financing.pdf [16] Kelland  K.  Global  Fund  seeks  $15  billion  to  control  three  big  killers.,Non-OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
Available at: http://www.un.org/en/ga/search/view_doc.asp?symbol=A/68/L.4 [18] Open Working Group on Sustainable Development Goals.,Non-OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
Available at: http://sustainabledevelopment.un.org/content/documents/3272cochairsletter.pdf [19] Open Working Group on Sustainable Development Goals.,Non-OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
Available  at:  https://sustainabledevelopment.un.org/ content/documents/3392OWG10%20Clusters.pdf [20] United Nations General Assembly.,Non-OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
"Transforming our world: the 2030 Agenda for Sustainable Development A/RES/70/1 2015 [Accessed on: Sep 2015]; Available at: https://sustainabledevelopment.un.org/?menu=1300 [21] May RM, Anderson RM.",Non-OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
Available  at:  http://news.bbc.co.uk/ 2/hi/africa/4433069.stm [23] Epstein H. God and the fight against AIDS.,Non-OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
"[http://dx.doi.org/10.1126/science.1093166 ] [PMID: 15118157 ] [25] Low-Beer D, Stoneburner RL.",OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
[http://dx.doi.org/10.2989/16085906.2003.9626555 ] [PMID: 25871935 ] [26] Thai National AIDS Committee.,Non-OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
Available at: http://www.unaids.org/sites/default/files/country/documents//THA_narrative_report_2014.pdf [27] UNAIDS.,Non-OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
Available  at: http://www.unaids.org/en/resources/presscentre  /featurestories/2014/november/20141107_condoms [28] Agababyona B. Museveni: Uganda to fight AIDS with or without aid.,Non-OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
Available at: http://chimpreports.com/ we-shall-fund-aids-treatment-with-or-without-aid-museveni,Non-OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
Online Available at: http://www.avac.org/prevention-option/aids-vaccines [30] UNAIDS.,Non-OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
"Available at: http://www.unaids.org/sites/ default/files/media_asset/20151027_UNAIDS_PCB37_15_18_EN_rev1.pdf [31] Piot P, Greener R, Russell S. Squaring the circle: AIDS, poverty, and human development.",Non-OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
"[http://dx.doi.org/10.1371/journal.pmed.0040314 ] [PMID: 17958469 ] [32] Halperin DT, Steiner MJ, Cassell MM, et al.",OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
[http://dx.doi.org/10.1016/S0140-6736(04)17487-4 ] [PMID: 15566989 ] [33] Green EC.,OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/10/1a/TOAIDJ-10-65.PMC4893686.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/c5/rjw102.PMC4893731.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010342).,Non-OADS,/arxiv_data1/oa_pdf/3f/8f/bmjopen-2015-010342.PMC4893843.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010968).,Non-OADS,/arxiv_data1/oa_pdf/80/ef/bmjopen-2015-010968.PMC4893844.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010704).,Non-OADS,/arxiv_data1/oa_pdf/29/3c/bmjopen-2015-010704.PMC4893845.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/29/3c/bmjopen-2015-010704.PMC4893845.pdf
"Vienna, Austria: R Foundation for StatisticalComputing, 2016. http://www.R-project.org (accessed26 Apr 2016)).",Non-OADS,/arxiv_data1/oa_pdf/c5/54/bmjopen-2015-010099.PMC4893846.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c5/54/bmjopen-2015-010099.PMC4893846.pdf
http://www.goldcopd.org/(accessed 23 Mar 2015).,OADS,/arxiv_data1/oa_pdf/c5/54/bmjopen-2015-010099.PMC4893846.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010004).,Non-OADS,/arxiv_data1/oa_pdf/d7/b9/bmjopen-2015-010004.PMC4893847.pdf
2014. http://www.who.int/phe/ health_topics/outdoorair/databases/en/ (accessed 28 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/d7/b9/bmjopen-2015-010004.PMC4893847.pdf
"Stockholm, Sweden: IVL Svenska Miljöinstitutet, 2014. http://www.ivl.se/download/18.343dc99d14e8bb0f58b754c/1446710048540/B1792.pdf (accessed28 May 2016).",Non-OADS,/arxiv_data1/oa_pdf/d7/b9/bmjopen-2015-010004.PMC4893847.pdf
"Stockholm, Sweden: IVL Svenska Miljöinstitutet, 2007.http://www3.ivl.se/rapporter/pdf/B1749.pdf (accessed 28 May 2016).",Non-OADS,/arxiv_data1/oa_pdf/d7/b9/bmjopen-2015-010004.PMC4893847.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010666).,Non-OADS,/arxiv_data1/oa_pdf/78/7c/bmjopen-2015-010666.PMC4893849.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a7/1a/bmjopen-2016-011454.PMC4893850.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011445).,Non-OADS,/arxiv_data1/oa_pdf/3b/ec/bmjopen-2016-011445.PMC4893851.pdf
https://www.unodc.org/documents/wdr2015/World_Drug_Report_2015.pdf (accessed 25 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/3b/ec/bmjopen-2016-011445.PMC4893851.pdf
http://www.emcdda.europa.eu/attachements.cfm/att_239505_EN_TDAT15001ENN.pdf (accessed 25 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/3b/ec/bmjopen-2016-011445.PMC4893851.pdf
http://www.drogenbeauftragte.de/fileadmin/dateien-dba/Presse/Downloads/Drogen-_und_Suchtbericht_2014_Gesamt_WEB_07.pdf (accessed 25 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/3b/ec/bmjopen-2016-011445.PMC4893851.pdf
2010. http://www.emcdda.europa.eu/system/files/publications/578/EMCDDA_SI10_Amphetamines_242746.pdf(accessed 25 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/3b/ec/bmjopen-2016-011445.PMC4893851.pdf
Dresden.http://www.lpr.sachsen.de/download/landespraeventionsrat/Sucht2013.pdf (accessed 25 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/3b/ec/bmjopen-2016-011445.PMC4893851.pdf
Dresden.http://www.slsev.de/fileadmin/user/Dokumente/Die_SLS/Sucht2014.,Non-OADS,/arxiv_data1/oa_pdf/3b/ec/bmjopen-2016-011445.PMC4893851.pdf
2014.http://drogenbeauftragte.de/fileadmin/dateien-dba/Presse/Downloads/ATS-Bericht_final.pdf (accessed 25 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/3b/ec/bmjopen-2016-011445.PMC4893851.pdf
http://www.suchthilfe.de/therapie/index.phpzuletzt geprüft am 07.01.2016.,Non-OADS,/arxiv_data1/oa_pdf/3b/ec/bmjopen-2016-011445.PMC4893851.pdf
https://www.deutsche-rentenversicherung.de/cae/servlet/contentblob/232574/publicationFile/51584/entwoehnungsbehandlung.pdf(accessed 25 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/3b/ec/bmjopen-2016-011445.PMC4893851.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-009337).,Non-OADS,/arxiv_data1/oa_pdf/7a/0a/bmjopen-2015-009337.PMC4893852.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7a/0a/bmjopen-2015-009337.PMC4893852.pdf
"Office for National Statistics, 2010. http://www.ons.",Non-OADS,/arxiv_data1/oa_pdf/7a/0a/bmjopen-2015-009337.PMC4893852.pdf
http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/ab/JCVI/DH_094744 (accessed 23 Apr 2015).,OADS,/arxiv_data1/oa_pdf/7a/0a/bmjopen-2015-009337.PMC4893852.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011777).,Non-OADS,/arxiv_data1/oa_pdf/ff/5d/bmjopen-2016-011777.PMC4893853.pdf
Prospective Register of Systematic Reviews with registra- tion number CRD42015029204 (http://www.crd.york.ac.,Non-OADS,/arxiv_data1/oa_pdf/ff/5d/bmjopen-2016-011777.PMC4893853.pdf
2015. http://www.goldcopd.com 2.,Non-OADS,/arxiv_data1/oa_pdf/ff/5d/bmjopen-2016-011777.PMC4893853.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011188).,Non-OADS,/arxiv_data1/oa_pdf/07/ca/bmjopen-2016-011188.PMC4893854.pdf
"Beginning with the original CONSORT statement in 1996,25there have been many attempts to standardise and improve report-ing of different types of studies through guidelines (see http://www.equator-network.",Non-OADS,/arxiv_data1/oa_pdf/07/ca/bmjopen-2016-011188.PMC4893854.pdf
"Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011] .T h e Cochrane Collaboration, 2011. http://www.cochrane-handbook.org.Section 8.3.2.",OADS,/arxiv_data1/oa_pdf/07/ca/bmjopen-2016-011188.PMC4893854.pdf
December 2014.http://www.icmje.org/icmje-recommendations.pdf 8.,Non-OADS,/arxiv_data1/oa_pdf/07/ca/bmjopen-2016-011188.PMC4893854.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010944).,Non-OADS,/arxiv_data1/oa_pdf/72/70/bmjopen-2015-010944.PMC4893855.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/72/70/bmjopen-2015-010944.PMC4893855.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010909).,Non-OADS,/arxiv_data1/oa_pdf/fc/27/bmjopen-2015-010909.PMC4893856.pdf
2014. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb182-Medicaid-Uninsured-Hospitalizations-2012.pdf 53.,OADS,/arxiv_data1/oa_pdf/fc/27/bmjopen-2015-010909.PMC4893856.pdf
Australas Med J 2008;1. http://www.amj.net.au/index.,OADS,/arxiv_data1/oa_pdf/fc/27/bmjopen-2015-010909.PMC4893856.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011306).,Non-OADS,/arxiv_data1/oa_pdf/99/3f/bmjopen-2016-011306.PMC4893857.pdf
"Funding The study was funded by the Academy of Finland (http://www.aka.fi, decision number 138255) and the Social Insurance Institution of Finland (decision number 10/26/2007).",Non-OADS,/arxiv_data1/oa_pdf/99/3f/bmjopen-2016-011306.PMC4893857.pdf
http://www.whocc.no/atcddd/ (accessed Jan 2016).,OADS,/arxiv_data1/oa_pdf/99/3f/bmjopen-2016-011306.PMC4893857.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010192).,Non-OADS,/arxiv_data1/oa_pdf/aa/61/bmjopen-2015-010192.PMC4893858.pdf
http://www.who.int/ violence_injury_prevention/other_injury/falls/en/index.html / (lastaccessed Jan 2010).,Non-OADS,/arxiv_data1/oa_pdf/aa/61/bmjopen-2015-010192.PMC4893858.pdf
https://http://www.diabetesaustralia.com.au/tools-e-learning 7.,Non-OADS,/arxiv_data1/oa_pdf/c1/31/bmjdrc-2015-000191.PMC4893859.pdf
http://www.health.gov.au/internet/mbsonline/publishing.nsf/Content/Downloads-2014-11 9.,Non-OADS,/arxiv_data1/oa_pdf/c1/31/bmjdrc-2015-000191.PMC4893859.pdf
http://www.gethealthynsw.com.au/ 12.,Non-OADS,/arxiv_data1/oa_pdf/c1/31/bmjdrc-2015-000191.PMC4893859.pdf
http://www.censusdata.abs.gov.au/census_services/getproduct/census/2011/communityprofile/POA2148 14.,OADS,/arxiv_data1/oa_pdf/c1/31/bmjdrc-2015-000191.PMC4893859.pdf
http://www.censusdata.abs.gov.au/census_services/getproduct/census/2011/communityprofile/POA5041 15.,OADS,/arxiv_data1/oa_pdf/c1/31/bmjdrc-2015-000191.PMC4893859.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010400).,Non-OADS,/arxiv_data1/oa_pdf/48/03/bmjopen-2015-010400.PMC4893862.pdf
doi:10.1136/bmjopen-2015- 009707 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-009707).,Non-OADS,/arxiv_data1/oa_pdf/d6/a5/bmjopen-2015-009707.PMC4893863.pdf
"DianaWeb uses a specificinteractive website (http://www.dianaweb.org/) and,with very few exceptions, all communications will bemade through the web.",Non-OADS,/arxiv_data1/oa_pdf/d6/a5/bmjopen-2015-009707.PMC4893863.pdf
"All these factors can be modi ﬁed favourably through adopting a diet inspired to the traditional Mediterranean Diet and to the European Code Against Cancer (ECAC;http://cancer-code-europe.iarc.fr), the latter including recommendations on diet and on physical exercise of moderate intensity.",Non-OADS,/arxiv_data1/oa_pdf/d6/a5/bmjopen-2015-009707.PMC4893863.pdf
doi:10.1136/ bmjopen-2015-010183 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010183).,Non-OADS,/arxiv_data1/oa_pdf/2b/73/bmjopen-2015-010183.PMC4893869.pdf
"Geneva: World Health Organization, 2014. http://www.who.int/mediacentre/factsheets/fs398/en/ 2.",Non-OADS,/arxiv_data1/oa_pdf/2b/73/bmjopen-2015-010183.PMC4893869.pdf
"Korean Ministry of Health and Welfare, 2015. http://m.mw.go.kr/mobile/noticeView.jsp?MENU_ID=0403&cont_seq=299571&page=4 4.",Non-OADS,/arxiv_data1/oa_pdf/2b/73/bmjopen-2015-010183.PMC4893869.pdf
"World Health Organization, 2015. http://www.who.int/gho/ncd/risk_factors/overweight/en/index1.html 20.",Non-OADS,/arxiv_data1/oa_pdf/2b/73/bmjopen-2015-010183.PMC4893869.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011124).,Non-OADS,/arxiv_data1/oa_pdf/24/49/bmjopen-2016-011124.PMC4893870.pdf
The FISM statute is available at: http://www.fism.it/cm/navigatore.jhtml?param1_1=N116cd41e995b96df0aa.,OADS,/arxiv_data1/oa_pdf/24/49/bmjopen-2016-011124.PMC4893870.pdf
The complete list of medicalsocieties belonging to the Federation is available at: http://www.fism.it/cm/navigatore.jhtml?param1_1=N1156174839debd2c050(accessed 28 Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/24/49/bmjopen-2016-011124.PMC4893870.pdf
Bando per l’ammissione alle Scuole di specializzazione in Medicina a.a. 2013/ 14. http://attiministeriali.miur.it/anno-2014/agosto/dm-08082014.aspx(accessed 28 April 2015).,Non-OADS,/arxiv_data1/oa_pdf/24/49/bmjopen-2016-011124.PMC4893870.pdf
http://www.acp.it (accessed 28 Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/24/49/bmjopen-2016-011124.PMC4893870.pdf
http://www.simmweb.it/fileadmin/documenti/Simm_x_news/2012/2012.Regolamento_SIMM.pdf (accessed 28 Apr 2015).,OADS,/arxiv_data1/oa_pdf/24/49/bmjopen-2016-011124.PMC4893870.pdf
http://www.nazionale.sism.org/la-nostra-policy (accessed 28 Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/24/49/bmjopen-2016-011124.PMC4893870.pdf
doi:10.1136/bmjopen-2016- 011097 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011097).,Non-OADS,/arxiv_data1/oa_pdf/1a/7e/bmjopen-2016-011097.PMC4893871.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010596).,Non-OADS,/arxiv_data1/oa_pdf/d8/8f/bmjopen-2015-010596.PMC4893873.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010981).,Non-OADS,/arxiv_data1/oa_pdf/61/6f/bmjopen-2015-010981.PMC4893875.pdf
2014. https://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site 4.,Non-OADS,/arxiv_data1/oa_pdf/61/6f/bmjopen-2015-010981.PMC4893875.pdf
"Learning —Educational Attainment, 2012. http://www4.hrsdc.gc.ca/.3ndic.1t.4r@-eng.jsp?iid=29#M_2.",Non-OADS,/arxiv_data1/oa_pdf/61/6f/bmjopen-2015-010981.PMC4893875.pdf
2013. http://www12.statcan.gc.ca/census-recensement/2011/dp-pd/tbt-tt/Rp-eng.cfm?LANG=E&APATH=3&DETAIL=0&DIM=0&FL=A&FREE=0&GC=0&GID=0&GK=0&GRP=1&PID=101998&PRID=0&PTYPE=101955&S=0&SHOWALL=0&SUB=0&Temporal=2011&THEME=88&VID=0&VNAMEE=&VNAMEF= 43.,OADS,/arxiv_data1/oa_pdf/61/6f/bmjopen-2015-010981.PMC4893875.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010850).,Non-OADS,/arxiv_data1/oa_pdf/5b/93/bmjopen-2015-010850.PMC4893876.pdf
http://www.who.int/gho/child_health/mortality/neonatal_infant_text/en/ 2.,Non-OADS,/arxiv_data1/oa_pdf/5b/93/bmjopen-2015-010850.PMC4893876.pdf
"Area, population and population density by province, Hanoi 2015. http://www.gso.gov.vn/default_en.",OADS,/arxiv_data1/oa_pdf/77/ea/bmjopen-2016-011532.PMC4893929.pdf
http://unikorea.go.kr/content.do?,Non-OADS,/arxiv_data1/oa_pdf/6d/d2/bmjopen-2015-010849.PMC4893935.pdf
http://www.who.int/chp/steps/dpr_korea/en/ index.html (accessed 30 Nov 2015).,OADS,/arxiv_data1/oa_pdf/6d/d2/bmjopen-2015-010849.PMC4893935.pdf
http://knhanes.cdc.go.kr/ (accessed 30 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/6d/d2/bmjopen-2015-010849.PMC4893935.pdf
Email: dlandin@lsu.edu doi: http://dx.doi.org/10.14740/jocmr2478w,Non-OADS,/arxiv_data1/oa_pdf/56/9e/jocmr-08-489.PMC4894017.pdf
Email: rosa-peraita@telefonica.net doi: http://dx.doi.org/10.14740/jocmr2569w,Non-OADS,/arxiv_data1/oa_pdf/83/40/jocmr-08-495.PMC4894018.pdf
Email: isiasios@ubns.com doi: http://dx.doi.org/10.14740/jocmr2572w,Non-OADS,/arxiv_data1/oa_pdf/bd/e7/jocmr-08-506.PMC4894019.pdf
Email: kalptekin79@hotmail.com doi: http://dx.doi.org/10.14740/jocmr2589w,Non-OADS,/arxiv_data1/oa_pdf/d1/a0/jocmr-08-513.PMC4894020.pdf
Email: alvaradocosme@yahoo.com doi: http://dx.doi.org/10.14740/jocmr2576w,Non-OADS,/arxiv_data1/oa_pdf/34/50/jocmr-08-519.PMC4894021.pdf
Email: cdminelli@yahoo.com.br doi: http://dx.doi.org/10.14740/jocmr2582w,Non-OADS,/arxiv_data1/oa_pdf/fb/af/jocmr-08-524.PMC4894022.pdf
Censo 2010. http://cidades.ibge.gov.br/xtras/perfil.php?lang=&codmun=352930.,OADS,/arxiv_data1/oa_pdf/fb/af/jocmr-08-524.PMC4894022.pdf
http://dab.saude.gov.br/portaldab /historico_ cobertura_sf.php/Unidade Geogra-fica/Sao Paulo/Matao/Periodo 2015.,Non-OADS,/arxiv_data1/oa_pdf/fb/af/jocmr-08-524.PMC4894022.pdf
http://tabnet.datasus.gov.br/cgi/tabnet.exe?idb2012/g02.def.,OADS,/arxiv_data1/oa_pdf/fb/af/jocmr-08-524.PMC4894022.pdf
Email: jsw@gilhospital.com doi: http://dx.doi.org/10.14740/jocmr2594w,Non-OADS,/arxiv_data1/oa_pdf/1c/80/jocmr-08-531.PMC4894023.pdf
Email: lavi.oud@ttuhsc.edu doi: http://dx.doi.org/10.14740/jocmr2573w,Non-OADS,/arxiv_data1/oa_pdf/31/43/jocmr-08-537.PMC4894024.pdf
http://www.dshs.state.tx.us/thcic/hospitals/Inpatientpudf.shtm.,Non-OADS,/arxiv_data1/oa_pdf/31/43/jocmr-08-537.PMC4894024.pdf
http://www.census.gov/topics/population.html#.,OADS,/arxiv_data1/oa_pdf/31/43/jocmr-08-537.PMC4894024.pdf
Email: kibriyafidan@yahoo.co.uk doi: http://dx.doi.org/10.14740/jocmr2157w,Non-OADS,/arxiv_data1/oa_pdf/b4/88/jocmr-08-544.PMC4894025.pdf
Email: mashamitsu1975@gmail.com doi: http://dx.doi.org/10.14740/jocmr2538w,Non-OADS,/arxiv_data1/oa_pdf/6a/f7/jocmr-08-548.PMC4894026.pdf
Email: bbanjant@bronxleb.org doi: http://dx.doi.org/10.14740/jocmr2595w,Non-OADS,/arxiv_data1/oa_pdf/52/a3/jocmr-08-550.PMC4894027.pdf
Email: wangqiangdoctor@126.com doi: http://dx.doi.org/10.14740/jocmr2550w,Non-OADS,/arxiv_data1/oa_pdf/cf/b6/jocmr-08-555.PMC4894028.pdf
Email: yigitacil@gmail.com doi: http://dx.doi.org/10.14740/jocmr2585w,Non-OADS,/arxiv_data1/oa_pdf/9c/ec/jocmr-08-560.PMC4894029.pdf
Email: miuras@cis.fukuoka-u.ac.jp doi: http://dx.doi.org/10.14740/jocmr2596w,Non-OADS,/arxiv_data1/oa_pdf/1b/c9/jocmr-08-562.PMC4894030.pdf
Available from:  http://www.nhfpc.gov.cn/guihuaxxs/s3585u/201310/64c040eab6f94 57db66c8e632eabe418.shtml.,Non-OADS,/arxiv_data1/oa_pdf/8b/86/CMJ-129-1280.PMC4894036.pdf
Available from: http://www.nhfpc.gov.cn/zhuzhan/mtbd/201310 /37a9b1530e714d2d841b0b809fc75d7e.shtml.,Non-OADS,/arxiv_data1/oa_pdf/8b/86/CMJ-129-1280.PMC4894036.pdf
Available from: http://www.xxgk.hainan.gov.cn/hi/HI0110/201205/ t20120502_670180.htm.,Non-OADS,/arxiv_data1/oa_pdf/8b/86/CMJ-129-1280.PMC4894036.pdf
Available from: http://www.xxgk.hainan.gov.cn/hi/HI0110/201301/ t20130122_897492.htm.,Non-OADS,/arxiv_data1/oa_pdf/8b/86/CMJ-129-1280.PMC4894036.pdf
Available from: http://www.who.int/mental_health/media/68.,Non-OADS,/arxiv_data1/oa_pdf/4c/bd/CMJ-129-1285.PMC4894037.pdf
The  questionnaire was mainly based on the content of “Chronic  Kidney Disease Patient Database” (http://ckd.edc‑china.,Non-OADS,/arxiv_data1/oa_pdf/33/20/CMJ-129-1291.PMC4894038.pdf
"Operational taxonomic  units (OTUs) were clustered with 97% similarity cutoff  using UPARSE (version 7.1; http://drive5.com/uparse/),  and chimeric sequences were identified and removed using  UCHIME.",OADS,/arxiv_data1/oa_pdf/0b/da/CMJ-129-1298.PMC4894039.pdf
"The LDA  score ≥2 was considered to be important contributors to  the model,[15] and LEfSe was used online in the Galaxy  workflow framework (http://huttenhower.sph.harvard.edu/ galaxy/root?tool_id = lefse_upload).",OADS,/arxiv_data1/oa_pdf/0b/da/CMJ-129-1298.PMC4894039.pdf
Available from: http://www.who.int/tb/ publications/global_report/en/.,Non-OADS,/arxiv_data1/oa_pdf/ad/2b/CMJ-129-1330.PMC4894044.pdf
Acute myeloid leukemia 1‑eight‑twenty‑one protein  localized at an acute myeloid leukemia 1‑biding site  and triggered epigenetic silencing of eyes absent 4  genomic region A bioinformatics search  (http://www.cbrc.jp/research/ db/TFSEARCH.html) of the 5’‑end of the predicted  “core promoter” sequence showed the presence of one  putative AML1‑binding sites surrounded by the CpG  islands on the EYA4  upstream region (nt −1000 to +1  relative to EYA4 ) [Figure  2a].,Non-OADS,/arxiv_data1/oa_pdf/f8/98/CMJ-129-1355.PMC4894048.pdf
"Comparisons between groups for ReHo were implemented with non-parametric permutations(10,000 permutations, two-sample t-test) us- ing the non-parametric SPM toolbox (SnPM, http://warwick.ac.uk/snpm ), with age and gender as covariates of no interest.",OADS,/arxiv_data1/oa_pdf/59/91/S1041610216000429a.PMC4894061.pdf
"Supplementary material To view supplementary material for this article, please visit http://dx.doi.org/10.1017/ S1041610216000429 .",Non-OADS,/arxiv_data1/oa_pdf/59/91/S1041610216000429a.PMC4894061.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/29/94/evw045.PMC4894063.pdf
"addition, the main results from genome assembly, annotation, and analysis can be downloaded at http://prodata.swmed.",OADS,/arxiv_data1/oa_pdf/29/94/evw045.PMC4894063.pdf
"The USGS home page is http://www.usgs.gov , last accessed March 11, 2016.",Non-OADS,/arxiv_data1/oa_pdf/29/94/evw045.PMC4894063.pdf
Supplementary Data Supplementary tables S1–S5 and ﬁgures S1–S6 are available atGenome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/29/94/evw045.PMC4894063.pdf
"Major in-house scripts and intermediate results are available at http://prodata.swmed.edu/LepDB/, last accessed March 11, 2016.",Non-OADS,/arxiv_data1/oa_pdf/29/94/evw045.PMC4894063.pdf
2007. bold: The Barcode of Life Data System (http://www.barcodinglife.org ).,Non-OADS,/arxiv_data1/oa_pdf/29/94/evw045.PMC4894063.pdf
"Available from: http://www.repeatmasker.org Smit AFA, Hubley R, Green P. 1996–2010.",Non-OADS,/arxiv_data1/oa_pdf/29/94/evw045.PMC4894063.pdf
Available from: http://www.repeatmasker.org .,Non-OADS,/arxiv_data1/oa_pdf/29/94/evw045.PMC4894063.pdf
"[ 6,7] This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial- NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, dis- tribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/b7/71/iere-11-007.PMC4894076.pdf
Available from http://www.novonordisk.com/bin/ getPDF.1856972.pdf 64.,OADS,/arxiv_data1/oa_pdf/b7/71/iere-11-007.PMC4894076.pdf
Available from: http://www.novonor disk.com/content/Denmark/HQ/www- novonordisk-com/en_gb/home/media/ news-details.1954709.html .,Non-OADS,/arxiv_data1/oa_pdf/b7/71/iere-11-007.PMC4894076.pdf
Available from: https://www.medicines.,Non-OADS,/arxiv_data1/oa_pdf/b7/71/iere-11-007.PMC4894076.pdf
Available from: http://www.idf.org/ sites/default/files/Atlas-poster-2014_ EN.pdf .,Non-OADS,/arxiv_data1/oa_pdf/b7/71/iere-11-007.PMC4894076.pdf
"This is an Open Access article distributed under the terms of th e Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, dist ribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/62/iabo-2-068.PMC4894078.pdf
"1, 68–78http://dx.doi.org/10.1080/23337931.2016.1178583",Non-OADS,/arxiv_data1/oa_pdf/e9/62/iabo-2-068.PMC4894078.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/7b/8e/ijem-14-01-29601.PMC4894079.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/97/hepatmon-16-04-35558.PMC4894080.pdf
Supplements Appendices 1 - 5 (13-145) are available at below link: http://hepatmon.com/?page=download&ﬁle_id=56809 Acknowledgments The authors would like to thank the staﬀ of the Baqiy- atallah Research Center for gastroenterology and liver dis- eases.,Non-OADS,/arxiv_data1/oa_pdf/83/97/hepatmon-16-04-35558.PMC4894080.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/8e/ircmj-18-04-29649.PMC4894081.pdf
Available from: http://repositorio.ul.pt/handle/10451/2406 .,Non-OADS,/arxiv_data1/oa_pdf/ee/8e/ircmj-18-04-29649.PMC4894081.pdf
"2–4, 86–92http://dx.doi.org/10.3109/23337931.2015.1102639 ORIGINAL ARTICLE Translucency of monolithic and core zirconia after hydrothermal aging Salma M. Fathya, Abeer A. El-Fallala, Salwa A. El-Negolyaand Abu Baker El Bedawyb aDepartment of Dental Biomaterial, Faculty of Dentistry, Mansura University, Mansoura, Egypt;bDepartment of Physics, Faculty of Science, Mansura University, Mansoura, Egypt ABSTRACT Objective : To evaluate the hydrothermal aging effect on the translucency of partially stabilized tetragonal zirconia with yttria (Y-TZP) used as monolithic or fully milled zirconia and of core type.Methods : Twenty disc-shaped specimens (1 and 10 mm) for each type of monolithic and core Y-TZP materials were milled and sintered according to the manufacturer’s instruction.",Non-OADS,/arxiv_data1/oa_pdf/81/be/iabo-1-086.PMC4894082.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any med ium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/81/be/iabo-1-086.PMC4894082.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any med ium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/e2/iabo-2-007.PMC4894085.pdf
Available from: http://web.iitd.ac.in/ /C24bishnoi/files/ ShashankBishnoiPhDThesis.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7c/e2/iabo-2-007.PMC4894085.pdf
2013; [cited 2013 Jan 31].Available from: http://www.selectscience.net/products/ mastersizer-microplus/?prodID ¼9785.,Non-OADS,/arxiv_data1/oa_pdf/7c/e2/iabo-2-007.PMC4894085.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any med ium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/91/d9/iabo-2-012.PMC4894086.pdf
"1, 1–6http://dx.doi.org/10.3109/23337931.2015.1125296 ORIGINAL ARTICLE Release of cetyl pyridinium chloride from fatty acid chelate temporary dental cement Andrew Hurta, Nichola J. Colemana, Tamer Tu ¨z u¨nerb, Bora Bagisc, Fatih Mehmet Korkmazd and John W. Nicholsone aDepartment of Pharmaceutical, Chemical & Environmental Sciences, University of Greenwich, Medway Campus, Chatham, Kent, UK; bDepartment of Paediatric Dentistry, Faculty of Dentistry, Karadiniez Technical University, Trabzon, Turkey;cDepartment of Prosthodontics, _Izmir Katip C ¸elebi University, Faculty of Dentistry, Izmir, Turkey;dDepartment of Prosthodontics, Faculty of Dentistry, Karadiniez Technical University, Trabzon, Turkey;eBluefield Centre for Biomaterials, London, UK ABSTRACT Objective To determine whether the antimicrobial nature of a fatty acid chelate temporary dental cement can be enhanced by the addition of 5% cetyl pyridinium chloride (CPC).",Non-OADS,/arxiv_data1/oa_pdf/5b/b7/iabo-2-001.PMC4894088.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any med ium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5b/b7/iabo-2-001.PMC4894088.pdf
"1112 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/70/pnv020.PMC4894244.pdf
"Adverse events were coded by inves- tigators by system organ class (SOC) and preferred termbased on the Medical Dictionary for Regulatory Activitiesreporting system (MedDRA, http://www.meddra.org)(MedDRA MSSO, McLean, VA, USA).",OADS,/arxiv_data1/oa_pdf/b6/70/pnv020.PMC4894244.pdf
"Available at: http://www.samhsa.gov/data/sites/default/files/DAWN2k11ED/DAWN2k11ED/ DAWN2k11ED.htm (accessed February 6, 2015).",OADS,/arxiv_data1/oa_pdf/b6/70/pnv020.PMC4894244.pdf
"Rockville, MD: U.S.Department of Health and Human Services; 2013.Available at: http://www.samhsa.gov/data/NSDUH/2012SummNatFindDetTables/Index.aspx (accessedFebruary 6, 2015).",Non-OADS,/arxiv_data1/oa_pdf/b6/70/pnv020.PMC4894244.pdf
"Available at: http://www.cdc.gov/mmwr/pdf/wk/mm60e1101.pdf (accessed February6, 2015).",OADS,/arxiv_data1/oa_pdf/b6/70/pnv020.PMC4894244.pdf
"Available at: http://www.gao.gov/new.items/d04110.pdf (accessed February 6, 2015).",OADS,/arxiv_data1/oa_pdf/b6/70/pnv020.PMC4894244.pdf
"Availableat: http://www.fda.gov/downloads/drugs/guidance-complianceregulatoryinformation/guidances/ucm334743.pdf (accessed February 6, 2015).",Non-OADS,/arxiv_data1/oa_pdf/b6/70/pnv020.PMC4894244.pdf
"Available at: http://conference.painweek.org/media/mediafile_attachments/00/650-painwee-k2013acceptedabstracts.pdf (abstract 52, pp 92–93) (accessed February 6, 2015).",Non-OADS,/arxiv_data1/oa_pdf/b6/70/pnv020.PMC4894244.pdf
"Preliminary Report of THC Influence on SubjectAbility to Discriminate Between Active Opioid andPlacebo in Human Abuse Liability Study.Presentation at the CPDD 76th Annual ScientificMeeting, June 14–19, 2014, San Juan, Puerto Rico.Available at: http://www.cpdd.org/Pages/Meetings/CPDD14AbstractBook.pdf (poster #673, pp 169)(accessed February 7, 2015).",Non-OADS,/arxiv_data1/oa_pdf/b6/70/pnv020.PMC4894244.pdf
"Available at: http://www.fda.gov/downloads/regulatoryinformation/guidances/ucm126833.pdf (accessed February 6, 2015).",Non-OADS,/arxiv_data1/oa_pdf/b6/70/pnv020.PMC4894244.pdf
"Available at: https://v8doc.sas.com/sashtml/stat/chap30/sect1.htm(accessed February 6, 2015).",OADS,/arxiv_data1/oa_pdf/b6/70/pnv020.PMC4894244.pdf
"Available at: http://www.painmed.org/2014posters/abstract-193/ (accessed February 6, 2015).",Non-OADS,/arxiv_data1/oa_pdf/b6/70/pnv020.PMC4894244.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/Licenses/by-nc- nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built  upon in any way.Characteristics of and factors associated with  dengue vector breeding sites in the City of  Colombo, Sri Lanka Valérie R. Louis1* , Carlos Alberto Montenegro Quiñonez1* ,   Pad Kusumawathie2, Paba Palihawadana3, Sakoo Janaki4, Yesim Tozan1,5 ,  Ruwan Wijemuni6, Annelies Wilder-Smith1,7,8, Hasitha A. Tissera3,4 1Institute of Public Health, Heidelberg University, Heidelberg, Germany, 2Regional Malaria Office, Ministry  of Health, Kandy, Sri Lanka, 3Epidemiology Unit, Ministry of Health, Colombo, Sri Lanka, 4National Dengue  Control Unit, Ministry of Health, Colombo, Sri Lanka, 5College of Global Public Health, New York University, New  York, NY, USA, 6Department of Public Health, Colombo Municipal Council, Colombo, Sri Lanka, 7Lee Kong Chian  School of Medicine, Nanyang Technological University, Singapore, 8Department of Public Health and Clinical  Medicine, Epidemiology and Global Health, Umeå University, Umeå, Sweden Introduction: Dengue has emerged as a major public health problem in Sri Lanka.",Non-OADS,/arxiv_data1/oa_pdf/dc/0b/ypgh-110-79.PMC4894263.pdf
274 p.   Available from: http://www.statistics.gov.lk/PopHouSat/CPH2011/ index.php?fileName=Activities/TentativelistofPublications .,OADS,/arxiv_data1/oa_pdf/dc/0b/ypgh-110-79.PMC4894263.pdf
Available  from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409110/.,Non-OADS,/arxiv_data1/oa_pdf/dc/0b/ypgh-110-79.PMC4894263.pdf
"Wallingford ; New York: CAB International; 1997. xi, 478 p. Available  from: http://www.loc.gov/catdir/enhancements/fy0605/97013184-d.html .",Non-OADS,/arxiv_data1/oa_pdf/dc/0b/ypgh-110-79.PMC4894263.pdf
Available  from: http://www.sljol.info/index.php/GMJ/article/view/4355 .,Non-OADS,/arxiv_data1/oa_pdf/dc/0b/ypgh-110-79.PMC4894263.pdf
2013;1(2):47–52.ORCID Louis Valérie R.  http://orcid.org/0000-0002-0186-5028 Carlos Alberto Montenegro Quiñonez  http://orcid.,Non-OADS,/arxiv_data1/oa_pdf/dc/0b/ypgh-110-79.PMC4894263.pdf
"org/0000-0002-5640-9142 Yesim Tozan  http://orcid.org/0000-0001-8997-8897 References  1  Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ,  et al.",OADS,/arxiv_data1/oa_pdf/dc/0b/ypgh-110-79.PMC4894263.pdf
Available  from: http://www.who.int/denguecontrol/mosquito/en/ .,Non-OADS,/arxiv_data1/oa_pdf/dc/0b/ypgh-110-79.PMC4894263.pdf
Available from: http://www.denguevaccines.,Non-OADS,/arxiv_data1/oa_pdf/dc/0b/ypgh-110-79.PMC4894263.pdf
Available  from: http://wwwnc.cdc.gov/eid/article/17/11/10-1893_article.htm .,OADS,/arxiv_data1/oa_pdf/dc/0b/ypgh-110-79.PMC4894263.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/f0/fnw134.PMC4894279.pdf
3) Political books (unpublished http://www.orgnet.com/cases.,Non-OADS,/arxiv_data1/oa_pdf/0b/3b/srep03241.PMC4894381.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3241 | DOI: 10.1038/srep03241 7",Non-OADS,/arxiv_data1/oa_pdf/0b/3b/srep03241.PMC4894381.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/76/cb/srep03467.PMC4894382.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3467 | DOI: 10.1038/srep03467 10",Non-OADS,/arxiv_data1/oa_pdf/76/cb/srep03467.PMC4894382.pdf
"Cell Rep. 5, http://dx.doi.org/10.1016/j.celrep.2013.08.031 (2013).",OADS,/arxiv_data1/oa_pdf/16/71/srep03845.PMC4894384.pdf
A. Firefly version 8.0.0. http://classic.chem.msu.su/gran/firefly/ index.html.,Non-OADS,/arxiv_data1/oa_pdf/16/71/srep03845.PMC4894384.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/16/71/srep03845.PMC4894384.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3845 | DOI: 10.1038/srep03845 8",Non-OADS,/arxiv_data1/oa_pdf/16/71/srep03845.PMC4894384.pdf
"Full details regarding the quality control procedures are provided in the data cleaning report posted on the GENEVA website (http://www.genevastudy.org/docs/GENEVA_Alcohol_QC_ report_8Oct2008.pdf) and in related publications35,36.",Non-OADS,/arxiv_data1/oa_pdf/21/5e/srep04497.PMC4894386.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4497 | DOI: 10.1038/srep04497 8",Non-OADS,/arxiv_data1/oa_pdf/21/5e/srep04497.PMC4894386.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3887 | DOI: 10.1038/srep03887 7",Non-OADS,/arxiv_data1/oa_pdf/85/f0/srep03887.PMC4894387.pdf
Structure figures were made with PyMOL (http://www.pymol.org).,OADS,/arxiv_data1/oa_pdf/be/ee/srep04464.PMC4894388.pdf
Additional information Database: Coordinates have been deposited into the Protein Data Bank database under the accession number 4NWY Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/be/ee/srep04464.PMC4894388.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4464 | DOI: 10.1038/srep04464 6",Non-OADS,/arxiv_data1/oa_pdf/be/ee/srep04464.PMC4894388.pdf
All authors reviewed the manuscript and approved the final version of the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: S.N.,Non-OADS,/arxiv_data1/oa_pdf/75/4e/srep04632.PMC4894389.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4632 | DOI: 10.1038/srep04632 9",Non-OADS,/arxiv_data1/oa_pdf/75/4e/srep04632.PMC4894389.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/8f/d7/srep04693.PMC4894391.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4693 | DOI: 10.1038/srep04693 6",Non-OADS,/arxiv_data1/oa_pdf/8f/d7/srep04693.PMC4894391.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ed/65/srep04963.PMC4894394.pdf
"To viewa copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4963 | DOI: 10.1038/srep04963 8",Non-OADS,/arxiv_data1/oa_pdf/ed/65/srep04963.PMC4894394.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8040 | DOI: 10.1038/srep08040 8",Non-OADS,/arxiv_data1/oa_pdf/b4/82/srep08040.PMC4894400.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/28/d8/srep08075.PMC4894403.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8075 | DOI: 10.1038/srep08075 16",Non-OADS,/arxiv_data1/oa_pdf/28/d8/srep08075.PMC4894403.pdf
"A video of an early version of the game, which was developed in collaboration with Jessica Bayliss, can be found at: https://www.youtube.com/watch?v 571RML96XxCI Below we provide full details on the actual dichoptic game play during training.",Non-OADS,/arxiv_data1/oa_pdf/00/ec/srep08482.PMC4894407.pdf
This method of alpha blending (with a black background; see http://www.stonesc.com/pubs/Contrast%20Metrics.htm for more details) alters the luminance and contrast of the complex images in the video game.,Non-OADS,/arxiv_data1/oa_pdf/00/ec/srep08482.PMC4894407.pdf
"Unreal tournament, 2004. http://www.unrealtournament.com/ utgoty/, Accessed 2 November 2004.",Non-OADS,/arxiv_data1/oa_pdf/00/ec/srep08482.PMC4894407.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/00/ec/srep08482.PMC4894407.pdf
"Global Health Observatory, (2012) (Date accessed: 24/03/2012) http://www.who.int/gho/publications/world_health_statistics/EN_WHS2012_Full.pdf.",Non-OADS,/arxiv_data1/oa_pdf/81/cf/srep07513.PMC4894410.pdf
"Morbidity and Mortality Weekly Report, (2008) (Date accessed: 12/08/2012) http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5745a3.htm.",Non-OADS,/arxiv_data1/oa_pdf/81/cf/srep07513.PMC4894410.pdf
http://www.ncbi.nlm.nih.gov/books/NBK53018/.,Non-OADS,/arxiv_data1/oa_pdf/81/cf/srep07513.PMC4894410.pdf
"(CSHL Press., 1997) (Date accessed: 10/11/2014) http://www.ncbi.nlm.nih.gov/books/ NBK20086/.",Non-OADS,/arxiv_data1/oa_pdf/81/cf/srep07513.PMC4894410.pdf
"Developmental Biology 302, 1–12, doi:http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/81/cf/srep07513.PMC4894410.pdf
Additional information Accession codes Microarray data and methods: Gene Expression Omnibus (GEO) GSE30666 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc 5GSE30666 Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/7f/83/srep07387.PMC4894413.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/de/71/srep06554.PMC4894414.pdf
"Analysis of RNA-seq data .RNA-seq reads mapping and alignment, transcript construction, quantification of transcript abundance, and identification of differential expression were carried out using an in-house analytical pipeline that includedBowtie (http://bowtie-bio.sourceforge.net/index.shtml), Tophat v2.0.9 (http:// tophat.cbcb.umd.edu/), and Cufflinks v2.1.1 (http://cufflinks.cbcb.umd.edu/), as we described previously 14.",OADS,/arxiv_data1/oa_pdf/f6/bc/srep07146.PMC4894415.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f6/bc/srep07146.PMC4894415.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7146 | DOI: 10.1038/srep07146 8",Non-OADS,/arxiv_data1/oa_pdf/f6/bc/srep07146.PMC4894415.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6626 | DOI: 10.1038/srep06626 7",Non-OADS,/arxiv_data1/oa_pdf/27/b3/srep06626.PMC4894416.pdf
http://obrietanlab.org.ohio-state.edu/.www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6930 | DOI: 10.1038/srep06930 5,Non-OADS,/arxiv_data1/oa_pdf/d1/db/srep06930.PMC4894418.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d1/db/srep06930.PMC4894418.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/1c/e4/srep06778.PMC4894419.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.How to cite this article: Spegazzini, N. et al.",Non-OADS,/arxiv_data1/oa_pdf/d0/c6/srep07013.PMC4894421.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 7013 | DOI: 10.1038/srep07013 7",Non-OADS,/arxiv_data1/oa_pdf/d0/c6/srep07013.PMC4894421.pdf
The complete list of exonic preferences (sequence and architecture) for miR-124-3p and the corresponding MREs are available on line at: https://cm.jefferson.edu/tools_and_downloads/clip_2014/output_exonic/mmu_miR_124_3p.output_exonic_bymiR.txt.,OADS,/arxiv_data1/oa_pdf/8d/92/srep05947.PMC4894423.pdf
On-line exploration of the data .The complete data (in both miRNA- centric and genome-centric views) for each analyzed human and mouse miRNA for all 34 datasets are available for interactive exploration on-line at https://cm.jefferson.edu/cl ip_2014/.,OADS,/arxiv_data1/oa_pdf/8d/92/srep05947.PMC4894423.pdf
"For those miRNAs that are not among the 34 analyzedCLIP-seq datasets, we make available version 2.0 of the rna22 method 17 at https://cm.jeffe rson.edu/rna22v2/.",Non-OADS,/arxiv_data1/oa_pdf/8d/92/srep05947.PMC4894423.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/8d/92/srep05947.PMC4894423.pdf
"Cartilage 3, 127–138, doi:http://dx.doi.org/10.1016/S1063- 4584(05)80045-7 (1995).",Non-OADS,/arxiv_data1/oa_pdf/f7/c9/srep05861.PMC4894424.pdf
"18, 225–237, doi:http://dx.doi.org/10.1016/S0945-053X(99)00024-4 (1999).",OADS,/arxiv_data1/oa_pdf/f7/c9/srep05861.PMC4894424.pdf
"41, 1375–1384, doi:http://dx.doi.org/10.1016/0006-2952(91)90111-H (1991).",Non-OADS,/arxiv_data1/oa_pdf/f7/c9/srep05861.PMC4894424.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5861 | DOI: 10.1038/srep05861 7",Non-OADS,/arxiv_data1/oa_pdf/f7/c9/srep05861.PMC4894424.pdf
"To determine the specific pathways on the basis of changes in gene expression, we used the IngenuityPathway Analysis (IPA) (http://www.ingenuity.com) commercial gene pathway analysis web tool.",OADS,/arxiv_data1/oa_pdf/3c/55/srep05577.PMC4894425.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3c/55/srep05577.PMC4894425.pdf
"National Technical Information Service: Trends in travel behavior, http://nhts.ornl.gov/2009/pub/Compendium_ 2013.pdf (2011) Date of Access: 01/07/2013.",Non-OADS,/arxiv_data1/oa_pdf/78/8f/srep05678.PMC4894426.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/78/8f/srep05678.PMC4894426.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5856 | DOI: 10.1038/srep05856 6",Non-OADS,/arxiv_data1/oa_pdf/df/29/srep05856.PMC4894428.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e2/93/srep05447.PMC4894430.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 5447 | DOI: 10.1038/srep05447 9",Non-OADS,/arxiv_data1/oa_pdf/e2/93/srep05447.PMC4894430.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e1/33/srep04145.PMC4894451.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4145 | DOI: 10.1038/srep04145 8",Non-OADS,/arxiv_data1/oa_pdf/e1/33/srep04145.PMC4894451.pdf
"Production and hosting by ElsevierSaudi Journal of Biological Sciences (2016) 23, 300 –310 King Saud University Saudi Journal of Biological Sciences www.ksu.edu.sa www.sciencedirect.com http://dx.doi.org/10.1016/j.sjbs.2015.09.015 1319-562X /C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/5a/d6/main.PMC4894452.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/d6/main.PMC4894452.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/d6/main.PMC4894452.pdf
"World J. http://dx.doi.org/10.1100/2012/859892 .Ali, S.F., Lal, G., Aishwath, O., Chahar, O., Choudhary, S., Mathews, C., Anwar, M., 2012.",Non-OADS,/arxiv_data1/oa_pdf/5a/d6/main.PMC4894452.pdf
3. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5a/d6/main.PMC4894452.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/18/96/srep04721.PMC4894453.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4721 | DOI: 10.1038/srep04721 9",Non-OADS,/arxiv_data1/oa_pdf/18/96/srep04721.PMC4894453.pdf
"A research report for the Association of NorthEast Councils by the Universities of Durham (Institute for LocalGovernance), Northumbria and Teesside and the North East regionof Citizens Advice, 2013. http://www.northeastcouncils.gov.uk/downloaddoc.asp?id=598 (31 September 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/6d/57/fdv031.PMC4894481.pdf
"Joseph Rowntree Foundation, 2014.http://www.jrf.org.uk/sites/ﬁles/jrf/Welfare-reform-impack-FULL.pdf (1 June 2014, date last accessed).5 Marmot Review.",Non-OADS,/arxiv_data1/oa_pdf/6d/57/fdv031.PMC4894481.pdf
"Report of the Inquiry on Health Equity for the North, 2014. http://www.cles.org.uk/wp-content/uploads/ 2014/09/Due-North-Report-of-the-Inquiry-on-Health-Equity-in-the- North-ﬁnal1.pdf (30 September 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/6d/57/fdv031.PMC4894481.pdf
"Department for Work and Pensions, 2014. https://www.gov.uk/government/uploads/system/uploads/attachment_data/ﬁle/329948/rr882-evaluation-of-removal-of-the-spare-room-subsidy.pdf (31 July 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/6d/57/fdv031.PMC4894481.pdf
"2012. http://www.legislation.gov.uk/ukpga/2012/ 5/contents/enacted/data.htm (12 January 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/6d/57/fdv031.PMC4894481.pdf
"Economic report: the labour market in the regions of England, 2014. http://www.tuc.org.uk/sites/default/ﬁles/EconomicReport_RegionalJobs_0.pdf (27 October 2014, date lastaccessed).",Non-OADS,/arxiv_data1/oa_pdf/6d/57/fdv031.PMC4894481.pdf
"Joseph Rowntree Foundation, 2014.http://www.jrf.org.uk/sites/ﬁles/jrf /housing-beneﬁt-size-criteria-FULL.",Non-OADS,/arxiv_data1/oa_pdf/6d/57/fdv031.PMC4894481.pdf
"Shefﬁeld: Shefﬁeld Hallam University, 2010. http://research.shu.ac.uk/cresr/living-through-change/ documents/RP7_SelfEsteem.pdf (7 July 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/6d/57/fdv031.PMC4894481.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/44/fdv093.PMC4894485.pdf
"2012. http://www.romadecade.org/index (22April 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/62/44/fdv093.PMC4894485.pdf
This is an open access article under the CC BY-NC-ND  license  ( http://creativecommons.org/licenses/by-nc-nd/4.0/  ).,Non-OADS,/arxiv_data1/oa_pdf/7e/ee/main.PMC4894747.pdf
"In 2009,  http://dx.doi.org/10.1016/j.jctube.2016.05.003   2405-5794/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/7e/ee/main.PMC4894747.pdf
Published by Elsevier Ltd.  T h i si sa n  open access article under the CC  BY-NC-ND  license ( http://creativecommons.org/licenses/by-nc-nd/4.0/  ).,Non-OADS,/arxiv_data1/oa_pdf/7e/ee/main.PMC4894747.pdf
Boletı ´nF a´rmacos 2013. http://www.saludyfarmacos org/boletin- farmacos/.,Non-OADS,/arxiv_data1/oa_pdf/a2/40/rmemi-27-95.PMC4894761.pdf
http://www.consumer.es/seguridad-alimentaria/sociedad-y- consumo/2003/12/20/10001.php.,Non-OADS,/arxiv_data1/oa_pdf/a2/40/rmemi-27-95.PMC4894761.pdf
http://www.med.uchile.cl/2012/julio/7553-la-preven- cion-es-clave-frente-a-klebsiella-pneumoniae-productora-de- kpc.html.,Non-OADS,/arxiv_data1/oa_pdf/a2/40/rmemi-27-95.PMC4894761.pdf
http://www.fao.org/3/a- a0849e.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a2/40/rmemi-27-95.PMC4894761.pdf
Key Words: clinical trial [publication type] ◼ coronary disease ◼ heart failure ◼ primary prevention ◼ safety Circulation is available at http://circ.ahajournals.org DOI: 10.1161/CIRCULATIONAHA.115.019014Continuing medical education (CME) credit is available for this article.,Non-OADS,/arxiv_data1/oa_pdf/80/bd/cir-133-1073.PMC4894764.pdf
Go to http://cme.ahajournals.org to take the quiz.,Non-OADS,/arxiv_data1/oa_pdf/80/bd/cir-133-1073.PMC4894764.pdf
"), University of Glasgow, UK.The online-only Data Supplement is available with this article at  http://circ.ahajournals.org/lookup/suppl/doi:10.1161/CIRCULATIONAHA.",Non-OADS,/arxiv_data1/oa_pdf/80/bd/cir-133-1073.PMC4894764.pdf
Go to http://cme.ahajournals.org to take the CME quiz for this article.,Non-OADS,/arxiv_data1/oa_pdf/80/bd/cir-133-1073.PMC4894764.pdf
"Detailed public information about eﬃcacy and safety results is given in the AusPAR, which is available at https://www.tga.gov.au/ﬁle/1303/download.",Non-OADS,/arxiv_data1/oa_pdf/23/73/ajp-32-435.PMC4894767.pdf
"The M pluscode is available as Document, Supplemental Digital Content 1, http://links.lww.com/NRES/A148.",Non-OADS,/arxiv_data1/oa_pdf/f3/2a/nnr-64-291.PMC4894769.pdf
"The study was conducted in accordance with the Consortchecklist, Supplemental Digital Content 1, http://links.lww.com/CJP/A151.",Non-OADS,/arxiv_data1/oa_pdf/66/ca/ajp-31-968.PMC4894772.pdf
Statistics A power analysis was performed using a web-based statistical tool (http://www.quantitativeskills.com).,OADS,/arxiv_data1/oa_pdf/66/ca/ajp-31-968.PMC4894772.pdf
"The 244 patients of European ancestry from the ﬁrst 2 studies, and the 887 subset of patients of European ancestry from eitherthe United States or Canada from all 6 studies, were included in stage 1 (sequencing and genotyping) and stage 2 (genotyping only) of genetic analysis, respectively (SeeSupplemental Digital Content Tables 1 and 2, Supple-mental Digital Content 1, http://links.lww.com/CJP/A149).",OADS,/arxiv_data1/oa_pdf/8a/c7/ajp-31-976.PMC4894774.pdf
Controls Population reference sample (POPRES) cohort : geno- typing data generated through the targeted deep sequenc- ing are available through the dbGaP (http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin /study.cgi?study_id = phs000145.,OADS,/arxiv_data1/oa_pdf/8a/c7/ajp-31-976.PMC4894774.pdf
"32PCR primers, LDR primers, and synthetic templates are listed in Supplemental DigitalContent Tables 3, 4, and 5 (Supplemental Digital Content 1, http://links.lww.com/CJP/A149), respectively.",OADS,/arxiv_data1/oa_pdf/8a/c7/ajp-31-976.PMC4894774.pdf
"To increase the case sample size and use controlsbetter matched to cases, we next genotyped additional casesfrom 4 additional clinical studies (NCT00993018, 26 NCT00455520,27NCT01041859, and NCT01063868) and Coriell controls from the United States and Canada (SeeSupplemental Digital Content Table 2, SupplementalDigital Content 1, http://links.lww.com/CJP/A149).",Non-OADS,/arxiv_data1/oa_pdf/8a/c7/ajp-31-976.PMC4894774.pdf
"Slight deviation from the Hardy-Weinberg Equilibrium for p.D1908G in both cases and controls were also observed; however, a visual inspection of the multiplex PCR-LDRassay trace ﬁles (Supplemental Digital Content Figure 1,Supplemental Digital Content 1, http://links.lww.com/CJP/ A149) suggested that the genotyping assay was robust.",Non-OADS,/arxiv_data1/oa_pdf/8a/c7/ajp-31-976.PMC4894774.pdf
"3  Nevertheless, MSCs remain attractive for the treatment of Integrative Physiology Circulation Research is available at http://circres.ahajournals.org DOI: 10.1161/CIRCRESAHA.115.307516Rationale:  The effectiveness of transplanted bone marrow mesenchymal stem cells (MSCs) for cardiac repair has  been limited; thus, strategies for optimizing stem-cell–based myocardial therapy are needed.",Non-OADS,/arxiv_data1/oa_pdf/23/07/res-118-970.PMC4894788.pdf
*These authors contributed equally to this article.The online-only Data Supplement is available with this article at http://circres.ahajournals.org/lookup/suppl/doi:10.1161/CIRCRESAHA.,OADS,/arxiv_data1/oa_pdf/23/07/res-118-970.PMC4894788.pdf
"Arterioscler Thromb Vasc Biol is available at http://atvb.ahajournals.org DOI: 10.1161/ATVBAHA.115.306230Objective —During neovessel formation, angiogenic growth factors associate with the extracellular matrix.",Non-OADS,/arxiv_data1/oa_pdf/6d/dc/atv-35-2161.PMC4894810.pdf
"From the Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/doi:10.1161/ATVBAHA.115.306230/-/DC1.Correspondence to Stefania Mitola, Department of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123 Brescia, Italy.",Non-OADS,/arxiv_data1/oa_pdf/6d/dc/atv-35-2161.PMC4894810.pdf
"Cell paths (40–50 cells per experimental point) were generated from centroid positions, and migration parameters were analyzed with the Chemotaxis and Migration Tool of ImageJ Software (http://rsbweb.nih.gov/ij).",OADS,/arxiv_data1/oa_pdf/6d/dc/atv-35-2161.PMC4894810.pdf
"Cell paths (40–50 cells per experimental point) were generated from centroid positions, and migration parameters were ana-lyzed with the Chemotaxis and Migration Tool of ImageJ Software (http://rsbweb.nih.gov/ij).",OADS,/arxiv_data1/oa_pdf/6d/dc/atv-35-2161.PMC4894810.pdf
"Cell paths (40–50 cells per experimental point) were generated from centroid positions, and migration parameters were analyzed with the Chemotaxis and Migration Tool of ImageJ Software (http://rsbweb.nih.gov/ij).",OADS,/arxiv_data1/oa_pdf/6d/dc/atv-35-2161.PMC4894810.pdf
"MATLAB Toolbox was used to generate images of place cell ﬁring for use inﬁgures (http://fmatoolbox.sourceforge.net/index.html; MATLAB R12, Mathworks, Natick, MA, USA).",OADS,/arxiv_data1/oa_pdf/86/c0/41537_2015_Article_BFnpjschz201511.PMC4894816.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies the paper on the npj Schizophrenia website (http://www.nature.com/npjschz)Spatial coding defect in schizophrenia mouse model L Mesbah-Oskui et al 7 © 2015 Schizophrenia International Research Group/Nature Publishing Group npj Schizophrenia (2015) 15011",Non-OADS,/arxiv_data1/oa_pdf/86/c0/41537_2015_Article_BFnpjschz201511.PMC4894816.pdf
"[http://dx.doi.org/10.1111/j.1467-954X.2008.00790.x] [2] Kato TA, Shinfuku N, Sartorius N, Kanba S. Are Japan’s hikikomori  and depression in young people spreading abroad?",Non-OADS,/arxiv_data1/oa_pdf/aa/e1/CPEMH-12-38.PMC4894832.pdf
"[http://dx.doi.org/10.1016/S0140-6736(11)61475-X] [PMID: 21924990] [3] Koyama A, Miyake Y, Kawakami N, Tsuchiya M, Tachimori H, Takeshima T. Lifetime prevalence, psychiatric comorbidity and demographic correlates of “hikikomori” in a community population in Japan.",Non-OADS,/arxiv_data1/oa_pdf/aa/e1/CPEMH-12-38.PMC4894832.pdf
"[http://dx.doi.org/10.1016/j.psychres.2008.10.019] [PMID: 20074814] [4] Cooney G, Dwan K, Mead G. Exercise for depression.",OADS,/arxiv_data1/oa_pdf/aa/e1/CPEMH-12-38.PMC4894832.pdf
"[http://dx.doi.org/10.1001/jama.2014.4930] [PMID: 24938566] [5] Trivedi MH, Greer TL, Church TS, et al.",OADS,/arxiv_data1/oa_pdf/aa/e1/CPEMH-12-38.PMC4894832.pdf
"[http://dx.doi.org/10.4088/JCP.10m06743] [PMID: 21658349] [6] Enomoto M, Endo T, Suenaga K, et al.",OADS,/arxiv_data1/oa_pdf/aa/e1/CPEMH-12-38.PMC4894832.pdf
"[http://dx.doi.org/10.1111/j.1479-8425.2008.00377.x] [7] Maki A, Yamashita Y, Ito Y, Watanabe E, Mayanagi Y, Koizumi H. Spatial and temporal analysis of human motor activity using noninvasive NIR topography.",OADS,/arxiv_data1/oa_pdf/aa/e1/CPEMH-12-38.PMC4894832.pdf
"[http://dx.doi.org/10.1118/1.597496] [PMID: 8746704] [8] Schaffner KF, McGorry PD.",OADS,/arxiv_data1/oa_pdf/aa/e1/CPEMH-12-38.PMC4894832.pdf
"[http://dx.doi.org/10.1016/S0920-9964(01)00234-1] [PMID: 11479061] [9] Helmich I, Latini A, Sigwalt A, et al.",OADS,/arxiv_data1/oa_pdf/aa/e1/CPEMH-12-38.PMC4894832.pdf
"[http://dx.doi.org/10.2174/1745017901006010115] [PMID: 21283646] [10] Takizawa R, Fukuda M, Kawasaki S, et al.",OADS,/arxiv_data1/oa_pdf/aa/e1/CPEMH-12-38.PMC4894832.pdf
"[http://dx.doi.org/10.1016/j.neuroimage.2013.05.126] [PMID: 23764293] [11] Noda T, Yoshida  S, Matsuda T, et al.",OADS,/arxiv_data1/oa_pdf/aa/e1/CPEMH-12-38.PMC4894832.pdf
"[http://dx.doi.org/10.1016/j.jpsychires.2012.04.001] [PMID: 22572569] [12] Watanabe A, Kato T. Cerebrovascular response to cognitive tasks in patients with schizophrenia measured by near infrared spectroscopy.",OADS,/arxiv_data1/oa_pdf/aa/e1/CPEMH-12-38.PMC4894832.pdf
[http://dx.doi.org/10.1111/acps.12095] [PMID: 23488807] © Nishida et al.,OADS,/arxiv_data1/oa_pdf/aa/e1/CPEMH-12-38.PMC4894832.pdf
"This is an open access articles licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/e1/CPEMH-12-38.PMC4894832.pdf
[http://dx.doi.org/10.1016/S0140-6736(13)61611-6 ] [PMID: 23993280 ] [2] Ghaemi SN.,OADS,/arxiv_data1/oa_pdf/14/c2/CPEMH-12-14.PMC4894833.pdf
"[http://dx.doi.org/10.1093/schbul/sbl061 ] [PMID: 17122410 ] [3] Cassano GB, Akiskal HS, Savino M, Soriani A, Musetti L, Perugi G. Single episode of major depressive disorder.",Non-OADS,/arxiv_data1/oa_pdf/14/c2/CPEMH-12-14.PMC4894833.pdf
"[http://dx.doi.org/10.1007/BF02190251 ] [PMID: 8323988 ] [4] Angst J, Merikangas K. The depressive spectrum: diagnostic classification and course.",Non-OADS,/arxiv_data1/oa_pdf/14/c2/CPEMH-12-14.PMC4894833.pdf
"[http://dx.doi.org/10.1016/S0165-0327(97)00057-8 ] [PMID: 9268773 ] [5] Cassano GB, Akiskal HS, Savino M, Musetti L, Perugi G. Proposed subtypes of bipolar II and related disorders: with hypomanic episodes (or cyclothymia) and with hyperthymic temperament.",Non-OADS,/arxiv_data1/oa_pdf/14/c2/CPEMH-12-14.PMC4894833.pdf
"[http://dx.doi.org/10.1016/0165-0327(92)90044-7 ] [PMID: 1447430 ] [6] Cassano GB, Rucci P, Frank E, et al.",OADS,/arxiv_data1/oa_pdf/14/c2/CPEMH-12-14.PMC4894833.pdf
"[http://dx.doi.org/10.1176/appi.ajp.161.7.1264 ] [PMID: 15229060 ] [7] Akiskal HS, Pinto O.",Non-OADS,/arxiv_data1/oa_pdf/14/c2/CPEMH-12-14.PMC4894833.pdf
"[http://dx.doi.org/10.1016/S0193-953X(05)70093-9 ] [PMID: 10550853 ] [8] Mitchell PB, Goodwin GM, Johnson GF, Hirschfeld RM.",OADS,/arxiv_data1/oa_pdf/14/c2/CPEMH-12-14.PMC4894833.pdf
"[http://dx.doi.org/10.1111/j.1399-5618.2007.00559.x ] [PMID: 18199233 ] [9] Cassano GB, Frank E, Miniati M, et al.",OADS,/arxiv_data1/oa_pdf/14/c2/CPEMH-12-14.PMC4894833.pdf
[http://dx.doi.org/10.1016/S0193-953X(02)00025-4 ] [PMID: 12462856 ] [10] American Psychiatric Association DSM-5 Task Force Diagnostic and statistical manual of mental disorders: DSM-5.,Non-OADS,/arxiv_data1/oa_pdf/14/c2/CPEMH-12-14.PMC4894833.pdf
[http://dx.doi.org/10.1186/2194-7511-1-12 ] [PMID: 25505679 ] [12] Paris J.,Non-OADS,/arxiv_data1/oa_pdf/14/c2/CPEMH-12-14.PMC4894833.pdf
"[http://dx.doi.org/10.1007/s11920-014-0461-0 ] [PMID: 24930522 ] [13] Rucci P, Maser JD.",Non-OADS,/arxiv_data1/oa_pdf/14/c2/CPEMH-12-14.PMC4894833.pdf
"[http://dx.doi.org/10.1017/S1121189X00008381 ] [PMID: 11256057 ] [14] Dell’Osso L, Armani A, Rucci P, et al.",Non-OADS,/arxiv_data1/oa_pdf/14/c2/CPEMH-12-14.PMC4894833.pdf
"[http://dx.doi.org/10.1053/comp.2002.29852 ] [PMID: 11788923 ] [15] Cassano  GB,  Dell’Osso  L,  Frank  E,  et  al.",OADS,/arxiv_data1/oa_pdf/14/c2/CPEMH-12-14.PMC4894833.pdf
"[http://dx.doi.org/10.1016/S0165-0327(98)00158-X ] [PMID: 10467978 ] [16] Berrocal C, Ruiz Moreno M, Merchán P, Mansukhani A, Rucci P, Cassano GB.",OADS,/arxiv_data1/oa_pdf/14/c2/CPEMH-12-14.PMC4894833.pdf
"[http://dx.doi.org/10.1002/da.20169 ] [PMID: 16550540 ] [17] Miniati M, Rucci P, Frank E, et al.",OADS,/arxiv_data1/oa_pdf/14/c2/CPEMH-12-14.PMC4894833.pdf
[http://dx.doi.org/10.1159/000201937 ] [PMID: 19218830 ] [18] American Psychiatric Association Task Force on DSM-IV Diagnostic and statistical manual of mental disorders: DSM-IV-TR.,Non-OADS,/arxiv_data1/oa_pdf/14/c2/CPEMH-12-14.PMC4894833.pdf
"[http://dx.doi.org/10.1192/bjp.134.4.382 ] [PMID: 444788 ] [20] Young RC, Biggs JT, Ziegler VE, Meyer DA.",OADS,/arxiv_data1/oa_pdf/14/c2/CPEMH-12-14.PMC4894833.pdf
"[http://dx.doi.org/10.1192/bjp.133.5.429 ] [PMID: 728692 ] [21] Goldberg DP, Blackwell B.",Non-OADS,/arxiv_data1/oa_pdf/14/c2/CPEMH-12-14.PMC4894833.pdf
[http://dx.doi.org/10.1016/j.jad.2015.08.045 ] [PMID: 26342172 ] [23] Goldberg DW.,OADS,/arxiv_data1/oa_pdf/14/c2/CPEMH-12-14.PMC4894833.pdf
"[http://dx.doi.org/10.1016/j.jad.2014.04.064 ] [PMID: 25012426 ] [27] Benvenuti A, Miniati M, Callari A, Giorgi Mariani M, Mauri M, Dell’Osso L. Mood Spectrum Model: Evidence reconsidered in the light of DSM-5.",Non-OADS,/arxiv_data1/oa_pdf/14/c2/CPEMH-12-14.PMC4894833.pdf
"[http://dx.doi.org/10.1097/YIC.0b013e328333ee8e ] [PMID: 20061961 ] [29] Rucci  P,  Frank  E,  Calugi  S,  et  al.",OADS,/arxiv_data1/oa_pdf/14/c2/CPEMH-12-14.PMC4894833.pdf
"[http://dx.doi.org/10.1002/da.20894 ] [PMID: 21898715 ] [30] Carmassi C, Gesi C, Corsi M, et al.",OADS,/arxiv_data1/oa_pdf/14/c2/CPEMH-12-14.PMC4894833.pdf
"[http://dx.doi.org/10.1016/j.comppsych.2014.11.012 ] [PMID: 25595519 ] [31] Dell’osso L, Stratta P, Conversano C, et al.",OADS,/arxiv_data1/oa_pdf/14/c2/CPEMH-12-14.PMC4894833.pdf
"Psychometric Properties of Mood Spectrum Self-Report Questionnaire Clinical Practice & Epidemiology in Mental Health, 2016, Volume 12    23 [http://dx.doi.org/10.1016/j.comppsych.2013.08.017 ] [PMID: 24269194 ] [32] Cassano  GB,  Rucci  P,  Benvenuti  A,  et  al.",Non-OADS,/arxiv_data1/oa_pdf/14/c2/CPEMH-12-14.PMC4894833.pdf
"[http://dx.doi.org/10.4088/JCP.11m06946 ] [PMID: 22316575 ] [33] Rucci PC, Miniati M, Fagiolini A.",Non-OADS,/arxiv_data1/oa_pdf/14/c2/CPEMH-12-14.PMC4894833.pdf
"This is an open access articles licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC  4.0)  ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ),  which  permits  unrestricted,  non-commercial  use,  distribution  and reproduction  in  any  medium,  provided  that  the  work  is  properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/14/c2/CPEMH-12-14.PMC4894833.pdf
"[http://dx.doi.org/10.1006/frne.2001.0216 ] [PMID: 11456468 ] [5] Rueda Alfaro S, Serra-Prat M, Palomera E, et al.",OADS,/arxiv_data1/oa_pdf/b6/ee/CPEMH-12-24.PMC4894834.pdf
"[http://dx.doi.org/10.1016/S1575-0922(08)75076-9 ] [PMID: 22974452 ] [6] Peixoto  C,  Devicari  Cheda  JN,  Nardi  AE,  Veras  AB,  Cardoso  A.",OADS,/arxiv_data1/oa_pdf/b6/ee/CPEMH-12-24.PMC4894834.pdf
"[http://dx.doi.org/10.2174/1389450115666140717111116 ] [PMID: 25039497 ] [7] Lennartsson AK, Theorell T, Kushnir MM, Jonsdottir IH.",OADS,/arxiv_data1/oa_pdf/b6/ee/CPEMH-12-24.PMC4894834.pdf
"[http://dx.doi.org/10.1371/journal.pone.0140054 ] [PMID: 26441131 ] [8] Ghisleni C, Bollmann S, Biason-Lauber A, et al.",OADS,/arxiv_data1/oa_pdf/b6/ee/CPEMH-12-24.PMC4894834.pdf
"[http://dx.doi.org/10.1371/journal.pone.0135827 ] [PMID: 26356576 ] [9] Haren MT, Banks WA, Perry Iii HM, et al.",OADS,/arxiv_data1/oa_pdf/b6/ee/CPEMH-12-24.PMC4894834.pdf
"[http://dx.doi.org/10.1001/archinte.160.14.2193 ] [PMID: 10904463 ] [11] Yaffe K, Ettinger B, Pressman A, et al.",OADS,/arxiv_data1/oa_pdf/b6/ee/CPEMH-12-24.PMC4894834.pdf
"[http://dx.doi.org/10.1016/S0006-3223(97)00303-X ] [PMID: 9583004 ] [12] Fonda SJ, Bertrand R, O’Donnell A, Longcope C, McKinlay JB.",OADS,/arxiv_data1/oa_pdf/b6/ee/CPEMH-12-24.PMC4894834.pdf
"[http://dx.doi.org/10.1093/gerona/60.3.385 ] [PMID: 15860479 ] [13] Castanho TC, Moreira PS, Portugal-Nunes C, et al.",OADS,/arxiv_data1/oa_pdf/b6/ee/CPEMH-12-24.PMC4894834.pdf
"[http://dx.doi.org/10.1016/j.jsbmb.2014.03.014 ] [PMID: 24794824 ] [15] Guyton AC, Hall JE.",OADS,/arxiv_data1/oa_pdf/b6/ee/CPEMH-12-24.PMC4894834.pdf
"[http://dx.doi.org/10.3109/13697137.2010.492496 ] [PMID: 20540592 ] [17] Pittenger C, Duman RS.",OADS,/arxiv_data1/oa_pdf/b6/ee/CPEMH-12-24.PMC4894834.pdf
"[http://dx.doi.org/10.1038/sj.npp.1301574 ] [PMID: 17851537 ] [18] Maninger  N,  Wolkowitz  OM,  Reus  VI,  Epel  ES,  Mellon  SH.",Non-OADS,/arxiv_data1/oa_pdf/b6/ee/CPEMH-12-24.PMC4894834.pdf
"[http://dx.doi.org/10.1016/j.yfrne.2008.11.002 ] [PMID: 19063914 ] [19] Charalampopoulos I, Remboutsika E, Margioris AN, Gravanis A. Neurosteroids as modulators of neurogenesis and neuronal survival.",Non-OADS,/arxiv_data1/oa_pdf/b6/ee/CPEMH-12-24.PMC4894834.pdf
"[http://dx.doi.org/10.1016/j.tem.2008.07.004 ] [PMID: 18771935 ] [20] Moser U, Wadsak W, Spindelegger C, et al.",OADS,/arxiv_data1/oa_pdf/b6/ee/CPEMH-12-24.PMC4894834.pdf
"[http://dx.doi.org/10.1016/j.neulet.2010.04.020 ] [PMID: 20399839 ] [21] Lezak MD, Howieson DB, Loring DW.",OADS,/arxiv_data1/oa_pdf/b6/ee/CPEMH-12-24.PMC4894834.pdf
"[http://dx.doi.org/10.1371/journal.pmed.1000097 ] [PMID: 19621072 ] [26] Antunes HK, Santos RF, Cassilhas R, et al.",Non-OADS,/arxiv_data1/oa_pdf/b6/ee/CPEMH-12-24.PMC4894834.pdf
"[http://dx.doi.org/10.1590/S1517-86922006000200011 ] [27] Glei DA, Goldman N, Weinstein M, Liu IW.",Non-OADS,/arxiv_data1/oa_pdf/b6/ee/CPEMH-12-24.PMC4894834.pdf
"[http://dx.doi.org/10.1016/j.exger.2003.11.003 ] [PMID: 15036391 ] [28] Goldman N, Glei DA.",OADS,/arxiv_data1/oa_pdf/b6/ee/CPEMH-12-24.PMC4894834.pdf
"[http://dx.doi.org/10.1016/j.exger.2007.05.005 ] [PMID: 17604586 ] [29] Fukai S, Akishita M, Yamada S, et al.",OADS,/arxiv_data1/oa_pdf/b6/ee/CPEMH-12-24.PMC4894834.pdf
"[http://dx.doi.org/10.1111/j.1447-0594.2009.00534.x ] [PMID: 19702939 ] [30] Carlson LE, Sherwin BB.",OADS,/arxiv_data1/oa_pdf/b6/ee/CPEMH-12-24.PMC4894834.pdf
